
<html lang="en"     class="pb-page"  data-request-id="7244347c-afd6-40c6-a299-333137fe1a2a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm401895u;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2014.57.issue-11"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Novel Arylsulfonamide Derivatives with 5-HT6/5-HT7 Receptor Antagonism Targeting Behavioral and Psychological Symptoms of Dementia" /></meta><meta name="dc.Creator" content="Marcin  Kołaczkowski" /></meta><meta name="dc.Creator" content="Monika  Marcinkowska" /></meta><meta name="dc.Creator" content="Adam  Bucki" /></meta><meta name="dc.Creator" content="Maciej  Pawłowski" /></meta><meta name="dc.Creator" content="Katarzyna  Mitka" /></meta><meta name="dc.Creator" content="Jolanta  Jaśkowska" /></meta><meta name="dc.Creator" content="Piotr  Kowalski" /></meta><meta name="dc.Creator" content="Grzegorz  Kazek" /></meta><meta name="dc.Creator" content="Agata  Siwek" /></meta><meta name="dc.Creator" content="Anna  Wasik" /></meta><meta name="dc.Creator" content="Anna  Wesołowska" /></meta><meta name="dc.Creator" content="Paweł  Mierzejewski" /></meta><meta name="dc.Creator" content="Przemyslaw  Bienkowski" /></meta><meta name="dc.Description" content="In order to target behavioral and psychological symptoms of dementia (BPSD), we used molecular modeling-assisted design to obtain novel multifunctional arylsulfonamide derivatives that potently ant..." /></meta><meta name="Description" content="In order to target behavioral and psychological symptoms of dementia (BPSD), we used molecular modeling-assisted design to obtain novel multifunctional arylsulfonamide derivatives that potently ant..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 23, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401895u" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401895u" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401895u" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401895u" /></link>
        
    
    

<title>Novel Arylsulfonamide Derivatives with 5-HT6/5-HT7 Receptor Antagonism Targeting Behavioral and Psychological Symptoms of Dementia | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401895u" /></meta><meta property="og:title" content="Novel Arylsulfonamide Derivatives with 5-HT6/5-HT7 Receptor Antagonism Targeting Behavioral and Psychological Symptoms of Dementia" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/large/jm-2013-01895u_0007.jpeg" /></meta><meta property="og:description" content="In order to target behavioral and psychological symptoms of dementia (BPSD), we used molecular modeling-assisted design to obtain novel multifunctional arylsulfonamide derivatives that potently antagonize 5-HT6/7/2A and D2 receptors, without interacting with M1 receptors and hERG channels. In vitro studies confirmed their antagonism of 5-HT7/2A and D2 receptors and weak interactions with key antitargets (M1R and hERG) associated with side effects. Marked 5-HT6 receptor affinities were also observed, notably for 6-fluoro-3-(piperidin-4-yl)-1,2-benzoxazole derivatives connected by a 3–4 unit alkyl linker with mono- or bicyclic, lipophilic arylsulfonamide moieties. N-[4-[4-(6-Fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]butyl]benzothiophene-2-sulfonamide (72) was characterized in vitro on 14 targets and antitargets. It displayed dual blockade of 5-HT6 and D2 receptors and negligible interactions at hERG and M1 receptors. Unlike reference antipsychotics, 72 displayed marked antipsychotic and antidepressant activity in rats after oral administration, in the absence of cognitive or motor impairment. This profile is particularly attractive when targeting a fragile, elderly BPSD patient population." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401895u"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401895u">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401895u&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401895u&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401895u&amp;href=/doi/10.1021/jm401895u" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 4543-4557</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm500458c" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm500270w" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Arylsulfonamide Derivatives with 5-HT<sub>6</sub>/5-HT<sub>7</sub> Receptor Antagonism Targeting Behavioral and Psychological Symptoms of Dementia</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marcin++Ko%C5%82aczkowski">Marcin Kołaczkowski</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Monika++Marcinkowska">Monika Marcinkowska</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adam++Bucki">Adam Bucki</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maciej++Paw%C5%82owski">Maciej Pawłowski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katarzyna++Mitka">Katarzyna Mitka</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jolanta++Ja%C5%9Bkowska">Jolanta Jaśkowska</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Piotr++Kowalski">Piotr Kowalski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Grzegorz++Kazek">Grzegorz Kazek</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Agata++Siwek">Agata Siwek</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna++Wasik">Anna Wasik</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna++Weso%C5%82owska">Anna Wesołowska</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pawe%C5%82++Mierzejewski">Paweł Mierzejewski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Przemyslaw++Bienkowski">Przemyslaw Bienkowski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Adamed Ltd., Pieńków 149, 05-152 Czosnów, Poland</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Faculty of Pharmacy, Jagiellonian University Collegium Medicum, 9 Medyczna Street, 30-688 Cracow, Poland</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Cracow University of Technology, 24 Warszawska Street, 31-155 Cracow, Poland</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Institute of Psychiatry and Neurology, 9 Sobieskiego Street, 02-957 Warsaw, Poland</span></div><div class="corresp-info"><strong>*</strong>Phone: 48-697064058. Fax: 48-126205458. E-mail: <a href="/cdn-cgi/l/email-protection#f69b9784959f98d89d999a97958c9d9981859d9fb69792979b9392d895999bd8869a"><span class="__cf_email__" data-cfemail="15787467767c7b3b7e7a7974766f7e7a62667e7c557471747870713b767a783b6579">[email protected]</span></a>; <a href="/cdn-cgi/l/email-protection#f39e9281909a9ddd989c9f929089989c8480989ab38699dd969786dd839f"><span class="__cf_email__" data-cfemail="670a0615040e09490c080b06041d0c0810140c0e27120d4902031249170b">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401895u&amp;href=/doi/10.1021%2Fjm401895u" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 4543–4557</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 7, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 December 2013</li><li><span class="item_label"><b>Published</b> online</span>23 May 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 June 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401895u" title="DOI URL">https://doi.org/10.1021/jm401895u</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4543%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMarcin%2BKo%25C5%2582aczkowski%252C%2BMonika%2BMarcinkowska%252C%2BAdam%2BBucki%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D11%26contentID%3Djm401895u%26title%3DNovel%2BArylsulfonamide%2BDerivatives%2Bwith%2B5-HT6%252F5-HT7%2BReceptor%2BAntagonism%2BTargeting%2BBehavioral%2Band%2BPsychological%2BSymptoms%2Bof%2BDementia%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4557%26publicationDate%3DJune%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401895u"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1952</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">42</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401895u" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Arylsulfonamide Derivatives with 5-HT6/5-HT7 Receptor Antagonism Targeting Behavioral and Psychological Symptoms of Dementia&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Marcin&quot;,&quot;last_name&quot;:&quot;Kołaczkowski&quot;},{&quot;first_name&quot;:&quot;Monika&quot;,&quot;last_name&quot;:&quot;Marcinkowska&quot;},{&quot;first_name&quot;:&quot;Adam&quot;,&quot;last_name&quot;:&quot;Bucki&quot;},{&quot;first_name&quot;:&quot;Maciej&quot;,&quot;last_name&quot;:&quot;Pawłowski&quot;},{&quot;first_name&quot;:&quot;Katarzyna&quot;,&quot;last_name&quot;:&quot;Mitka&quot;},{&quot;first_name&quot;:&quot;Jolanta&quot;,&quot;last_name&quot;:&quot;Jaśkowska&quot;},{&quot;first_name&quot;:&quot;Piotr&quot;,&quot;last_name&quot;:&quot;Kowalski&quot;},{&quot;first_name&quot;:&quot;Grzegorz&quot;,&quot;last_name&quot;:&quot;Kazek&quot;},{&quot;first_name&quot;:&quot;Agata&quot;,&quot;last_name&quot;:&quot;Siwek&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Wasik&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Wesołowska&quot;},{&quot;first_name&quot;:&quot;Paweł&quot;,&quot;last_name&quot;:&quot;Mierzejewski&quot;},{&quot;first_name&quot;:&quot;Przemyslaw&quot;,&quot;last_name&quot;:&quot;Bienkowski&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;4543-4557&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401895u&quot;},&quot;abstract&quot;:&quot;In order to target behavioral and psychological symptoms of dementia (BPSD), we used molecular modeling-assisted design to obtain novel multifunctional arylsulfonamide derivatives that potently antagonize 5-HT6/7/2A and D2 receptors, without interacting with M1 receptors and hERG channels. In vitro studies confirmed their antagonism of 5-HT7/2A and D2 receptors and weak interactions with key antitargets (M1R and hERG) associated with side effects. Marked 5-HT6 receptor affinities were also observed, notably for 6-fluoro-3-(piperidin-4-yl)-1,2-benzoxazole derivatives connected by a 3–4 unit alkyl linker with mono- or bicyclic, lipophilic arylsulfonamide moieties. N-[4-[4-(6-Fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]butyl]benzothiophene-2-sulfonamide (72) was characterized in vitro on 14 targets and antitargets. It displayed dual blockade of 5-HT6 and D2 receptors and negligible interactions at hERG and M1 receptors. Unlike reference antipsychotics, 72 displayed marked antipsychotic and antidepressant activity &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401895u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401895u" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401895u&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401895u" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401895u&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401895u" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401895u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401895u&amp;href=/doi/10.1021/jm401895u" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401895u" /></input><a href="/doi/pdf/10.1021/jm401895u" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (9 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401895u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401895u%26sid%3Dliteratum%253Aachs%26pmid%3D24805037%26genre%3Darticle%26aulast%3DKo%25C5%2582aczkowski%26date%3D2014%26atitle%3DNovel%2BArylsulfonamide%2BDerivatives%2Bwith%2B5-HT6%252F5-HT7%2BReceptor%2BAntagonism%2BTargeting%2BBehavioral%2Band%2BPsychological%2BSymptoms%2Bof%2BDementia%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D11%26spage%3D4543%26epage%3D4557%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292461" title="Neurophysiology">Neurophysiology</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jmcmar.2014.57.issue-11/production/jmcmar.2014.57.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/medium/jm-2013-01895u_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/large/jm-2013-01895u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401895u&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In order to target behavioral and psychological symptoms of dementia (BPSD), we used molecular modeling-assisted design to obtain novel multifunctional arylsulfonamide derivatives that potently antagonize 5-HT<sub>6/7/2A</sub> and D<sub>2</sub> receptors, without interacting with M<sub>1</sub> receptors and hERG channels. <i>In vitro</i> studies confirmed their antagonism of 5-HT<sub>7/2A</sub> and D<sub>2</sub> receptors and weak interactions with key antitargets (M<sub>1</sub>R and hERG) associated with side effects. Marked 5-HT<sub>6</sub> receptor affinities were also observed, notably for 6-fluoro-3-(piperidin-4-yl)-1,2-benzoxazole derivatives connected by a 3–4 unit alkyl linker with mono- or bicyclic, lipophilic arylsulfonamide moieties. <i>N</i>-[4-[4-(6-Fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]butyl]benzothiophene-2-sulfonamide (<b>72</b>) was characterized <i>in vitro</i> on 14 targets and antitargets. It displayed dual blockade of 5-HT<sub>6</sub> and D<sub>2</sub> receptors and negligible interactions at hERG and M<sub>1</sub> receptors. Unlike reference antipsychotics, <b>72</b> displayed marked antipsychotic and antidepressant activity in rats after oral administration, in the absence of cognitive or motor impairment. This profile is particularly attractive when targeting a fragile, elderly BPSD patient population.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54664" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54664" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Over 50% of patients with Alzheimer’s disease (AD) or with other dementias experience psychotic symptoms,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and, together with other behavioral and psychological symptoms, their treatment constitutes a substantial unmet medical need. Indeed, effective pharmacological treatment of psychosis in elderly patients with cognitive deficits can be particularly intractable because psychotropic medications used in patients with dementia may themselves be a cause of further cognitive impairment.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Moreover, the use of currently available antipsychotics in elderly patients with dementia has also been associated with other side effects, including motor, metabolic, or cardiac disturbances and, consequently, increased mortality.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Despite “boxed warnings” issued by the Food and Drug Administration (FDA) for antipsychotics and their lack of approval for treatment of Behavioral and Psychological Symptoms of Dementia (BPSD),<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> such drugs have been commonly used off-label.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> This is probably due to the fact that psychosis and physical aggression by dementia patients (rather than their cognitive impairment) are a major challenge for caregivers and are the most common cause of patient institutionalization.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Therefore, the discovery of novel antipsychotic drugs with an improved safety profile and that do not induce cognitive deficits would permit improved treatment of BPSD.</div><div class="NLM_p">At a pharmacological level, converging lines of evidence indicate that blockade of serotonin 5-HT<sub>6</sub> receptors (5-HT<sub>6</sub>Rs) may be implicated in pro-cognitive effects due to the facilitation of cholinergic transmission,<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> in antidepressant activity due to the increase in noradrenergic and dopaminergic tones, as well as in an anxiolytic effect, mediated by interaction with GABA-ergic transmission.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> These findings are further supported by the exclusive localization of 5-HT<sub>6</sub> receptors in the central nervous system (CNS), especially in limbic and cortical brain areas involved in the control of mood and cognition.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Recently, the selective 5-HT<sub>6</sub>R antagonists 3-phenylsulfonyl-8-(piperazin-1-yl)quinoline (SB-742457) and [2-(6-fluoro-1<i>H</i>-indol-3-yl)-ethyl]-[3-(2,2,3,3-tetrafluoropropoxy)-benzyl]-amine (Lu AE58054) showed pro-cognitive effects in phase II clinical trials with AD patients,<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> confirming the therapeutic potential and relevance of 5-HT<sub>6</sub>R antagonists for dementia patients.</div><div class="NLM_p">Another serotonin receptor subtype, 5-HT<sub>7</sub>, may play a role in the control of circadian rhythms, sleep, thermoregulation, pain, and migraine, as well as cognitive processes. Indeed, the high affinity and antagonistic activity of several antipsychotic and antidepressant drugs at 5-HT<sub>7</sub> receptors suggest a potential role of these receptors in the pathophysiology of many neuropsychiatric disorders. Accordingly, selective 5-HT<sub>7</sub> receptor antagonists produce antidepressant and anxiolytic activity in rats and mice.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Moreover, Galici et al. and Waters et al. showed that a selective 5-HT<sub>7</sub> receptor antagonist (2<i>R</i>)-1-[(3-hydroxyphenyl)sulfonyl]-2-(2-(4-methyl-1-piperidinyl)ethyl)pyrrolidine may also evoke antipsychotic-like effects.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a></div><div class="NLM_p">The above considerations suggest that targeting 5-HT<sub>6</sub> and/or 5-HT<sub>7</sub> receptors with antagonist drugs could constitute a promising strategy for treating symptoms of BPSD while avoiding some of the side effects of current antipsychotic drugs. Nevertheless, due to the complex pathology of dementia and accompanying behavioral and psychological symptoms, it seems unlikely that focusing on a single therapeutic target would be sufficient to provide adequate clinical benefit, and it is likely that successful development of novel anti-BPSD agents should involve a “designed” multifactorial approach.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> Indeed, although some of the currently available antipsychotics block 5-HT<sub>6</sub> or 5-HT<sub>7</sub> receptors, they also interact with many other targets, including those that may elicit some side effects and/or limit (mask) their therapeutic efficacy. For example, these drugs also bind potently to muscarinic and histamine receptors, which are associated with cholinergic interference and sedation, respectively. In addition, they act as potent 5-HT<sub>2C</sub> receptor antagonists, a property which is a risk factor for metabolic dysfunction.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> Some authors proposed that an improved antipsychotic profile may be achieved by combining 5-HT<sub>6</sub> antagonism with an absence of antimuscarinic activity, as is observed for sertindole, but not clozapine or olanzapine.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> However, clinical evaluation of sertindole was hampered by its arrhythmogenic potential, caused by potent hERG channel inhibition.</div><div class="NLM_p last">On the basis of the above considerations, we designed a series of novel arylsulfonamide derivatives displaying high affinity for serotonin 5-HT<sub>6</sub>, 5-HT<sub>7</sub>, and 5-HT<sub>2A</sub> receptor subtypes, as well as dopamine D<sub>2</sub> receptors, and devoid of significant interaction with muscarinic receptors or hERG channels.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The present study describes computer-aided design and the synthesis, as well as the <i>in vitro</i> receptor profile of this new series of multimodal molecules. Moreover, the extensive pharmacological characterization of one of the most promising compounds, compound <b>72</b>, is presented and discussed in relation to comparative data for 8 currently used reference antipsychotics.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16035" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16035" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Design of Multifunctional Ligands</h3><div class="NLM_p">In the course of our research into the structure of monoaminergic G protein-coupled receptors (GPCRs), we proposed a model of the binding mode of selective 5-HT<sub>7</sub> receptor (5-HT<sub>7</sub>R) antagonists.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> On the basis of molecular modeling studies, we concluded that the most selective 5-HT<sub>7</sub> antagonists bind preferentially in the cavity between transmembrane helices (TMHs) 7–3 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A). We also hypothesized that 5-HT<sub>7</sub>R ligands capable of forming strong interactions with this site may not be dependent on interactions with the cavity between TMHs 4–6, which is much more structurally conserved between monoaminergic GPCRs. Therefore, such ligands are likely to be more selective than those requiring specific interactions with the more conserved cavity between TMHs 4–6. Considering the fact that our goal was to design multifunctional ligands acting on 5-HT<sub>7</sub>R, we found that the N-aminoalkylarylsulfonamide fragment is a suitable basis for structural modifications. Indeed, it provides strong 5-HT<sub>7</sub>R antagonism by anchoring between TMHs 7–3 (particularly Phe3.28 and Arg7.36) and allows for the introduction of additional moieties providing activity at other targets, such as the dopamine D<sub>2</sub> receptor (D<sub>2</sub>R), serotonin 5-HT<sub>2A</sub> receptor (5-HT<sub>2A</sub>R), or serotonin transporter (SERT) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> In the present study, we focused on the moieties that block D<sub>2</sub> and 5-HT<sub>2A</sub> receptors and exert potential antipsychotic-like activity. In view of this objective, we searched for commercially available fragments that could provide antagonism of D<sub>2</sub> and 5-HT<sub>2A</sub> receptors and would be synthetically suitable for combination with the arylsulfonamide moiety by an alkyl linker. To this end, we analyzed structures of the D<sub>2</sub>/5-HT<sub>2A</sub> ligands available in the ChEMBL database (<i>K</i><sub>i</sub> < 10 nM for both receptors) and identified the arylamine moieties that could bind in the cavity between TMHs 4–6, which had been identified as a tolerant region for chemical expansion. Benzazolepiperazine/piperidine moieties were found to meet the above-mentioned criteria, and their drug-likeness was further supported by the fact that they could be found in some clinically used drugs.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> As a next step, a prototype hybrid molecule (compound <b>2</b>) was designed by combining the 3-methyl-<i>N</i>-propylbenzenesulfonamide fragment with the 3-(piperazin-1-yl)-1,2-benzothiazole moiety (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>C).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/medium/jm-2013-01895u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/large/jm-2013-01895u_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of multifunctional ligands. Proposed binding modes presented for (1<i>R</i>)-3,<i>N</i>-dimethyl-<i>N</i>-[1-methyl-3-(4-methylpiperidin-1-yl)propyl]benzenesulfonamide (SB-258719)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> in 5-HT<sub>7</sub>R (A) and compound <b>2</b> in the 5-HT<sub>6</sub>R (C) and hERG channel (D). Amino acid residues engaged in ligand binding (within 4 Å from the ligand atoms) are shown as thick sticks together with their van der Waals surfaces (wire frame). Distances between key amino acid moieties and ligand structural elements are shown in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Tables S1 and S2. The numbers in brackets next to the residues in the hERG channel indicate the subunit number. Docking of <b>2</b> in M<sub>1</sub>R resulted in no valid poses (E). Dotted yellow lines represent H-bonds with polar residues. For the sake of clarity, ECL2 was hidden (A and C). TMH, transmembrane helix; ECL, extracellular loop.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/large/jm-2013-01895u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401895u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The molecule was then docked to the models of 5-HT<sub>7</sub>, 5-HT<sub>2A</sub>, and D<sub>2</sub> receptors, showing good fit and favorable interactions that confirmed the assumed ligand binding mode at those targets (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A, B, and C, respectively). Because 5-HT<sub>6</sub>R antagonism was considered a highly desirable feature of these ligands, the prototype, hybrid compound <b>2</b>, was also docked to the 5-HT<sub>6</sub>R model, in order to assess the possibility of its interactions with this target or potential modifications required for this activity to occur. Surprisingly, compound <b>2</b> was very well accommodated by the 5-HT<sub>6</sub> receptor, suggesting that it possessed marked affinity for this site, without particular modifications. The general orientation of the ligand in the binding site was similar to that observed for 5-HT<sub>7</sub>, 5-HT<sub>2A</sub>, or D<sub>2</sub> receptors (Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>C and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>D).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/medium/jm-2013-01895u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/large/jm-2013-01895u_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding mode of compound <b>2</b> in (A) 5-HT<sub>7</sub>R, (B) 5-HT<sub>2A</sub>R, (C) D<sub>2</sub>R, and (D) 5-HT<sub>6</sub>R. Residues in the binding site (within 4 Å from the ligand atoms) are presented as thick sticks together with their van der Waals surfaces (wire frame). Distances between key amino acid moieties and ligand structural elements are shown in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Table S2. Dotted yellow lines represent H-bonds with polar residues. Where possible, ECL2 was partially or entirely hidden for the sake of clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/large/jm-2013-01895u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401895u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As mentioned above for 5-HT<sub>7</sub>R, the binding sites of 5-HT<sub>2A</sub>, D<sub>2</sub>, and 5-HT<sub>6</sub>R are also divided into two pockets that extend to both sides of the main ligand-anchoring residue in monoaminergic receptors, Asp3.32. The first pocket is situated between TMHs 4–6, and its most important role in ligand binding lies in the formation of hydrophobic/aromatic interactions with aromatic clusters consisting of Phe6.51, Phe6.52, and Trp6.48, which are the conserved amino acid residues in these receptors. The second pocket is formed between TMHs 7–3, with the contribution of residues that ensure both aromatic (Phe3.28 in 5-HT<sub>7</sub>R and D<sub>2</sub>R or Trp3.28 in 5-HT<sub>6</sub>R and 5-HT<sub>2A</sub>R) and H-bond interactions (Arg7.36 in 5-HT<sub>7</sub>R, Asn7.36 in 5-HT<sub>2A</sub>R, and Thr7.39 in D<sub>2</sub>R). The 3-(piperazin-1-yl)-1,2-benzothiazole moiety of compound <b>2</b> was found to form charge-reinforced H-bond interactions between the protonated nitrogen atom of piperazine and Asp3.32, as well as hydrophobic/aromatic interactions between the benzisothiazole moiety and the aromatic cluster of TMH6, showing very similar poses in this conserved pocket in all 4 receptors. The arylsulfonamide moiety occupies the second pocket, forming interactions between the aryl ring and particular aromatic residue (Phe/Trp3.28). Because of the relatively higher sequence diversity in the second pocket, there are some differences in the arrangement of the arylsulfonamide moiety between the receptors. For example, the aromatic residue in the 3.28 position determines the conformation of the latter. In the case of 5-HT<sub>6</sub>R and 5-HT<sub>2A</sub>R containing the Trp residue, the arylsulfonamide moiety expands between TMH1 and TMH2, while in 5-HT<sub>7</sub>R and D<sub>2</sub>R with the Phe residue, it kinks in between TMH2 and TMH3. Both of those geometries are additionally stabilized by H-bonds, formed between the sulfonamide group and Arg181, Arg7.36, or Ser226 of 5-HT<sub>6</sub>R, 5-HT<sub>7</sub>R, and 5-HT<sub>2A</sub>R, respectively.</div><div class="NLM_p">Encouraged by the promising <i>in silico</i> properties, which suggested high affinity for the most important therapeutic targets (5-HT<sub>6</sub>, 5-HT<sub>7</sub>, 5-HT<sub>2A</sub>, and D<sub>2</sub> receptors), possible interactions with the undesired off-targets (called “anti-targets”), hERG channels or M<sub>1</sub> receptors, were also examined because blockade of these sites could negatively affect the compounds’ safety profile and mask potential therapeutic activity. In contrast to 5-HT<sub>6</sub>, 5-HT<sub>7</sub>, 5-HT<sub>2A</sub>, and D<sub>2</sub> receptors, compound <b>2</b> was not optimally accommodated within the binding sites of the antitargets. In the case of the M<sub>1</sub> receptor, the relatively long molecule could not freely expand throughout the binding site and form favorable interactions, similar to those observed in the targeted receptors, due to the relatively limited volume of binding sites in muscarinic receptors (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>E and Figure S1 in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> In general, amino acid sequence homology in the region of the binding site between M<sub>1</sub>R and the receptors described above is low. There are numerous differences in sequence, which contribute to various dissimilarities in shape and properties. The binding site of M<sub>1</sub>R is substantially restricted spatially with higher contribution of hydrophilic residues. The reason for that is basically the presence of tyrosine residues, which replace several important amino acids present in previously discussed receptors. The first binding pocket (between TMHs 4–6) is confined by the presence of Tyr3.33 (instead of Val in the above-mentioned receptors) and Tyr6.51 (instead of Phe). Nevertheless, crucial for selectivity is in fact the absence of the second binding pocket (between TMHs 7–3). It is caused by the presence of Tyr7.39, Tyr2.61, and Tyr2.64, which respectively substitute Thr7.39, Ala2.61, and Asn2.64 in 5-HT<sub>6</sub>R, thus making the second binding cavity inaccessible for the ligand. Docking studies suggested the potentially poor blocking activity of compound <b>2</b> at the hERG channel as well. Although it could be accommodated in the hERG channel model, its binding mode was suboptimal, due to the lack of the hydrophobic/aromatic interactions in regions of four phenylalanine (Phe656) residues, which are considered important for channel blockade (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>D and Figure S2 in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> The prototype molecule binds to the model by a H-bond between the protonated nitrogen of piperazine and Ser624, although it seems to be insufficiently stabilized by aromatic interactions. In particular, there is no additional, required interaction in the region between Phe656(1) and Phe656(4) or in the vicinity of Phe656(3), where the sulfonamide moiety is placed.</div><div class="NLM_p">All those findings prompted us to synthesize a diverse set of multifunctional ligands that explored various parts of the prototype compound <b>2</b>, including arylsulfonamide fragment, alkyl linker, and arylamine moiety (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>F). The selection of particular building blocks was based primarily on their best fit to the binding site of 5-HT<sub>6</sub>R, which was considered the most important receptor target. Analysis of the composition of the binding site of 5-HT<sub>6</sub>R as well as the binding mode of compound <b>2</b> and its close analogues revealed that the aryl moiety connected with sulfonamide fragment penetrates the hydrophobic regions near TMHs 7 and 2. It forms van der Waals interactions with the hydrophobic residues of TMH2 (Ala2.61, Ala2.65), TMH3 (Trp3.28), or TMH7 (Trp7.40), and therefore, the arylsulfonyl moieties selected for the designed series were predominantly lipophilic, with a few exceptions to confirm this hypothesis (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/medium/jm-2013-01895u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/large/jm-2013-01895u_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. General structures of hybrid molecules, benzazolepiperazines/piperidines I–III and arylsulfonyl fragments Ar (<b>1</b>–<b>15</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/large/jm-2013-01895u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401895u&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Moreover, the space available in the regions accommodating the arylsulfonamide moiety suggested that mono- or bicyclic aromatic fragments should be considered in the diverse set (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). On the basis of the visual inspection of ligand–receptor complexes, the optimal length of the alkyl linker was assumed to be 3 or 4 units, and those lengths were selected to be thoroughly explored in the designed series. The longer linkers were not considered due to a high molecular weight of the resulting hybrids. However, considering their lower molecular weight, several combinations with a 2-unit alkyl linker were also obtained for comparison. All of the designed molecules were docked to 5-HT<sub>6</sub>, 5-HT<sub>7</sub>, 5-HT<sub>2A</sub>, D<sub>2</sub>, and M<sub>1</sub> receptors as well as hERG channels, and their binding mode was analyzed, confirming in general the observations made for compound <b>2</b> and its close analogues. Consequently, the series of 185 combinations was selected for chemical synthesis.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> In this article, for the sake of clarity, we present 81 representative examples out of a total of 185 compounds synthesized and tested (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structure and Receptor Binding Profile of Compounds <b>1</b>–<b>81</b><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/medium/jm-2013-01895u_0006.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>Table a</sup><p class="last">Data expressed as the mean ± SD of two independent experiments in duplicate. Affinities of reference compounds are as follows: 5-HT<sub>6</sub><i>K</i><sub>i</sub> = 4.1 ± 0.7 nM and 5-HT<sub>7</sub><i>K</i><sub>i</sub> = 0.9 ± 0.1 nM (methiothepin), 5-HT<sub>2A</sub><i>K</i><sub>i</sub> = 1.0 ± 0.2 nM (risperidone), D<sub>2</sub><i>K</i><sub>i</sub> = 4.0 ± 0.3 nM (haloperidol), M<sub>1</sub><i>K</i><sub>i</sub> = 15 ± 3.1 nM (pirenzepine), hERG IC<sub>50</sub> = 89 ± 18 nM (E-4031).</p></div></div><div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Synthesis</h3><div class="NLM_p">A series of hybrid molecules (1–81) was prepared in the three-step synthesis as presented in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. In the first step, the alkylation of benzazolepiperazines/piperidines I–III with 2-(bromoalkyl)-1<i>H</i>-isoindoline-1,3(2<i>H</i>)-diones IV–VI afforded corresponding derivatives VII–XIV. Next, hydrolysis of the 1<i>H</i>-isoindoline-1,3(2<i>H</i>)-dione group with 40% methylamine aqueous solution afforded key intermediates XV–XXII, which were reacted with various commercially available sulfonyl chlorides (<b>1</b>–<b>15</b>) to give final arylsulfonamide derivatives (<b>1</b>–<b>81</b>).</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/medium/jm-2013-01895u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/large/jm-2013-01895u_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of Hybrid Molecules<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/large/jm-2013-01895u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401895u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, KI, DMF, rt, 48 h or DIPEA, KI, DMF/CH<sub>3</sub>CN 1:1, 70 °C, 3 days; (b) 40% aq MeNH<sub>2</sub>, rt, 76 h; (c) Et<sub>3</sub>N, DCM, 3 h, 10 °C then rt.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Structure–Affinity Relationships</h3><div class="NLM_p">The series of hybrid molecules that we had generated was evaluated in radioligand binding assays measuring their affinity for 5-HT<sub>6</sub>, 5-HT<sub>7</sub>, 5-HT<sub>2A</sub>, D<sub>2</sub>, and M<sub>1</sub> receptors as well as in the automated patch-clamp assay for hERG channel blockade (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_p">The majority of the compounds displayed marked affinity (<i>K</i><sub>i</sub> < 100 nM) for the targeted receptors and much lower activity at the antitargets (<50% inhibition of ligand binding at 1 μM). Moreover, numerous compounds possessed high affinity at the main targets (<i>K</i><sub>i</sub> < 10 nM), with some of them binding in the subnanomolar range, thus confirming the validity of the applied rational design approach. In general, the compounds displayed the highest affinity for 5-HT<sub>7</sub> and 5-HT<sub>2A</sub> receptors as well as strong binding to D<sub>2</sub> receptors, i.e., with the sites that were primarily targeted during the design process of the hybrid molecules. According to the molecular modeling studies, high affinity for 5-HT<sub>7</sub> receptors is provided by the <i>N</i>-aminoalkylarylsulfonamide moiety, which strongly interacts with the part of the binding site between TMHs 7–3. This makes it relatively less sensitive to the influence of the arylamine part, accommodated in the region of TMHs 4–6. These properties of the <i>N</i>-aminoalkylarylsulfonamide moiety are complemented by those of the benzazolepiperazine/piperidine moiety, which provides high affinity for 5-HT<sub>2A</sub> and D<sub>2</sub> receptors, the former being favored in this respect. However, 5-HT<sub>6</sub>R affinity varied widely, and some clear structure–activity relationships could be observed.</div><div class="NLM_p">First, the analogues containing the 6-fluoro-3-(piperidin-4-yl)-1,2-benzoxazole <b>III</b> were somewhat more active at 5-HT<sub>6</sub> sites than those containing 3-(piperazin-1-yl)-1,2-benzothiazole <b>I</b>, but both of these groups were much more active than the corresponding 3-(piperazin-1-yl)-1,2-benzoxazole <b>II</b> derivatives. Similar preferences were observed also for the other main targets, although to a less marked extent in the case of 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R between 6-fluoro-3-(piperidin-4-yl)-1,2-benzoxazole and 3-(piperazin-1-yl)-1,2-benzothiazole derivatives.</div><div class="NLM_p">Second, the arylsulfonamide moieties containing nitrogen or oxygen atoms in the aryl part were less potent at 5-HT<sub>6</sub>R than those which are more hydrophobic, especially those containing a benzene ring in the distal part of this fragment (e.g., compounds <b>68</b> and <b>77</b> vs <b>79</b> and <b>81</b>). These findings are in line with our docking experiments, which positioned the aromatic moieties of arylsulfonamide groups in the hydrophobic pocket between TMHs 7 and 2 of 5-HT<sub>6</sub>R (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/medium/jm-2013-01895u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/large/jm-2013-01895u_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Binding mode of the compounds (A) <b>51</b> and (B) <b>72</b> in the 5-HT<sub>6</sub> receptor. Residues in the binding site (within 4 Å from the ligand atoms) are presented as thick sticks together with their van der Waals surfaces (wire frame). Distances between key amino acid moieties and ligand structural elements are shown in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Tables S3 and S4. Dotted yellow lines represent H-bonds with polar residues. ECL2 was partially hidden for the sake of clarity. TMH, transmembrane helix; ECL, extracellular loop.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/large/jm-2013-01895u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401895u&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Third, the analogues with the ethyl linker were substantially less active than those with longer spacers. Interestingly, differing structure–activity relationships were observed for the compounds with 3 or 4 unit linkers. In the groups of 6-fluoro-3-(piperidin-4-yl)-1,2-benzoxazole <b>III</b> and 3-(piperazin-1-yl)-1,2-benzothiazole <b>I</b>, the propyl analogues formed the optimal combinations with the monocyclic arylsulfonamides, while the butyl derivatives were more active in combination with the bicyclic ones. These observations could be explained by the somewhat different binding modes of ligands with mono- and bicyclic arylsulfonamides in the 5-HT<sub>6</sub>R binding site (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). It is hypothesized that monocyclic substituents attached to arylpiperazine by shorter propyl linkers reach a lower part of the pocket, interacting with the hydrophobic surface of Trp3.28, Ala2.61, and possibly Trp7.40 and Tyr7.43. At the same time, the sulfonamide moiety creates an H-bond with polar Arg181. However, bicyclic derivatives with a butyl linker tend to explore the pocket even further, interacting with Ala2.65 and Trp7.40. In this case, the sulfonamide moiety establishes an H-bond with Asp7.36, rather than with Arg181. The middle position occupied by the other derivative configurations are unfavorable, probably due to the fact that the aryl substituent takes position in the vicinity of polar residues, i.e., Arg181, Asp7.36, or Asn2.64. The same trend, although less pronounced, could be noticed regarding the 5-HT<sub>7</sub>R affinity. On the contrary, in the group of 3-(piperazin-1-yl)-1,2-benzoxazole <b>II</b>, the 4-unit alkyl linker derivatives were significantly more active at all receptors, especially 5-HT<sub>6</sub>, regardless of the arylsulfonamide structure. The reason for this discrepancy, as well as for the generally low activity of propyl derivatives of 3-(piperazin-1-yl)-1,2-benzoxazole, is currently unclear and could not be explained by the present molecular modeling experiments.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Intrinsic Activity Studies</h3><div class="NLM_p">On the basis of the binding affinity results, a series of 12 compounds possessing affinity below 20 nM for all four targeted receptors was selected for functional profile characterization using <i>in vitro</i> measures of receptor activation. All of the tested compounds confirmed their high activity at the targets of interest and showed significant antagonist properties (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Functional Data for the Selected Compounds with Highest Affinity for Main Targets<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center"><i>K</i><sub>b</sub> [nM]</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">5-HT<sub>6</sub></th><th class="colsep0 rowsep0" align="center">5-HT<sub>7</sub></th><th class="colsep0 rowsep0" align="center">5-HT<sub>2A</sub></th><th class="colsep0 rowsep0" align="center">D<sub>2</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">7.6 ± 0.2</td><td class="colsep0 rowsep0" align="left">44 ± 9.0</td><td class="colsep0 rowsep0" align="left">110 ± 2.0</td><td class="colsep0 rowsep0" align="left">5.5 ± 1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">11 ± 1.9</td><td class="colsep0 rowsep0" align="left">9.2 ± 3.9</td><td class="colsep0 rowsep0" align="left">11 ± 1.4</td><td class="colsep0 rowsep0" align="left">11 ± 6.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">2.5 ± 0.0</td><td class="colsep0 rowsep0" align="left">0.5 ± 0.3</td><td class="colsep0 rowsep0" align="left">15 ± 1.0</td><td class="colsep0 rowsep0" align="left">1.8 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">12 ± 3.3</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.7</td><td class="colsep0 rowsep0" align="left">23 ± 7</td><td class="colsep0 rowsep0" align="left">14 ± 1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">7.4 ± 2.1</td><td class="colsep0 rowsep0" align="left">0.8 ± 0.5</td><td class="colsep0 rowsep0" align="left">7.0 ± 0.6</td><td class="colsep0 rowsep0" align="left">1.1 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="left">17 ± 1.8</td><td class="colsep0 rowsep0" align="left">3.0 ± 0.9</td><td class="colsep0 rowsep0" align="left">76 ± 25</td><td class="colsep0 rowsep0" align="left">8.4 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>66</b></td><td class="colsep0 rowsep0" align="left">3.8 ± 0.2</td><td class="colsep0 rowsep0" align="left">8.8 ± 1.2</td><td class="colsep0 rowsep0" align="left">14 ± 2.5</td><td class="colsep0 rowsep0" align="left">2.4 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="left">8.3 ± 1.7</td><td class="colsep0 rowsep0" align="left">1.0 ± 0.1</td><td class="colsep0 rowsep0" align="left">6.5 ± 0.6</td><td class="colsep0 rowsep0" align="left">7.3 ± 2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>72</b></td><td class="colsep0 rowsep0" align="left">9.9 ± 5.1</td><td class="colsep0 rowsep0" align="left">7.8 ± 3.3</td><td class="colsep0 rowsep0" align="left">8,8 ± 1.5</td><td class="colsep0 rowsep0" align="left">17 ± 3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>74</b></td><td class="colsep0 rowsep0" align="left">21 ± 4.0</td><td class="colsep0 rowsep0" align="left">2.8 ± 0.6</td><td class="colsep0 rowsep0" align="left">55 ± 5.0</td><td class="colsep0 rowsep0" align="left">15 ± 1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>76</b></td><td class="colsep0 rowsep0" align="left">14 ± 1.0</td><td class="colsep0 rowsep0" align="left">2.2 ± 1.2</td><td class="colsep0 rowsep0" align="left">5.0 ± 1.7</td><td class="colsep0 rowsep0" align="left">3.4 ± 0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>77</b></td><td class="colsep0 rowsep0" align="left">22 ± 3.5</td><td class="colsep0 rowsep0" align="left">5.6 ± 2.1</td><td class="colsep0 rowsep0" align="left">9.5 ± 3.5</td><td class="colsep0 rowsep0" align="left">11 ± 2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SB-271046</td><td class="colsep0 rowsep0" align="left">5.8 ± 0.6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SB-269970</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.2 ± 0.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ketanserin</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2.9 ± 0.2</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">chlorpromazine</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.3 ± 0.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Data are expressed as the mean ± SD of two independent experiments in duplicate.</p></div></div></div><div class="NLM_p last">No activation of any of the receptors was observed, and the compounds showed potent antagonist properties at all the receptors, especially the 5-HT<sub>7</sub>. The compounds with monocyclic arylsulfonamides and propyl linker (e.g., compounds <b>51</b> and <b>55</b>) showed low subnanomolar <i>K</i><sub>b</sub> values at 5-HT<sub>7</sub> sites, which is in line with previous findings on optimal structures for 5-HT<sub>7</sub>R antagonism.<a onclick="showRef(event, 'ref24 ref30'); return false;" href="javascript:void(0);" class="ref ref24 ref30">(24, 30)</a> No clear impact of linker length or arlylsulfonamide fragment composition on 5-HT<sub>6</sub>R antagonism was observed in this group of high affinity compounds. Potent 5-HT<sub>6</sub>R antagonists were identified among both the monocyclic arylsulfonamides with propyl linker and bicyclic arylsulfonamides with butyl linker, achieving single-digit nanomolar <i>K</i><sub>b</sub> values (compounds <b>14</b>, <b>51</b>, <b>55</b>, <b>66</b>, <b>68</b>, and <b>72</b>). Seven compounds (<b>38</b>, <b>51</b>, <b>55</b>, <b>66</b>, <b>68</b>, <b>72</b>, and <b>76</b>) displayed potent antagonistic properties at all four main targets, with <i>K</i><sub>b</sub> values <20 nM. Recently, we have published the pharmacological profile of a representative example of this series, compound <b>51</b>.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Here, we present the extended <i>in vitro</i> and <i>in vivo</i> characterization of compound <b>72</b> possessing the most balanced receptor affinity profile as well as improved activity after oral administration.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Extended <i>in Vitro</i> Profile of Compound <b>72</b></h3><div class="NLM_p">Compound <b>72</b>, tested in the independent laboratory of Cerep (France), displayed very high affinity and antagonism at all four main targets (<i>K</i><sub>i</sub> and <i>K</i><sub>b</sub> values <20 nM for 5-HT<sub>6</sub>, 5-HT<sub>7</sub>, 5-HT<sub>2A</sub>, and D<sub>2</sub> receptors). A notable feature of the compound is its concurrent antagonism of 5-HT<sub>6</sub> and D<sub>2</sub> receptors (<i>K</i><sub>b</sub> = 16 and 13 nM, respectively), which corresponds to our goal of identifying compounds that combine activity at targets that are associated with both antipsychotic-like properties and favorable cognitive properties. In comparison, compound <b>72</b> did not bind significantly to muscarinic receptors (<i>K</i><sub>i</sub> >1000 nM) and only weakly blocked hERG channels (IC<sub>50</sub> ∼4 μM, ChanTest, USA), thus achieving a large separation (several orders of magnitude) between the activity at the principle therapeutic targets and that at some key antitargets. These observations are in sharp contrast to some existing drugs that act at both D<sub>2</sub> and 5-HT<sub>6</sub> receptors, e.g., olanzapine and clozapine, which also strongly antagonize muscarinic receptors (<i>K</i><sub>i</sub> < 10 nM),<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> or sertindole, which is a potent hERG channel blocker (IC<sub>50</sub> = 2.7 nM).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_p">In addition to the main targets and antitargets, compound <b>72</b> was also tested for affinity and intrinsic activity at a battery of dopaminergic (D<sub>3</sub>, D<sub>4</sub>, D<sub>1</sub>), adrenergic (α<sub>1A</sub>, α<sub>2C</sub>), histaminergic (H<sub>1</sub>), muscarinic (M<sub>2</sub>–M<sub>5</sub>), and serotonergic (5-HT<sub>1A</sub>, 5-HT<sub>2C</sub>) receptors as well as the serotonin transporter (SERT) (Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Extended Receptor Binding Profile of Compound <b>72</b><a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">receptor</th><th class="colsep0 rowsep0" align="center">cell line</th><th class="colsep0 rowsep0" align="center">radioligand or read-out</th><th class="colsep0 rowsep0" align="center">reference ligand (<i>K</i><sub>i</sub>, nM)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub>  ± SEM (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h 5-HT<sub>6</sub></td><td class="colsep0 rowsep0" align="left">CHO cells</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]LSD</td><td class="colsep0 rowsep0" align="left">serotonin (33)</td><td class="colsep0 rowsep0" align="left">4.1 ± 1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h 5-HT<sub>7</sub></td><td class="colsep0 rowsep0" align="left">CHO cells</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]LSD</td><td class="colsep0 rowsep0" align="left">serotonin (0.8)</td><td class="colsep0 rowsep0" align="left">1.9 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h 5-HT<sub>2A</sub></td><td class="colsep0 rowsep0" align="left">HEK-293 cells</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]ketanserin</td><td class="colsep0 rowsep0" align="left">ketanserin (0.3)</td><td class="colsep0 rowsep0" align="left">0.5 ± 0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h 5-HT<sub>1A</sub></td><td class="colsep0 rowsep0" align="left">HEK-293 cells</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]8-OH-DPAT</td><td class="colsep0 rowsep0" align="left">8-OH-DPAT (0.4)</td><td class="colsep0 rowsep0" align="left">110 ± 53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h 5-HT<sub>2C</sub></td><td class="colsep0 rowsep0" align="left">HEK-293 cells</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]mesulergine</td><td class="colsep0 rowsep0" align="left">RS102221 (0.6)</td><td class="colsep0 rowsep0" align="left">540 ± 139</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h D<sub>2S</sub></td><td class="colsep0 rowsep0" align="left">HEK-293 cells</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]methyl-spiperone</td><td class="colsep0 rowsep0" align="left">(+)butaclamol (0.04)</td><td class="colsep0 rowsep0" align="left">1.8 ± 0.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h D<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CHO cells</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]methyl-spiperone</td><td class="colsep0 rowsep0" align="left">(+)butaclamol (0.04)</td><td class="colsep0 rowsep0" align="left">1.1 ± 0.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h D<sub>4</sub></td><td class="colsep0 rowsep0" align="left">CHO cells</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]methyl-spiperone</td><td class="colsep0 rowsep0" align="left">clozapine (17)</td><td class="colsep0 rowsep0" align="left">14 ± 0.82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h D<sub>1</sub></td><td class="colsep0 rowsep0" align="left">CHO cells</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]SCH23 390</td><td class="colsep0 rowsep0" align="left">SCH23390 (0.1)</td><td class="colsep0 rowsep0" align="left">3.3 ± 0.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h α<sub>1A</sub></td><td class="colsep0 rowsep0" align="left">CHO cells</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]prazosin</td><td class="colsep0 rowsep0" align="left">prazosin (0.04)</td><td class="colsep0 rowsep0" align="left">0.8 ± 0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h α<sub>2C</sub></td><td class="colsep0 rowsep0" align="left">CHO cells</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]RX 821 002</td><td class="colsep0 rowsep0" align="left">yohimbine (0.5)</td><td class="colsep0 rowsep0" align="left">1.9 ± 1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h H<sub>1</sub></td><td class="colsep0 rowsep0" align="left">HEK-293 cells</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]pyrilamine</td><td class="colsep0 rowsep0" align="left">pyrilamine (1.7)</td><td class="colsep0 rowsep0" align="left">69 ± 19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h M<sub>1</sub></td><td class="colsep0 rowsep0" align="left">CHO cells</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]pirenzepine</td><td class="colsep0 rowsep0" align="left">pirenzepine (16)</td><td class="colsep0 rowsep0" align="left">>1000<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h M<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CHO cells</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]AF-DX 384</td><td class="colsep0 rowsep0" align="left">methoctramine (27)</td><td class="colsep0 rowsep0" align="left">>1000<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h M<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CHO cells</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]4-DAMP</td><td class="colsep0 rowsep0" align="left">4-DAMP (0.44)</td><td class="colsep0 rowsep0" align="left">>1000<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h M<sub>4</sub></td><td class="colsep0 rowsep0" align="left">CHO cells</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]4-DAMP</td><td class="colsep0 rowsep0" align="left">4-DAMP (0.88)</td><td class="colsep0 rowsep0" align="left">>1000<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h M<sub>5</sub></td><td class="colsep0 rowsep0" align="left">CHO cells</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]4-DAMP</td><td class="colsep0 rowsep0" align="left">4-DAMP (0.48)</td><td class="colsep0 rowsep0" align="left">>1000<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h SERT</td><td class="colsep0 rowsep0" align="left">CHO cells</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]imipramine</td><td class="colsep0 rowsep0" align="left">imipramine (2.1)</td><td class="colsep0 rowsep0" align="left">>1000<a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG</td><td class="colsep0 rowsep0" align="left">CHO cells</td><td class="colsep0 rowsep0" align="left">inhibition of K+ current</td><td class="colsep0 rowsep0" align="left">E-4031 (89)</td><td class="colsep0 rowsep0" align="left">4000 ± 900<a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Data are expressed as the mean ± SEM of three independent experiments performed in duplicate. Each cell line was transfected to stably express the indicated human recombinant receptor.</p></div><div class="footnote" id="t3fn1"><sup>b</sup><p class="last">Less than 40% inhibition of binding observed at a concentration of 1 μM (<i>n</i> = 2).</p></div><div class="footnote" id="t3fn2"><sup>c</sup><p class="last">IC<sub>50</sub> value. h: human recombinant.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Extended Functional Profile of Compound <b>72</b><a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">receptor</th><th class="colsep0 rowsep0" align="center">functional test</th><th class="colsep0 rowsep0" align="center">agonist (conc, nM)</th><th class="colsep0 rowsep0" align="center">reference ligand (IC<sub>50</sub>, nM)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>b</sub> ± SEM [nM]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h 5-HT<sub>6</sub></td><td class="colsep0 rowsep0" align="left">cAMP</td><td class="colsep0 rowsep0" align="left">serotonin (300)</td><td class="colsep0 rowsep0" align="left">methiothepin (11)</td><td class="colsep0 rowsep0" align="left">16 ± 4.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h 5-HT<sub>7</sub></td><td class="colsep0 rowsep0" align="left">cAMP</td><td class="colsep0 rowsep0" align="left">serotonin (300)</td><td class="colsep0 rowsep0" align="left">methiothepin (1.5)</td><td class="colsep0 rowsep0" align="left">4.5 ± 1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h 5-HT<sub>2A</sub></td><td class="colsep0 rowsep0" align="left">IP1</td><td class="colsep0 rowsep0" align="left">serotonin (100)</td><td class="colsep0 rowsep0" align="left">ketanserin (14)</td><td class="colsep0 rowsep0" align="left">4.8 ± 0.87</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h 5-HT<sub>1A</sub></td><td class="colsep0 rowsep0" align="left">cellular dielectric spectroscopy</td><td class="colsep0 rowsep0" align="left">8-OH-DPAT (100)</td><td class="colsep0 rowsep0" align="left">WAY100635 (2.1)</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h 5-HT<sub>2C</sub></td><td class="colsep0 rowsep0" align="left">IP1</td><td class="colsep0 rowsep0" align="left">serotonin (10)</td><td class="colsep0 rowsep0" align="left">SB-206553 (9.4)</td><td class="colsep0 rowsep0" align="left">N.C.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h D<sub>2S</sub></td><td class="colsep0 rowsep0" align="left">cAMP</td><td class="colsep0 rowsep0" align="left">dopamine (300)</td><td class="colsep0 rowsep0" align="left">butaclamol (5.0)</td><td class="colsep0 rowsep0" align="left">13 ± 8.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h D<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cAMP</td><td class="colsep0 rowsep0" align="left">dopamine (10)</td><td class="colsep0 rowsep0" align="left">butaclamol (16)</td><td class="colsep0 rowsep0" align="left">2.3 ± 0.47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h D<sub>4</sub></td><td class="colsep0 rowsep0" align="left">cAMP</td><td class="colsep0 rowsep0" align="left">dopamine (100)</td><td class="colsep0 rowsep0" align="left">clozapine (168)</td><td class="colsep0 rowsep0" align="left">23 ± 6.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h D<sub>1</sub></td><td class="colsep0 rowsep0" align="left">cAMP</td><td class="colsep0 rowsep0" align="left">dopamine (300)</td><td class="colsep0 rowsep0" align="left"> SCH23390 (1.7)</td><td class="colsep0 rowsep0" align="left">37 ± 18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h α<sub>1A</sub></td><td class="colsep0 rowsep0" align="left">intracellular Ca<sup>2+</sup> release</td><td class="colsep0 rowsep0" align="left">epinephrine (3.0)</td><td class="colsep0 rowsep0" align="left"> WB4101 (1.0)</td><td class="colsep0 rowsep0" align="left">1.8 ± 0.17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h α<sub>2C</sub></td><td class="colsep0 rowsep0" align="left">cAMP</td><td class="colsep0 rowsep0" align="left">epinephrine (30)</td><td class="colsep0 rowsep0" align="left">rauwolscine (16)</td><td class="colsep0 rowsep0" align="left">25 ± 4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h H<sub>1</sub></td><td class="colsep0 rowsep0" align="left">intracellular Ca<sup>2+</sup> release</td><td class="colsep0 rowsep0" align="left">histamine (300)</td><td class="colsep0 rowsep0" align="left">pyrilamine (3.0)</td><td class="colsep0 rowsep0" align="left">140 ± 20</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Data are expressed as the mean ± SEM of three independent experiments performed in duplicate. cAMP, cyclic adenylyl monophosphate; IP1, inositol phosphate; h, human recombinant; N.C., noncalculable.</p></div></div></div><div class="NLM_p">Compound <b>72</b> displayed high affinity (<i>K</i><sub>i</sub> < 10 nM) for D<sub>1</sub>, D<sub>3</sub>, α<sub>1A</sub>, and α<sub>2C</sub> receptors and showed potent antagonism (<i>K</i><sub>b</sub> < 10 nM) at D<sub>3</sub> and α<sub>1A</sub> receptors. Antagonism of D<sub>1</sub> and α<sub>2C</sub> receptors was somewhat weaker but also observed (<i>K</i><sub>b</sub> = 37 and 25 nM, respectively). Significant binding affinity for D<sub>4</sub> and H<sub>1</sub> receptors (<i>K</i><sub>i</sub> = 14 and 69 nM, respectively) was in line with the antagonistic effects at those sites (<i>K</i><sub>b</sub> = 23 and 136 nM, respectively). However, compound <b>72</b> only weakly bound to 5-HT<sub>1A</sub> and 5-HT<sub>2C</sub> receptors or to the serotonin transporter, resulting in very weak antagonist properties (<i>K</i><sub>b</sub> or IC<sub>50</sub> > 1000 nM).</div><div class="NLM_p">Of the above properties of compound <b>72</b>, strong blockade of D<sub>3</sub> receptors may be considered as a desirable attribute since it elicits procognitive effects via the facilitation of acetylcholine release.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Moreover, antagonism of α<sub>2C</sub> adrenergic receptors could also positively influence the mood-modulating properties of compound <b>72</b> due to the elevation of prefrontal cortical monoamine outflow.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_p">Antagonism of central α<sub>1</sub> receptors may also be beneficial for a compound targeting behavioral and psychological symptoms of dementia, especially agitation and aggression. Indeed, the α<sub>1</sub> receptor antagonist, prazosin, elicited pronounced antiagitation and antiaggressive effects in patients with Alzheimer’s disease without significant sedation or hypotension.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Furthermore, in patients with Alzheimer’s disease, α<sub>1</sub> receptor deregulation has been reported in the frontal cortex of the post-mortem brain,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> suggesting that targeting this receptor may correct a neurobiological imbalance associated with the disorder. However, antagonism of peripheral α<sub>1</sub> receptors is associated with hypotensive activity, which would need to be addressed in elderly patients with potentially fragile cardiac function.</div><div class="NLM_p last">In spite of significant activity at H<sub>1</sub> receptors, the separation between the antagonist properties at those sites and the main therapeutic targets is an order of magnitude (<i>K</i><sub>b</sub> = 140 nM vs 4.5–16 nM). In contrast, antipsychotic compounds with known, strong antihistaminic properties, like olanzapine or clozapine, show the opposite trend, with higher affinity at H<sub>1</sub> receptors than at the principal therapeutic targets.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Since the blockade of H<sub>1</sub> receptors has been associated with sedative effects,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> the relatively weak antihistaminic activity of compound <b>72</b> may contribute to its low propensity to elicit sedation (see the next section). Moreover, the low affinity and absence of antagonist properties of compound <b>72</b> at 5-HT<sub>2C</sub> receptors avoids concerns associated with this site related to increased appetite and body weight or metabolic disturbances.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> <i>In Vivo</i> Activity of Compound <b>72</b></h3><div class="NLM_p last">In view of the encouraging <i>in vitro</i> profile described above, compound <b>72</b> was subjected to pharmacological experiments in rats. Specifically, the antipsychotic-like and antidepressant-like activity of compound <b>72</b> was compared with its influence on cognition. Psychotic disturbances in dementia may have different neurobiological substrates than in schizophrenia, so nondopaminergic models of psychosis were employed. Indeed, MK-801-induced hyperlocomotion and DOI-induced head twitches represent experimental paradigms based on the disruption of glutamate and serotonin transmission, respectively. Antidepressant-like activity was measured using Porsolt’s forced swim test (FST), a well validated procedure for primary screening, while the influence of compound <b>72</b> on cognition was tested using the passive avoidance test. Moreover, given that potential motor impairment is an important consideration in elderly patients, induction of catalepsy and changes in spontaneous locomotor activity were also quantified. The results showed that compound <b>72</b> dose-dependently reversed hyperlocomotion and head-twitches induced by MK-801 and DOI, with minimum effective doses (MED) of 10 and 3 mg/kg p.o. respectively, thus demonstrating a pronounced antipsychotic-like effect. Furthermore, it decreased immobility time in the FST by 20% over a relatively broad dose range, from 0.3 to 3 mg/kg p.o., consistent with a prominent antidepressant-like effect. The effect size of compound <b>72</b> in the FST was substantial and similar to that of the tricyclic antidepressant, imipramine, tested under the same conditions. In contrast, among the 8 clinically used antipsychotic drugs tested as references, only clozapine was able to show activity in the FST at more than one dose, with a maximal effect size >11% of control value, whereas the other drugs had little or no activity in the FST (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Table S5).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In addition to a robust, oral activity in the therapeutic-like models, compound <b>72</b> did not disrupt memory in the passive avoidance test even at the highest dose tested (100 mg/kg p.o.). This is a striking observation because dementia patients with BPSD also suffer from core, cognitive deficits that should not be further exacerbated by pharmacotherapy. In contrast, the reference antipsychotic drugs dose-dependently disrupted cognition in the passive avoidance test at antipsychotic-like doses, in accordance with clinical findings on the cognitive impairments elicited by these medications (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Table S5).<a onclick="showRef(event, 'ref2 ref23'); return false;" href="javascript:void(0);" class="ref ref2 ref23">(2, 23)</a> The only exception was aripiprazole, which did not disrupt passive avoidance response but also failed to exhibit robust antipsychotic-like effects. This observation is in line with clinical studies on aripiprazole, showing a lack of satisfactory antipsychotic efficacy in dementia patients.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Finally, compound <b>72</b> did not significantly modify spontaneous locomotor activity or induce catalepsy up to a dose of 100 mg/kg p.o., suggesting that it does not interfere with normal motor control. In contrast, most of the reference antipsychotics tested produced dose-dependent catalepsy, and all of them produced significant sedation at doses in the therapeutic-like range (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Table S5).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50762" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50762" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Taken together, the present study indicates that the applied drug design and structure–activity relationship (SAR) strategy enabled us to generate a series of compounds that display the desired <i>in vitro</i> receptor profile. Namely, we managed to obtain multimodal ligands that exert simultaneous blockade of 5-HT<sub>6</sub> and D<sub>2</sub> receptors and without deleterious interactions with key antitargets (muscarinic receptors or hERG channels) and distinct from currently available antipsychotics. Such a molecular interaction pattern, enriched with antagonism of other important targets, including 5-HT<sub>7</sub> and 5-HT<sub>2A</sub> receptors, should elicit potentially beneficial psychotropic effects with an improved side effect profile.</div><div class="NLM_p last">In addition, <i>in vivo</i> characterization of a representative molecule from the series, compound <b>72</b>, revealed its exceptional activity in behavioral tests. Unlike reference antipsychotics, compound <b>72</b> achieved marked therapeutic-like activity in rat models of psychosis and depression without interfering with cognitive function or motor control and indicates that further investigation of this chemical series is warranted.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25773" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25773" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Molecular Modeling</h3><div class="NLM_p">The homology models of the human D<sub>2</sub> dopamine and 5-HT<sub>7</sub> serotonin receptors used herein were the same as those generated and described in our previously published papers.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> The additional homology models of other GPCRs presented in the current article (i.e., serotonin 5-HT<sub>6</sub>, 5-HT<sub>2A</sub> and muscarinic M<sub>1</sub> receptors) were derived in accordance with the same, well validated method.</div><div class="NLM_p">It should be noted that the models used in the present work differ from most of previously published models of the GPCRs in question,<a onclick="showRef(event, 'ref43 ref44 ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref43 ref44 ref45 ref46 ref47">(43-47)</a> in at least one of the two main aspects. First, they were prepared using templates of recently characterized high-resolution crystal structures of human β<sub>2</sub> adrenergic and D<sub>3</sub> dopaminergic receptors, displaying much higher structural identity with the modeled receptors than the previously used templates, e.g., bovine rhodopsin. Second, the optimization of the binding sites of the new models was performed using the recently introduced methodology, based on the ligand-induced fit, which has been shown to result in significantly more robust models.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The specific characteristics of the receptor models used in the present study are described in detail below.</div><div class="NLM_p">The homology model of the hERG potassium channel and its induced fit structure applied for docking studies were acquired from <a href="http://www.schrodinger.com" class="extLink">http://www.schrodinger.com</a>.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The novel models used for docking experiments were built on the template of β<sub>2</sub> adrenergic receptor (β<sub>2</sub>R) crystal structure (Protein Data Bank ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RH1">2RH1</a>).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Reasonable sequence similarity between modeled receptors and the adrenergic β<sub>2</sub> receptor justified the choice of the latter structure as a template for homology modeling. The crystal structure containing the heptahelical bundle and all of the originally occurring loops was used, with the exception of artificial fragments replacing the third intracellular loop (ICL3) in the crystallized receptor, which were removed. Short loops were created then to avoid modeling of the long ICL3, which is distant from the binding site and therefore beyond the scope of our experiments. Sequence alignment was performed via GeneSilico Metaserver,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> which is a gateway to multiple fold recognition servers. The results proposed by a profile–profile comparison tool, hhsearch, were selected as the starting alignments between the sequences of 5-HT<sub>6</sub>, 5-HT<sub>2A</sub>, and M<sub>1</sub> receptors (UniProt accession numbers <a href="https://P50406" class="ext-link">P50406</a>, <a href="https://P28223" class="ext-link">P28223</a>, and <a href="https://P11229" class="ext-link">P11229</a>, respectively)<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> and the template. The alignments were manually adjusted in Swiss Pdb Viewer and submitted to the SwissModel server. Using the SwissModel algorithm, energy-minimized (GROMOS96) homology models were obtained.<a onclick="showRef(event, 'ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref52 ref53 ref54">(52-54)</a> Further improvements of the models were applied using software implemented in Schrödinger Suite 2009. All of the operations engaging Schrödinger’s tools were executed with default settings, unless stated otherwise. The homology models were validated by processing in Protein Preparation Wizard, which consisted of optimizing the hydrogen-bonding network and restrained minimization of the whole system with the OPLS_2005 force field. The least conserved fragments of the models, i.e., extracellular loops (ECLs), among which ECL2 is known to be involved in ligand binding, were additionally refined using the Prime Refinement tool.</div><div class="NLM_p">Binding pockets of the resulting homology models were optimized using modified induced fit docking (IFD) workflow.<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55, 56)</a> This method of ligand-based structure optimization proved to be useful in homology modeling of GPCRs.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> It combines flexible ligand docking (Glide algorithm, which uses the GlideScore scoring function)<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57, 58)</a> with protein structure prediction and side chain refinement (Prime protein prediction program).<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59, 60)</a> Modification of the IFD procedure consisted of appending another cycle of optimization of the receptor structure and docking the ligand using Glide XP (extra precision). The modified procedure allowed the models to improve in terms of assessing the proper ligand binding mode.</div><div class="NLM_p">For each optimized receptor, a group of several bioactive compounds were selected for the purpose of ligand-steered binding site optimization. Two-dimensional structures of the ligands were sketched or sourced from the ChEMBL database<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> and then converted to 3D and optimized using LigPrep (OPLS_2001 force field was applied). If available, ring conformations for cyclic ligands were taken from their crystal structures deposited in the Cambridge Crystalographic Data Centre (CCDC) database and retained in the process of flexible docking.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> The top-scoring ligand–receptor complexes obtained by way of IFD were inspected visually to check the compliance with the common binding mode for monoaminergic receptor ligands. That procedure resulted in models that served as molecular targets in further docking studies.</div><div class="NLM_p">Parameters of Glide docking procedure were set to defaults, with the exception of docking precision set to XP (extra precision) and the flexible docking option retaining original conformations of amide bonds. H-bond constraints were applied on Asp3.32 since its interaction with the protonated nitrogen atom of the ligand is considered crucial for the monoaminergic GPCRs.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> The centroid of a grid box (22 × 22 × 22 Å) was located on Asp3.32.</div><div class="NLM_p last">Glide, induced fit docking, LigPrep, Prime, and Protein Preparation Wizard were implemented in Schrödinger Suite 2009, which was licensed for Adamed Ltd.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Chemistry</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> General Methods</h4><div class="NLM_p">All the reagents were purchased from Aldrich, Alfa Aesar, and Fluorochem.</div><div class="NLM_p"><sup>1</sup>HNMR and <sup>13</sup>CNMR spectra were obtained with a Varian BB 200 spectrometer using TMS (0.00 ppm) in chloroform-<i>d</i><sub>1</sub> and DMSO-<i>d</i><sub>6</sub> and were recorded at 300 and 75 MHz, respectively. <i>J</i> values are in hertz (Hz), and splitting patterns are designated as follows: s (singlet), bs (broad singlet), d (doublet), t (triplet), and m (multiplet).</div><div class="NLM_p last">The UPLC/MS system consisted of a Waters Aquity UPLC coupled to a Waters SQD mass spectrometer. Chromatographic separations were carried out using the Acquity UPLC BEH C18 column, 2.1 × 100 mm and 1.7 μm particle size. The column was maintained at 60 °C and eluted under gradient conditions: 0–4 min, a linear gradient from 80–0.1% of eluent A, at a flow rate of 0.5 mL/min. Eluent A, water/formic acid (0.02%, v/v); and eluent B, methanol–acidic gradient. Eluent A, water/formic acid/ammonia solution (0.01%:0.1%, v/v/v); and eluent B, methanol–alkaline gradient. The UPLC/MS purity of all compounds except <b>58</b> and <b>60</b> was confirmed to be >95%. The table with the specific purity values for all compounds in 2 gradients is available in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Synthetic Procedures</h4><div id="sec4_2_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> General Procedure for the Synthesis of Phthalimide Derivatives VII–XIV</h5><div class="NLM_p last">A mixture of 10 mmol of appropriate benzazole/I–III and 10 mmol of appropriate 2-(bromoalkyl)-1<i>H</i>-isoindoline-1,3(2<i>H</i>)-dione IV–VI, 30 mmol of potassium carbonate, catalytic amount of potassium iodide, and 20 mL of <i>N,N</i>-dimethylformamide was stirred at room temperature until the disappearance of starting materials (TLC monitoring). The reaction mixture was subsequently poured into 50 mL of water, and the precipitate thus formed was isolated by filtration. The crude product was suspended in 20 mL of methanol, and then the solid was filtered off and dried to constant weight. Alternatively, the reaction was carried out in the mixture of acetonitrile and <i>N,N</i>-dimethylformamide stirring at 70 °C for 3 days in the presence of 30 mmol of DIPEA and a catalytic amount of potassium iodide.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> General Procedure for the Deprotection of the Phthalimide Group (XV–XXII)</h5><div class="NLM_p last">A mixture of 6 mmol of an appropriate compound VII–XIV and 30 mL of 40% aqueous solution of methylamine was stirred at room temperature for 3 days. To the resulting solution, 30 mL of 20% aqueous solution of sodium hydroxide was added, and the resulted mixture was stirred for 1.5 h. Then 4 g of sodium chloride was added, and the solution was extracted with methylene chloride (30 mL). The organic layer was washed with water (30 mL) and then dried over anhydrous magnesium sulfate. The product was obtained by evaporation of methylene chloride from dry solution. If necessary, the product was purified using column chromatography on silica gel using chloroform/methanol 95:5 as eluent. The structure was confirmed by mass spectrometry.</div></div><div id="sec4_2_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> General Procedure for the Preparation of Sulfonamide Derivatives (<b>1</b>–<b>81</b>)</h5><div class="NLM_p">Triethylamine (3.6 mmol (7.2 equiv)) and 0.5 mmol (1 equiv) of suitable arylsulfonyl chloride (<b>1</b>–<b>15</b>) were added to the solution of 0.5 mmol (1 equiv) of amine, XV–XXII, in 10 mL of methylene chloride at 10 °C. The reaction mixture was left at room temperature for 3 h, then the solvent and excess of triethylamine were evaporated. The resulting precipitate was then dissolved in 10 mL of methylene chloride and washed subsequently with 5% solution of sodium hydrogen carbonate (10 mL) and water (10 mL). The organic layer was dried over anhydrous magnesium sulfate, and the solvent was evaporated. Crude sulfonamides were purified by crystallization from methanol and some of them were by using column chromatography on silica gel using chloroform/methanol 9:1 as eluent. The structure and purity of prepared compounds was confirmed by LCMS data, and for selected compounds, structure identification was confirmed by NMR analysis.</div><div class="NLM_p last">Chemical information for the 9 structurally most representative examples is presented below, while the data for all the other compounds are available in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec4_2_3_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> <i>N</i>-(2-(4-(1,2-Benzothiazol-3-yl)piperazin-1-yl)ethyl)-3-methylbenzenesulfonamide (<b>1</b>)</h5><div class="NLM_p last">The title compound was prepared starting from amine (XV, R = H, X = N, Y = S, <i>n</i> = 0; 0.5 mmol, 131.19 mg) and 3-methylbenzenesulfonyl chloride (1, 0.5 mmol, 95.32 mg). Yield: 49% (102 mg), yellowish oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7. 79–7. 86 (m, 2H), 7.66–7.72 (m, 2H), 7.31–7.49 (m, 4H), 5.28 (s, 1H), 3.43–3.48 (m, 4H), 3.01–3.08 (m, 2H), 2.46–2.53 (m, 6H), 2.43 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 163.59, 152.76, 139.37, 139.30, 133.48, 129.00, 127.88, 127.61, 127.50, 124.16, 123.96, 123.72, 120.61, 55.81, 52.28, 49.81, 39.17, 21.39. MS: 417 [M + H<sup>+</sup>].</div></div><div id="sec4_2_3_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> <i>N</i>-(3-(4-(1,2-Benzothiazol-3-yl)piperazin-1-yl)propyl)-3-methylbenzenesulfonamide (<b>2</b>)</h5><div class="NLM_p last">The title compound was prepared starting from the amine (XVI, R = H, X = N, Y = S, <i>n</i> = 1; 0.5 mmol, 138.20 mg) and 3-methylbenzenesulfonyl chloride (1, 0.5 mmol, 95.32 mg). Yield: 49% (105 mg), yellowish oil. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.03 (t, 2H, <i>J</i> = 7.2 Hz), 7.60–7.39 (m, 6H), 3.35–3.39 (m, 4H), 2.82–2.94 (m, 2H), 2.46–2.50 (m, 4H), 2.38 (s, 3H), 2.30 (t, 2H, <i>J</i> = 7.2 Hz), 1.54 (quintet, 2H, <i>J</i> = 6.9 Hz). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 163.78, 152.18, 139.96, 139.85, 132.42, 128.89, 127.63, 127.57, 127.51, 124.04, 123.98, 123.94, 120.61, 58.18, 52.89, 49.91, 43.96, 23.96, 20.73. MS: 431 [M + H<sup>+</sup>].</div></div><div id="sec4_2_3_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> <i>N</i>-(4-(4-(1,2-Benzothiazol-3-yl)piperazin-1-yl)butyl)-3-methylbenzenesulfonamide (<b>3</b>)</h5><div class="NLM_p last">The title compound was prepared starting from the amine (XVII, R = H, X = N, Y = S, <i>n</i> = 2, 0.5 mmol, 145.21 mg) and 3-methylbenzenesulfonyl chloride (1, 0.5 mmol, 95.32 mg). Yield: 51% (113 mg), yellowish oil. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.05 (d, 2H, <i>J</i> = 7.2 Hz), 7.41–7.60 (m, 6H), 3.35–3.40 (m, 4H), 2.72–2.79 (m, 2H), 2.48–2.50 (m, 4H), 2.38 (s, 3H), 2.26–2.28 (m, 2H), 1.44–1.36 (m, 4H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 163.70, 152.61, 139.81, 139.75, 133.21, 128.89, 127.51, 127.31, 126.91, 124.20, 124.07, 123.67, 120.61, 58.21, 48.76, 42.77, 21.34. MS: 445 [M + H<sup>+</sup>].</div></div><div id="sec4_2_3_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> <i>N</i>-(3-(4-(Benzo[<i>d</i>]isoxazol-3-yl)piperazin-1-yl)propyl)-3-methylbenzenesulfonamide (<b>27</b>)</h5><div class="NLM_p last">The title compound was prepared starting from amine (XIX, R = H, X = N, Y = O, <i>n</i> = 1, 0.5 mmol, 130.17 mg) and 3-methylbenzenesulfonyl chloride (1, 0.5 mmol, 95.32 mg). Yield: 47% (120 mg), yellowish oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.63–7.68 (m, 2H), 7.32–7.41 (m, 2H), 7.24–7.27 (m, 2H), 7.13–7.18 (m, 1H), 6.99–7.08 (m, 1H), 3.58–3.76 (m, 4H), 3.08–3.14 (m, 2H), 2.40–2.55 (m, 6H), 1.64–1.72 (m, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 163.28, 152.70, 143.28, 139.96, 139.28, 133.28, 130.58, 127.28, 124.03, 118.42, 116.36, 108.78. MS: 515 [M + H<sup>+</sup>].</div></div><div id="sec4_2_3_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> <i>N</i>-(4-(4-(Benzo[<i>d</i>]isoxazol-3-yl)piperazin-1-yl)butyl)-3-methylbenzenesulfonamide (<b>28</b>)</h5><div class="NLM_p last">The title compound was prepared starting from the amine (XVIII, R = H, X = N, Y = O, <i>n</i> = 2, 0.5 mmol, 137.18 mg) and 3-methylbenzenesulfonyl chloride (1, 0.5 mmol, 95.32 mg). Yield: 53% (117 mg), pale yellow solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.61 (bs, 1H), 8.21–8.00 (m, 1H), 7.55–7.65 (m, 4H), 7.42–7.50 (m, 2H), 7.30–7.36 (m, 1H), 4.08–4.31 (m, 2H), 3.42–3.58 (m, 4H), 3.00–3.25 (m, 4H), 2.70–2.78 (m, 2H), 2.30 (s, 3H), 1.60–1.72 (m, 2H), 1.35–1.48 (m, 2H). <sup>13</sup>C NMR (75 MHz, DMSO-d6) δ 163.77, 161.10, 140.30, 139.38, 133.47, 130.91, 129.58, 127.12, 124.05, 117.25, 110.70, 55.82, 50.42, 45.18, 40.77, 21.33, 20.97, 26.30. MS: 445 [M + H<sup>+</sup>].</div></div><div id="sec4_2_3_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> <i>N</i>-[2-[4-(6-Fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-3-methylbenzenesulfonamide (<b>50</b>)</h5><div class="NLM_p last">The title compound was prepared starting from the amine (XXII, R = F, X = C, Y = O, <i>n</i> = 0, 0.5 mmol, 131.66 mg) and 3-methylbenzenesulfonyl chloride (1, 0.5 mmol, 95.32 mg). Yield: 41% (85 mg), yellowish oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 7.66–7.71 (m, 3H), 7.38–7.64 (m, 2H), 7.26–7.36 (m, 1H), 7.08 (t, 1H, <i>J</i> = 9 Hz), 5.27 (s, 1H), 2.98–3.08 (m, 3H), 2.73–2.77 (m, 2H), 2.42–2.48 (m, 5H), 2.07–2.16 (m, 2H), 1.96–2.03 (m, 4H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 165.62, 163.91, 162.40, 160.27, 139.25, 139.92 132.90, 128.71, 127.20, 123.90, 122.12 (d, <i>J</i> = 11 Hz), 112.62 (d, <i>J</i> = 25.4 Hz), 97.30 (d, <i>J</i> = 26.5 Hz), 55.23, 52.81, 39.53, 34.12, 30.41, 21.30. MS: 418 [M + H+].</div></div><div id="sec4_2_3_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> <i>N</i>-[3-[4-(6-Fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]propyl]-3-methylbenzenesulfonamide (<b>51</b>)</h5><div class="NLM_p last">The title compound was prepared starting from the amine (XXI, R = F, X = C, Y = O, <i>n</i> = 1, 0.5 mmol, 138.67 mg) and 3-methylbenzenesulfonyl chloride (1, 0.5 mmol, 95.32 mg). Yield: 55% (118 mg), white solid. <sup>1</sup>H NMR (300 MHz, DMSO-d6): δ 7.80–7.85 (m, 1H), 7.63–7.69 (m, 2H), 7.34–7.41 (m, 2H), 7.20–7.25 (m, 1H), 7.04–7.12 (m, 1H), 3.08–3.12 (m, 3H), 2.96–3.04 (m, 2H), 2.44–2.50 (m, 2H), 2.40 (s, 3H), 2.04–2.18 (m, 6H), 1.62–1.70 (m, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 165.77, 164,14 (d, <i>J</i> = 13.8 Hz), 162.45, 160.71, 139.90, 139.19, 133.15, 128.90, 127.31, 124.02, 123.10 (d, <i>J</i> = 11 Hz), 112.78 (d, <i>J</i> = 24.8 Hz), 97.53 (d, <i>J</i> = 26.5 Hz), 58.23, 53.19, 44.28, 34. 25, 30.41, 23.95, 21.36. MS: 432 [M + H<sup>+</sup>].</div></div><div id="sec4_2_3_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> <i>N</i>-(4-(4-(6-Fluorobenzo[<i>d</i>]isoxazol-3-yl)piperidin-1-yl)butyl)benzo[<i>b</i>]thiophene-2-sulfonamide (<b>72</b>)</h5><div class="NLM_p last">The title compound was prepared starting from the amine (XX, R = F, X = C, Y = O, <i>n</i> = 2, 0.5 mmol, 145.68 mg) and benzo[<i>b</i>]thiophene-2-sulfonyl chloride (10, 0.5 mmol, 116.35 mg). Yield: 87% (211 mg), yellowish oil. <sup>1</sup>H NMR (300 MHz, CDOD<sub>3</sub>) δ: 7.90–7.98 (m, 4H), 7.45–7.51 (m, 2H), 7.38–7.44 (m, 1H), 7.15–7.23 (m, 1H), 3.46–3.70 (m, 3H), 3.04–3.28 (m, 6H), 2.22–2.42 (m, 4H), 1.82–1.90 (m, 2H), 1.68–1.56 (m, 2H). <sup>19</sup>F-NMR (300 MHz, CDOD<sub>3</sub>): δ −109.30–109.45 (1F, m). <sup>13</sup>C NMR (75 MHz, CDOD<sub>3</sub>): δ 166.15, 163.86 (d, <i>J</i> = 13.8 Hz), 162.84, 159.43, 141.59 (d, <i>J</i> = 15 Hz), 137.82, 128.5, 126.9, 125.3, 125.25, 122.9 (d, <i>J</i> = 11 Hz), 122.3, 116.7, 112.41 (d, <i>J</i> = 25 Hz), 96.81 (d, <i>J</i> = 27 Hz). MS: 488 [M + H<sup>+</sup>].</div></div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Radioligand Binding Assays for 5-HT<sub>6</sub>, 5-HT<sub>7</sub>, 5-HT<sub>2A</sub>, and D<sub>2</sub> Receptors</h3><div class="NLM_p">One millimolar stock solutions of the compounds to be tested were prepared in DMSO. Serial dilutions of compounds were prepared in 96-well microplates in assay buffers using an automated pipetting system (epMotion 5070; Eppendorf). Radioligand binding was performed using cryopreserved membranes from cells stably expressing the relevant human receptor under conditions as indicated in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. Fifty microliters of working solution of the tested compounds, 50 μL radioligand solution, and 150 μL of diluted membranes prepared in assay buffer were transferred to 96-well microplates. These were covered with sealing tape, mixed, and incubated. The reaction was terminated by rapid filtration through a UniFilter 96 GF/B filter microplate, and 10 rapid washes with 200 μL of 50 mM Tris buffer (4 °C, pH 7.4) were performed using a vacuum manifold and 96-well pipettor. The UniFilter microplates were dried overnight at 37 °C in a dry incubator. The UniFilter bottoms were sealed, and 30 μL of liquid scintillator Betaplate Scint (PerkinElmer) was added to each well. The plates were allowed to equilibrate for 1 h, and then radioactivity was counted in a MicroBeta TriLux 1450 scintillation counter (PerkinElmer) at approximately 30% efficiency. Data were fitted to a one-site curve-fitting equation with Prism 5 (GraphPad Software), and <i>K</i><sub>i</sub> values were calculated using the Cheng–Prusoff equation.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Radioligand Binding Assay Conditions for 5 HT<sub>6</sub>, 5 HT<sub>7</sub>, 5 HT<sub>2A</sub>, and D<sub>2</sub> Receptors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">receptor (source)</th><th class="colsep0 rowsep0" align="center">radioligand (final concentration/<i>K</i><sub>d</sub>)</th><th class="colsep0 rowsep0" align="center">nonspecific binding</th><th class="colsep0 rowsep0" align="center">assay buffer</th><th class="colsep0 rowsep0" align="center">incubation condition</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>6</sub> (human recombinant, HEK-293 cells)</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]LSDm (2.5/2.0 nM)</td><td class="colsep0 rowsep0" align="left">10 μM methiothepin</td><td class="colsep0 rowsep0" align="left">50 mM Tris, 10 mM MgCl<sub>2</sub>,0.5 mM EDTA, pH 7.4</td><td class="colsep0 rowsep0" align="left">60 min, 37 °C</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>7</sub> (human recombinant, CHO-K1 cells)</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]LSD (3.0/2.4 nM)</td><td class="colsep0 rowsep0" align="left">10 μM methiothepin</td><td class="colsep0 rowsep0" align="left">50 mM Tris, 10 mM MgSO<sub>4</sub>, 0.5 mM EDTA, pH 7.4</td><td class="colsep0 rowsep0" align="left">120 min, 27 °C</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>2A</sub> (human recombinant, CHO-K1 cells)</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]ketanserin (1.0/0.5 nM)</td><td class="colsep0 rowsep0" align="left">100 μM serotonin</td><td class="colsep0 rowsep0" align="left">50 mM Tris, 4 mM CaCl<sub>2</sub>, 0.1% ascorbic acid, pH 7.4</td><td class="colsep0 rowsep0" align="left">60 min, 27 °C</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D<sub>2</sub> (human recombinant, CHO-K1 cells)</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]<i>N</i>-methylspiperone (0.4/0.2 nM)</td><td class="colsep0 rowsep0" align="left">10 μM (+)-butaclamol</td><td class="colsep0 rowsep0" align="left">50 mM HEPES, 50 mM NaCl, 5 mM MgCl<sub>2</sub>, 0.5 mM EDTA, pH 7.4</td><td class="colsep0 rowsep0" align="left">60 min, 37 °C</td></tr></tbody></table></div></div><div class="NLM_p">A large number of data points were generated in the screening experiments: in total, 185 compounds were tested on 4 receptors; of these, 81 representative compounds, tested on 4 receptors, are shown in the present article. The <i>K</i><sub>i</sub> values shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> are the means of two independent experiments. Each compound was tested in 10 concentrations from 1 × 10<sup>–06</sup> M to 1 × 10<sup>–10</sup> M (final concentration). All of the assays were carried out in duplicate (<i>n</i> = 2).</div><div class="NLM_p last">The assays presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> were performed at the Faculty of Pharmacy, Jagiellonian University Collegium Medicum, except for M<sub>1</sub>R and hERG, which were tested by Cerep and ChanTest, respectively (see below).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Functional Assays for 5 HT<sub>6</sub>, 5 HT<sub>7</sub>, 5 HT<sub>2A</sub>, and D<sub>2</sub> Receptors</h3><div class="NLM_p">One millimolar stock solutions of the tested compounds were prepared in DMSO. Serial dilutions were prepared in 96-well microplate in assay buffers using an automated pipetting system epMotion 5070 (Eppendorf). Two independent experiments in duplicate were performed, and 6 to 10 concentrations were tested.</div><div class="NLM_p">A cellular aequorin-based functional assay was performed with γ-irradiated recombinant CHO-K1 cells expressing mitochondrially targeted Aequorin, human GPCR, and the promiscuous G protein α16 for 5-HT<sub>6</sub> and 5-HT<sub>2A</sub> receptors, Gαqi/5 for D<sub>2</sub> receptor (PerkinElemer). The assay was performed according to the standard protocol provided by the manufacturer. After thawing, cells were transferred to assay buffer (DMEM/HAM’s F12 with 0.1% protease-free BSA) and centrifuged. The cell pellet was resuspended in assay buffer and coelenterazine h was added at final concentrations of 5 μM. The cell suspension was incubated at 21 °C, protected from light with constant agitation for 4 h, and then diluted with assay buffer to a concentration of 250,000 cells/mL. After 1 h of incubation, 50 μL of the cell suspension was dispensed using automatic injectors built into the radiometric and luminescence plate counter MicroBeta2 LumiJET (PerkinElmer, USA) into white opaque 96-well microplates preloaded with test compounds. Immediate light emission generated following calcium mobilization was recorded for 30–60 s. In antagonist mode, after 15–30 min of incubation the reference agonist was added to the above assay mix, and light emission was recorded again. Final concentration of the reference agonist was equal to EC<sub>80</sub>: 40 nM serotonin for the 5-HT<sub>6</sub> receptor, 30 nM α-methylserotonin for the 5-HT<sub>2A</sub> receptor, and 30 nM apomorphine for the D<sub>2</sub> receptor.</div><div class="NLM_p">For the 5-HT<sub>7</sub> receptor, adenylyl cyclase activity was monitored using cryopreserved CHO-K1 cells, expressing the human serotonin 5-HT<sub>7</sub> receptor. Thawed cells were resuspended in stimulation buffer (HBSS, 5 mM HEPES, 0.5 IBMX, and 0.1% BSA at pH 7.4) at 200,000 cells/mL. Ten microliters of cell suspension was added to 10 μL of tested compounds loaded onto a white opaque half area 96-well microplate. An antagonist response experiment was performed with 10 nM serotonin as the reference agonist, and the agonist and antagonist were added simultaneously. Cell stimulation was performed for 60 min at room temperature. After incubation, cAMP measurements were performed with homogeneous TR-FRET immunoassay using the LANCE Ultra cAMP kit (PerkinElmer, USA). Ten microliters of Eu-cAMP Tracer Working Solution and 10 μL of ULight-anti-cAMP Tracer Working Solution were added, mixed, and incubated for 1 h. The TR-FRET signal was read on an EnVision microplate reader (PerkinElmer, USA).</div><div class="NLM_p">IC<sub>50</sub> and EC<sub>50</sub> were determined by nonlinear regression analysis using GraphPad Prism 6.0 software. The log IC<sub>50</sub> was used to obtain the <i>K</i><sub>b</sub> by applying the Cheng–Prusoff approximation. The assays presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> were performed at Faculty of Pharmacy, Jagiellonian University Collegium Medicum.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Other <i>in Vitro</i> Studies</h4><div class="NLM_p">The extended pharmacological profile <i>in vitro</i> for compound <b>72</b>, with respect to GPCRs and SERT, was outsourced to Cerep (Le Bois l’Evêque, Poitiers, France). An outline of methodologies is shown in Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Further methodological details are available on the company Web site (<a href="http://www.cerep.fr" class="extLink">www.cerep.fr</a>). Data from all experiments were analyzed using nonlinear curve fitting programs, and the results are given as <i>K</i><sub>i</sub> values for binding affinity or <i>K</i><sub>b</sub> values for antagonist potency.</div><div class="NLM_p">Blockade of hERG-mediated potassium currents was carried out by ChanTest (Cleveland, Ohio) and expressed as the mean % of inhibition at 1.0 × 10<sup>–06</sup> M (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) or IC<sub>50</sub> value (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Ability to block hERG potassium channels was determined using the electrophysiological method and cloned hERG potassium channels (KCNH2 gene, expressed in CHO cells) as biological material. The effects were evaluated using an IonWorks Quattro system (Molecular Devices Corporation, Union City CA). hERG current was elicited using a pulse pattern with fixed amplitudes (conditioning prepulse, −80 mV for 25 ms; test pulse, +40 mV for 80 ms) from a holding potential of 0 mV. hERG current was measured as a difference between the peak current at 1 ms after the test step to +40 mV and the steady-state current at the end of the step to +40 mV. Data acquisition and analyses were performed using the IonWorks Quattro system operation software (version 2.0.2; Molecular Devices Corporation, Union City, CA). Data were corrected for leak current. The hERG block was calculated as % block = (1 – I TA/IControl) × 100%, where IControl and ITA were the currents elicited by the test pulse in control and in the presence of a test compound, respectively.</div><div class="NLM_p last">All assays for the lead compound <b>72</b> (shown in Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) were performed in 3–4 independent experiments. The <i>K</i><sub>i</sub> and <i>K</i><sub>b</sub> values were determined from 6 concentrations from 1 × 10<sup>–06</sup> M to 1 × 10<sup>–10</sup> M. All of the assays were carried out in duplicate (<i>n</i> = 2).</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>In Vivo</i> Studies</h4><div id="sec4_4_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> Animals</h5><div class="NLM_p last">Drug-naive male Wistar rats (Charles River, Sulzfeld, Germany) weighing 200–225 g on arrival were used for behavioral experiments. Animals were supplied by the breeder 2–3 weeks before experimentation. Rats were housed four per plastic cage and kept in a room with constant environmental conditions (22 ± 1 °C, relative humidity 60%, a 12:12 light-dark cycle with lights on at 7:00 a.m.). During this time, the rats were weighed and handled several times. Tap water and standard laboratory chow (Labofeed H, WPIK, Kcynia, Poland) were available ad libitum. All tests were carried out in a sound-attenuated experimental room between 09:00 a.m. and 3:00 p.m. All procedures for the treatment of rats in the present study were as humane as possible and were reviewed and approved by the institutional ethics committee. Procedures conformed to animal care standards laid down in Polish regulations and complied with international European guidelines (Directive no. 86/609/EEC).</div></div><div id="sec4_4_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> MK-801-Induced Hyperlocomotion</h5><div class="NLM_p">Antipsychotic-like activity was assessed by the inhibition of hyperactivity elicited by the NMDA receptor antagonist, [5<i>R</i>,10<i>S</i>]-[+]-5-methyl-10,11-dihydro-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>]cyclohepten-5,10-imine (MK-801).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Briefly, groups of drug-naive rats (<i>n</i> = 7–8) were transferred in their home cages to the experimental room 24 h prior to testing and allowed to habituate for 60 min and returned to the colony room. The next day, locomotor activity was assessed in black octagonal open fields (80 cm in diameter, 30 cm high) under dim light and continuous white noise (65 dB). Each animal was placed in the center of the open field and allowed to explore the whole area for 30 min. Subjects did not have visual contact with other rats. Forward locomotion (cm/30 min) was recorded and analyzed with the aid of a computerized video tracking system (Videomot, TSE, Bad Homburg, Germany).</div><div class="NLM_p last">Rats were preadministered the drug or vehicle p.o. 60 min before the start of the locomotor activity test. Fifteen minutes before the start of the test, rats were administered MK-801 (0.3 mg/kg i.p.). When assessing spontaneous locomotor activity, rats were administered saline 15 min prior to the test.</div></div><div id="sec4_4_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> DOI-Induced Head Twitches</h5><div class="NLM_p last">All tests were carried out in a sound-attenuated experimental room between 10:00 a.m. and 4:00 p.m. DOI-induced head twitches were scored as described by Schreiber et al.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Rats were injected with 2,5-dimethoxy-4-iodoamphetamine (DOI 2.5 mg/kg, i.p.) and placed in glass observation cages (25 × 25 × 40 cm<sup>3</sup>, <i>W</i> × <i>H</i> × <i>L</i>) with wood chip bedding on the floor. Five minutes later, head twitches were counted for 5 min by a trained observer. The test compound or its vehicle was injected p.o. 60 min before the start of the observation period.</div></div><div id="sec4_4_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> Forced Swimming Test</h5><div class="NLM_p last">The procedure used to determine antidepressant-like activity was based on the technique described previously.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Briefly, rats were individually placed in glass cylinders (40 cm in height, 17 cm in diameter) filled with water (temperature: 23 ± 1 °C) at a height that made it impossible to reach the bottom with hind paws (25 cm) There were two swimming sessions separated by 24 h: an initial 15 min pretest and a 5 min test. The duration of immobility (s) in the test session was recorded by a blind observer located in an adjacent room with the aid of a video camera. A rat was considered immobile when it floated without moving except to keep its head above the water surface. The test compound or its vehicle was administered p.o. 60 min before the experiment.</div></div><div id="sec4_4_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> Step-through Passive Avoidance Test</h5><div class="NLM_p">Effects of antipsychotics on memory function were evaluated as previously described.<a onclick="showRef(event, 'ref23 ref31'); return false;" href="javascript:void(0);" class="ref ref23 ref31">(23, 31)</a> Briefly, the passive avoidance apparatus (PACS-30, Columbus Instruments, Columbus, OH, USA) comprised four identical stainless-steel cages with black Plexiglas covers. Each cage consisted of lighted and dark compartments (23 × 23 × 23 cm<sup>3</sup>) and a stainless-steel grid floor. The compartments were separated by an automated sliding door. In the training (acquisition) session, animals were individually placed in the lighted compartment and allowed to explore it for 10 s. The sliding door was then opened, and the step-through latency for animals to enter the dark compartment was measured (300-s cutoff time). As soon as the animals entered the dark compartment, the door was closed. An inescapable foot-shock (0.5 mA pulse constant current for 3 s) was delivered 3 s later through the grid floor with a constant current shock generator (EACS-30 Columbus Instruments). The test compound or its vehicle was administered p.o. 60 min before the start of the training session. All vehicle-treated animals entered the dark compartment during the training session and received a foot-shock. Drug-treated animals that did not enter the dark compartment in the training session were not subjected to the test session. In the present study, all of the tested animals entered the dark compartment.</div><div class="NLM_p last">The test session was performed 24 h after the training session using the same paradigm but without the foot-shock. Step-through latencies for animals to enter the dark compartment were measured with a 300-s cutoff time. Drug-induced decreases in step-through latencies to enter the dark compartment in the test session were taken as a measure of the drug’s “amnesic” effects.</div></div><div id="sec4_4_2_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> Catalepsy Bar Test</h5><div class="NLM_p last">Catalepsy was assessed using the bar test. Each rat was placed on a clean, smooth table with a wooden bar (2 × 3 × 25 cm<sup>3</sup>, <i>H</i> × <i>W</i> × <i>L</i>) suspended 10 cm above the working surface. The animal’s hindlimbs were freely placed on the table, the tail laid out to the back, and the forelimbs gently placed over the bar. The length of time the animal touched the bar with both front paws was measured up to a preset cutoff time of 180 s. Results of each trial were scored as follows: 0 for holding the position for <15 s, 1 for holding it for 15–29.9 s, 2 for holding it for 30–59.9 s, and a maximum score of 3 for staying on the bar for >60 s. The minimum cataleptogenic dose was defined as the lowest dose inducing a mean catalepsy score of >1.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Catalepsy was scored 30, 60, and 120 min after administration of vehicle or a test drug (p.o.).</div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42"><a href="/doi/suppl/10.1021/jm401895u">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38111" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38111" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Additional binding site and ligand binding mode descriptions, extended chemical information and compound characterization, and detailed purity data for all compounds. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401895u/suppl_file/jm401895u_si_001.pdf">jm401895u_si_001.pdf (1.14 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm401895u" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84527" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84527" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marcin Kołaczkowski</span> - <span class="hlFld-Affiliation affiliation">Adamed Ltd., Pieńków
149, 05-152 Czosnów, Poland</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, Jagiellonian University Collegium
Medicum, 9 Medyczna Street, 30-688 Cracow, Poland</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#721f1300111b1c5c191d1e131108191d0501191b321316131f17165c111d1f5c021e521f1300111b1c5c191d1e131108191d0501191b3207185c1716075c021e"><span class="__cf_email__" data-cfemail="f994988b9a9097d7929695989a8392968e8a9290b9989d98949c9dd79a9694d78995">[email protected]</span> <span class="__cf_email__" data-cfemail="a0cdc1d2c3c9ce8ecbcfccc1c3dacbcfd7d3cbc9e0d5ca8ec5c4d58ed0cc">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Monika Marcinkowska</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, Jagiellonian University Collegium
Medicum, 9 Medyczna Street, 30-688 Cracow, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adam Bucki</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, Jagiellonian University Collegium
Medicum, 9 Medyczna Street, 30-688 Cracow, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maciej Pawłowski</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, Jagiellonian University Collegium
Medicum, 9 Medyczna Street, 30-688 Cracow, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katarzyna Mitka</span> - <span class="hlFld-Affiliation affiliation">Cracow
University of Technology, 24 Warszawska Street, 31-155 Cracow, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jolanta Jaśkowska</span> - <span class="hlFld-Affiliation affiliation">Cracow
University of Technology, 24 Warszawska Street, 31-155 Cracow, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Piotr Kowalski</span> - <span class="hlFld-Affiliation affiliation">Cracow
University of Technology, 24 Warszawska Street, 31-155 Cracow, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Grzegorz Kazek</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, Jagiellonian University Collegium
Medicum, 9 Medyczna Street, 30-688 Cracow, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Agata Siwek</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, Jagiellonian University Collegium
Medicum, 9 Medyczna Street, 30-688 Cracow, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Wasik</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, Jagiellonian University Collegium
Medicum, 9 Medyczna Street, 30-688 Cracow, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Wesołowska</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, Jagiellonian University Collegium
Medicum, 9 Medyczna Street, 30-688 Cracow, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paweł Mierzejewski</span> - <span class="hlFld-Affiliation affiliation">Institute
of Psychiatry and Neurology, 9 Sobieskiego Street, 02-957 Warsaw, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Przemyslaw Bienkowski</span> - <span class="hlFld-Affiliation affiliation">Institute
of Psychiatry and Neurology, 9 Sobieskiego Street, 02-957 Warsaw, Poland</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): Marcin Kolaczkowski is an employee of Adamed Ltd.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2254e3807-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25031" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25031" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This study was financially supported by Adamed Ltd. and the National Centre for Research and Development (NCBR) Grant No. KB/88/12655/IT1-C/U/08.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i44" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i44"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i45" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i45"> Abbreviations Used</h2><tr><td class="NLM_term">BPSD</td><td class="NLM_def"><p class="first last">behavioral and psychological symptoms of dementia</p></td></tr><tr><td class="NLM_term">5-HT<sub>2A</sub>R</td><td class="NLM_def"><p class="first last">5-HT<sub>2A</sub> serotonin receptor</p></td></tr><tr><td class="NLM_term">5-HT<sub>6</sub>R</td><td class="NLM_def"><p class="first last">5-HT<sub>6</sub> serotonin receptor</p></td></tr><tr><td class="NLM_term">5-HT<sub>7</sub>R</td><td class="NLM_def"><p class="first last">5-HT<sub>7</sub> serotonin receptor</p></td></tr><tr><td class="NLM_term">D<sub>2</sub>R</td><td class="NLM_def"><p class="first last">D<sub>2</sub> dopamine receptor</p></td></tr><tr><td class="NLM_term">M<sub>1</sub>R</td><td class="NLM_def"><p class="first last">M<sub>1</sub> muscarinic receptor</p></td></tr><tr><td class="NLM_term">β<sub>2</sub>R</td><td class="NLM_def"><p class="first last">β<sub>2</sub> adrenergic receptor</p></td></tr><tr><td class="NLM_term">TMH</td><td class="NLM_def"><p class="first last">transmembrane helix</p></td></tr><tr><td class="NLM_term">ECL</td><td class="NLM_def"><p class="first last">extracellular loop</p></td></tr><tr><td class="NLM_term">ICL</td><td class="NLM_def"><p class="first last">intracellular loop</p></td></tr><tr><td class="NLM_term">IFD</td><td class="NLM_def"><p class="first last">induced fit docking</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75876" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75876" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 67 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Liperoti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corsonello, A.</span><span> </span><span class="NLM_article-title">Antipsychotics for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)</span> <span class="citation_source-journal">Curr. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.2174%2F157015908784533860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=19305792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVaktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=117-124&author=R.+Liperotiauthor=C.+Pedoneauthor=A.+Corsonello&title=Antipsychotics+for+the+Treatment+of+Behavioral+and+Psychological+Symptoms+of+Dementia+%28BPSD%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Antipsychotics for the treatment of behavioral and psychological symptoms of dementia (BPSD)</span></div><div class="casAuthors">Liperoti, Rosa; Pedone, Claudio; Corsonello, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-124</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Behavioral and psychol. symptoms of dementia (BPSD), i.e. verbal and phys. aggression, agitation, psychotic symptoms (hallucinations and delusions), sleep disturbances, oppositional behavior, and wandering, are a common and potentially severe problem complicating dementia.  Their prevalence is very high and it is estd. that up to 90% of patients with Alzheimer's disease (AD) may present at least one BPSD.  Beside the obvious impact on the quality of life of people with dementia, BPSD are responsible for increased risk of patient institutionalization and increased costs.  Furthermore, they are assocd. with caregivers' stress and depression.  Drugs used include antipsychotics, antidepressants, anticonvulsivants, anxiolytics, cholinesterase inhibitors and N-methyl-D-aspartate receptor modulators.  Among these, the most commonly used are anti-psychotics.  These drugs have been used for many decades, but in the last years new compds. have been marketed with the promise of comparable efficacy but less frequent adverse effects (esp. extra-pyramidal side effects).  Their safety, however, has been challenged by data showing a potential increase in adverse cerebrovascular side effects and mortality.  This review will summarize the pathophysiol. and neuropharmacol. of BPSD, it will describe the characteristics of the anti-psychotics most commonly used focusing on their efficacy and safety in BPSD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAjjq7EOofHrVg90H21EOLACvtfcHk0lgKb6ctYeU08g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVaktLc%253D&md5=701fde11f34cc112cff2ba303853e36d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F157015908784533860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157015908784533860%26sid%3Dliteratum%253Aachs%26aulast%3DLiperoti%26aufirst%3DR.%26aulast%3DPedone%26aufirst%3DC.%26aulast%3DCorsonello%26aufirst%3DA.%26atitle%3DAntipsychotics%2520for%2520the%2520Treatment%2520of%2520Behavioral%2520and%2520Psychological%2520Symptoms%2520of%2520Dementia%2520%2528BPSD%2529%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2008%26volume%3D6%26spage%3D117%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Jeste, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blazer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meeks, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tariot, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaffe, K.</span><span> </span><span class="NLM_article-title">ACNP White Paper: Update on Use of Antipsychotic Drugs in Elderly Persons with Dementia</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">957</span><span class="NLM_x">–</span> <span class="NLM_lpage">970</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=957-970&author=D.+V.+Jesteauthor=D.+Blazerauthor=D.+Caseyauthor=T.+Meeksauthor=C.+Salzmanauthor=L.+Schneiderauthor=P.+Tariotauthor=K.+Yaffe&title=ACNP+White+Paper%3A+Update+on+Use+of+Antipsychotic+Drugs+in+Elderly+Persons+with+Dementia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJeste%26aufirst%3DD.%2BV.%26aulast%3DBlazer%26aufirst%3DD.%26aulast%3DCasey%26aufirst%3DD.%26aulast%3DMeeks%26aufirst%3DT.%26aulast%3DSalzman%26aufirst%3DC.%26aulast%3DSchneider%26aufirst%3DL.%26aulast%3DTariot%26aufirst%3DP.%26aulast%3DYaffe%26aufirst%3DK.%26atitle%3DACNP%2520White%2520Paper%253A%2520Update%2520on%2520Use%2520of%2520Antipsychotic%2520Drugs%2520in%2520Elderly%2520Persons%2520with%2520Dementia%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26spage%3D957%26epage%3D970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Carson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonagh, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, K.</span><span> </span><span class="NLM_article-title">A Systematic Review of the Efficacy and Safety of Atypical Antipsychotics in Patients with Psychological and Behavioral Symptoms of Dementia</span> <span class="citation_source-journal">J. Am. Geriatr. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">354</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1111%2Fj.1532-5415.2005.00566.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=16460391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FnsFOqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=354-361&author=S.+Carsonauthor=M.+S.+McDonaghauthor=K.+Peterson&title=A+Systematic+Review+of+the+Efficacy+and+Safety+of+Atypical+Antipsychotics+in+Patients+with+Psychological+and+Behavioral+Symptoms+of+Dementia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A systematic review of the efficacy and safety of atypical antipsychotics in patients with psychological and behavioral symptoms of dementia</span></div><div class="casAuthors">Carson Susan; McDonagh Marian S; Peterson Kim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Geriatrics Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">354-61</span>
        ISSN:<span class="NLM_cas:issn">0002-8614</span>.
    </div><div class="casAbstract">Although the Food and Drug Administration (FDA) has not approved atypical antipsychotics for use in patients with dementia, they are commonly prescribed in this population.  Recent concerns about increased risk of cerebrovascular events and mortality have led to warnings.  A systematic review was conducted to assess the benefits and harms of atypical antipsychotics when used in patients with behavioral and psychological symptoms of dementia.  Electronic searches (through March 2005) of the Cochrane Library, Medline, Embase, and PsycINFO were supplemented with hand searches of reference lists, dossiers submitted by pharmaceutical companies, and a review of the FDA Website and industry-sponsored results database.  Using predetermined criteria, each study was assessed for inclusion, and data about study design, population, interventions, and outcomes were abstracted.  An overall quality rating (good, fair, or poor) was assigned based on internal validity.  The evidence for olanzapine and risperidone supports their effectiveness compared with placebo.  Short-term adverse events were similar to placebo.  Risperidone had no advantage over haloperidol on efficacy measures in the better-quality studies.  Risperidone had an advantage over haloperidol on some measures of extrapyramidal symptoms.  Evidence for the other atypical antipsychotics is too limited to assess efficacy and safety.  Trials were short term and conducted in highly selected populations.  The potential for increased risk of cerebrovascular adverse events and mortality is a serious concern.  To make judgments about when the benefits of atypical antipsychotics outweigh the potential harms, clinicians need more information.  Additional data from existing trials and more-complete reporting of trial results could provide this information.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQZBZckcskL0xFwe7cAcrfPfW6udTcc2eY_0RkKkBPcxLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FnsFOqtQ%253D%253D&md5=d9c2bdfb8a6f44c9fbe2b42273f19c7d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1532-5415.2005.00566.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1532-5415.2005.00566.x%26sid%3Dliteratum%253Aachs%26aulast%3DCarson%26aufirst%3DS.%26aulast%3DMcDonagh%26aufirst%3DM.%2BS.%26aulast%3DPeterson%26aufirst%3DK.%26atitle%3DA%2520Systematic%2520Review%2520of%2520the%2520Efficacy%2520and%2520Safety%2520of%2520Atypical%2520Antipsychotics%2520in%2520Patients%2520with%2520Psychological%2520and%2520Behavioral%2520Symptoms%2520of%2520Dementia%26jtitle%3DJ.%2520Am.%2520Geriatr.%2520Soc.%26date%3D2006%26volume%3D54%26spage%3D354%26epage%3D361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">U.S. Food and Drug Administration</span><span class="NLM_x">. </span>Public Health Advisory: Deaths with Antipsychotics in Elderly Patients with Behavioral Disturbances; <span class="NLM_publisher-name">Center for Drug Evaluation and Research</span>: <span class="NLM_publisher-loc">Rockville, MD</span>, Apr 11,<span class="NLM_x"> </span><span class="NLM_year">2005</span>. <a href="http://www.fda.gov/Drugs/DrugSafety" class="extLink">www.fda.gov/Drugs/DrugSafety</a> (accessed Nov 28, 2013).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=U.S.+Food+and+Drug+Administration&title=Public+Health+Advisory%3A+Deaths+with+Antipsychotics+in+Elderly+Patients+with+Behavioral+Disturbances"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DPublic%2520Health%2520Advisory%253A%2520Deaths%2520with%2520Antipsychotics%2520in%2520Elderly%2520Patients%2520with%2520Behavioral%2520Disturbances%26pub%3DCenter%2520for%2520Drug%2520Evaluation%2520and%2520Research%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">U.S. Food and Drug Administration</span><span class="NLM_x">. </span>Information on Conventional Antipsychotics. <span class="NLM_publisher-name">Center for Drug Evaluation and Research</span>: <span class="NLM_publisher-loc">Rockville, MD</span>, Jun 16,<span class="NLM_x"> </span><span class="NLM_year">2008</span>. <a href="http://www.fda.gov/Drugs/DrugSafety" class="extLink">www.fda.gov/Drugs/DrugSafety</a> (accessed Nov 28, 2013).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=U.S.+Food+and+Drug+Administration&title=Information+on+Conventional+Antipsychotics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DInformation%2520on%2520Conventional%2520Antipsychotics%26pub%3DCenter%2520for%2520Drug%2520Evaluation%2520and%2520Research%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Schulze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Bussche, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaeske, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaduszkiewicz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, F.</span><span> </span><span class="NLM_article-title">Impact of Safety Warnings on Antipsychotic Prescriptions in Dementia: Nothing Has Changed but the Years and the Substances</span> <span class="citation_source-journal">Eur. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1034</span><span class="NLM_x">–</span> <span class="NLM_lpage">1042</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1016%2Fj.euroneuro.2013.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=23498307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFajsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1034-1042&author=J.+Schulzeauthor=H.+van+den+Busscheauthor=G.+Glaeskeauthor=H.+Kaduszkiewiczauthor=B.+Wieseauthor=F.+Hoffmann&title=Impact+of+Safety+Warnings+on+Antipsychotic+Prescriptions+in+Dementia%3A+Nothing+Has+Changed+but+the+Years+and+the+Substances"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of safety warnings on antipsychotic prescriptions in dementia: Nothing has changed but the years and the substances</span></div><div class="casAuthors">Schulze, Jana; van den Bussche, Hendrik; Glaeske, Gerd; Kaduszkiewicz, Hanna; Wiese, Birgitt; Hoffmann, Falk</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1034-1042</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dementia patients suffering from behavioral and psychol. symptoms (BPSD) are often treated with antipsychotics.  Trial results document an increased risk for serious adverse events and mortality in dementia patients taking these agents.  Furthermore, the efficacy of treating BPSD with antipsychotics seems to be only modest.  Using data of a German statutory health insurance company, we examd. prescription trends of antipsychotics in prevalent dementia patients in the context of official warnings.  The study period is 2004-2009.  We studied trends in demographics, age and sex, as well as need of care and the intake of typical and atypical antipsychotics.  Seeking for linear trends adjusted for age, sex and level of care between 2004 and 2009, we obtained p-values from a multivariate logistic regression.  Prescription vols. were calcd. by no. of packages as well as defined daily doses (DDDs) using multiple linear regressions for trends in prescriptions amt.  We included 3460-8042 patients per yr (mean age 80 years).  The prescription prevalence of antipsychotics decreased from 35.5% in 2004 to 32.5% in 2009 (multivariate anal. for linear trend: p=0.1645).  Overall prescriptions for typical antipsychotics decreased (from 27.2% in 2004 to 23.0% in 2009, p<0.0001) and prescriptions for atypical antipsychotics increased from 17.1% to 18.9% (p<0.0001).  The mean DDD per treated patient increased from 80.5 to 91.2 (2004-2009; p=0.0047).  Our findings imply that warnings of international drug authorities and manufacturers against adverse drug events in dementia patients receiving antipsychotics did not impact overall prescription behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFa2CSPI3OaLVg90H21EOLACvtfcHk0liSMRQPH57v1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFajsr0%253D&md5=8513f2c5a854e15bcc458a835b8136d1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2013.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2013.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DSchulze%26aufirst%3DJ.%26aulast%3Dvan%2Bden%2BBussche%26aufirst%3DH.%26aulast%3DGlaeske%26aufirst%3DG.%26aulast%3DKaduszkiewicz%26aufirst%3DH.%26aulast%3DWiese%26aufirst%3DB.%26aulast%3DHoffmann%26aufirst%3DF.%26atitle%3DImpact%2520of%2520Safety%2520Warnings%2520on%2520Antipsychotic%2520Prescriptions%2520in%2520Dementia%253A%2520Nothing%2520Has%2520Changed%2520but%2520the%2520Years%2520and%2520the%2520Substances%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2013%26volume%3D23%26spage%3D1034%26epage%3D1042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Riemer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levet-Trafit, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R. H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bös, M.</span><span> </span><span class="NLM_article-title">Influence of the 5-HT6 Receptor on Acetylcholine Release in the Cortex: Pharmacological Characterization of 4-(2-Bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a Potent and Selective 5-HT6 Receptor Antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1273</span><span class="NLM_x">–</span> <span class="NLM_lpage">1276</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm021085c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1273-1276&author=C.+Riemerauthor=E.+Borroniauthor=B.+Levet-Trafitauthor=J.+R.+Martinauthor=S.+Poliauthor=R.+H.+P.+Porterauthor=M.+B%C3%B6s&title=Influence+of+the+5-HT6+Receptor+on+Acetylcholine+Release+in+the+Cortex%3A+Pharmacological+Characterization+of+4-%282-Bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl%29phenylamine%2C+a+Potent+and+Selective+5-HT6+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm021085c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm021085c%26sid%3Dliteratum%253Aachs%26aulast%3DRiemer%26aufirst%3DC.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DLevet-Trafit%26aufirst%3DB.%26aulast%3DMartin%26aufirst%3DJ.%2BR.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DPorter%26aufirst%3DR.%2BH.%2BP.%26aulast%3DB%25C3%25B6s%26aufirst%3DM.%26atitle%3DInfluence%2520of%2520the%25205-HT6%2520Receptor%2520on%2520Acetylcholine%2520Release%2520in%2520the%2520Cortex%253A%2520Pharmacological%2520Characterization%2520of%25204-%25282-Bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl%2529phenylamine%252C%2520a%2520Potent%2520and%2520Selective%25205-HT6%2520Receptor%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1273%26epage%3D1276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Liu, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">5-HT6 Antagonists as Potential Treatment for Cognitive Dysfunction</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2009&pages=145-168&author=K.+G.+Liuauthor=A.+J.+Robichaud&title=5-HT6+Antagonists+as+Potential+Treatment+for+Cognitive+Dysfunction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%2BG.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3D5-HT6%2520Antagonists%2520as%2520Potential%2520Treatment%2520for%2520Cognitive%2520Dysfunction%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2009%26volume%3D70%26spage%3D145%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Wesołowska, A.</span><span> </span><span class="NLM_article-title">Potential Role of the 5-HT6 Receptor in Depression and Anxiety: An Overview of Preclinical Data</span> <span class="citation_source-journal">Pharmacol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">564</span><span class="NLM_x">–</span> <span class="NLM_lpage">577</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1016%2FS1734-1140%2810%2970315-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=20884998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitFGju7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=564-577&author=A.+Weso%C5%82owska&title=Potential+Role+of+the+5-HT6+Receptor+in+Depression+and+Anxiety%3A+An+Overview+of+Preclinical+Data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data</span></div><div class="casAuthors">Wesolowska, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reports</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">564-577</span>CODEN:
                <span class="NLM_cas:coden">PRHEDU</span>;
        ISSN:<span class="NLM_cas:issn">1734-1140</span>.
    
            (<span class="NLM_cas:orgname">Polish Academy of Sciences, Institute of Pharmacology</span>)
        </div><div class="casAbstract">A review.  Mental disorders, such as depression and anxiety, pose both medical and social challenges.  The clin. efficacy of current antidepressant/anxiolytic therapies is unsatisfactory; both antidepressant and anxiolytic drugs induce a variety of unwanted effects and have delayed onsets of action.  Thus, a search for better and safer agents is continuously in progress.  Preclin. results published so far have brought new insights into the possible role of recently discovered serotonin 5-HT6 receptors in these disorders.  This review surveys the current state of knowledge regarding potential antidepressant and anxiolytic activities of selective 5-HT6 receptor ligands, namely, full agonists and antagonists, in animal models commonly used to predict such activity.  Evidence indicates that both 5-HT6 agonists and antagonists may evoke identical responses in animal models of depression and anxiety; however, the possible mechanisms of these effects seem to be diverse and are not clearly understood.  Esp. interesting are the augmented effects achieved by combining antidepressants or diazepam with a selective 5-HT6 receptor antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI0iD46m6HHrVg90H21EOLACvtfcHk0lieEW_q-LtrSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitFGju7w%253D&md5=4284754e9b9fb26d3026605123567973</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS1734-1140%2810%2970315-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1734-1140%252810%252970315-7%26sid%3Dliteratum%253Aachs%26aulast%3DWeso%25C5%2582owska%26aufirst%3DA.%26atitle%3DPotential%2520Role%2520of%2520the%25205-HT6%2520Receptor%2520in%2520Depression%2520and%2520Anxiety%253A%2520An%2520Overview%2520of%2520Preclinical%2520Data%26jtitle%3DPharmacol.%2520Rep.%26date%3D2010%26volume%3D62%26spage%3D564%26epage%3D577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Wesołowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikiforuk, A.</span><span> </span><span class="NLM_article-title">Effects of the Brain-Penetrant and Selective 5-HT6 Receptor Antagonist SB-399885 in Animal Models of Anxiety and Depression</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1274</span><span class="NLM_x">–</span> <span class="NLM_lpage">1283</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2007&pages=1274-1283&author=A.+Weso%C5%82owskaauthor=A.+Nikiforuk&title=Effects+of+the+Brain-Penetrant+and+Selective+5-HT6+Receptor+Antagonist+SB-399885+in+Animal+Models+of+Anxiety+and+Depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeso%25C5%2582owska%26aufirst%3DA.%26aulast%3DNikiforuk%26aufirst%3DA.%26atitle%3DEffects%2520of%2520the%2520Brain-Penetrant%2520and%2520Selective%25205-HT6%2520Receptor%2520Antagonist%2520SB-399885%2520in%2520Animal%2520Models%2520of%2520Anxiety%2520and%2520Depression%26jtitle%3DNeuropharmacology%26date%3D2007%26volume%3D52%26spage%3D1274%26epage%3D1283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Woolley, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fone, K. C.</span><span> </span><span class="NLM_article-title">5-ht6 Receptors</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=59-79&author=M.+L.+Woolleyauthor=C.+A.+Marsdenauthor=K.+C.+Fone&title=5-ht6+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">5-ht6 receptors</span></div><div class="casAuthors">Woolley, Marie L.; Marsden, Charles A.; Fone, Kevin C. F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-79</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The 5-hydroxytryptamine6 (5-ht6) was 1 of the most recent addns. to the 5-HT receptor family, selective antagonists have recently been developed and potential functional roles are now becoming apparent.  The high affinity of a wide range of psychiatric drugs for the 5-ht6 receptor, together with its almost exclusive expression in the central nervous system, being abundant in limbic and cortical regions, has stimulated significant research interest.  The 5-ht6 receptor appears to regulate glutamatergic and cholinergic neuronal activity, and increasing evidence suggests that it may be involved in the regulation of cognition, feeding and, possibly, affective state and seizures.  The current article will review all aspects of the discovery, genetics, distribution, pharmacol., and function of the 5-ht6 receptor.  Taken together, this wealth of information warrants the use of the upper case nomenclature for the 5-ht6 receptor to be approved and its true status recognized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozK0SUNoG7ubVg90H21EOLACvtfcHk0lieEW_q-LtrSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWks78%253D&md5=3883fe6d1a7764bf81a6b22e255fbf4d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoolley%26aufirst%3DM.%2BL.%26aulast%3DMarsden%26aufirst%3DC.%2BA.%26aulast%3DFone%26aufirst%3DK.%2BC.%26atitle%3D5-ht6%2520Receptors%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2004%26volume%3D3%26spage%3D59%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Maher-Edwards, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvartau-Hind, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P.</span><span> </span><span class="NLM_article-title">Double-Blind, Controlled Phase II Study of a 5-HT6 Receptor Antagonist, SB-742457, in Alzheimer’s Disease</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">374</span><span class="NLM_x">–</span> <span class="NLM_lpage">385</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.2174%2F156720510791383831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=20043816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslSms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=374-385&author=G.+Maher-Edwardsauthor=M.+Zvartau-Hindauthor=A.+J.+Hunterauthor=M.+Goldauthor=G.+Hoptonauthor=G.+Jacobsauthor=M.+Davyauthor=P.+Williams&title=Double-Blind%2C+Controlled+Phase+II+Study+of+a+5-HT6+Receptor+Antagonist%2C+SB-742457%2C+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Double-blind, controlled phase II study of a 5-HT6 receptor antagonist, SB-742457, in Alzheimer's disease</span></div><div class="casAuthors">Maher-Edwards, G.; Zvartau-Hind, M.; Hunter, A. J.; Gold, M.; Hopton, G.; Jacobs, G.; Davy, M.; Williams, P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">374-385</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: This randomized, double-blind, placebo-controlled study investigated the efficacy and tolerability of the 5-HT6 receptor antagonist, SB-742457, in subjects with mild-to-moderate probable Alzheimer's disease (AD).  Methods: Participating subjects had a Mini-Mental State Examn. (MMSE) score of 12 to 26 after a 4-wk, single-blind, placebo run-in phase, and were randomized (2:1:1:2) to receive placebo, SB-742457 5 mg, 15 mg, or 35 mg once daily for 24 wk.  Coprimary efficacy endpoints were the Clinician's Interview-Based Impression of Change with care-giver input (CIBIC+) score and change from baseline in Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) score at Week 24, in the intent-to-treat (ITT) population.  A model-based design provided 90% power to detect a linear trend in treatment response across increasing doses and ≥90% power to compare SB-742457 35 mg with placebo.  Results: 371 subjects were randomized.  In the ITT population (n = 357), linear trend anal. at Week 24 suggested a dose response for CIBIC+ with a mean slope of -0.05 points/5-mg dose increase (95% confidence interval [CI]: -0.09, -0.01; p = 0.016).  The dose response slope for change from baseline in ADAS-Cog was -0.22 points/5-mg dose increase (95% CI: -0.45, 0.01; p = 0.059).  The adjusted mean treatment difference from placebo at Week 24 for SB-742457 35 mg (-0.31) was significant on CIBIC+ (95% CI: -0.62, -0.00; p = 0.047) but non-significant on ADAS-Cog (-1.28 [95% CI: -2.96, 0.40]; p = 0.135).  Adverse events occurred in 24-37% in the SB-742457 groups vs 29% for placebo; 11-16% discontinued SB-742457 vs 15% for placebo.  Comments: SB-742457 was generally safe and well tolerated and may be efficacious in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonAtHIMhwg2rVg90H21EOLACvtfcHk0lieEW_q-LtrSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslSms7s%253D&md5=9deecf58e64bdcc615c4e0d9b6a8874f</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F156720510791383831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720510791383831%26sid%3Dliteratum%253Aachs%26aulast%3DMaher-Edwards%26aufirst%3DG.%26aulast%3DZvartau-Hind%26aufirst%3DM.%26aulast%3DHunter%26aufirst%3DA.%2BJ.%26aulast%3DGold%26aufirst%3DM.%26aulast%3DHopton%26aufirst%3DG.%26aulast%3DJacobs%26aufirst%3DG.%26aulast%3DDavy%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DP.%26atitle%3DDouble-Blind%252C%2520Controlled%2520Phase%2520II%2520Study%2520of%2520a%25205-HT6%2520Receptor%2520Antagonist%252C%2520SB-742457%252C%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2010%26volume%3D7%26spage%3D374%26epage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">H. Lundbeck A/S</span><span class="NLM_x">. </span><span> </span><span class="NLM_article-title">Lundbeck’s Lu AE58054 Meets Primary Endpoint in Large Placebo-Controlled Clinical Proof of Concept Study in People with Alzheimer’s Disease</span>.  <span class="citation_source-journal">Corp. Release</span> <span class="NLM_volume">472</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span>. Published Online: May 29,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span>. <a href="http://investor.lundbeck.com/releasedetail.cfm?ReleaseID=677436" class="extLink">http://investor.lundbeck.com/releasedetail.cfm?ReleaseID=677436</a> (accessed Oct 23, 2012).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=472&publication_year=2012&pages=1-4&author=H.+Lundbeck+A%2FS&title=Lundbeck%E2%80%99s+Lu+AE58054+Meets+Primary+Endpoint+in+Large+Placebo-Controlled+Clinical+Proof+of+Concept+Study+in+People+with+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DLundbeck%25E2%2580%2599s%2520Lu%2520AE58054%2520Meets%2520Primary%2520Endpoint%2520in%2520Large%2520Placebo-Controlled%2520Clinical%2520Proof%2520of%2520Concept%2520Study%2520in%2520People%2520with%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DCorp.%2520Release%26volume%3D472%26spage%3D1%26epage%3D4%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Wesołowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikiforuk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachowicz, K.</span><span> </span><span class="NLM_article-title">Potential Anxiolytic and Antidepressant Effects of the Selective 5-HT7 Receptor Antagonist SB 269970 after Intrahippocampal Administration to Rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">553</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1016%2Fj.ejphar.2006.09.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=17097082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Ciu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=553&publication_year=2006&pages=185-190&author=A.+Weso%C5%82owskaauthor=A.+Nikiforukauthor=K.+Stachowicz&title=Potential+Anxiolytic+and+Antidepressant+Effects+of+the+Selective+5-HT7+Receptor+Antagonist+SB+269970+after+Intrahippocampal+Administration+to+Rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats</span></div><div class="casAuthors">Wesolowska, Anna; Nikiforuk, Agnieszka; Stachowicz, Katarzyna</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">553</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">185-190</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Using conflict drinking and forced swimming tests in rats, we examd. the anxiolytic- and the antidepressant-like activity, resp., of (2R)-1-[(3-hydroxyphenyl)sulfonyl]-2-[2-(4-methyl-1-piperidinyl)ethyl]-pyrrolidine (SB 269970), a selective 5-HT7 receptor antagonist, after its intrahippocampal administration.  SB 269970 at doses of 0.3, 1 and 3 μg showed an anticonflict effect which was weaker than that of diazepam (40 μg), whereas SB 269970 at doses of 3 and 10 μg had marked anti-immobility action comparable to that of imipramine (0.1 μg).  Importantly, the anxiolytic- and antidepressant-like activity of SB 269970 seemed to be specific, since that agent - when given by the same route in doses effective in either model - affected neither the shock threshold, nor the non-punished water consumption, nor the exploratory activity of rats.  The obtained results indicate that the hippocampus is one of the neuroanatomical structures involved in the potential anxiolytic and, in particular, antidepressant activity of SB 269970.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBHrggXO0ITrVg90H21EOLACvtfcHk0ljrL3itqjhvaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Ciu7bP&md5=60726295111355c2aa4aa9f3b175c302</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.09.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.09.064%26sid%3Dliteratum%253Aachs%26aulast%3DWeso%25C5%2582owska%26aufirst%3DA.%26aulast%3DNikiforuk%26aufirst%3DA.%26aulast%3DStachowicz%26aufirst%3DK.%26atitle%3DPotential%2520Anxiolytic%2520and%2520Antidepressant%2520Effects%2520of%2520the%2520Selective%25205-HT7%2520Receptor%2520Antagonist%2520SB%2520269970%2520after%2520Intrahippocampal%2520Administration%2520to%2520Rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D553%26spage%3D185%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Galici, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atack, J. R.</span><span> </span><span class="NLM_article-title">Effects of SB-269970, a 5-HT7 Receptor Antagonist, in Mouse Models Predictive of Antipsychotic-Like Activity</span> <span class="citation_source-journal">Behav. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1097%2FFBP.0b013e3282f62d8c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=18332680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtVektLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=153-159&author=R.+Galiciauthor=J.+D.+Boggsauthor=K.+L.+Millerauthor=P.+Bonaventureauthor=J.+R.+Atack&title=Effects+of+SB-269970%2C+a+5-HT7+Receptor+Antagonist%2C+in+Mouse+Models+Predictive+of+Antipsychotic-Like+Activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity</span></div><div class="casAuthors">Galici, Ruggero; Boggs, Jamin D.; Miller, Kirsten L.; Bonaventure, Pascal; Atack, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-159</span>CODEN:
                <span class="NLM_cas:coden">BPHAEL</span>;
        ISSN:<span class="NLM_cas:issn">0955-8810</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">5-HT7 receptors have been linked to a no. of psychiatric disorders including anxiety and depression.  The localization of 5-HT7 receptors in the thalamus, a key sensory processing center, and the high affinity of many atypical antipsychotic compds. for these receptors have led to the speculation of the utility of 5-HT7 antagonists in schizophrenia.  The goal of these studies was to examine the effects of pharmacol. blockade and genetic ablation of 5-HT7 receptors in animal models predictive of antipsychotic-like activity.  We evaluated the effects of SB-269970, a selective 5-HT7 receptor antagonist, on amphetamine and ketamine-induced hyperactivity and prepulse inhibition (PPI) deficits.  In addn., sensorimotor gating function and locomotor activity were evaluated in 5-HT7 knockout mice.  Locomotor activity was measured for up to 180 min using an automated IR photobeam system, and PPI was evaluated in startle chambers.  SB-269970 (3, 10 and 30 mg/kg, i.p.) significantly blocked amphetamine [3 mg/kg, s.c. (s.c.)] and ketamine (30 mg/kg, s.c.)-induced hyperactivity and reversed amphetamine (10 mg/kg, s.c.)-induced but not ketamine (30 mg/kg, s.c.)-induced PPI deficits, without changing spontaneous locomotor activity and startle amplitude.  The largest dose of SB-269970 did not block the effects of amphetamine in 5-HT7 knockout mice.  Collectively, these results indicate that blockade of 5-HT7 receptors partially modulates glutamatergic and dopaminergic function and could be clin. useful for the treatment of pos. symptoms of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx7-6Jq_YB-7Vg90H21EOLACvtfcHk0ljrL3itqjhvaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtVektLk%253D&md5=df107f3585744046400818d90dcbba2e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1097%2FFBP.0b013e3282f62d8c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFBP.0b013e3282f62d8c%26sid%3Dliteratum%253Aachs%26aulast%3DGalici%26aufirst%3DR.%26aulast%3DBoggs%26aufirst%3DJ.%2BD.%26aulast%3DMiller%26aufirst%3DK.%2BL.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DAtack%26aufirst%3DJ.%2BR.%26atitle%3DEffects%2520of%2520SB-269970%252C%2520a%25205-HT7%2520Receptor%2520Antagonist%252C%2520in%2520Mouse%2520Models%2520Predictive%2520of%2520Antipsychotic-Like%2520Activity%26jtitle%3DBehav.%2520Pharmacol.%26date%3D2008%26volume%3D19%26spage%3D153%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Waters, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stean, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virley, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kew, J. N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, I.</span><span> </span><span class="NLM_article-title">Effects of the Selective 5-HT(7) Receptor Antagonist SB-269970 in Animal Models of Psychosis and Cognition</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">228</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2012&pages=211-218&author=K.+A.+Watersauthor=T.+O.+Steanauthor=B.+Hammondauthor=D.+J.+Virleyauthor=N.+Uptonauthor=J.+N.+C.+Kewauthor=I.+Hussain&title=Effects+of+the+Selective+5-HT%287%29+Receptor+Antagonist+SB-269970+in+Animal+Models+of+Psychosis+and+Cognition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWaters%26aufirst%3DK.%2BA.%26aulast%3DStean%26aufirst%3DT.%2BO.%26aulast%3DHammond%26aufirst%3DB.%26aulast%3DVirley%26aufirst%3DD.%2BJ.%26aulast%3DUpton%26aufirst%3DN.%26aulast%3DKew%26aufirst%3DJ.%2BN.%2BC.%26aulast%3DHussain%26aufirst%3DI.%26atitle%3DEffects%2520of%2520the%2520Selective%25205-HT%25287%2529%2520Receptor%2520Antagonist%2520SB-269970%2520in%2520Animal%2520Models%2520of%2520Psychosis%2520and%2520Cognition%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2012%26volume%3D228%26spage%3D211%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Kim, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maneen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, S. M.</span><span> </span><span class="NLM_article-title">Building a Better Antipsychotic: Receptor Targets for the Treatment of Multiple Symptom Dimensions of Schizophrenia</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=78-85&author=D.+H.+Kimauthor=M.+J.+Maneenauthor=S.+M.+Stahl&title=Building+a+Better+Antipsychotic%3A+Receptor+Targets+for+the+Treatment+of+Multiple+Symptom+Dimensions+of+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DManeen%26aufirst%3DM.%2BJ.%26aulast%3DStahl%26aufirst%3DS.%2BM.%26atitle%3DBuilding%2520a%2520Better%2520Antipsychotic%253A%2520Receptor%2520Targets%2520for%2520the%2520Treatment%2520of%2520Multiple%2520Symptom%2520Dimensions%2520of%2520Schizophrenia%26jtitle%3DNeurotherapeutics%26date%3D2009%26volume%3D6%26spage%3D78%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designed Multiple Ligands. An Emerging Drug Discovery Paradigm</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6523</span><span class="NLM_x">–</span> <span class="NLM_lpage">6543</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058225d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6523-6543&author=R.+Morphyauthor=Z.+Rankovic&title=Designed+Multiple+Ligands.+An+Emerging+Drug+Discovery+Paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Designed Multiple Ligands.</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6523-6543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review discusses main areas in designed multiple ligands (DMLs) discovery that include 5HT transporter-based DMLs for depression, dopamine D2-receptor based DMLs for schizophrenia, histamine H1 receptor-based DMLs for allergies, DMLs targeting the angiotensin system for hypertension, nonsteroidal anti-inflammatory drugs, and PPAR-based DMLs for metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgouWcjsiKgbVg90H21EOLACvtfcHk0ljA4M_yO-x7YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL&md5=00e3bf5a521fc91996ce95bb379a0b5c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm058225d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058225d%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigned%2520Multiple%2520Ligands.%2520An%2520Emerging%2520Drug%2520Discovery%2520Paradigm%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6523%26epage%3D6543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Reynolds, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirk, S. L.</span><span> </span><span class="NLM_article-title">Metabolic Side Effects of Antipsychotic Drug Treatment: Pharmacological Mechanisms</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1016%2Fj.pharmthera.2009.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=19931306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFyiu77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2010&pages=169-179&author=G.+P.+Reynoldsauthor=S.+L.+Kirk&title=Metabolic+Side+Effects+of+Antipsychotic+Drug+Treatment%3A+Pharmacological+Mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic side effects of antipsychotic drug treatment - pharmacological mechanisms</span></div><div class="casAuthors">Reynolds, Gavin P.; Kirk, Shona L.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">169-179</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Obesity and metabolic syndrome, with increased risk of eventual cardiovascular disease and type II diabetes, are significant problems for patients receiving antipsychotic drugs and are likely contribute to their decreased life expectancy.  Several drug-related mechanisms may contribute to these problems, including effects both influencing food intake and on glucose and lipid metab.  The metabolic consequences of different antipsychotic drugs vary substantially; these variations reflect differences in receptor pharmacol. and provide clues as to the underlying pharmacol. mechanisms.  The two drugs with the greatest effects on body wt., olanzapine and clozapine, also have high affinity for the 5-HT2C and histamine H1 receptors, which implicate these receptors in antipsychotic-induced wt. gain, while peripheral M3 muscarinic receptor antagonism as well as central 5-HT2C effects may contribute to obesity-independent diabetes.  Other receptor mechanisms may have additive or synergistic effects; dopamine D2 receptor antagonism can enhance 5-HT2C-mediated effects on food intake, as well as influencing lipid and glucose metab. via disinhibition of prolactin secretion.  Pharmacogenetic assocns. of drug-induced wt. gain with 5-HT2C receptor and leptin gene polymorphisms, among others, have provided further clues.  Elevated leptin secretion in the absence of a decrease in food intake indicates drug-induced leptin insensitivity in the hypothalamus.  The minimal wt. gain seen with ziprasidone and aripiprazole may reflect their having further pharmacol. effects that protect against changes in food intake and related metabolic factors.  Understanding the pharmacol. of metabolic consequences of current antipsychotic drug treatment is clearly the key to developing improved pharmacotherapies that avoid these problematic and limiting adverse effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt7JyuRcCdILVg90H21EOLACvtfcHk0ljA4M_yO-x7YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFyiu77E&md5=548d49d2cca697e4405549be6ba0dd6f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2009.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2009.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DG.%2BP.%26aulast%3DKirk%26aufirst%3DS.%2BL.%26atitle%3DMetabolic%2520Side%2520Effects%2520of%2520Antipsychotic%2520Drug%2520Treatment%253A%2520Pharmacological%2520Mechanisms%26jtitle%3DPharmacol.%2520Ther.%26date%3D2010%26volume%3D125%26spage%3D169%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Bai, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liou, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, C.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, S.-J.</span><span> </span><span class="NLM_article-title">Association between HTR2C Polymorphisms and Metabolic Syndrome in Patients with Schizophrenia Treated with Atypical Antipsychotics</span> <span class="citation_source-journal">Schizophr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1016%2Fj.schres.2010.11.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=21185157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A280%3ADC%252BC3M7lt12htA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2011&pages=179-186&author=Y.+M.+Baiauthor=T.-T.+Chenauthor=Y.-J.+Liouauthor=C.-J.+Hongauthor=S.-J.+Tsai&title=Association+between+HTR2C+Polymorphisms+and+Metabolic+Syndrome+in+Patients+with+Schizophrenia+Treated+with+Atypical+Antipsychotics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Association between HTR2C polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics</span></div><div class="casAuthors">Bai Ya Mei; Chen Tzu-Ting; Liou Ying-Jay; Hong Chen-Jee; Tsai Shih-Jen</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">179-86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Previous research indicates that common single-nucleotide polymorphisms (SNPs) in the serotonin 5-HT2C receptor gene (HTR2C) are associated with metabolic syndrome (MetS) related to antipsychotic treatment.  This study analyzes a large sample of patients with schizophrenia treated with atypical antipsychotics to determine whether variation in the HTR2C is associated with MetS.  METHODS:  Six tag SNPs, capturing all common genetic variations in the HTR2C gene in the Han population, were genotyped in 456 Chinese schizophrenic inpatients treated with atypical antipsychotics (clozapine: 171, olanzapine: 91, and risperidone: 194).  RESULTS:  Single-marker based analysis shows that of the six HTR2C SNPs, the rs498177 SNP showed a significant association with MetS in female patients, and the C allele was associated with an increased risk of MetS (for genotype TT/TC/CC: MetS vs. non-MetS=50%/27%/23% vs. 69%/28%/3%, and for allele T/C: MetS vs. non-MetS=63%/37% vs. 83%/17%, p=0.0007).  Haplotype analysis shows that the A-C type of rs521018-rs498177 in the HTR2C gene significantly decreased the risk of MetS (corrected p=0.0108) in female patients.  CONCLUSIONS:  The results of this study support the role of HTR2C genetic variants in susceptibility to MetS in patients treated with atypical antipsychotics.  However, this association is gender-dependent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTnBdXwzFJU0FvAgqb2vdc5fW6udTcc2eZYtzJ8I4yRorntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7lt12htA%253D%253D&md5=cd478a49cd55f3e036443560be5bac18</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.schres.2010.11.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.schres.2010.11.030%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DY.%2BM.%26aulast%3DChen%26aufirst%3DT.-T.%26aulast%3DLiou%26aufirst%3DY.-J.%26aulast%3DHong%26aufirst%3DC.-J.%26aulast%3DTsai%26aufirst%3DS.-J.%26atitle%3DAssociation%2520between%2520HTR2C%2520Polymorphisms%2520and%2520Metabolic%2520Syndrome%2520in%2520Patients%2520with%2520Schizophrenia%2520Treated%2520with%2520Atypical%2520Antipsychotics%26jtitle%3DSchizophr.%2520Res.%26date%3D2011%26volume%3D125%26spage%3D179%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Rodefer, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnt, J.</span><span> </span><span class="NLM_article-title">Reversal of Subchronic PCP-Induced Deficits in Attentional Set Shifting in Rats by Sertindole and a 5-HT6 Receptor Antagonist: Comparison among Antipsychotics</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">2657</span><span class="NLM_x">–</span> <span class="NLM_lpage">2666</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=2657-2666&author=J.+S.+Rodeferauthor=T.+N.+Nguyenauthor=J.-J.+Karlssonauthor=J.+Arnt&title=Reversal+of+Subchronic+PCP-Induced+Deficits+in+Attentional+Set+Shifting+in+Rats+by+Sertindole+and+a+5-HT6+Receptor+Antagonist%3A+Comparison+among+Antipsychotics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodefer%26aufirst%3DJ.%2BS.%26aulast%3DNguyen%26aufirst%3DT.%2BN.%26aulast%3DKarlsson%26aufirst%3DJ.-J.%26aulast%3DArnt%26aufirst%3DJ.%26atitle%3DReversal%2520of%2520Subchronic%2520PCP-Induced%2520Deficits%2520in%2520Attentional%2520Set%2520Shifting%2520in%2520Rats%2520by%2520Sertindole%2520and%2520a%25205-HT6%2520Receptor%2520Antagonist%253A%2520Comparison%2520among%2520Antipsychotics%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26spage%3D2657%26epage%3D2666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Kołaczkowski, M.; Kowalski, P.; Jaśkowska, J.; Marcinkowska, M.; Mitka, K.; Bucki, A.; Wesołowska, A.; Pawłowski, M.</span><span> </span><span class="NLM_article-title">Arylsulfonamides for the Treatment of CNS Diseases</span>. PCT Int. Appl. WO 2012035123 (A1), Mar 22,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+Ko%C5%82aczkowski&author=P.+Kowalski&author=J.+Ja%C5%9Bkowska&author=M.+Marcinkowska&author=K.+Mitka&author=A.+Bucki&author=A.+Weso%C5%82owska&author=M.+Paw%C5%82owski&title=Arylsulfonamides+for+the+Treatment+of+CNS+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKo%25C5%2582aczkowski%26aufirst%3DM.%26atitle%3DArylsulfonamides%2520for%2520the%2520Treatment%2520of%2520CNS%2520Diseases%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Kołaczkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mierzejewski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienkowski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesołowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman-Tancredi, A.</span><span> </span><span class="NLM_article-title">Antipsychotic, Antidepressant, and Cognitive-Impairment Properties of Antipsychotics: Rat Profile and Implications for Behavioral and Psychological Symptoms of Dementia</span> <span class="citation_source-journal">Naunyn–Schmiedeberg’s Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">557</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1007%2Fs00210-014-0966-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=24599316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsF2isbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2014&pages=545-557&author=M.+Ko%C5%82aczkowskiauthor=P.+Mierzejewskiauthor=P.+Bienkowskiauthor=A.+Weso%C5%82owskaauthor=A.+Newman-Tancredi&title=Antipsychotic%2C+Antidepressant%2C+and+Cognitive-Impairment+Properties+of+Antipsychotics%3A+Rat+Profile+and+Implications+for+Behavioral+and+Psychological+Symptoms+of+Dementia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Antipsychotic, antidepressant, and cognitive-impairment properties of antipsychotics: rat profile and implications for behavioral and psychological symptoms of dementia</span></div><div class="casAuthors">Kolaczkowski, Marcin; Mierzejewski, Pawel; Bienkowski, Przemyslaw; Wesolowska, Anna; Newman-Tancredi, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">387</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">545-557</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Many dementia patients exhibit behavioral and psychol. symptoms (BPSD), including psychosis and depression.  Although antipsychotics are frequently prescribed off-label, they can have marked side effects.  In addn., comparative preclin. studies of their effects are surprisingly scarce, and strategies for discovery of novel pharmacotherapeutics are lacking.  We therefore compared eight antipsychotics in rat behavioral tests of psychosis, antidepressant-like activity, and cognitive impairment as a basis for preclin. evaluation of new drug candidates.  The methods used in this study include inhibition of MK-801-induced hyperactivity, forced swim test (FST), passive avoidance (PA), spontaneous locomotor activity, and catalepsy.  The drugs exhibited antipsychotic-like activity in the MK-801 test but with diverse profiles in the other models.  Risperidone impaired PA performance, but with some dose sepn. vs. its actions in the MK-801 test.  In contrast, clozapine, olanzapine, lurasidone, and asenapine showed little or no dose sepn. in these tests.  Aripiprazole did not impair PA performance but was poorly active in the MK-801 test.  Diverse effects were also obsd. in the FST: chlorpromazine was inactive and most other drugs reduced immobility over narrow dose ranges, whereas clozapine reduced immobility over a wider dose range, overlapping with antipsychotic activity.  Although the propensity of second-generation antipsychotics to produce catalepsy was lower, they all elicited pronounced sedation.  Consistent with clin. data, most currently available second-generation antipsychotics induced cognitive and motor side effects with little sepn. from therapeutic-like doses.  This study provides a uniform in vivo comparative basis on which to evaluate future early-stage drug candidates intended for potential pharmacotherapy of BPSD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjkNKMBogumrVg90H21EOLACvtfcHk0ljIpY6PYVYtBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsF2isbc%253D&md5=1202744b1594b23d9fa454061ef45ee6</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2Fs00210-014-0966-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-014-0966-4%26sid%3Dliteratum%253Aachs%26aulast%3DKo%25C5%2582aczkowski%26aufirst%3DM.%26aulast%3DMierzejewski%26aufirst%3DP.%26aulast%3DBienkowski%26aufirst%3DP.%26aulast%3DWeso%25C5%2582owska%26aufirst%3DA.%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26atitle%3DAntipsychotic%252C%2520Antidepressant%252C%2520and%2520Cognitive-Impairment%2520Properties%2520of%2520Antipsychotics%253A%2520Rat%2520Profile%2520and%2520Implications%2520for%2520Behavioral%2520and%2520Psychological%2520Symptoms%2520of%2520Dementia%26jtitle%3DNaunyn%25E2%2580%2593Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D2014%26volume%3D387%26spage%3D545%26epage%3D557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Kołaczkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawłowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bojarski, A. J.</span><span> </span><span class="NLM_article-title">Receptor-Based Pharmacophores for Serotonin 5-HT7R Antagonists-Implications to Selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6732</span><span class="NLM_x">–</span> <span class="NLM_lpage">6741</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060300c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6732-6741&author=M.+Ko%C5%82aczkowskiauthor=M.+Nowakauthor=M.+Paw%C5%82owskiauthor=A.+J.+Bojarski&title=Receptor-Based+Pharmacophores+for+Serotonin+5-HT7R+Antagonists-Implications+to+Selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm060300c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060300c%26sid%3Dliteratum%253Aachs%26aulast%3DKo%25C5%2582aczkowski%26aufirst%3DM.%26aulast%3DNowak%26aufirst%3DM.%26aulast%3DPaw%25C5%2582owski%26aufirst%3DM.%26aulast%3DBojarski%26aufirst%3DA.%2BJ.%26atitle%3DReceptor-Based%2520Pharmacophores%2520for%2520Serotonin%25205-HT7R%2520Antagonists-Implications%2520to%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6732%26epage%3D6741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Lemke, T. L.; Williams, D. A.</span> <span class="citation_source-book">Foye’s Principles of Medicinal Chemistry</span>; <span class="NLM_publisher-name">Lippincott Williams & Wilkins</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=T.+L.+Lemke&author=D.+A.+Williams&title=Foye%E2%80%99s+Principles+of+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLemke%26aufirst%3DT.%2BL.%26btitle%3DFoye%25E2%2580%2599s%2520Principles%2520of%2520Medicinal%2520Chemistry%26pub%3DLippincott%2520Williams%2520%2526%2520Wilkins%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Haga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yurugi-Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiroishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span> </span><span class="NLM_article-title">Structure of the Human M2Muscarinic Acetylcholine Receptor Bound to an Antagonist</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">482</span><span class="NLM_x">, </span> <span class="NLM_fpage">547</span><span class="NLM_x">–</span> <span class="NLM_lpage">551</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1038%2Fnature10753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=22278061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ejsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=482&publication_year=2012&pages=547-551&author=K.+Hagaauthor=A.+C.+Kruseauthor=H.+Asadaauthor=T.+Yurugi-Kobayashiauthor=M.+Shiroishiauthor=C.+Zhangauthor=W.+I.+Weisauthor=T.+Okadaauthor=B.+K.+Kobilkaauthor=T.+Hagaauthor=T.+Kobayashi&title=Structure+of+the+Human+M2Muscarinic+Acetylcholine+Receptor+Bound+to+an+Antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist</span></div><div class="casAuthors">Haga, Kazuko; Kruse, Andrew C.; Asada, Hidetsugu; Yurugi-Kobayashi, Takami; Shiroishi, Mitsunori; Zhang, Cheng; Weis, William I.; Okada, Tetsuji; Kobilka, Brian K.; Haga, Tatsuya; Kobayashi, Takuya</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">482</span>
        (<span class="NLM_cas:issue">7386</span>),
    <span class="NLM_cas:pages">547-551</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The X-ray crystal structure of the M2 muscarinic acetylcholine receptor, which is essential for the physiol. control of cardiovascular function, is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosewFev-FNErVg90H21EOLACvtfcHk0ljIpY6PYVYtBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ejsro%253D&md5=c33b8d9303d58db7dfdd4c18ec4f597b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnature10753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10753%26sid%3Dliteratum%253Aachs%26aulast%3DHaga%26aufirst%3DK.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DAsada%26aufirst%3DH.%26aulast%3DYurugi-Kobayashi%26aufirst%3DT.%26aulast%3DShiroishi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DOkada%26aufirst%3DT.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DHaga%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DT.%26atitle%3DStructure%2520of%2520the%2520Human%2520M2Muscarinic%2520Acetylcholine%2520Receptor%2520Bound%2520to%2520an%2520Antagonist%26jtitle%3DNature%26date%3D2012%26volume%3D482%26spage%3D547%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Kruse, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arlow, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbaum, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosemond, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chae, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dror, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wess, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span> </span><span class="NLM_article-title">Structure and Dynamics of the M3Muscarinic Acetylcholine Receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">482</span><span class="NLM_x">, </span> <span class="NLM_fpage">552</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=482&publication_year=2012&pages=552-556&author=A.+C.+Kruseauthor=J.+Huauthor=A.+C.+Panauthor=D.+H.+Arlowauthor=D.+M.+Rosenbaumauthor=E.+Rosemondauthor=H.+F.+Greenauthor=T.+Liuauthor=P.+S.+Chaeauthor=R.+O.+Drorauthor=D.+E.+Shawauthor=W.+I.+Weisauthor=J.+Wessauthor=B.+K.+Kobilka&title=Structure+and+Dynamics+of+the+M3Muscarinic+Acetylcholine+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DA.%2BC.%26aulast%3DArlow%26aufirst%3DD.%2BH.%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26aulast%3DRosemond%26aufirst%3DE.%26aulast%3DGreen%26aufirst%3DH.%2BF.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DChae%26aufirst%3DP.%2BS.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DWess%26aufirst%3DJ.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DStructure%2520and%2520Dynamics%2520of%2520the%2520M3Muscarinic%2520Acetylcholine%2520Receptor%26jtitle%3DNature%26date%3D2012%26volume%3D482%26spage%3D552%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Pearlstein, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preobrazhenskaya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shchekotikhin, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korolev, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lysenkova, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miroshnikova, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampe, D.</span><span> </span><span class="NLM_article-title">Characterization of HERG Potassium Channel Inhibition Using CoMSiA 3D QSAR and Homology Modeling Approaches</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1829</span><span class="NLM_x">–</span> <span class="NLM_lpage">1835</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1016%2FS0960-894X%2803%2900196-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=12729675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1Kjtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1829-1835&author=R.+A.+Pearlsteinauthor=R.+J.+Vazauthor=J.+Kangauthor=X.-L.+Chenauthor=M.+Preobrazhenskayaauthor=A.+E.+Shchekotikhinauthor=A.+M.+Korolevauthor=L.+N.+Lysenkovaauthor=O.+V.+Miroshnikovaauthor=J.+Hendrixauthor=D.+Rampe&title=Characterization+of+HERG+Potassium+Channel+Inhibition+Using+CoMSiA+3D+QSAR+and+Homology+Modeling+Approaches"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches</span></div><div class="casAuthors">Pearlstein, Robert A.; Vaz, Roy J.; Kang, Jiesheng; Chen, Xiao-Liang; Preobrazhenskaya, Maria; Shchekotikhin, Andrey E.; Korolev, Alexander M.; Lysenkova, Ludmila N.; Miroshnikova, Olga V.; Hendrix, James; Rampe, David</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1829-1835</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A data set consisting of twenty-two sertindole analogs and ten structurally diverse inhibitors, spanning a wide range in potency, was analyzed using CoMSiA.  A homol. model of HERG was constructed from the crystal structure of the open MthK potassium channel.  A complementary relationship between our CoMSiA and homol. models is apparent when the long inhibitor axis is oriented parallel to the longitudinal axis of the pore, with the tail region pointed toward the selectivity filter.  The key elements of the pharmacophore, the CoMSiA and the homol. model are: (1) The hydrophobic feature optimally consists of an arom. group that is capable of engaging in π-stacking with a Phe656 side chain.  Optionally, a second arom. or hydrophobic group present in some inhibitors may contact an addnl. Phe656 side chain. (2) The basic nitrogen appears to undergo a π-cation interaction with Tyr652. (3) The pore diam. (12 A+), and depth of the selectivity loop relative to the intracellular opening, act as constraints on the conformation-dependent inhibitor dimensions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnw_0UOBKeybVg90H21EOLACvtfcHk0lh3BrhO_c5mBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1Kjtrk%253D&md5=6c14583c31c65a3c71731a51e6b9e0f7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900196-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900196-3%26sid%3Dliteratum%253Aachs%26aulast%3DPearlstein%26aufirst%3DR.%2BA.%26aulast%3DVaz%26aufirst%3DR.%2BJ.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.-L.%26aulast%3DPreobrazhenskaya%26aufirst%3DM.%26aulast%3DShchekotikhin%26aufirst%3DA.%2BE.%26aulast%3DKorolev%26aufirst%3DA.%2BM.%26aulast%3DLysenkova%26aufirst%3DL.%2BN.%26aulast%3DMiroshnikova%26aufirst%3DO.%2BV.%26aulast%3DHendrix%26aufirst%3DJ.%26aulast%3DRampe%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520HERG%2520Potassium%2520Channel%2520Inhibition%2520Using%2520CoMSiA%25203D%2520QSAR%2520and%2520Homology%2520Modeling%2520Approaches%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1829%26epage%3D1835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Osterberg, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aqvist, J.</span><span> </span><span class="NLM_article-title">Exploring Blocker Binding to a Homology Model of the Open hERG K+ Channel Using Docking and Molecular Dynamics Methods</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">579</span><span class="NLM_x">, </span> <span class="NLM_fpage">2939</span><span class="NLM_x">–</span> <span class="NLM_lpage">2944</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=579&publication_year=2005&pages=2939-2944&author=F.+Osterbergauthor=J.+Aqvist&title=Exploring+Blocker+Binding+to+a+Homology+Model+of+the+Open+hERG+K%2B+Channel+Using+Docking+and+Molecular+Dynamics+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOsterberg%26aufirst%3DF.%26aulast%3DAqvist%26aufirst%3DJ.%26atitle%3DExploring%2520Blocker%2520Binding%2520to%2520a%2520Homology%2520Model%2520of%2520the%2520Open%2520hERG%2520K%252B%2520Channel%2520Using%2520Docking%2520and%2520Molecular%2520Dynamics%2520Methods%26jtitle%3DFEBS%2520Lett.%26date%3D2005%26volume%3D579%26spage%3D2939%26epage%3D2944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Forbes, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabbs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duckworth, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, N.</span><span> </span><span class="NLM_article-title">(R)-3,N-Dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-Yl) propyl]benzenesulfonamide: The First Selective 5-HT7 Receptor Antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">657</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970519e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=655-657&author=I.+T.+Forbesauthor=S.+Dabbsauthor=D.+M.+Duckworthauthor=A.+J.+Jenningsauthor=F.+D.+Kingauthor=P.+J.+Lovellauthor=A.+M.+Brownauthor=L.+Collinauthor=J.+J.+Haganauthor=D.+N.+Middlemissauthor=G.+J.+Rileyauthor=D.+R.+Thomasauthor=N.+Upton&title=%28R%29-3%2CN-Dimethyl-N-%5B1-methyl-3-%284-methyl-piperidin-1-Yl%29+propyl%5Dbenzenesulfonamide%3A+The+First+Selective+5-HT7+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm970519e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970519e%26sid%3Dliteratum%253Aachs%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DDabbs%26aufirst%3DS.%26aulast%3DDuckworth%26aufirst%3DD.%2BM.%26aulast%3DJennings%26aufirst%3DA.%2BJ.%26aulast%3DKing%26aufirst%3DF.%2BD.%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DCollin%26aufirst%3DL.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DRiley%26aufirst%3DG.%2BJ.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26aulast%3DUpton%26aufirst%3DN.%26atitle%3D%2528R%2529-3%252CN-Dimethyl-N-%255B1-methyl-3-%25284-methyl-piperidin-1-Yl%2529%2520propyl%255Dbenzenesulfonamide%253A%2520The%2520First%2520Selective%25205-HT7%2520Receptor%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D655%26epage%3D657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Kołaczkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mierzejewski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bieńkowski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesołowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman-Tancredi, A.</span><span> </span><span class="NLM_article-title">ADN-1184 a Monoaminergic Ligand with 5-HT6/7 Receptor Antagonist Activity: Pharmacological Profile and Potential Therapeutic Utility</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">984</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1111%2Fbph.12509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=24199650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1ehtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=973-984&author=M.+Ko%C5%82aczkowskiauthor=P.+Mierzejewskiauthor=P.+Bie%C5%84kowskiauthor=A.+Weso%C5%82owskaauthor=A.+Newman-Tancredi&title=ADN-1184+a+Monoaminergic+Ligand+with+5-HT6%2F7+Receptor+Antagonist+Activity%3A+Pharmacological+Profile+and+Potential+Therapeutic+Utility"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">ADN-1184 a monoaminergic ligand with 5-HT6/7 receptor antagonist activity: pharmacological profile and potential therapeutic utility</span></div><div class="casAuthors">Kolaczkowski, M.; Mierzejewski, P.; Bienkowski, P.; Wesolowska, A.; Newman-Tancredi, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">973-984</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose: Many dementia patients exhibit behavioral and psychol. symptoms (BPSD) that include psychosis, aggressivity, depression and anxiety.  Antipsychotic drugs are frequently prescribed but fail to significantly attenuate mood deficits, may interfere with cognitive function and are assocd. with motor and cardiac side effects, which are problematic in elderly patients.  A need therefore exists for drugs that are better suited for the treatment of BPSD.  Exptl. Approach: We used in vitro cellular and in vivo behavioral tests to characterize ADN-1184, a novel arylsulfonamide ligand with potential utility for treatment of BPSD.  Key Results: ADN-1184 exhibits substantial 5-HT6/5-HT7/5-HT2A/D2 receptor affinity and antagonist properties in vitro.  In tests of antipsychotic-like activity, it reversed MK-801-induced hyperactivity and stereotypies and inhibited conditioned avoidance response (MED = 3 mg·kg-1 i.p.).  Remarkably, ADN-1184 also reduced immobility time in the forced swim test at low doses (0.3 and 1 mg·kg-1 i.p.; higher doses were not significantly active).  Notably, up to 30 mg·kg-1 ADN-1184 did not impair memory performance in the passive avoidance test or elicit significant catalepsy and only modestly inhibited spontaneous locomotor activity (MED = 30 mg·kg-1 i.p.).  Conclusions and Implications: ADN-1184 combines antipsychotic-like with antidepressant-like properties without interfering with memory function or locomotion.  This profile is better than that of commonly used atypical antipsychotics tested under the same conditions and suggests that it is feasible to identify drugs that improve BPSD, without exacerbating cognitive deficit or movement impairment, which are of particular concern in patients with dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRj9iM1zSMXrVg90H21EOLACvtfcHk0lh3BrhO_c5mBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1ehtbw%253D&md5=d72b8585ba495cc647ba280bbcf0d896</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1111%2Fbph.12509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12509%26sid%3Dliteratum%253Aachs%26aulast%3DKo%25C5%2582aczkowski%26aufirst%3DM.%26aulast%3DMierzejewski%26aufirst%3DP.%26aulast%3DBie%25C5%2584kowski%26aufirst%3DP.%26aulast%3DWeso%25C5%2582owska%26aufirst%3DA.%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26atitle%3DADN-1184%2520a%2520Monoaminergic%2520Ligand%2520with%25205-HT6%252F7%2520Receptor%2520Antagonist%2520Activity%253A%2520Pharmacological%2520Profile%2520and%2520Potential%2520Therapeutic%2520Utility%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D973%26epage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Millan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivet, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audinot, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman-Tancredi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiofiss, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Queriaux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Despaux, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peglion, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dekeyne, A.</span><span> </span><span class="NLM_article-title">S18327 (1-[2-[4-(6-Fluoro-1, 2-benzisoxazol-3-Yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a Novel, Potential Antipsychotic Displaying Marked Antagonist Properties at Alpha(1)- and Alpha(2)-Adrenergic Receptors: II. Functional Profile and a Multiparametric Comparison with Haloperidol, Clozapine, and 11 Other Antipsychotic Agents</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=10604931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhslGntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2000&pages=54-66&author=M.+J.+Millanauthor=M.+Broccoauthor=J.+M.+Rivetauthor=V.+Audinotauthor=A.+Newman-Tancrediauthor=L.+Maiofissauthor=S.+Queriauxauthor=N.+Despauxauthor=J.+L.+Peglionauthor=A.+Dekeyne&title=S18327+%281-%5B2-%5B4-%286-Fluoro-1%2C+2-benzisoxazol-3-Yl%29piperid-1-yl%5Dethyl%5D3-phenyl+imidazolin-2-one%29%2C+a+Novel%2C+Potential+Antipsychotic+Displaying+Marked+Antagonist+Properties+at+Alpha%281%29-+and+Alpha%282%29-Adrenergic+Receptors%3A+II.+Functional+Profile+and+a+Multiparametric+Comparison+with+Haloperidol%2C+Clozapine%2C+and+11+Other+Antipsychotic+Agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at α1- and α2-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents</span></div><div class="casAuthors">Millan, Mark J.; Brocco, Mauricette; Rivet, Jean-Michel; Audinot, Valerie; Newman-Tancredi, Adrian; Maiofiss, Lisa; Queriaux, Sophie; Despaux, Nicole; Peglion, Jean-Louis; Dekeyne, Anne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-66</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">S18327 was dose-dependently active in several models of potential antipsychotic activity involving dopaminergic hyperactivity: inhibition of apomorphine-induced climbing in mice, of cocaine- and amphetamine-induced hyperlocomotion in rats, and of conditioned avoidance responses in rats.  Furthermore, reflecting its high affinity at serotonin2A sites, S18327 potently blocked phencyclidine-induced locomotion and 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane-induced head-twitches in rats.  In models of glutamatergic hypoactivity, S18327 blocked hyperlocomotion and spontaneous tail-flicks elicited by the N-methyl-D-aspartate antagonist dizocilpine.  The actions of S18327, together with its binding profile at multiple monoaminergic receptors (15 parameters in total), were compared with those of clozapine, haloperidol, and 11 other antipsychotics by multiparametric anal., and the resulting dendrogram positioned S18327 close to clozapine.  Consistent with a clopazine-like profile, S18327 generalized to a clozapine discriminative stimulus and evoked latent inhibition in rats, blocked aggression in isolated mice, and displayed anxiolytic properties in the ultrasonic vocalization and Vogel procedures in rats.  Relative to the above paradigms, only markedly (>20-fold) higher doses of S18327 were active in models predictive of potential extrapyramidal side effects: induction of catalepsy and prolactin secretion, and inhibition of methylphenidate-induced gnawing in rats.  S18327 showed only modest affinity for histaminic and muscarinic receptors.  Multiparametric anal. of these data distinguished S18327 from both haloperidol (high extrapyramidal potential) and clozapine (high histaminic and muscarinic affinity).  In conclusion, S18327 displays a broad-based pattern of potential antipsychotic activity at doses appreciably lower than those eliciting extrapyramidal side effects.  In this respect, S18327 closely resembles clozapine, but it is chem. distinct and displays weak affinity for histaminic and muscarinic receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgjrqW0hyvMLVg90H21EOLACvtfcHk0ljJbWPHK1Mfeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhslGntw%253D%253D&md5=8ec991a5e87a8f49603e5354caebda98</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3DBrocco%26aufirst%3DM.%26aulast%3DRivet%26aufirst%3DJ.%2BM.%26aulast%3DAudinot%26aufirst%3DV.%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26aulast%3DMaiofiss%26aufirst%3DL.%26aulast%3DQueriaux%26aufirst%3DS.%26aulast%3DDespaux%26aufirst%3DN.%26aulast%3DPeglion%26aufirst%3DJ.%2BL.%26aulast%3DDekeyne%26aufirst%3DA.%26atitle%3DS18327%2520%25281-%255B2-%255B4-%25286-Fluoro-1%252C%25202-benzisoxazol-3-Yl%2529piperid-1-yl%255Dethyl%255D3-phenyl%2520imidazolin-2-one%2529%252C%2520a%2520Novel%252C%2520Potential%2520Antipsychotic%2520Displaying%2520Marked%2520Antagonist%2520Properties%2520at%2520Alpha%25281%2529-%2520and%2520Alpha%25282%2529-Adrenergic%2520Receptors%253A%2520II.%2520Functional%2520Profile%2520and%2520a%2520Multiparametric%2520Comparison%2520with%2520Haloperidol%252C%2520Clozapine%252C%2520and%252011%2520Other%2520Antipsychotic%2520Agents%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D292%26spage%3D54%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Kongsamut, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roehr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampe, D.</span><span> </span><span class="NLM_article-title">A Comparison of the Receptor Binding and HERG Channel Affinities for a Series of Antipsychotic Drugs</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1016%2FS0014-2999%2802%2902074-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=12176106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtlKjsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2002&pages=37-41&author=S.+Kongsamutauthor=J.+Kangauthor=X.-L.+Chenauthor=J.+Roehrauthor=D.+Rampe&title=A+Comparison+of+the+Receptor+Binding+and+HERG+Channel+Affinities+for+a+Series+of+Antipsychotic+Drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs</span></div><div class="casAuthors">Kongsamut, Sathapana; Kang, Jiesheng; Chen, Xiao-Liang; Roehr, Joachim; Rampe, David</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">450</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-41</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Many antipsychotic drugs produce QT interval prolongation on the ECG.  Blockade of the human cardiac K+ channel known as human ether-a-go-go-related gene (HERG) often underlies such clin. findings.  In fact, HERG channel inhibition is now commonly used as a screen to predict the ability of a drug to prolong QT interval.  However, the exact relation between HERG channel blockade, target receptor binding affinity and clin. QT prolongation is not known.  Using patch-clamp electrophysiol., the authors examd. a series of seven antipsychotic drugs for their ability to block HERG, and detd. their IC50 values.  The authors then compared these results to their binding affinities (Ki values) for the dopamine D2 receptor, the 5-HT2A receptor and, where available, to clin. QT prolongation data.  The authors found that sertindole, pimozide and thioridazine displayed little (<10-fold) or no selectivity for dopamine D2 or 5-HT2A receptors relative to their HERG channel affinities.  This lack of selectivity likely underlies the significant QT interval prolongation obsd. with administration of these drugs.  Of the other drugs tested (ziprasidone, quetiapine, risperidone and olanzapine), olanzapine displayed the greatest selectivity for dopamine D2 and 5-HT2A receptor binding (100-1000-fold) compared to its HERG channel IC50.  The authors also compared these HERG channel IC50 values to QT interval prolongation and plasma drug levels obtained in a recent clin. study.  The authors found that the ratio of total plasma drug concn. to HERG IC50 value was indicative of the degree of QT prolongation obsd.  Target receptor affinity and expected clin. plasma levels are important parameters to consider for the interpretation of HERG channel data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1PPyFCa8xyrVg90H21EOLACvtfcHk0ljJbWPHK1Mfeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtlKjsbo%253D&md5=8b5879e5d59e01dcd490e71d57844fdf</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2902074-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252902074-5%26sid%3Dliteratum%253Aachs%26aulast%3DKongsamut%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.-L.%26aulast%3DRoehr%26aufirst%3DJ.%26aulast%3DRampe%26aufirst%3DD.%26atitle%3DA%2520Comparison%2520of%2520the%2520Receptor%2520Binding%2520and%2520HERG%2520Channel%2520Affinities%2520for%2520a%2520Series%2520of%2520Antipsychotic%2520Drugs%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D450%26spage%3D37%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Millan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cara, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dekeyne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panayi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Groote, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cistarelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billiras, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobert, A.</span><span> </span><span class="NLM_article-title">Selective Blockade of Dopamine D(3) versus D(2) Receptors Enhances Frontocortical Cholinergic Transmission and Social Memory in Rats: A Parallel Neurochemical and Behavioral Analysis</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">1047</span><span class="NLM_x">–</span> <span class="NLM_lpage">1061</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1111%2Fj.1471-4159.2006.04262.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=17266737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisFGnu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2007&pages=1047-1061&author=M.+J.+Millanauthor=B.+Di+Caraauthor=A.+Dekeyneauthor=F.+Panayiauthor=L.+De+Grooteauthor=D.+Sicardauthor=L.+Cistarelliauthor=R.+Billirasauthor=A.+Gobert&title=Selective+Blockade+of+Dopamine+D%283%29+versus+D%282%29+Receptors+Enhances+Frontocortical+Cholinergic+Transmission+and+Social+Memory+in+Rats%3A+A+Parallel+Neurochemical+and+Behavioral+Analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Selective blockade of dopamine D3 versus D2 receptors enhances frontal cortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioral analysis</span></div><div class="casAuthors">Millan, Mark J.; Di Cara, Benjamin; Dekeyne, Anne; Panayi, Fany; De Groote, Lotte; Sicard, Dorothee; Cistarelli, Laetitia; Billiras, Rodolphe; Gobert, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1047-1061</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Though dopaminergic mechanisms modulate cholinergic transmission and cognitive function, the significance of specific receptor subtypes remains uncertain.  Here, we examd. the roles of dopamine D3 vs. D2 receptors.  By analogy with tacrine (0.16-2.5 mg/kg, s.c.), the selective D3 receptor antagonists, S33084 (0.01-0.63) and SB277,011 (0.63-40.0), elicited dose-dependent, pronounced and sustained elevations in dialysis levels of acetylcholine (ACh) in the frontal cortex, but not the hippocampus, of freely-moving rats.  The actions of these antagonists were stereospecifically mimicked by (+)S14297 (1.25), whereas its inactive distomer, (-)S17777, was ineffective.  The preferential D2 receptor antagonist, L741,626 (10.0), failed to modify levels of ACh.  S33084 (0.01-0.63) and SB277,011 (0.16-2.5) also mimicked tacrine (0.04-0.63) by dose-dependently attenuating the deleterious influence of scopolamine (1.25) upon social memory (recognition by an adult rat of a juvenile conspecific).  Further, (+)S14297 (1.25) vs. (-)S17777 stereospecifically blocked the action of scopolamine.  Using an intersession interval of 120 min (spontaneous loss of recognition), S33084 (0.04-0.63), SB277,011 (0.16-10.0) and (+)S14297 (0.63-10.0) likewise mimicked tacrine (0.16-2.5) in enhancing social memory.  In contrast, L741,626 (0.16-10.0) displayed amnesic properties.  In conclusion, selective blockade of D3 receptors facilitates frontal cortical cholinergic transmission and improves social memory in rats.  These data support the pertinence of D3 receptors as a target for treatment of disorders in which cognitive function is compromised.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdxC_Nsga5b7Vg90H21EOLACvtfcHk0ljDhjBR_1rObA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisFGnu7g%253D&md5=e40dfd968d9f0a5ba2554511d84cd01e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04262.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04262.x%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3DDi%2BCara%26aufirst%3DB.%26aulast%3DDekeyne%26aufirst%3DA.%26aulast%3DPanayi%26aufirst%3DF.%26aulast%3DDe%2BGroote%26aufirst%3DL.%26aulast%3DSicard%26aufirst%3DD.%26aulast%3DCistarelli%26aufirst%3DL.%26aulast%3DBilliras%26aufirst%3DR.%26aulast%3DGobert%26aufirst%3DA.%26atitle%3DSelective%2520Blockade%2520of%2520Dopamine%2520D%25283%2529%2520versus%2520D%25282%2529%2520Receptors%2520Enhances%2520Frontocortical%2520Cholinergic%2520Transmission%2520and%2520Social%2520Memory%2520in%2520Rats%253A%2520A%2520Parallel%2520Neurochemical%2520and%2520Behavioral%2520Analysis%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D100%26spage%3D1047%26epage%3D1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Frånberg, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, T. H.</span><span> </span><span class="NLM_article-title">Involvement of 5-HT2A Receptor and α2-Adrenoceptor Blockade in the Asenapine-Induced Elevation of Prefrontal Cortical Monoamine Outflow</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">650</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2012&pages=650-660&author=O.+Fr%C3%A5nbergauthor=M.+M.+Marcusauthor=T.+H.+Svensson&title=Involvement+of+5-HT2A+Receptor+and+%CE%B12-Adrenoceptor+Blockade+in+the+Asenapine-Induced+Elevation+of+Prefrontal+Cortical+Monoamine+Outflow"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFr%25C3%25A5nberg%26aufirst%3DO.%26aulast%3DMarcus%26aufirst%3DM.%2BM.%26aulast%3DSvensson%26aufirst%3DT.%2BH.%26atitle%3DInvolvement%2520of%25205-HT2A%2520Receptor%2520and%2520%25CE%25B12-Adrenoceptor%2520Blockade%2520in%2520the%2520Asenapine-Induced%2520Elevation%2520of%2520Prefrontal%2520Cortical%2520Monoamine%2520Outflow%26jtitle%3DSynapse%26date%3D2012%26volume%3D66%26spage%3D650%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Wang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shofer, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoff, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFall, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raskind, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peskind, E. R.</span><span> </span><span class="NLM_article-title">Prazosin for the Treatment of Behavioral Symptoms in Patients with Alzheimer Disease with Agitation and Aggression</span> <span class="citation_source-journal">Am. J. Geriatr. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">744</span><span class="NLM_x">–</span> <span class="NLM_lpage">751</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1097%2FJGP.0b013e3181ab8c61" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=19700947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A280%3ADC%252BD1MrntlGmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=744-751&author=L.+Y.+Wangauthor=J.+B.+Shoferauthor=K.+Rohdeauthor=K.+L.+Hartauthor=D.+J.+Hoffauthor=Y.+H.+McFallauthor=M.+A.+Raskindauthor=E.+R.+Peskind&title=Prazosin+for+the+Treatment+of+Behavioral+Symptoms+in+Patients+with+Alzheimer+Disease+with+Agitation+and+Aggression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression</span></div><div class="casAuthors">Wang Lucy Y; Shofer Jane B; Rohde Kirsten; Hart Kim L; Hoff David J; McFall Yun H; Raskind Murray A; Peskind Elaine R</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">744-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  Agitation/aggression in Alzheimer disease (AD) is a major cause of patient distress, caregiver burden, and institutionalization.  Enhanced behavioral responsiveness to central nervous system norepinephrine (NE) release may contribute to the pathophysiology of agitation/aggression in AD.  Prazosin, a nonsedating generic medication used for hypertension and benign prostatic hypertrophy, antagonizes NE effects at brain postsynaptic alpha-1 adrenoreceptors.  This pilot study examined the efficacy and tolerability of prazosin for behavioral symptoms in patients with agitation/aggression in AD.  DESIGN:  Double-blind, placebo controlled, parallel group study.  SETTING:  A university AD center and a nursing home in Seattle, WA.  PARTICIPANTS:  Twenty-two nursing home and community-dwelling participants with agitation/aggression and probable or possible AD (mean age: 80.6 +/- 11.2).  INTERVENTION:  Randomization to placebo (N = 11) or prazosin (N = 11).  Medication was initiated at 1 mg/day and increased up to 6 mg/day using a flexible dosing algorithm.  MEASUREMENTS:  The Brief Psychiatric Rating Scale (BPRS) and Neuropsychiatric Inventory (NPI) at Weeks 1, 2, 4, 6, and 8.  The Clinical Global Impression of Change (CGIC) at Week 8.  RESULTS:  Participants taking prazosin (mean dose: 5.7 +/- 0.9 mg/day) had greater improvements than those taking placebo (mean dose: 5.6 +/- 1.2 mg/day) on the NPI (mean change: -19 +/- 21 versus -2 +/- 15, chi = 6.32, df = 1, p = 0.012) and BPRS (mean change: -9 +/- 9 versus -3 +/- 5, chi = 4.42, df = 1, p = 0.036) based on linear mixed effects models and the CGIC (mean: 2.6 +/- 1.0 versus 4.5 +/- 1.6, z = 2.57, p = 0.011 [Mann-Whitney test]).  Adverse effects and blood pressure changes were similar between prazosin and placebo groups.  CONCLUSION:  Prazosin was well tolerated and improved behavioral symptoms in patients with agitation/aggression in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQHerY8I1UKWUPI-fCgwosgfW6udTcc2eZMUPmSF4r9Xbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrntlGmsw%253D%253D&md5=e08f8232272a62e15ba0ad29fb7c176c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1097%2FJGP.0b013e3181ab8c61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FJGP.0b013e3181ab8c61%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%2BY.%26aulast%3DShofer%26aufirst%3DJ.%2BB.%26aulast%3DRohde%26aufirst%3DK.%26aulast%3DHart%26aufirst%3DK.%2BL.%26aulast%3DHoff%26aufirst%3DD.%2BJ.%26aulast%3DMcFall%26aufirst%3DY.%2BH.%26aulast%3DRaskind%26aufirst%3DM.%2BA.%26aulast%3DPeskind%26aufirst%3DE.%2BR.%26atitle%3DPrazosin%2520for%2520the%2520Treatment%2520of%2520Behavioral%2520Symptoms%2520in%2520Patients%2520with%2520Alzheimer%2520Disease%2520with%2520Agitation%2520and%2520Aggression%26jtitle%3DAm.%2520J.%2520Geriatr.%2520Psychiatry%26date%3D2009%26volume%3D17%26spage%3D744%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Szot, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenup, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverenz, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peskind, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raskind, M. A.</span><span> </span><span class="NLM_article-title">Compensatory Changes in the Noradrenergic Nervous System in the Locus Ceruleus and Hippocampus of Postmortem Subjects with Alzheimer’s Disease and Dementia with Lewy Bodies</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1523%2FJNEUROSCI.4265-05.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=16407544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD28XosFWkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=467-478&author=P.+Szotauthor=S.+S.+Whiteauthor=J.+L.+Greenupauthor=J.+B.+Leverenzauthor=E.+R.+Peskindauthor=M.+A.+Raskind&title=Compensatory+Changes+in+the+Noradrenergic+Nervous+System+in+the+Locus+Ceruleus+and+Hippocampus+of+Postmortem+Subjects+with+Alzheimer%E2%80%99s+Disease+and+Dementia+with+Lewy+Bodies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies</span></div><div class="casAuthors">Szot, Patricia; White, Sylvia S.; Greenup, J. Lynne; Leverenz, James B.; Peskind, Elaine R.; Raskind, Murray A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">467-478</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">In Alzheimer's disease (AD), there is a significant loss of locus ceruleus (LC) noradrenergic neurons.  However, functional and anatomical evidence indicates that the remaining noradrenergic neurons may be compensating for the loss.  Because the noradrenergic system plays an important role in learning and memory, it is important to det. whether compensation occurs in noradrenergic neurons in the LC and hippocampus of subjects with AD or a related dementing disorder, dementia with Lewy bodies (DLB).  We obsd. profound neuronal loss in the LC in AD and DLB subjects with three major changes in the noradrenergic system consistent with compensation: (1) an increase in tyrosine hydroxylase (TH) mRNA expression in the remaining neurons; (2) sprouting of dendrites into peri-LC dendritic zone, as detd. by α2-adrenoreceptors (ARs) and norepinephrine transporter binding sites; and (3) sprouting of axonal projections to the hippocampus as detd. by α2-ARs.  In AD and DLB subjects, the postsynaptic α1-ARs were normal to elevated.  Expression of α1A- and α2A-AR mRNA in the hippocampus of AD and DLB subjects were not altered, but expression of α1D- and α2C-AR mRNA was significantly reduced in the hippocampus of AD and DLB subjects.  Therefore, in AD and DLB subjects, there is compensation occurring in the remaining noradrenergic neurons, but there does appear to be a loss of specific AR in the hippocampus.  Because changes in these noradrenergic markers in AD vs. DLB subjects were similar (except neuronal loss and the increase in TH mRNA were somewhat greater in DLB subjects), the presence of Lewy bodies in addn. to plaques and tangles in DLB subjects does not appear to further affect the noradrenergic compensatory changes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxgbShoKhvPrVg90H21EOLACvtfcHk0liOyrIZtI6oQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosFWkuw%253D%253D&md5=0aaa93806c5f581442e6a8be0e33ac17</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4265-05.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4265-05.2006%26sid%3Dliteratum%253Aachs%26aulast%3DSzot%26aufirst%3DP.%26aulast%3DWhite%26aufirst%3DS.%2BS.%26aulast%3DGreenup%26aufirst%3DJ.%2BL.%26aulast%3DLeverenz%26aufirst%3DJ.%2BB.%26aulast%3DPeskind%26aufirst%3DE.%2BR.%26aulast%3DRaskind%26aufirst%3DM.%2BA.%26atitle%3DCompensatory%2520Changes%2520in%2520the%2520Noradrenergic%2520Nervous%2520System%2520in%2520the%2520Locus%2520Ceruleus%2520and%2520Hippocampus%2520of%2520Postmortem%2520Subjects%2520with%2520Alzheimer%25E2%2580%2599s%2520Disease%2520and%2520Dementia%2520with%2520Lewy%2520Bodies%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D467%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Reiner, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamondi, A.</span><span> </span><span class="NLM_article-title">Mechanisms of Antihistamine-Induced Sedation in the Human Brain: H1 Receptor Activation Reduces a Background Leakage Potassium Current</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">588</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1994&pages=579-588&author=P.+B.+Reinerauthor=A.+Kamondi&title=Mechanisms+of+Antihistamine-Induced+Sedation+in+the+Human+Brain%3A+H1+Receptor+Activation+Reduces+a+Background+Leakage+Potassium+Current"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReiner%26aufirst%3DP.%2BB.%26aulast%3DKamondi%26aufirst%3DA.%26atitle%3DMechanisms%2520of%2520Antihistamine-Induced%2520Sedation%2520in%2520the%2520Human%2520Brain%253A%2520H1%2520Receptor%2520Activation%2520Reduces%2520a%2520Background%2520Leakage%2520Potassium%2520Current%26jtitle%3DNeuroscience%26date%3D1994%26volume%3D59%26spage%3D579%26epage%3D588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Kirk, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glazebrook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grayson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neill, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, G. P.</span><span> </span><span class="NLM_article-title">Olanzapine-Induced Weight Gain in the Rat: Role of 5-HT2C and Histamine H1 Receptors</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">207</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2009&pages=119-125&author=S.+L.+Kirkauthor=J.+Glazebrookauthor=B.+Graysonauthor=J.+C.+Neillauthor=G.+P.+Reynolds&title=Olanzapine-Induced+Weight+Gain+in+the+Rat%3A+Role+of+5-HT2C+and+Histamine+H1+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKirk%26aufirst%3DS.%2BL.%26aulast%3DGlazebrook%26aufirst%3DJ.%26aulast%3DGrayson%26aufirst%3DB.%26aulast%3DNeill%26aufirst%3DJ.%2BC.%26aulast%3DReynolds%26aufirst%3DG.%2BP.%26atitle%3DOlanzapine-Induced%2520Weight%2520Gain%2520in%2520the%2520Rat%253A%2520Role%2520of%25205-HT2C%2520and%2520Histamine%2520H1%2520Receptors%26jtitle%3DPsychopharmacology%26date%3D2009%26volume%3D207%26spage%3D119%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">De Deyn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeste, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breder, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwamoto, T.</span><span> </span><span class="NLM_article-title">Aripiprazole for the Treatment of Psychosis in Patients with Alzheimer’s Disease: A Randomized, Placebo-Controlled Study</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1097%2F01.jcp.0000178415.22309.8f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=16160622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVShsLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=463-467&author=P.+De+Deynauthor=D.+V.+Jesteauthor=R.+Swaninkauthor=D.+Kosticauthor=C.+Brederauthor=W.+H.+Carsonauthor=T.+Iwamoto&title=Aripiprazole+for+the+Treatment+of+Psychosis+in+Patients+with+Alzheimer%E2%80%99s+Disease%3A+A+Randomized%2C+Placebo-Controlled+Study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Aripiprazole for the treatment of psychosis in patients with Alzheimer's disease: a randomized, placebo-controlled study</span></div><div class="casAuthors">De Deyn, Peter; Jeste, Dilip V.; Swanink, Rene; Kostic, Dusan; Breder, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">463-467</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">This study compared the efficacy, safety, and tolerability of aripiprazole, a novel antipsychotic, with placebo in patients with psychosis assocd. with Alzheimer's Disease (AD).  This 10-wk, double-blind, multicenter study randomized 208 outpatients (mean age, 81.5 years) with AD-assocd. psychosis to aripiprazole (n = 106) or placebo (n = 102).  The initial aripiprazole dose of 2 mg/d was titrated upwards (5, 10, or 15 mg/d) according to efficacy and tolerability.  Evaluations included Neuropsychiatric Inventory (NPI) Psychosis subscale and Brief Psychiatric Rating Scale (BPRS), adverse event (AE) reports, extrapyramidal symptoms (EPS) rating scales, and body wt.  Overall, 172 patients (83%) completed the study.  Mean aripiprazole dose at end point was 10.0 mg/d.  The NPI Psychosis subscale score showed improvements in both groups (aripiprazole, -6.55; placebo, -5.52; P = 0.17 at end point).  Aripiprazole-treated patients showed significantly greater improvements from baseline in BPRS Psychosis and BPRS Core subscale scores at end point compared with placebo.  AEs were generally mild to moderate in severity and included (aripiprazole vs. placebo): urinary tract infection (8% vs. 12%), accidental injury (8% vs. 5%), somnolence (8% vs. 1%), and bronchitis (6% vs. 3%).  Somnolence was mild and not assocd. with falls or accidental injury.  There were no significant differences from placebo in EPS scores, or clin. significant ECG abnormalities, vital signs, or wt.  In conclusion, aripiprazole showed similar improvements to placebo in psychotic symptoms as assessed by NPI Psychosis subscale scores, but significantly greater effects on BPRS Core and Psychosis assessments in community-living AD patients with psychosis.  Aripiprazole was safe and well tolerated in this patient population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcxfeaX0-hlrVg90H21EOLACvtfcHk0liOyrIZtI6oQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVShsLjP&md5=1f6f19fd6321c2060958ccf31ea1a71b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1097%2F01.jcp.0000178415.22309.8f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.jcp.0000178415.22309.8f%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BDeyn%26aufirst%3DP.%26aulast%3DJeste%26aufirst%3DD.%2BV.%26aulast%3DSwanink%26aufirst%3DR.%26aulast%3DKostic%26aufirst%3DD.%26aulast%3DBreder%26aufirst%3DC.%26aulast%3DCarson%26aufirst%3DW.%2BH.%26aulast%3DIwamoto%26aufirst%3DT.%26atitle%3DAripiprazole%2520for%2520the%2520Treatment%2520of%2520Psychosis%2520in%2520Patients%2520with%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520A%2520Randomized%252C%2520Placebo-Controlled%2520Study%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D2005%26volume%3D25%26spage%3D463%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Kołaczkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawłowski, M.</span><span> </span><span class="NLM_article-title">Ligand-Optimized Homology Models of D1 and D2 Dopamine Receptors: Application for Virtual Screening</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">638</span><span class="NLM_x">–</span> <span class="NLM_lpage">648</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci300413h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1yhsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=638-648&author=M.+Ko%C5%82aczkowskiauthor=A.+Buckiauthor=M.+Federauthor=M.+Paw%C5%82owski&title=Ligand-Optimized+Homology+Models+of+D1+and+D2+Dopamine+Receptors%3A+Application+for+Virtual+Screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-Optimized Homology Models of D1 and D2 Dopamine Receptors: Application for Virtual Screening</span></div><div class="casAuthors">Kolaczkowski, Marcin; Bucki, Adam; Feder, Marcin; Pawlowski, Maciej</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">638-648</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent breakthroughs in crystallog. studies of G protein-coupled receptors (GPCRs), together with continuous progress in mol. modeling methods, have opened new perspectives for structure-based drug discovery.  A crucial enhancement in this area was development of induced fit docking procedures that allow optimization of binding pocket conformation guided by the features of its active ligands.  In the course of our research program aimed at discovery of novel antipsychotic agents, our attention focused on dopaminergic D2 and D1 receptors (D2R and D1R).  Thus, we decided to investigate whether the availability of a novel structure of the closely related D3 receptor and application of induced fit docking procedures for binding pocket refinement would permit the building of models of D2R and D1R that facilitate a successful virtual screening (VS).  Here, we provide an in-depth description of the modeling procedure and the discussion of the results of a VS benchmark we performed to compare efficiency of the ligand-optimized receptors in comparison with the regular homol. models.  We obsd. that application of the ligand-optimized models significantly improved the VS performance both in terms of BEDROC (0.325 vs 0.182 for D1R and 0.383 vs 0.301 for D2R) as well as EF1% (20 vs 11 for D1R and 18 vs 10 for D2R).  In contrast, no improvement was obsd. for the performance of a D2R model built on the D3R template, when compared with that derived from the structure of the previously published and more evolutionary distant β2 adrenergic receptor.  The comparison of results for receptors built according to various protocols and templates revealed that the most significant factor for the receptor performance was a proper selection of tool ligand used in induced fit docking procedure.  Taken together, our results suggest that the described homol. modeling procedure could be a viable tool for structure-based GPCR ligand design, even for the targets for which only a relatively distant structural template is available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHGgw5lOnO9bVg90H21EOLACvtfcHk0lisMGac5xAz6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1yhsb0%253D&md5=58f111e8132b7229898f1a44feb6199b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fci300413h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci300413h%26sid%3Dliteratum%253Aachs%26aulast%3DKo%25C5%2582aczkowski%26aufirst%3DM.%26aulast%3DBucki%26aufirst%3DA.%26aulast%3DFeder%26aufirst%3DM.%26aulast%3DPaw%25C5%2582owski%26aufirst%3DM.%26atitle%3DLigand-Optimized%2520Homology%2520Models%2520of%2520D1%2520and%2520D2%2520Dopamine%2520Receptors%253A%2520Application%2520for%2520Virtual%2520Screening%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26spage%3D638%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Kowalski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaśkowska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bojarski, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duszyńska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kołaczkowski, M.</span><span> </span><span class="NLM_article-title">Evaluation of 1-Arylpiperazine Derivative of Hydroxybenzamides as 5-HT 1A and 5-HT7 Serotonin Receptor Ligands: An Experimental and Molecular Modeling Approach</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">192</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2011&pages=192-198&author=P.+Kowalskiauthor=J.+Ja%C5%9Bkowskaauthor=A.+J.+Bojarskiauthor=B.+Duszy%C5%84skaauthor=A.+Buckiauthor=M.+Ko%C5%82aczkowski&title=Evaluation+of+1-Arylpiperazine+Derivative+of+Hydroxybenzamides+as+5-HT+1A+and+5-HT7+Serotonin+Receptor+Ligands%3A+An+Experimental+and+Molecular+Modeling+Approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKowalski%26aufirst%3DP.%26aulast%3DJa%25C5%259Bkowska%26aufirst%3DJ.%26aulast%3DBojarski%26aufirst%3DA.%2BJ.%26aulast%3DDuszy%25C5%2584ska%26aufirst%3DB.%26aulast%3DBucki%26aufirst%3DA.%26aulast%3DKo%25C5%2582aczkowski%26aufirst%3DM.%26atitle%3DEvaluation%2520of%25201-Arylpiperazine%2520Derivative%2520of%2520Hydroxybenzamides%2520as%25205-HT%25201A%2520and%25205-HT7%2520Serotonin%2520Receptor%2520Ligands%253A%2520An%2520Experimental%2520and%2520Molecular%2520Modeling%2520Approach%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D2011%26volume%3D48%26spage%3D192%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Aranda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raviña, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masaguer, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Areias, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domínguez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selent, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loza, M. I.</span><span> </span><span class="NLM_article-title">Synthesis, Binding Affinity, and Molecular Docking Analysis of New Benzofuranone Derivatives as Potential Antipsychotics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6085</span><span class="NLM_x">–</span> <span class="NLM_lpage">6094</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800602w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6085-6094&author=R.+Arandaauthor=K.+Villalbaauthor=E.+Ravi%C3%B1aauthor=C.+F.+Masaguerauthor=J.+Breaauthor=F.+Areiasauthor=E.+Dom%C3%ADnguezauthor=J.+Selentauthor=L.+L%C3%B3pezauthor=F.+Sanzauthor=M.+Pastorauthor=M.+I.+Loza&title=Synthesis%2C+Binding+Affinity%2C+and+Molecular+Docking+Analysis+of+New+Benzofuranone+Derivatives+as+Potential+Antipsychotics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm800602w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800602w%26sid%3Dliteratum%253Aachs%26aulast%3DAranda%26aufirst%3DR.%26aulast%3DVillalba%26aufirst%3DK.%26aulast%3DRavi%25C3%25B1a%26aufirst%3DE.%26aulast%3DMasaguer%26aufirst%3DC.%2BF.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DAreias%26aufirst%3DF.%26aulast%3DDom%25C3%25ADnguez%26aufirst%3DE.%26aulast%3DSelent%26aufirst%3DJ.%26aulast%3DL%25C3%25B3pez%26aufirst%3DL.%26aulast%3DSanz%26aufirst%3DF.%26aulast%3DPastor%26aufirst%3DM.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26atitle%3DSynthesis%252C%2520Binding%2520Affinity%252C%2520and%2520Molecular%2520Docking%2520Analysis%2520of%2520New%2520Benzofuranone%2520Derivatives%2520as%2520Potential%2520Antipsychotics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6085%26epage%3D6094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Dukat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosier, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolanos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Binding of Serotonin and N1-Benzenesulfonyltryptamine-Related Analogs at Human 5-HT6 Serotonin Receptors: Receptor Modeling Studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">611</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070910s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=603-611&author=M.+Dukatauthor=P.+D.+Mosierauthor=R.+Kolanosauthor=B.+L.+Rothauthor=R.+A.+Glennon&title=Binding+of+Serotonin+and+N1-Benzenesulfonyltryptamine-Related+Analogs+at+Human+5-HT6+Serotonin+Receptors%3A+Receptor+Modeling+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm070910s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070910s%26sid%3Dliteratum%253Aachs%26aulast%3DDukat%26aufirst%3DM.%26aulast%3DMosier%26aufirst%3DP.%2BD.%26aulast%3DKolanos%26aufirst%3DR.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DBinding%2520of%2520Serotonin%2520and%2520N1-Benzenesulfonyltryptamine-Related%2520Analogs%2520at%2520Human%25205-HT6%2520Serotonin%2520Receptors%253A%2520Receptor%2520Modeling%2520Studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D603%26epage%3D611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">De la Fuente, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martín-Fontecha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sallander, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamú, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellissier, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claeysen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumuis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Rodríguez, M. L.</span><span> </span><span class="NLM_article-title">Benzimidazole Derivatives as New Serotonin 5-HT6 Receptor Antagonists. Molecular Mechanisms of Receptor Inactivation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1357</span><span class="NLM_x">–</span> <span class="NLM_lpage">1369</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901672k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1357-1369&author=T.+De+la+Fuenteauthor=M.+Mart%C3%ADn-Fontechaauthor=J.+Sallanderauthor=B.+Benham%C3%BAauthor=M.+Campilloauthor=R.+A.+Medinaauthor=L.+P.+Pellissierauthor=S.+Claeysenauthor=A.+Dumuisauthor=L.+Pardoauthor=M.+L.+L%C3%B3pez-Rodr%C3%ADguez&title=Benzimidazole+Derivatives+as+New+Serotonin+5-HT6+Receptor+Antagonists.+Molecular+Mechanisms+of+Receptor+Inactivation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm901672k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901672k%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2Bla%2BFuente%26aufirst%3DT.%26aulast%3DMart%25C3%25ADn-Fontecha%26aufirst%3DM.%26aulast%3DSallander%26aufirst%3DJ.%26aulast%3DBenham%25C3%25BA%26aufirst%3DB.%26aulast%3DCampillo%26aufirst%3DM.%26aulast%3DMedina%26aufirst%3DR.%2BA.%26aulast%3DPellissier%26aufirst%3DL.%2BP.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DDumuis%26aufirst%3DA.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26atitle%3DBenzimidazole%2520Derivatives%2520as%2520New%2520Serotonin%25205-HT6%2520Receptor%2520Antagonists.%2520Molecular%2520Mechanisms%2520of%2520Receptor%2520Inactivation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1357%26epage%3D1369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Van Loevezijn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venhorst, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwema Bakker, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Korte, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Looff, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoog, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Wees, J.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Hoeve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Woestijne, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Neut, M. A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borst, A. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dongen, M. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bruin, N. M. W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keizer, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, C. G.</span><span> </span><span class="NLM_article-title">N′-(Arylsulfonyl)pyrazoline-1-carboxamidines as Novel, Neutral 5-Hydroxytryptamine 6 Receptor (5-HT6R) Antagonists with Unique Structural Features</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7030</span><span class="NLM_x">–</span> <span class="NLM_lpage">7054</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200466r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7030-7054&author=A.+Van+Loevezijnauthor=J.+Venhorstauthor=W.+I.+Iwema+Bakkerauthor=C.+G.+de+Korteauthor=W.+de+Looffauthor=S.+Verhoogauthor=J.-W.+van+Weesauthor=M.+van+Hoeveauthor=R.+P.+van+de+Woestijneauthor=M.+A.+W.+van+der+Neutauthor=A.+J.+M.+Borstauthor=M.+J.+P.+van+Dongenauthor=N.+M.+W.+J.+de+Bruinauthor=H.+G.+Keizerauthor=C.+G.+Kruse&title=N%E2%80%B2-%28Arylsulfonyl%29pyrazoline-1-carboxamidines+as+Novel%2C+Neutral+5-Hydroxytryptamine+6+Receptor+%285-HT6R%29+Antagonists+with+Unique+Structural+Features"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm200466r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200466r%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BLoevezijn%26aufirst%3DA.%26aulast%3DVenhorst%26aufirst%3DJ.%26aulast%3DIwema%2BBakker%26aufirst%3DW.%2BI.%26aulast%3Dde%2BKorte%26aufirst%3DC.%2BG.%26aulast%3Dde%2BLooff%26aufirst%3DW.%26aulast%3DVerhoog%26aufirst%3DS.%26aulast%3Dvan%2BWees%26aufirst%3DJ.-W.%26aulast%3Dvan%2BHoeve%26aufirst%3DM.%26aulast%3Dvan%2Bde%2BWoestijne%26aufirst%3DR.%2BP.%26aulast%3Dvan%2Bder%2BNeut%26aufirst%3DM.%2BA.%2BW.%26aulast%3DBorst%26aufirst%3DA.%2BJ.%2BM.%26aulast%3Dvan%2BDongen%26aufirst%3DM.%2BJ.%2BP.%26aulast%3Dde%2BBruin%26aufirst%3DN.%2BM.%2BW.%2BJ.%26aulast%3DKeizer%26aufirst%3DH.%2BG.%26aulast%3DKruse%26aufirst%3DC.%2BG.%26atitle%3DN%25E2%2580%25B2-%2528Arylsulfonyl%2529pyrazoline-1-carboxamidines%2520as%2520Novel%252C%2520Neutral%25205-Hydroxytryptamine%25206%2520Receptor%2520%25285-HT6R%2529%2520Antagonists%2520with%2520Unique%2520Structural%2520Features%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7030%26epage%3D7054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Medina, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sallander, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamú, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porras, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Rodríguez, M. L.</span><span> </span><span class="NLM_article-title">Synthesis of New Serotonin 5-HT7 Receptor Ligands. Determinants of 5-HT7/5-HT1A Receptor Selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2384</span><span class="NLM_x">–</span> <span class="NLM_lpage">2392</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8014553" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2384-2392&author=R.+A.+Medinaauthor=J.+Sallanderauthor=B.+Benham%C3%BAauthor=E.+Porrasauthor=M.+Campilloauthor=L.+Pardoauthor=M.+L.+L%C3%B3pez-Rodr%C3%ADguez&title=Synthesis+of+New+Serotonin+5-HT7+Receptor+Ligands.+Determinants+of+5-HT7%2F5-HT1A+Receptor+Selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm8014553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8014553%26sid%3Dliteratum%253Aachs%26aulast%3DMedina%26aufirst%3DR.%2BA.%26aulast%3DSallander%26aufirst%3DJ.%26aulast%3DBenham%25C3%25BA%26aufirst%3DB.%26aulast%3DPorras%26aufirst%3DE.%26aulast%3DCampillo%26aufirst%3DM.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26atitle%3DSynthesis%2520of%2520New%2520Serotonin%25205-HT7%2520Receptor%2520Ligands.%2520Determinants%2520of%25205-HT7%252F5-HT1A%2520Receptor%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2384%26epage%3D2392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Farid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearlstein, R. A.</span><span> </span><span class="NLM_article-title">New Insights about HERG Blockade Obtained from Protein Modeling, Potential Energy Mapping, and Docking Studies</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3160</span><span class="NLM_x">–</span> <span class="NLM_lpage">3173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1016%2Fj.bmc.2005.12.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=16413785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1ehs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=3160-3173&author=R.+Faridauthor=T.+Dayauthor=R.+A.+Friesnerauthor=R.+A.+Pearlstein&title=New+Insights+about+HERG+Blockade+Obtained+from+Protein+Modeling%2C+Potential+Energy+Mapping%2C+and+Docking+Studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies</span></div><div class="casAuthors">Farid, Ramy; Day, Tyler; Friesner, Richard A.; Pearlstein, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3160-3173</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We created a homol. model of the homo-tetrameric pore domain of HERG using the crystal structure of the bacterial potassium channel, KvAP, as a template.  We docked a set of known blockers with well-characterized effects on channel function into the lumen of the pore between the selectivity filter and extracellular entrance using a novel docking and refinement procedure incorporating Glide and Prime.  Key arom. groups of the blockers are predicted to form multiple simultaneous ring stacking and hydrophobic interactions among the eight arom. residues lining the pore.  Furthermore, each blocker can achieve these interactions via multiple docking configurations.  To further interpret the docking results, we mapped hydrophobic and hydrophilic potentials within the lumen of each refined docked complex.  Hydrophilic iso-potential contours define a 'propeller-shaped' vol. at the selectivity filter entrance.  Hydrophobic contours define a hollow 'crown-shaped' vol. located above the 'propeller', whose hydrophobic 'rim' extends along the pore axis between Tyr652 and Phe656.  Blockers adopt conformations/binding orientations that closely mimic the shapes and properties of these contours.  Blocker basic groups are localized in the hydrophilic 'propeller', forming electrostatic interactions with Ser624 rather than a generally accepted π-cation interaction with Tyr652.  Terfenadine, cisapride, sertindole, ibutilide, and clofilium adopt similar docked poses, in which their N-substituents bridge radially across the hollow interior of the 'crown' (analogous to the hub and spokes of a wheel), and project arom./hydrophobic portions into the hydrophobic 'rim'.  MK-499 docks with its longitudinal axis parallel to the axis of the pore and crown', and its hydrophobic groups buried within the hydrophobic 'rim'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-1RsiljwGxrVg90H21EOLACvtfcHk0lil-2pBIRHjdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1ehs7o%253D&md5=8df638aa78d2d35337bb82d8a94357c4</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.12.032%26sid%3Dliteratum%253Aachs%26aulast%3DFarid%26aufirst%3DR.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DPearlstein%26aufirst%3DR.%2BA.%26atitle%3DNew%2520Insights%2520about%2520HERG%2520Blockade%2520Obtained%2520from%2520Protein%2520Modeling%252C%2520Potential%2520Energy%2520Mapping%252C%2520and%2520Docking%2520Studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D3160%26epage%3D3173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbaum, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, S. G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thian, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">High-Resolution Crystal Structure of an Engineered Human beta2-Adrenergic G Protein-Coupled Receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">1258</span><span class="NLM_x">–</span> <span class="NLM_lpage">1265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1126%2Fscience.1150577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=17962520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmur7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=1258-1265&author=V.+Cherezovauthor=D.+M.+Rosenbaumauthor=M.+A.+Hansonauthor=S.+G.+F.+Rasmussenauthor=F.+S.+Thianauthor=T.+S.+Kobilkaauthor=H.-J.+Choiauthor=P.+Kuhnauthor=W.+I.+Weisauthor=B.+K.+Kobilkaauthor=R.+C.+Stevens&title=High-Resolution+Crystal+Structure+of+an+Engineered+Human+beta2-Adrenergic+G+Protein-Coupled+Receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein-Coupled Receptor</span></div><div class="casAuthors">Cherezov, Vadim; Rosenbaum, Daniel M.; Hanson, Michael A.; Rasmussen, Soren G. F.; Thian, Foon Sun; Kobilka, Tong Sun; Choi, Hee-Jung; Kuhn, Peter; Weis, William I.; Kobilka, Brian K.; Stevens, Raymond C.; Takeda, S.; Kadowaki, S.; Haga, T.; Takaesu, H.; Mitaku, S.; Fredriksson, R.; Lagerstrom, M. C.; Lundin, L. G.; Schioth, H. B.; Pierce, K. L.; Premont, R. T.; Lefkowitz, R. J.; Lefkowitz, R. J.; Shenoy, S. K.; Rosenbaum, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">5854</span>),
    <span class="NLM_cas:pages">1258-1265</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Second extracellular loop, which in the β2-adrenergic receptor contains an unusual pair of disulfide bonds and an extra helix.  This loop and the absence Heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors constitute the largest family of eukaryotic signal transduction proteins that communicate across the membrane.  We report the crystal structure of a human β2-adrenergic receptor-T4 lysozyme fusion protein bound to the partial inverse agonist carazolol at 2.4 angstrom resoln.  The structure provides a high-resoln. view of a human G protein-coupled receptor bound to a diffusible ligand.  Ligand-binding site accessibility is enabled by the second extracellular loop, which is held out of the binding cavity by a pair of closely spaced disulfide bridges and a short helical segment within the loop.  Cholesterol, a necessary component for crystn., mediates an intriguing parallel assocn. of receptor mols. in the crystal lattice.  Although the location of carazolol in the β2-adrenergic receptor is very similar to that of retinal in rhodopsin, structural differences in the ligand-binding site and other regions highlight the challenges in using rhodopsin as a template model for this large receptor family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC-8wZ2k2GHLVg90H21EOLACvtfcHk0lil-2pBIRHjdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmur7I&md5=12c5bacb8464a4b243fe9341192b5b3b</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1126%2Fscience.1150577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1150577%26sid%3Dliteratum%253Aachs%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DRasmussen%26aufirst%3DS.%2BG.%2BF.%26aulast%3DThian%26aufirst%3DF.%2BS.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DChoi%26aufirst%3DH.-J.%26aulast%3DKuhn%26aufirst%3DP.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DHigh-Resolution%2520Crystal%2520Structure%2520of%2520an%2520Engineered%2520Human%2520beta2-Adrenergic%2520G%2520Protein-Coupled%2520Receptor%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D1258%26epage%3D1265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Kurowski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bujnicki, J. M.</span><span> </span><span class="NLM_article-title">GeneSilico Protein Structure Prediction Meta-Server</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">3305</span><span class="NLM_x">–</span> <span class="NLM_lpage">3307</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=3305-3307&author=M.+A.+Kurowskiauthor=J.+M.+Bujnicki&title=GeneSilico+Protein+Structure+Prediction+Meta-Server"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKurowski%26aufirst%3DM.%2BA.%26aulast%3DBujnicki%26aufirst%3DJ.%2BM.%26atitle%3DGeneSilico%2520Protein%2520Structure%2520Prediction%2520Meta-Server%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2003%26volume%3D31%26spage%3D3305%26epage%3D3307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Jain, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bairoch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redaschi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzek, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGarvey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasteiger, E.</span><span> </span><span class="NLM_article-title">Infrastructure for the Life Sciences: Design and Implementation of the UniProt Website</span> <span class="citation_source-journal">BMC Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=136&author=E.+Jainauthor=A.+Bairochauthor=S.+Duvaudauthor=I.+Phanauthor=N.+Redaschiauthor=B.+E.+Suzekauthor=M.+J.+Martinauthor=P.+McGarveyauthor=E.+Gasteiger&title=Infrastructure+for+the+Life+Sciences%3A+Design+and+Implementation+of+the+UniProt+Website"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DE.%26aulast%3DBairoch%26aufirst%3DA.%26aulast%3DDuvaud%26aufirst%3DS.%26aulast%3DPhan%26aufirst%3DI.%26aulast%3DRedaschi%26aufirst%3DN.%26aulast%3DSuzek%26aufirst%3DB.%2BE.%26aulast%3DMartin%26aufirst%3DM.%2BJ.%26aulast%3DMcGarvey%26aufirst%3DP.%26aulast%3DGasteiger%26aufirst%3DE.%26atitle%3DInfrastructure%2520for%2520the%2520Life%2520Sciences%253A%2520Design%2520and%2520Implementation%2520of%2520the%2520UniProt%2520Website%26jtitle%3DBMC%2520Bioinformatics%26date%3D2009%26volume%3D10%26spage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Arnold, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordoli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwede, T.</span><span> </span><span class="NLM_article-title">The SWISS-MODEL Workspace: A Web-Based Environment for Protein Structure Homology Modelling</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1093%2Fbioinformatics%2Fbti770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=16301204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD28XovVCltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=195-201&author=K.+Arnoldauthor=L.+Bordoliauthor=J.+Koppauthor=T.+Schwede&title=The+SWISS-MODEL+Workspace%3A+A+Web-Based+Environment+for+Protein+Structure+Homology+Modelling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling</span></div><div class="casAuthors">Arnold, Konstantin; Bordoli, Lorenza; Kopp, Juergen; Schwede, Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-201</span>CODEN:
                <span class="NLM_cas:coden">BOINFP</span>;
        ISSN:<span class="NLM_cas:issn">1367-4803</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Motivation: Homol. models of proteins are of great interest for planning and analyzing biol. expts. when no exptl. three-dimensional structures are available.  Building homol. models requires specialized programs and up-to-date sequence and structural databases.  Integrating all required tools, programs and databases into a single web-based workspace facilitates access to homol. modeling from a computer with web connection without the need of downloading and installing large program packages and databases.  Results: SWISS-MODEL workspace is a web-based integrated service dedicated to protein structure homol. modeling.  It assists and guides the user in building protein homol. models at different levels of complexity.  A personal working environment is provided for each user where several modeling projects can be carried out in parallel.  Protein sequence and structure databases necessary for modeling are accessible from the workspace and are updated in regular intervals.  Tools for template selection, model building and structure quality evaluation can be invoked from within the workspace.  Workflow and usage of the workspace are illustrated by modeling human Cyclin A1 and human Transmembrane Protease 3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDwXLAG5Kz27Vg90H21EOLACvtfcHk0lj6Ai4Vdu7DyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovVCltw%253D%253D&md5=66fa733d2ad6d2abf7d3d87ae837ebce</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbti770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbti770%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DK.%26aulast%3DBordoli%26aufirst%3DL.%26aulast%3DKopp%26aufirst%3DJ.%26aulast%3DSchwede%26aufirst%3DT.%26atitle%3DThe%2520SWISS-MODEL%2520Workspace%253A%2520A%2520Web-Based%2520Environment%2520for%2520Protein%2520Structure%2520Homology%2520Modelling%26jtitle%3DBioinformatics%26date%3D2006%26volume%3D22%26spage%3D195%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Guex, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peitsch, M. C.</span><span> </span><span class="NLM_article-title">SWISS-MODEL and the Swiss-PdbViewer: An Environment for Comparative Protein Modeling</span> <span class="citation_source-journal">Electrophoresis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2714</span><span class="NLM_x">–</span> <span class="NLM_lpage">2723</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1002%2Felps.1150181505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=9504803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADyaK1cXhvFaks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=2714-2723&author=N.+Guexauthor=M.+C.+Peitsch&title=SWISS-MODEL+and+the+Swiss-PdbViewer%3A+An+Environment+for+Comparative+Protein+Modeling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">SWISS-MODEL and the Swiss-PdbViewer. An environment for comparative protein modeling</span></div><div class="casAuthors">Guex, Nicolas; Peitsch, Manuel C.</div><div class="citationInfo"><span class="NLM_cas:title">Electrophoresis</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2714-2723</span>CODEN:
                <span class="NLM_cas:coden">ELCTDN</span>;
        ISSN:<span class="NLM_cas:issn">0173-0835</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">Comparative protein modeling is increasingly gaining interest since it is of great assistance during the rational design of mutagenesis expts.  The availability of this method, and the resulting models, has however been restricted by the availability of expensive computer hardware and software.  To overcome these limitations, the authors have developed an environment for comparative protein modeling that consists of SWISS-MODEL, a server for automated comparative protein modeling and of the SWISS-PdbViewer, a sequence to structure workbench.  The Swiss-PdbViewer not only acts as a client for SWISS-MODEL, but also provides a large selection of structure anal. and display tools.  In addn., the authors provide the SWISS-MODEL Repository, a database contg. more than 3500 automatically generated protein models.  By making such tools freely available to the scientific community, the authors hope to increase the use of protein structures and models in the process of expt. design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQsoTgcUeb6bVg90H21EOLACvtfcHk0lj6Ai4Vdu7DyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhvFaks70%253D&md5=f97197dfdb1cf196099b0576f150d14b</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1002%2Felps.1150181505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Felps.1150181505%26sid%3Dliteratum%253Aachs%26aulast%3DGuex%26aufirst%3DN.%26aulast%3DPeitsch%26aufirst%3DM.%2BC.%26atitle%3DSWISS-MODEL%2520and%2520the%2520Swiss-PdbViewer%253A%2520An%2520Environment%2520for%2520Comparative%2520Protein%2520Modeling%26jtitle%3DElectrophoresis%26date%3D1997%26volume%3D18%26spage%3D2714%26epage%3D2723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Schwede, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guex, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peitsch, M. C.</span><span> </span><span class="NLM_article-title">SWISS-MODEL: An Automated Protein Homology-Modeling Server</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">3381</span><span class="NLM_x">–</span> <span class="NLM_lpage">3385</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=3381-3385&author=T.+Schwedeauthor=J.+Koppauthor=N.+Guexauthor=M.+C.+Peitsch&title=SWISS-MODEL%3A+An+Automated+Protein+Homology-Modeling+Server"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchwede%26aufirst%3DT.%26aulast%3DKopp%26aufirst%3DJ.%26aulast%3DGuex%26aufirst%3DN.%26aulast%3DPeitsch%26aufirst%3DM.%2BC.%26atitle%3DSWISS-MODEL%253A%2520An%2520Automated%2520Protein%2520Homology-Modeling%2520Server%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2003%26volume%3D31%26spage%3D3381%26epage%3D3385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Sherman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farid, R.</span><span> </span><span class="NLM_article-title">Use of an Induced Fit Receptor Structure in Virtual Screening</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1111%2Fj.1747-0285.2005.00327.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=16492153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVSjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=83-84&author=W.+Shermanauthor=H.+S.+Beardauthor=R.+Farid&title=Use+of+an+Induced+Fit+Receptor+Structure+in+Virtual+Screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Use of an induced fit receptor structure in virtual screening</span></div><div class="casAuthors">Sherman, Woody; Beard, Hege S.; Farid, Ramy</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-84</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The automated induced fit docking protocol was used to generate the DFG-out conformation from a p38 MAP kinase activation loop starting from a DFG-in structure (1a9u) and the ligand from 1kv1 (BMU).  In a virtual screening study of 25K decoy ligands and 46 known actives, using an ensemble consisting of the induced fit docking structure (DFG-out) and the 1a9u crystal structure (DFG-in), 14 actives were identified in the top 1% of the database, including BMU and BIRB 796.  3 Actives were identified when 1a9u was used alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PRgtFzy8u7Vg90H21EOLACvtfcHk0liCTl5b7ySW2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVSjtL0%253D&md5=efe9900aacaaea6af805c1cbdb350c73</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2005.00327.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2005.00327.x%26sid%3Dliteratum%253Aachs%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DFarid%26aufirst%3DR.%26atitle%3DUse%2520of%2520an%2520Induced%2520Fit%2520Receptor%2520Structure%2520in%2520Virtual%2520Screening%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2006%26volume%3D67%26spage%3D83%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Sherman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farid, R.</span><span> </span><span class="NLM_article-title">Novel Procedure for Modeling Ligand/receptor Induced Fit Effects</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050540c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCgsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=534-553&author=W.+Shermanauthor=T.+Dayauthor=M.+P.+Jacobsonauthor=R.+A.+Friesnerauthor=R.+Farid&title=Novel+Procedure+for+Modeling+Ligand%2Freceptor+Induced+Fit+Effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Procedure for Modeling Ligand/Receptor Induced Fit Effects</span></div><div class="casAuthors">Sherman, Woody; Day, Tyler; Jacobson, Matthew P.; Friesner, Richard A.; Farid, Ramy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">534-553</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present a novel protein-ligand docking method that accurately accounts for both ligand and receptor flexibility by iteratively combining rigid receptor docking (Glide) with protein structure prediction (Prime) techniques.  While traditional rigid-receptor docking methods are useful when the receptor structure does not change substantially upon ligand binding, success is limited when the protein must be "induced" into the correct binding conformation for a given ligand.  We provide an in-depth description of our novel methodol. and present results for 21 pharmaceutically relevant examples.  Traditional rigid-receptor docking for these 21 cases yields an av. RMSD of 5.5 Å.  The av. ligand RMSD for docking to a flexible receptor for the 21 pairs is 1.4 Å; the RMSD is ≤1.8 Å for 18 of the cases.  For the three cases with RMSDs greater than 1.8 Å, the core of the ligand is properly docked and all key protein/ligand interactions are captured.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm3E6ctnPGSrVg90H21EOLACvtfcHk0liCTl5b7ySW2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCgsr7I&md5=388811ead5cee1fd460951263de486cb</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm050540c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050540c%26sid%3Dliteratum%253Aachs%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DFarid%26aufirst%3DR.%26atitle%3DNovel%2520Procedure%2520for%2520Modeling%2520Ligand%252Freceptor%2520Induced%2520Fit%2520Effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D534%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klicic, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenkin, P. S.</span><span> </span><span class="NLM_article-title">Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1739</span><span class="NLM_x">–</span> <span class="NLM_lpage">1749</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+A+New+Approach+for+Rapid%2C+Accurate+Docking+and+Scoring.+1.+Method+and+Assessment+of+Docking+Accuracy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0liCTl5b7ySW2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520A%2520New%2520Approach%2520for%2520Rapid%252C%2520Accurate%2520Docking%2520and%2520Scoring.%25201.%2520Method%2520and%2520Assessment%2520of%2520Docking%2520Accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenwood, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanschagrin, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span> </span><span class="NLM_article-title">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6177</span><span class="NLM_x">–</span> <span class="NLM_lpage">6196</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051256o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6177-6196&author=R.+A.+Friesnerauthor=R.+B.+Murphyauthor=M.+P.+Repaskyauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=T.+A.+Halgrenauthor=P.+C.+Sanschagrinauthor=D.+T.+Mainz&title=Extra+Precision+Glide%3A+Docking+and+Scoring+Incorporating+a+Model+of+Hydrophobic+Enclosure+for+Protein-Ligand+Complexes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span></div><div class="casAuthors">Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P.; Frye, Leah L.; Greenwood, Jeremy R.; Halgren, Thomas A.; Sanschagrin, Paul C.; Mainz, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6177-6196</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel scoring function to est. protein-ligand binding affinities has been developed and implemented as the Glide 4.0 XP scoring function and docking protocol.  In addn. to unique water desolvation energy terms, protein-ligand structural motifs leading to enhanced binding affinity are included:(1) hydrophobic enclosure where groups of lipophilic ligand atoms are enclosed on opposite faces by lipophilic protein atoms, (2) neutral-neutral single or correlated hydrogen bonds in a hydrophobically enclosed environment, and (3) five categories of charged-charged hydrogen bonds.  The XP scoring function and docking protocol have been developed to reproduce exptl. binding affinities for a set of 198 complexes (RMSDs of 2.26 and 1.73 kcal/mol over all and well-docked ligands, resp.) and to yield quality enrichments for a set of fifteen screens of pharmaceutical importance.  Enrichment results demonstrate the importance of the novel XP mol. recognition and water scoring in sepg. active and inactive ligands and avoiding false positives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZiwN12vaY7Vg90H21EOLACvtfcHk0lhLZjOB9m-g_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D&md5=ea428c82ead0d8c27f8c1a7b694a1edf</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm051256o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051256o%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DSanschagrin%26aufirst%3DP.%2BC.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26atitle%3DExtra%2520Precision%2520Glide%253A%2520Docking%2520and%2520Scoring%2520Incorporating%2520a%2520Model%2520of%2520Hydrophobic%2520Enclosure%2520for%2520Protein-Ligand%2520Complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6177%26epage%3D6196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honig, B.</span><span> </span><span class="NLM_article-title">On the Role of the Crystal Environment in Determining Protein Side-Chain Conformations</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1016%2FS0022-2836%2802%2900470-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=12096912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD38XltVKmu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2002&pages=597-608&author=M.+P.+Jacobsonauthor=R.+A.+Friesnerauthor=Z.+Xiangauthor=B.+Honig&title=On+the+Role+of+the+Crystal+Environment+in+Determining+Protein+Side-Chain+Conformations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">On the Role of the Crystal Environment in Determining Protein Side-chain Conformations</span></div><div class="casAuthors">Jacobson, Matthew P.; Friesner, Richard A.; Xiang, Zhexin; Honig, Barry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">597-608</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The role of crystal packing in detg. the obsd. conformations of amino acid side-chains in protein crystals is investigated by (1) anal. of a database of proteins that have been crystd. in different unit cells (space group or unit cell dimensions) and (2) theor. predictions of side-chain conformations with the crystal environment explicitly represented.  Both of these approaches indicate that the crystal environment plays an important role in detg. the conformations of polar side-chains on the surfaces of proteins.  Inclusion of the crystal environment permits a more sensitive measurement of the achievable accuracy of side-chain prediction programs, when validating against structures obtained by x-ray crystallog.  Our side-chain prediction program uses an all-atom force field and a Generalized Born model of solvation and is thus capable of modeling simple packing effects (i.e. van der Waals interactions), electrostatic effects, and desolvation, which are all important mechanisms by which the crystal environment impacts obsd. side-chain conformations.  Our results are also relevant to the understanding of changes in side-chain conformation that may result from ligand docking and protein-protein assocn., insofar as the results reveal how side-chain conformations change in response to their local environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgHEOVpIEiErVg90H21EOLACvtfcHk0lhLZjOB9m-g_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltVKmu70%253D&md5=006de6bd2d0f233ab32d6798dc1a3fbc</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2802%2900470-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252802%252900470-9%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DHonig%26aufirst%3DB.%26atitle%3DOn%2520the%2520Role%2520of%2520the%2520Crystal%2520Environment%2520in%2520Determining%2520Protein%2520Side-Chain%2520Conformations%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2002%26volume%3D320%26spage%3D597%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pincus, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapp, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, T. J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honig, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">A Hierarchical Approach to All-Atom Protein Loop Prediction</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1002%2Fprot.10613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=15048827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFKhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=351-367&author=M.+P.+Jacobsonauthor=D.+L.+Pincusauthor=C.+S.+Rappauthor=T.+J.+F.+Dayauthor=B.+Honigauthor=D.+E.+Shawauthor=R.+A.+Friesner&title=A+Hierarchical+Approach+to+All-Atom+Protein+Loop+Prediction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">A hierarchical approach to all-atom protein loop prediction</span></div><div class="casAuthors">Jacobson, Matthew P.; Pincus, David L.; Rapp, Chaya S.; Day, Tyler J. F.; Honig, Barry; Shaw, David E.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">351-367</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The application of all-atom force fields (and explicit or implicit solvent models) to protein homol.-modeling tasks such as side-chain and loop prediction remains challenging both because of the expense of the individual energy calcns. and because of the difficulty of sampling the rugged all-atom energy surface.  Here the authors address this challenge for the problem of loop prediction through the development of numerous new algorithms, with an emphasis on multiscale and hierarchical techniques.  As a first step in evaluating the performance of the authors' loop prediction algorithm, the authors have applied it to the problem of reconstructing loops in native structures; the authors also explicitly include crystal packing to provide a fair comparison with crystal structures.  In brief, large nos. of loops are generated by using a dihedral angle-based buildup procedure followed by iterative cycles of clustering, side-chain optimization, and complete energy minimization of selected loop structures.  The authors evaluate this method by the largest test set yet used for validation of a loop prediction method, with a total of 833 loops ranging from 4 to 12 residues in length.  Av./median backbone root-mean-square deviations (RMSDs) to the native structures (superimposing the body of the protein, not the loop itself) are 0.42/0.24 Å for 5 residue loops, 1.00/0.44 Å for 8 residue loops, and 2.47/1.83 Å for 11 residue loops.  Median RMSDs are substantially lower than the avs. because of a small no. of outliers; the causes of these failures are examd. in some detail, and many can be attributed to errors in assignment of protonation states of titratable residues, omission of ligands from the simulation, and, in a few cases, probable errors in the exptl. detd. structures.  When these obvious problems in the data sets are filtered out, av. RMSDs to the native structures improve to 0.43 Å for 5 residue loops, 0.84 Å for 8 residue loops, and 1.63 Å for 11 residue loops.  In the vast majority of cases, the method locates energy min. that are lower than or equal to that of the minimized native loop, thus indicating that sampling rarely limits prediction accuracy.  The overall results are, to the authors' knowledge, the best reported to date, and the authors attribute this success to the combination of an accurate all-atom energy function, efficient methods for loop buildup and side-chain optimization, and, esp. for the longer loops, the hierarchical refinement protocol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHqYMnqaWXvLVg90H21EOLACvtfcHk0lhLZjOB9m-g_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFKhsrc%253D&md5=e0eff655eeefb30ea00ae041ea9099c8</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2Fprot.10613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.10613%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DPincus%26aufirst%3DD.%2BL.%26aulast%3DRapp%26aufirst%3DC.%2BS.%26aulast%3DDay%26aufirst%3DT.%2BJ.%2BF.%26aulast%3DHonig%26aufirst%3DB.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DA%2520Hierarchical%2520Approach%2520to%2520All-Atom%2520Protein%2520Loop%2520Prediction%26jtitle%3DProteins%26date%3D2004%26volume%3D55%26spage%3D351%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Gaulton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellis, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bento, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Light, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGlinchey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalovich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Lazikani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J. P.</span><span> </span><span class="NLM_article-title">ChEMBL: A Large-Scale Bioactivity Database for Drug Discovery</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">D1100</span><span class="NLM_x">–</span> <span class="NLM_lpage">1107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1093%2Fnar%2Fgkr777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=21948594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs12htbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=D1100-1107&author=A.+Gaultonauthor=L.+J.+Bellisauthor=A.+P.+Bentoauthor=J.+Chambersauthor=M.+Daviesauthor=A.+Herseyauthor=Y.+Lightauthor=S.+McGlincheyauthor=D.+Michalovichauthor=B.+Al-Lazikaniauthor=J.+P.+Overington&title=ChEMBL%3A+A+Large-Scale+Bioactivity+Database+for+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">ChEMBL: a large-scale bioactivity database for drug discovery</span></div><div class="casAuthors">Gaulton, Anna; Bellis, Louisa J.; Bento, A. Patricia; Chambers, Jon; Davies, Mark; Hersey, Anne; Light, Yvonne; McGlinchey, Shaun; Michalovich, David; Al-Lazikani, Bissan; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D1100-D1107</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">ChEMBL is an Open Data database contg. binding, functional and ADMET information for a large no. of drug-like bioactive compds.  These data are manually abstracted from the primary published literature on a regular basis, then further curated and standardized to maximize their quality and utility across a wide range of chem. biol. and drug-discovery research problems.  Currently, the database contains 5.4 million bioactivity measurements for more than 1 million compds. and 5200 protein targets.  Access is available through a web-based interface, data downloads and web services at: https://www.ebi.ac.uk/chembldb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9e9jRENTtubVg90H21EOLACvtfcHk0liLkbkOWtvugA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs12htbjN&md5=aedf7793e1ca54b6a4fa272ea3ef7d0e</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkr777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkr777%26sid%3Dliteratum%253Aachs%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DBellis%26aufirst%3DL.%2BJ.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DChambers%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DM.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DLight%26aufirst%3DY.%26aulast%3DMcGlinchey%26aufirst%3DS.%26aulast%3DMichalovich%26aufirst%3DD.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DChEMBL%253A%2520A%2520Large-Scale%2520Bioactivity%2520Database%2520for%2520Drug%2520Discovery%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2012%26volume%3D40%26spage%3DD1100%26epage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Allen, F. H.</span><span> </span><span class="NLM_article-title">The Cambridge Structural Database: A Quarter of a Million Crystal Structures and Rising</span> <span class="citation_source-journal">Acta Crystallogr., Sect. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1107%2FS0108768102003890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=12037359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD38XktVOqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=380-388&author=F.+H.+Allen&title=The+Cambridge+Structural+Database%3A+A+Quarter+of+a+Million+Crystal+Structures+and+Rising"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">The Cambridge Structural Database: a quarter of a million crystal structures and rising</span></div><div class="casAuthors">Allen, Frank H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section B: Structural Science</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">B58</span>
        (<span class="NLM_cas:issue">3, No. 1</span>),
    <span class="NLM_cas:pages">380-388</span>CODEN:
                <span class="NLM_cas:coden">ASBSDK</span>;
        ISSN:<span class="NLM_cas:issn">0108-7681</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">The Cambridge Structural Database (CSD) now contains data for more than a quarter of a million small-mol. crystal structures.  The information content of the CSD, together with methods for data acquisition, processing and validation, are summarized, with particular emphasis on the chem. information added by CSD editors.  Nearly 80% of new structural data arrives electronically, mostly in CIF format, and the CCDC acts as the official crystal structure data depository for 51 major journals.  The CCDC now maintains both a CIF archive (more than 73000 CIFs dating from 1996), as well as the distributed binary CSD archive; the availability of data in both archives is discussed.  A statistical survey of the CSD is also presented and projections concerning future accession rates indicate that the CSD will contain at least 500000 crystal structures by the year 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Uk3GetkiibVg90H21EOLACvtfcHk0liLkbkOWtvugA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktVOqu74%253D&md5=406cd0df6ea9035a0ebf8dd9eccbd1f8</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1107%2FS0108768102003890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108768102003890%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DF.%2BH.%26atitle%3DThe%2520Cambridge%2520Structural%2520Database%253A%2520A%2520Quarter%2520of%2520a%2520Million%2520Crystal%2520Structures%2520and%2520Rising%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520B%26date%3D2002%26volume%3D58%26spage%3D380%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Strader, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigal, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candelore, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rands, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, R. A.</span><span> </span><span class="NLM_article-title">Conserved Aspartic Acid Residues 79 and 113 of the Beta-Adrenergic Receptor Have Different Roles in Receptor Function</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x">, </span> <span class="NLM_fpage">10267</span><span class="NLM_x">–</span> <span class="NLM_lpage">10271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1988&pages=10267-10271&author=C.+D.+Straderauthor=I.+S.+Sigalauthor=M.+R.+Candeloreauthor=E.+Randsauthor=W.+S.+Hillauthor=R.+A.+Dixon&title=Conserved+Aspartic+Acid+Residues+79+and+113+of+the+Beta-Adrenergic+Receptor+Have+Different+Roles+in+Receptor+Function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStrader%26aufirst%3DC.%2BD.%26aulast%3DSigal%26aufirst%3DI.%2BS.%26aulast%3DCandelore%26aufirst%3DM.%2BR.%26aulast%3DRands%26aufirst%3DE.%26aulast%3DHill%26aufirst%3DW.%2BS.%26aulast%3DDixon%26aufirst%3DR.%2BA.%26atitle%3DConserved%2520Aspartic%2520Acid%2520Residues%252079%2520and%2520113%2520of%2520the%2520Beta-Adrenergic%2520Receptor%2520Have%2520Different%2520Roles%2520in%2520Receptor%2520Function%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1988%26volume%3D263%26spage%3D10267%26epage%3D10271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Andiné, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widermark, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axelsson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olofsson, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mårtensson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandberg, M.</span><span> </span><span class="NLM_article-title">Characterization of MK-801-Induced Behavior as a Putative Rat Model of Psychosis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">1393</span><span class="NLM_x">–</span> <span class="NLM_lpage">1408</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=10454519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADyaK1MXlsVOqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=1999&pages=1393-1408&author=P.+Andin%C3%A9author=N.+Widermarkauthor=R.+Axelssonauthor=G.+Nybergauthor=U.+Olofssonauthor=E.+M%C3%A5rtenssonauthor=M.+Sandberg&title=Characterization+of+MK-801-Induced+Behavior+as+a+Putative+Rat+Model+of+Psychosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of MK-801-induced behavior as a putative rat model of psychosis</span></div><div class="casAuthors">Andine, Peter; Widermark, Nina; Axelsson, Rolf; Nyberg, Gosta; Olofsson, Ulla; Martensson, Erik; Sandberg, Mats</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1393-1408</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The objective of this study was to characterize the behavior induced by the N-methyl-D-aspartate receptor antagonist MK-801 (dizocilpine maleate) in rats as a model of psychosis.  The temporal profile, dose dependence, age, and sex differences of the behavior are described.  A gas chromatog. method for the anal. of MK-801 in plasma and brain was developed.  Female rats showed 4 to 10 times more MK-801-induced behavior and displayed around 25 times higher serum and brain concns. of MK-801 than male rats.  Twenty-one neuroactive compds., including a no. of excitatory amino acid-active substances, were tested for the effect on MK-801-induced behavior.  Neuroleptics blocked MK-801-induced behavior in a dose-dependent manner that correlated to their antipsychotic potency in humans.  Adenosine receptor agonists and an N-methyl-D-aspartate receptor-assocd. glycine site antagonist showed putative antipsychotic effects.  In conclusion, MK-801-induced behavior represents a rat excitatory amino acid hypofunction model of psychosis that appears to be of clin. relevance and may be of value in the search for new antipsychotic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAjgP7sdQKXrVg90H21EOLACvtfcHk0liLkbkOWtvugA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlsVOqtLs%253D&md5=2a131b0078312ed59679b0327a30bc6c</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndin%25C3%25A9%26aufirst%3DP.%26aulast%3DWidermark%26aufirst%3DN.%26aulast%3DAxelsson%26aufirst%3DR.%26aulast%3DNyberg%26aufirst%3DG.%26aulast%3DOlofsson%26aufirst%3DU.%26aulast%3DM%25C3%25A5rtensson%26aufirst%3DE.%26aulast%3DSandberg%26aufirst%3DM.%26atitle%3DCharacterization%2520of%2520MK-801-Induced%2520Behavior%2520as%2520a%2520Putative%2520Rat%2520Model%2520of%2520Psychosis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D290%26spage%3D1393%26epage%3D1408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Schreiber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audinot, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veiga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millan, M. J.</span><span> </span><span class="NLM_article-title">(1-(2,5-Dimethoxy-4 iodophenyl)-2-aminopropane)-Induced Head- Twitches in the Rat Are Mediated by 5-Hydroxytryptamine (5-HT) 2A Receptors: Modulation by Novel 5-HT2A/2C Antagonists, D1 Antagonists and 5-HT1A Agonists</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=7714755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADyaK2MXltVGlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1995&pages=101-112&author=R.+Schreiberauthor=M.+Broccoauthor=V.+Audinotauthor=A.+Gobertauthor=S.+Veigaauthor=M.+J.+Millan&title=%281-%282%2C5-Dimethoxy-4+iodophenyl%29-2-aminopropane%29-Induced+Head-+Twitches+in+the+Rat+Are+Mediated+by+5-Hydroxytryptamine+%285-HT%29+2A+Receptors%3A+Modulation+by+Novel+5-HT2A%2F2C+Antagonists%2C+D1+Antagonists+and+5-HT1A+Agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">(1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT)2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists</span></div><div class="casAuthors">Schreiber, Rudy; Brocco, Mauricette; Audinot, Valerie; Gobert, Alain; Veiga, Sylvie; Millan, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-12</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">In this study, the involvement of serotonergic and dopaminergic receptors in the modulation of the head-twitch (HTW) response to the 5-hydroxytryptamine (5-HT)2A/5-HT2C agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, was characterized in rats using novel and selective ligands at 5-HT2A, 5-HT2C, D1, D2 and 5-HT1A receptors.  HTW were dose-dependently inhibited by the 5-HT2A/2C antagonists, ritanserin, metergoline, mesulergine, mianserin, ICI 169,369 and LY 58,537, by the preferential 5-HT2A antagonist, ketanserin and by the novel, selective 5-HT2A antagonist, SR 46349B.  A further selective 5-HT2A antagonist, MDL 100,907, very potently abolished HTW (ED50 = 0.005 mg/kg).  The order of relative potency correlated highly with their affinity at 5-HT1A (r = 0.83) but not 5-HT2C receptors (r = 0.06).  In addn., the novel, selective 5-HT2C antagonist, SB 200,646A, failed to abolish HTW and the 5-HT2C agonists/5-HT2A antagonists, 1-(3-chlorophenyl)piperazine and 1-(3-trifluoromethylphenyl)piperazine, blocked, rather than elicited, HTW.  The D1 antagonists, SCH 23390, NNC 112, NNC 756, SCH 39166 and A 69024, in this order of relative potency that correlated with their affinity at D1 receptors (r = 0.98), blocked HTW.  The D2 antagonists, raclopride, eticlopride and haloperidol also blocked HTW.  The 5-HT1A agonists, S 14671, S 14506, 8-hydroxy-2-(di-n-propylamino)tetralin, buspirone, ipsapirone and (+)-flesinoxan, abolished HTW.  The action of 8-hydroxy-2-(di-n-propylamino)tetralin was blocked by (-)-tertatolol (ID50 = 4.5 mg/kg), a novel 5-HT1A receptor antagonist.  Similarly, (-)-tertatolol attenuated the action of S 14506 and abolished that of S 14671, buspirone and ipsapirone.  A role of postsynaptic 5-HT1A receptors in the action of 5-HT1A agonists was suggested by the finding that p-chlorophenylalanine (3×300 mg/kg, i.p.), which depleted cerebral pools of 5-HT, did not modify the activity of ipsapirone.  The present data demonstrate that 5-HT2A receptors mediate HTW in rats and that both D1 and D2 receptors as well as (postsynaptic) 5-HT1A receptors play a role in their expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol-OqOe5qq7rVg90H21EOLACvtfcHk0lgBkbUEYucjhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXltVGlt7s%253D&md5=83ea96a14372dd4ab2834f0197daa1c8</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiber%26aufirst%3DR.%26aulast%3DBrocco%26aufirst%3DM.%26aulast%3DAudinot%26aufirst%3DV.%26aulast%3DGobert%26aufirst%3DA.%26aulast%3DVeiga%26aufirst%3DS.%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26atitle%3D%25281-%25282%252C5-Dimethoxy-4%2520iodophenyl%2529-2-aminopropane%2529-Induced%2520Head-%2520Twitches%2520in%2520the%2520Rat%2520Are%2520Mediated%2520by%25205-Hydroxytryptamine%2520%25285-HT%2529%25202A%2520Receptors%253A%2520Modulation%2520by%2520Novel%25205-HT2A%252F2C%2520Antagonists%252C%2520D1%2520Antagonists%2520and%25205-HT1A%2520Agonists%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1995%26volume%3D273%26spage%3D101%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Porsolt, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blavet, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalfre, M.</span><span> </span><span class="NLM_article-title">Behavioral Despair in Rats: A New Model Sensitive to Antidepressant Treatments</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1016%2F0014-2999%2878%2990118-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=204499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADyaE1cXhvVagsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1978&pages=379-391&author=R.+D.+Porsoltauthor=G.+Antonauthor=N.+Blavetauthor=M.+Jalfre&title=Behavioral+Despair+in+Rats%3A+A+New+Model+Sensitive+to+Antidepressant+Treatments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral despair in rats:  a new model sensitive to antidepressant treatments</span></div><div class="casAuthors">Porsolt, Roger D.; Anton, Guy; Blavet, Nadine; Jalfre, Maurice</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">379-91</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Rats when forced to swim in a cylinder from which they cannot escape will, after an initial period of vigorous activity, adopt a characteristic immobile posture which can be readily identified.  Immobility was decreased by various clin. effective antidepressant drugs at doses which otherwise decreased spontaneous motor activity in an open field.  Antidepressants could thus be distinguished from psychostimulants which decreased immobility at doses which increased general activity.  Anxiolytic compds. did not affect immobility, whereas major tranquilizers enhanced it.  Thus, immobility reflects a state of lowered mood in the rat which is selectively sensitive to antidepressant treatments.  Pos. findings with atypical antidepressant drugs such as iprindole and mianserin suggest that the method may be capable of discovering new antidepressants hitherto undetectable with classical pharmacol. tests.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0oUdFHAF1sLVg90H21EOLACvtfcHk0lgBkbUEYucjhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhvVagsr0%253D&md5=293e1fe8766c76315e86bc375c810a58</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2878%2990118-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252878%252990118-8%26sid%3Dliteratum%253Aachs%26aulast%3DPorsolt%26aufirst%3DR.%2BD.%26aulast%3DAnton%26aufirst%3DG.%26aulast%3DBlavet%26aufirst%3DN.%26aulast%3DJalfre%26aufirst%3DM.%26atitle%3DBehavioral%2520Despair%2520in%2520Rats%253A%2520A%2520New%2520Model%2520Sensitive%2520to%2520Antidepressant%2520Treatments%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1978%26volume%3D47%26spage%3D379%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Ogren, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Köhler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjöstrand, S. E.</span><span> </span><span class="NLM_article-title">The Selective Dopamine D2 Receptor Antagonist Raclopride Discriminates between Dopamine-Mediated Motor Functions</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1986&pages=287-294&author=S.+O.+Ogrenauthor=H.+Hallauthor=C.+K%C3%B6hlerauthor=O.+Magnussonauthor=S.+E.+Sj%C3%B6strand&title=The+Selective+Dopamine+D2+Receptor+Antagonist+Raclopride+Discriminates+between+Dopamine-Mediated+Motor+Functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOgren%26aufirst%3DS.%2BO.%26aulast%3DHall%26aufirst%3DH.%26aulast%3DK%25C3%25B6hler%26aufirst%3DC.%26aulast%3DMagnusson%26aufirst%3DO.%26aulast%3DSj%25C3%25B6strand%26aufirst%3DS.%2BE.%26atitle%3DThe%2520Selective%2520Dopamine%2520D2%2520Receptor%2520Antagonist%2520Raclopride%2520Discriminates%2520between%2520Dopamine-Mediated%2520Motor%2520Functions%26jtitle%3DPsychopharmacology%26date%3D1986%26volume%3D90%26spage%3D287%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 42 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Joanna Sniecikowska, Monika Gluch-Lutwin, Adam Bucki, Anna Więckowska, Agata Siwek, Magdalena Jastrzebska-Wiesek, Anna Partyka, Daria Wilczyńska, Karolina Pytka, Gniewomir Latacz, Katarzyna Przejczowska-Pomierny, Elżbieta Wyska, Anna Wesołowska, Maciej Pawłowski, Adrian Newman-Tancredi, <span class="NLM_string-name hlFld-ContribAuthor">Marcin Kolaczkowski</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel pERK1/2- or β-Arrestin-Preferring 5-HT1A Receptor-Biased Agonists: Diversified Therapeutic-like versus Side Effect Profile. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10946-10971. <a href="https://doi.org/10.1021/acs.jmedchem.0c00814" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00814</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00814%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BpERK1%25252F2-%252Bor%252B%2525CE%2525B2-Arrestin-Preferring%252B5-HT1A%252BReceptor-Biased%252BAgonists%25253A%252BDiversified%252BTherapeutic-like%252Bversus%252BSide%252BEffect%252BProfile%26aulast%3DSniecikowska%26aufirst%3DJoanna%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D13052020%26date%3D23092020%26date%3D04092020%26volume%3D63%26issue%3D19%26spage%3D10946%26epage%3D10971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rafał Kurczab, Vittorio Canale, Grzegorz Satała, Paweł Zajdel, <span class="NLM_string-name hlFld-ContribAuthor">Andrzej J. Bojarski</span>. </span><span class="cited-content_cbyCitation_article-title">Amino Acid Hot Spots of Halogen Bonding: A Combined Theoretical and Experimental Case Study of the 5-HT7 Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (19)
                                     , 8717-8733. <a href="https://doi.org/10.1021/acs.jmedchem.8b00828" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00828</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00828%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAmino%252BAcid%252BHot%252BSpots%252Bof%252BHalogen%252BBonding%25253A%252BA%252BCombined%252BTheoretical%252Band%252BExperimental%252BCase%252BStudy%252Bof%252Bthe%252B5-HT7%252BReceptor%26aulast%3DKurczab%26aufirst%3DRafa%25C5%2582%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D24052018%26date%3D21092018%26date%3D06092018%26volume%3D61%26issue%3D19%26spage%3D8717%26epage%3D8733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Anna Więckowska, Tomasz Wichur, Justyna Godyń, Adam Bucki, Monika Marcinkowska, Agata Siwek, Krzysztof Więckowski, Paula Zaręba, Damijan Knez, Monika Głuch-Lutwin, Grzegorz Kazek, Gniewomir Latacz, Kamil Mika, Marcin Kołaczkowski, Jan Korabecny, Ondrej Soukup, Marketa Benkova, Katarzyna Kieć-Kononowicz, Stanislav Gobec, <span class="NLM_string-name hlFld-ContribAuthor">Barbara Malawska</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2018,</strong> <em>9 </em>
                                    (5)
                                     , 1195-1214. <a href="https://doi.org/10.1021/acschemneuro.8b00024" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00024%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DNovel%252BMultitarget-Directed%252BLigands%252BAiming%252Bat%252BSymptoms%252Band%252BCauses%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DWi%25C4%2599ckowska%26aufirst%3DAnna%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D18012018%26date%3D31012018%26date%3D13022018%26date%3D31012018%26volume%3D9%26issue%3D5%26spage%3D1195%26epage%3D1214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam  Bucki</span>, <span class="hlFld-ContribAuthor ">Monika  Marcinkowska</span>, <span class="hlFld-ContribAuthor ">Joanna  Śniecikowska</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Więckowski</span>, <span class="hlFld-ContribAuthor ">Maciej  Pawłowski</span>, <span class="hlFld-ContribAuthor ">Monika  Głuch-Lutwin</span>, <span class="hlFld-ContribAuthor ">Anna  Gryboś</span>, <span class="hlFld-ContribAuthor ">Agata  Siwek</span>, <span class="hlFld-ContribAuthor ">Karolina  Pytka</span>, <span class="hlFld-ContribAuthor ">Magdalena  Jastrzębska-Więsek</span>, <span class="hlFld-ContribAuthor ">Anna  Partyka</span>, <span class="hlFld-ContribAuthor ">Anna  Wesołowska</span>, <span class="hlFld-ContribAuthor ">Paweł  Mierzejewski</span>, and <span class="hlFld-ContribAuthor ">Marcin  Kołaczkowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel 3-(1,2,3,6-Tetrahydropyridin-4-yl)-1H-indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (17)
                                     , 7483-7501. <a href="https://doi.org/10.1021/acs.jmedchem.7b00839" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00839</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00839%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B3-%2525281%25252C2%25252C3%25252C6-Tetrahydropyridin-4-yl%252529-1H-indole-Based%252BMultifunctional%252BLigands%252Bwith%252BAntipsychotic-Like%25252C%252BMood-Modulating%25252C%252Band%252BProcognitive%252BActivity%26aulast%3DBucki%26aufirst%3DAdam%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D12062017%26date%3D18082017%26date%3D14092017%26date%3D01082017%26volume%3D60%26issue%3D17%26spage%3D7483%26epage%3D7501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mustafa Zahrittin  Kazancioglu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Characterization of Novel
              N
              -Propylaniline-Phenylpiperazine Sulfonamide and Urea Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Polycyclic Aromatic Compounds</span><span> <strong>2021,</strong> <em>56 </em>, 1-12. <a href="https://doi.org/10.1080/10406638.2021.1954040" title="DOI URL">https://doi.org/10.1080/10406638.2021.1954040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10406638.2021.1954040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10406638.2021.1954040%26sid%3Dliteratum%253Aachs%26jtitle%3DPolycyclic%2520Aromatic%2520Compounds%26atitle%3DSynthesis%252Band%252BCharacterization%252Bof%252BNovel%252BN%252B-Propylaniline-Phenylpiperazine%252BSulfonamide%252Band%252BUrea%252BDerivatives%26aulast%3DKazancioglu%26aufirst%3DMustafa%2BZahrittin%26date%3D2021%26date%3D2021%26volume%3D56%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Damian  Kułaga</span>, <span class="hlFld-ContribAuthor ">Jolanta  Jaśkowska</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Satała</span>, <span class="hlFld-ContribAuthor ">Gniewomir  Latacz</span>, <span class="hlFld-ContribAuthor ">Paweł  Śliwa</span>. </span><span class="cited-content_cbyCitation_article-title">Aminotriazines with indole motif as novel, 5-HT7 receptor ligands with atypical binding mode. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>104 </em>, 104254. <a href="https://doi.org/10.1016/j.bioorg.2020.104254" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104254%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DAminotriazines%252Bwith%252Bindole%252Bmotif%252Bas%252Bnovel%25252C%252B5-HT7%252Breceptor%252Bligands%252Bwith%252Batypical%252Bbinding%252Bmode%26aulast%3DKu%25C5%2582aga%26aufirst%3DDamian%26date%3D2020%26volume%3D104%26spage%3D104254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agnieszka  Jankowska</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Satała</span>, <span class="hlFld-ContribAuthor ">Marcin  Kołaczkowski</span>, <span class="hlFld-ContribAuthor ">Adam  Bucki</span>, <span class="hlFld-ContribAuthor ">Monika  Głuch-Lutwin</span>, <span class="hlFld-ContribAuthor ">Artur  Świerczek</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Pociecha</span>, <span class="hlFld-ContribAuthor ">Anna  Partyka</span>, <span class="hlFld-ContribAuthor ">Magdalena  Jastrzębska-Więsek</span>, <span class="hlFld-ContribAuthor ">Annamaria  Lubelska</span>, <span class="hlFld-ContribAuthor ">Gniewomir  Latacz</span>, <span class="hlFld-ContribAuthor ">Alicja  Gawalska</span>, <span class="hlFld-ContribAuthor ">Andrzej J.  Bojarski</span>, <span class="hlFld-ContribAuthor ">Elżbieta  Wyska</span>, <span class="hlFld-ContribAuthor ">Grażyna  Chłoń-Rzepa</span>. </span><span class="cited-content_cbyCitation_article-title">Novel anilide and benzylamide derivatives of arylpiperazinylalkanoic acids as 5-HT1A/5-HT7 receptor antagonists and phosphodiesterase 4/7 inhibitors with procognitive and antidepressant activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>201 </em>, 112437. <a href="https://doi.org/10.1016/j.ejmech.2020.112437" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112437</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112437%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Banilide%252Band%252Bbenzylamide%252Bderivatives%252Bof%252Barylpiperazinylalkanoic%252Bacids%252Bas%252B5-HT1A%25252F5-HT7%252Breceptor%252Bantagonists%252Band%252Bphosphodiesterase%252B4%25252F7%252Binhibitors%252Bwith%252Bprocognitive%252Band%252Bantidepressant%252Bactivity%26aulast%3DJankowska%26aufirst%3DAgnieszka%26date%3D2020%26volume%3D201%26spage%3D112437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Przemysław  Zaręba</span>, <span class="hlFld-ContribAuthor ">Anna K.  Drabczyk</span>, <span class="hlFld-ContribAuthor ">Jolanta  Jaśkowska</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Satała</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical puzzles in the search for new, flexible derivatives of lurasidone as antipsychotic drugs. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (10)
                                     , 115459. <a href="https://doi.org/10.1016/j.bmc.2020.115459" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115459%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DChemical%252Bpuzzles%252Bin%252Bthe%252Bsearch%252Bfor%252Bnew%25252C%252Bflexible%252Bderivatives%252Bof%252Blurasidone%252Bas%252Bantipsychotic%252Bdrugs%26aulast%3DZar%25C4%2599ba%26aufirst%3DPrzemys%25C5%2582aw%26date%3D2020%26volume%3D28%26issue%3D10%26spage%3D115459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam  Bucki</span>, <span class="hlFld-ContribAuthor ">Monika  Marcinkowska</span>, <span class="hlFld-ContribAuthor ">Joanna  Śniecikowska</span>, <span class="hlFld-ContribAuthor ">Agnieszka  Zagórska</span>, <span class="hlFld-ContribAuthor ">Marek  Jamrozik</span>, <span class="hlFld-ContribAuthor ">Maciej  Pawłowski</span>, <span class="hlFld-ContribAuthor ">Monika  Głuch-Lutwin</span>, <span class="hlFld-ContribAuthor ">Agata  Siwek</span>, <span class="hlFld-ContribAuthor ">Magdalena  Jakubczyk</span>, <span class="hlFld-ContribAuthor ">Karolina  Pytka</span>, <span class="hlFld-ContribAuthor ">Magdalena  Jastrzębska-Więsek</span>, <span class="hlFld-ContribAuthor ">Anna  Partyka</span>, <span class="hlFld-ContribAuthor ">Anna  Wesołowska</span>, <span class="hlFld-ContribAuthor ">Paweł  Mierzejewski</span>, <span class="hlFld-ContribAuthor ">Marcin  Kołaczkowski</span>. </span><span class="cited-content_cbyCitation_article-title">Multifunctional 6-fluoro-3-[3-(pyrrolidin-1-yl)propyl]-1,2-benzoxazoles targeting behavioral and psychological symptoms of dementia (BPSD). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>191 </em>, 112149. <a href="https://doi.org/10.1016/j.ejmech.2020.112149" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112149</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112149%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMultifunctional%252B6-fluoro-3-%25255B3-%252528pyrrolidin-1-yl%252529propyl%25255D-1%25252C2-benzoxazoles%252Btargeting%252Bbehavioral%252Band%252Bpsychological%252Bsymptoms%252Bof%252Bdementia%252B%252528BPSD%252529%26aulast%3DBucki%26aufirst%3DAdam%26date%3D2020%26volume%3D191%26spage%3D112149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monika  Marcinkowska</span>, <span class="hlFld-ContribAuthor ">Joanna  Śniecikowska</span>, <span class="hlFld-ContribAuthor ">Nikola  Fajkis</span>, <span class="hlFld-ContribAuthor ">Paweł  Paśko</span>, <span class="hlFld-ContribAuthor ">Weronika  Franczyk</span>, <span class="hlFld-ContribAuthor ">Marcin  Kołaczkowski</span>. </span><span class="cited-content_cbyCitation_article-title">Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates. </span><span class="cited-content_cbyCitation_journal-name">CNS Drugs</span><span> <strong>2020,</strong> <em>34 </em>
                                    (3)
                                     , 243-268. <a href="https://doi.org/10.1007/s40263-020-00707-7" title="DOI URL">https://doi.org/10.1007/s40263-020-00707-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40263-020-00707-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40263-020-00707-7%26sid%3Dliteratum%253Aachs%26jtitle%3DCNS%2520Drugs%26atitle%3DManagement%252Bof%252BDementia-Related%252BPsychosis%25252C%252BAgitation%252Band%252BAggression%25253A%252BA%252BReview%252Bof%252Bthe%252BPharmacology%252Band%252BClinical%252BEffects%252Bof%252BPotential%252BDrug%252BCandidates%26aulast%3DMarcinkowska%26aufirst%3DMonika%26date%3D2020%26date%3D2020%26volume%3D34%26issue%3D3%26spage%3D243%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Damian  Kułaga</span>, <span class="hlFld-ContribAuthor ">Jolanta  Jaśkowska</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Satała</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel serotonin and dopamine receptor ligands being 6-bromohexyl saccharine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (21)
                                     , 126667. <a href="https://doi.org/10.1016/j.bmcl.2019.126667" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126667</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126667%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bserotonin%252Band%252Bdopamine%252Breceptor%252Bligands%252Bbeing%252B6-bromohexyl%252Bsaccharine%252Bderivatives%26aulast%3DKu%25C5%2582aga%26aufirst%3DDamian%26date%3D2019%26volume%3D29%26issue%3D21%26spage%3D126667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Megan D.  Hopkins</span>, <span class="hlFld-ContribAuthor ">Felagot A.  Abebe</span>, <span class="hlFld-ContribAuthor ">Kristina A.  Scott</span>, <span class="hlFld-ContribAuthor ">Garett L.  Ozmer</span>, <span class="hlFld-ContribAuthor ">Alec A.  Sheir</span>, <span class="hlFld-ContribAuthor ">Lucas J.  Schroeder</span>, <span class="hlFld-ContribAuthor ">Robert J.  Sheaff</span>, <span class="hlFld-ContribAuthor ">Angus A.  Lamar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and identification of heteroaromatic
              N
              -benzyl sulfonamides as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (36)
                                     , 8391-8402. <a href="https://doi.org/10.1039/C9OB01694E" title="DOI URL">https://doi.org/10.1039/C9OB01694E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01694E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01694E%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Band%252Bidentification%252Bof%252Bheteroaromatic%252BN%252B-benzyl%252Bsulfonamides%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DHopkins%26aufirst%3DMegan%2BD.%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D36%26spage%3D8391%26epage%3D8402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Czopek</span>, <span class="hlFld-ContribAuthor ">Adam  Bucki</span>, <span class="hlFld-ContribAuthor ">Marcin  Kołaczkowski</span>, <span class="hlFld-ContribAuthor ">Agnieszka  Zagórska</span>, <span class="hlFld-ContribAuthor ">Marcin  Drop</span>, <span class="hlFld-ContribAuthor ">Maciej  Pawłowski</span>, <span class="hlFld-ContribAuthor ">Agata  Siwek</span>, <span class="hlFld-ContribAuthor ">Monika  Głuch-Lutwin</span>, <span class="hlFld-ContribAuthor ">Elżbieta  Pękala</span>, <span class="hlFld-ContribAuthor ">Alicja  Chrzanowska</span>, <span class="hlFld-ContribAuthor ">Marta  Struga</span>, <span class="hlFld-ContribAuthor ">Anna  Partyka</span>, <span class="hlFld-ContribAuthor ">Anna  Wesołowska</span>. </span><span class="cited-content_cbyCitation_article-title">Novel multitarget 5-arylidenehydantoins with arylpiperazinealkyl fragment: Pharmacological evaluation and investigation of cytotoxicity and metabolic stability. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (18)
                                     , 4163-4173. <a href="https://doi.org/10.1016/j.bmc.2019.07.046" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.07.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.07.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.07.046%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bmultitarget%252B5-arylidenehydantoins%252Bwith%252Barylpiperazinealkyl%252Bfragment%25253A%252BPharmacological%252Bevaluation%252Band%252Binvestigation%252Bof%252Bcytotoxicity%252Band%252Bmetabolic%252Bstability%26aulast%3DCzopek%26aufirst%3DAnna%26date%3D2019%26volume%3D27%26issue%3D18%26spage%3D4163%26epage%3D4173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wesam  Ali</span>, <span class="hlFld-ContribAuthor ">Małgorzata  Więcek</span>, <span class="hlFld-ContribAuthor ">Dorota  Łażewska</span>, <span class="hlFld-ContribAuthor ">Rafał  Kurczab</span>, <span class="hlFld-ContribAuthor ">Magdalena  Jastrzębska-Więsek</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Satała</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Kucwaj-Brysz</span>, <span class="hlFld-ContribAuthor ">Annamaria  Lubelska</span>, <span class="hlFld-ContribAuthor ">Monika  Głuch-Lutwin</span>, <span class="hlFld-ContribAuthor ">Barbara  Mordyl</span>, <span class="hlFld-ContribAuthor ">Agata  Siwek</span>, <span class="hlFld-ContribAuthor ">Muhammad Jawad  Nasim</span>, <span class="hlFld-ContribAuthor ">Anna  Partyka</span>, <span class="hlFld-ContribAuthor ">Sylwia  Sudoł</span>, <span class="hlFld-ContribAuthor ">Gniewomir  Latacz</span>, <span class="hlFld-ContribAuthor ">Anna  Wesołowska</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Kieć-Kononowicz</span>, <span class="hlFld-ContribAuthor ">Jadwiga  Handzlik</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and computer-aided SAR studies for derivatives of phenoxyalkyl-1,3,5-triazine as the new potent ligands for serotonin receptors 5-HT6. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>178 </em>, 740-751. <a href="https://doi.org/10.1016/j.ejmech.2019.06.022" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.06.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.06.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.06.022%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bcomputer-aided%252BSAR%252Bstudies%252Bfor%252Bderivatives%252Bof%252Bphenoxyalkyl-1%25252C3%25252C5-triazine%252Bas%252Bthe%252Bnew%252Bpotent%252Bligands%252Bfor%252Bserotonin%252Breceptors%252B5-HT6%26aulast%3DAli%26aufirst%3DWesam%26date%3D2019%26volume%3D178%26spage%3D740%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarzyna  Pańczyk</span>, <span class="hlFld-ContribAuthor ">Karolina  Pytka</span>, <span class="hlFld-ContribAuthor ">Magdalena  Jakubczyk</span>, <span class="hlFld-ContribAuthor ">Anna  Rapacz</span>, <span class="hlFld-ContribAuthor ">Agata  Siwek</span>, <span class="hlFld-ContribAuthor ">Monika  Głuch‐Lutwin</span>, <span class="hlFld-ContribAuthor ">Anna  Gryboś</span>, <span class="hlFld-ContribAuthor ">Karolina  Słoczyńska</span>, <span class="hlFld-ContribAuthor ">Paulina  Koczurkiewicz</span>, <span class="hlFld-ContribAuthor ">Damian  Ryszawy</span>, <span class="hlFld-ContribAuthor ">Elżbieta  Pękala</span>, <span class="hlFld-ContribAuthor ">Bogusława  Budziszewska</span>, <span class="hlFld-ContribAuthor ">Beata  Starek‐Świechowicz</span>, <span class="hlFld-ContribAuthor ">Joanna  Suraj‐Prażmowska</span>, <span class="hlFld-ContribAuthor ">Maria  Walczak</span>, <span class="hlFld-ContribAuthor ">Ewa  Żesławska</span>, <span class="hlFld-ContribAuthor ">Wojciech  Nitek</span>, <span class="hlFld-ContribAuthor ">Adam  Bucki</span>, <span class="hlFld-ContribAuthor ">Marcin  Kołaczkowski</span>, <span class="hlFld-ContribAuthor ">Dorota  Żelaszczyk</span>, <span class="hlFld-ContribAuthor ">Renata  Francik</span>, <span class="hlFld-ContribAuthor ">Henryk  Marona</span>, <span class="hlFld-ContribAuthor ">Anna M.  Waszkielewicz</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of
              N
              ‐(phenoxyalkyl)‐,
              N
              ‐{2‐[2‐(phenoxy)ethoxy]ethyl}‐ or
              N
              ‐(phenoxyacetyl)piperazine Derivatives and Their Activity Within the Central Nervous System. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (32)
                                     , 9381-9391. <a href="https://doi.org/10.1002/slct.201902648" title="DOI URL">https://doi.org/10.1002/slct.201902648</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201902648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201902648%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%252Bof%252BN%252B%2525E2%252580%252590%252528phenoxyalkyl%252529%2525E2%252580%252590%25252C%252BN%252B%2525E2%252580%252590%25257B2%2525E2%252580%252590%25255B2%2525E2%252580%252590%252528phenoxy%252529ethoxy%25255Dethyl%25257D%2525E2%252580%252590%252Bor%252BN%252B%2525E2%252580%252590%252528phenoxyacetyl%252529piperazine%252BDerivatives%252Band%252BTheir%252BActivity%252BWithin%252Bthe%252BCentral%252BNervous%252BSystem%26aulast%3DPa%25C5%2584czyk%26aufirst%3DKatarzyna%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D32%26spage%3D9381%26epage%3D9391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Przemysław  Zaręba</span>, <span class="hlFld-ContribAuthor ">Jolanta  Jaśkowska</span>, <span class="hlFld-ContribAuthor ">Izabela  Czekaj</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Satała</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and molecular modelling of new bulky Fananserin derivatives with altered pharmacological profile as potential antidepressants. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (15)
                                     , 3396-3407. <a href="https://doi.org/10.1016/j.bmc.2019.06.028" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.06.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.06.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.06.028%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bmolecular%252Bmodelling%252Bof%252Bnew%252Bbulky%252BFananserin%252Bderivatives%252Bwith%252Baltered%252Bpharmacological%252Bprofile%252Bas%252Bpotential%252Bantidepressants%26aulast%3DZar%25C4%2599ba%26aufirst%3DPrzemys%25C5%2582aw%26date%3D2019%26volume%3D27%26issue%3D15%26spage%3D3396%26epage%3D3407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sinem  Apaydın</span>, <span class="hlFld-ContribAuthor ">Marianna  Török</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfonamide derivatives as multi-target agents for complex diseases. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (16)
                                     , 2042-2050. <a href="https://doi.org/10.1016/j.bmcl.2019.06.041" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.06.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.06.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.06.041%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSulfonamide%252Bderivatives%252Bas%252Bmulti-target%252Bagents%252Bfor%252Bcomplex%252Bdiseases%26aulast%3DApayd%25C4%25B1n%26aufirst%3DSinem%26date%3D2019%26volume%3D29%26issue%3D16%26spage%3D2042%26epage%3D2050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paweł  Śliwa</span>, <span class="hlFld-ContribAuthor ">Rafał  Kurczab</span>, <span class="hlFld-ContribAuthor ">Rafał  Kafel</span>, <span class="hlFld-ContribAuthor ">Anna  Drabczyk</span>, <span class="hlFld-ContribAuthor ">Jolanta  Jaśkowska</span>. </span><span class="cited-content_cbyCitation_article-title">Recognition of repulsive and attractive regions of selected serotonin receptor binding site using FMO-EDA approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2019,</strong> <em>25 </em>
                                    (5)
                                     <a href="https://doi.org/10.1007/s00894-019-3995-6" title="DOI URL">https://doi.org/10.1007/s00894-019-3995-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-019-3995-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-019-3995-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DRecognition%252Bof%252Brepulsive%252Band%252Battractive%252Bregions%252Bof%252Bselected%252Bserotonin%252Breceptor%252Bbinding%252Bsite%252Busing%252BFMO-EDA%252Bapproach%26aulast%3D%25C5%259Aliwa%26aufirst%3DPawe%25C5%2582%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Justyna  Kalinowska-Tłuścik</span>, <span class="hlFld-ContribAuthor ">Agata  Piaskowska</span>, <span class="hlFld-ContribAuthor ">Marcin  Kołaczkowski</span>. </span><span class="cited-content_cbyCitation_article-title">Multifunctional arylsulfonamide derivatives with 5-HT
              6
              /5-HT
              7
              receptor antagonistic activity: a structural study. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section C Structural Chemistry</span><span> <strong>2018,</strong> <em>74 </em>
                                    (11)
                                     , 1477-1486. <a href="https://doi.org/10.1107/S2053229618013748" title="DOI URL">https://doi.org/10.1107/S2053229618013748</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S2053229618013748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS2053229618013748%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520C%2520Structural%2520Chemistry%26atitle%3DMultifunctional%252Barylsulfonamide%252Bderivatives%252Bwith%252B5-HT%252B6%252B%25252F5-HT%252B7%252Breceptor%252Bantagonistic%252Bactivity%25253A%252Ba%252Bstructural%252Bstudy%26aulast%3DKalinowska-T%25C5%2582u%25C5%259Bcik%26aufirst%3DJustyna%26date%3D2018%26date%3D2018%26volume%3D74%26issue%3D11%26spage%3D1477%26epage%3D1486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Preeti  Jha</span>, <span class="hlFld-ContribAuthor ">Shubhra  Chaturvedi</span>, <span class="hlFld-ContribAuthor ">Swastika</span>, <span class="hlFld-ContribAuthor ">Sunil  Pal</span>, <span class="hlFld-ContribAuthor ">Nidhi  Jain</span>, <span class="hlFld-ContribAuthor ">Anil K.  Mishra</span>. </span><span class="cited-content_cbyCitation_article-title">Improvising 5-HT
              7
              R homology model for design of high affinity ligands: model validation with docking, embrace minimization, MM-GBSA, and molecular dynamic simulations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2018,</strong> <em>36 </em>
                                    (10)
                                     , 2475-2494. <a href="https://doi.org/10.1080/07391102.2017.1359907" title="DOI URL">https://doi.org/10.1080/07391102.2017.1359907</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2017.1359907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2017.1359907%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DImprovising%252B5-HT%252B7%252BR%252Bhomology%252Bmodel%252Bfor%252Bdesign%252Bof%252Bhigh%252Baffinity%252Bligands%25253A%252Bmodel%252Bvalidation%252Bwith%252Bdocking%25252C%252Bembrace%252Bminimization%25252C%252BMM-GBSA%25252C%252Band%252Bmolecular%252Bdynamic%252Bsimulations%26aulast%3DJha%26aufirst%3DPreeti%26date%3D2018%26date%3D2017%26volume%3D36%26issue%3D10%26spage%3D2475%26epage%3D2494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarzyna  Pańczyk</span>, <span class="hlFld-ContribAuthor ">Karolina  Pytka</span>, <span class="hlFld-ContribAuthor ">Magdalena  Jakubczyk</span>, <span class="hlFld-ContribAuthor ">Anna  Rapacz</span>, <span class="hlFld-ContribAuthor ">Kinga  Sałat</span>, <span class="hlFld-ContribAuthor ">Anna  Furgała</span>, <span class="hlFld-ContribAuthor ">Agata  Siwek</span>, <span class="hlFld-ContribAuthor ">Monika  Głuch-Lutwin</span>, <span class="hlFld-ContribAuthor ">Anna  Gryboś</span>, <span class="hlFld-ContribAuthor ">Karolina  Słoczyńska</span>, <span class="hlFld-ContribAuthor ">Elżbieta  Pękala</span>, <span class="hlFld-ContribAuthor ">Paweł  Żmudzki</span>, <span class="hlFld-ContribAuthor ">Adam  Bucki</span>, <span class="hlFld-ContribAuthor ">Marcin  Kołaczkowski</span>, <span class="hlFld-ContribAuthor ">Dorota  Żelaszczyk</span>, <span class="hlFld-ContribAuthor ">Henryk  Marona</span>, <span class="hlFld-ContribAuthor ">Anna M.  Waszkielewicz</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and activity of di- or trisubstituted N -(phenoxyalkyl)- or N -{2-[2-(phenoxy)ethoxy]ethyl}piperazine derivatives on the central nervous system. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (11)
                                     , 2039-2049. <a href="https://doi.org/10.1016/j.bmcl.2018.04.059" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.04.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.04.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.04.059%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bactivity%252Bof%252Bdi-%252Bor%252Btrisubstituted%252BN%252B-%252528phenoxyalkyl%252529-%252Bor%252BN%252B-%25257B2-%25255B2-%252528phenoxy%252529ethoxy%25255Dethyl%25257Dpiperazine%252Bderivatives%252Bon%252Bthe%252Bcentral%252Bnervous%252Bsystem%26aulast%3DPa%25C5%2584czyk%26aufirst%3DKatarzyna%26date%3D2018%26volume%3D28%26issue%3D11%26spage%3D2039%26epage%3D2049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raquel Nunes  da Silva</span>, <span class="hlFld-ContribAuthor ">Ângela  Cunha</span>, <span class="hlFld-ContribAuthor ">Augusto C.  Tomé</span>. </span><span class="cited-content_cbyCitation_article-title">Phthalocyanine–sulfonamide conjugates: Synthesis and photodynamic inactivation of Gram-negative and Gram-positive bacteria. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>154 </em>, 60-67. <a href="https://doi.org/10.1016/j.ejmech.2018.05.009" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.05.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.05.009%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPhthalocyanine%2525E2%252580%252593sulfonamide%252Bconjugates%25253A%252BSynthesis%252Band%252Bphotodynamic%252Binactivation%252Bof%252BGram-negative%252Band%252BGram-positive%252Bbacteria%26aulast%3Dda%2BSilva%26aufirst%3DRaquel%2BNunes%26date%3D2018%26volume%3D154%26spage%3D60%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">4-(Hetero)Arylpiperidines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 155-193. <a href="https://doi.org/10.1002/9781118686263.ch5" title="DOI URL">https://doi.org/10.1002/9781118686263.ch5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118686263.ch5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118686263.ch5%26sid%3Dliteratum%253Aachs%26atitle%3D4-%252528Hetero%252529Arylpiperidines%26date%3D2018%26date%3D2018%26spage%3D155%26epage%3D193%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DPrivileged%252BStructures%252Bin%252BDrug%252BDiscovery%26aulast%3DYet%26aufirst%3DLarry%26date%3D2018%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ádám A.  Kelemen</span>, <span class="hlFld-ContribAuthor ">Stefan  Mordalski</span>, <span class="hlFld-ContribAuthor ">Andrzej J.  Bojarski</span>, <span class="hlFld-ContribAuthor ">György M.  Keserű</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Modeling of Drugs for Alzheimer’s Disease: Design of Serotonin 5-HT6 Antagonists. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 419-461. <a href="https://doi.org/10.1007/978-1-4939-7404-7_15" title="DOI URL">https://doi.org/10.1007/978-1-4939-7404-7_15</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-7404-7_15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-7404-7_15%26sid%3Dliteratum%253Aachs%26atitle%3DComputational%252BModeling%252Bof%252BDrugs%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BDesign%252Bof%252BSerotonin%252B5-HT6%252BAntagonists%26aulast%3DKelemen%26aufirst%3D%25C3%2581d%25C3%25A1m%2BA.%26date%3D2018%26date%3D2017%26spage%3D419%26epage%3D461%26pub%3DSpringer%2520New%2520York%26atitle%3DComputational%252BModeling%252Bof%252BDrugs%252BAgainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DRoy%26aufirst%3DKunal%26date%3D2018%26volume%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Piotr  Kowalski</span>, <span class="hlFld-ContribAuthor ">Paweł  Śliwa</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Satała</span>, <span class="hlFld-ContribAuthor ">Rafał  Kurczab</span>, <span class="hlFld-ContribAuthor ">Ilona  Bartos</span>, <span class="hlFld-ContribAuthor ">Karol  Zuchowicz</span>. </span><span class="cited-content_cbyCitation_article-title">The Effect of Carboxamide/Sulfonamide Replacement in Arylpiperazinylalkyl Derivatives on Activity to Serotonin and Dopamine Receptors. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2017,</strong> <em>350 </em>
                                    (10)
                                     , 1700090. <a href="https://doi.org/10.1002/ardp.201700090" title="DOI URL">https://doi.org/10.1002/ardp.201700090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201700090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201700090%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DThe%252BEffect%252Bof%252BCarboxamide%25252FSulfonamide%252BReplacement%252Bin%252BArylpiperazinylalkyl%252BDerivatives%252Bon%252BActivity%252Bto%252BSerotonin%252Band%252BDopamine%252BReceptors%26aulast%3DKowalski%26aufirst%3DPiotr%26date%3D2017%26date%3D2017%26volume%3D350%26issue%3D10%26spage%3D1700090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kinga  Ostrowska</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Młodzikowska</span>, <span class="hlFld-ContribAuthor ">Monika  Głuch-Lutwin</span>, <span class="hlFld-ContribAuthor ">Anna  Gryboś</span>, <span class="hlFld-ContribAuthor ">Agata  Siwek</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of a new series of aryl/heteroarylpiperazinyl derivatives of 8-acetyl-7-hydroxy-4-methylcoumarin with low nanomolar 5-HT 1A affinities. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>137 </em>, 108-116. <a href="https://doi.org/10.1016/j.ejmech.2017.05.047" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.05.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.05.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.05.047%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Ba%252Bnew%252Bseries%252Bof%252Baryl%25252Fheteroarylpiperazinyl%252Bderivatives%252Bof%252B8-acetyl-7-hydroxy-4-methylcoumarin%252Bwith%252Blow%252Bnanomolar%252B5-HT%252B1A%252Baffinities%26aulast%3DOstrowska%26aufirst%3DKinga%26date%3D2017%26volume%3D137%26spage%3D108%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Feng  Xia</span>, <span class="hlFld-ContribAuthor ">Guo-Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Su-Li  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Visible-light-induced synthesis of benzothiophenes and benzoselenophenes via the annulation of thiophenols or 1,2-diphenyldiselane with alkynes. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2017,</strong> <em>73 </em>
                                    (19)
                                     , 2727-2730. <a href="https://doi.org/10.1016/j.tet.2017.03.053" title="DOI URL">https://doi.org/10.1016/j.tet.2017.03.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2017.03.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2017.03.053%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DVisible-light-induced%252Bsynthesis%252Bof%252Bbenzothiophenes%252Band%252Bbenzoselenophenes%252Bvia%252Bthe%252Bannulation%252Bof%252Bthiophenols%252Bor%252B1%25252C2-diphenyldiselane%252Bwith%252Balkynes%26aulast%3DXia%26aufirst%3DXiao-Feng%26date%3D2017%26volume%3D73%26issue%3D19%26spage%3D2727%26epage%3D2730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Grażyna  Chłoń-Rzepa</span>, <span class="hlFld-ContribAuthor ">Agnieszka  Zagórska</span>, <span class="hlFld-ContribAuthor ">Paweł  Żmudzki</span>, <span class="hlFld-ContribAuthor ">Adam  Bucki</span>, <span class="hlFld-ContribAuthor ">Marcin  Kołaczkowski</span>, <span class="hlFld-ContribAuthor ">Anna  Partyka</span>, <span class="hlFld-ContribAuthor ">Anna  Wesołowska</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Kazek</span>, <span class="hlFld-ContribAuthor ">Monika  Głuch-Lutwin</span>, <span class="hlFld-ContribAuthor ">Agata  Siwek</span>, <span class="hlFld-ContribAuthor ">Gabriela  Starowicz</span>, <span class="hlFld-ContribAuthor ">Maciej  Pawłowski</span>. </span><span class="cited-content_cbyCitation_article-title">Aminoalkyl Derivatives of 8-Alkoxypurine-2,6-diones: Multifunctional 5-HT
              1A
              /5-HT
              7
              Receptor Ligands and PDE Inhibitors with Antidepressant Activity. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2016,</strong> <em>349 </em>
                                    (12)
                                     , 889-903. <a href="https://doi.org/10.1002/ardp.201600260" title="DOI URL">https://doi.org/10.1002/ardp.201600260</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201600260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201600260%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DAminoalkyl%252BDerivatives%252Bof%252B8-Alkoxypurine-2%25252C6-diones%25253A%252BMultifunctional%252B5-HT%252B1A%252B%25252F5-HT%252B7%252BReceptor%252BLigands%252Band%252BPDE%252BInhibitors%252Bwith%252BAntidepressant%252BActivity%26aulast%3DCh%25C5%2582o%25C5%2584-Rzepa%26aufirst%3DGra%25C5%25BCyna%26date%3D2016%26date%3D2016%26volume%3D349%26issue%3D12%26spage%3D889%26epage%3D903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agnieszka  Zagórska</span>, <span class="hlFld-ContribAuthor ">Adam  Bucki</span>, <span class="hlFld-ContribAuthor ">Marcin  Kołaczkowski</span>, <span class="hlFld-ContribAuthor ">Agata  Siwek</span>, <span class="hlFld-ContribAuthor ">Monika  Głuch-Lutwin</span>, <span class="hlFld-ContribAuthor ">Gabriela  Starowicz</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Kazek</span>, <span class="hlFld-ContribAuthor ">Anna  Partyka</span>, <span class="hlFld-ContribAuthor ">Anna  Wesołowska</span>, <span class="hlFld-ContribAuthor ">Karolina  Słoczyńska</span>, <span class="hlFld-ContribAuthor ">Elżbieta  Pękala</span>, <span class="hlFld-ContribAuthor ">Maciej  Pawłowski</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 2-fluoro and 3-trifluoromethyl-phenyl-piperazinylalkyl derivatives of 1
              H
              -imidazo[2,1-
              f
              ]purine-2,4(3
              H
              ,8
              H
              )-dione as potential antidepressant agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2016,</strong> <em>31 </em>
                                    (sup3)
                                     , 10-24. <a href="https://doi.org/10.1080/14756366.2016.1198902" title="DOI URL">https://doi.org/10.1080/14756366.2016.1198902</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2016.1198902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2016.1198902%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B2-fluoro%252Band%252B3-trifluoromethyl-phenyl-piperazinylalkyl%252Bderivatives%252Bof%252B1%252BH%252B-imidazo%25255B2%25252C1-%252Bf%252B%25255Dpurine-2%25252C4%2525283%252BH%252B%25252C8%252BH%252B%252529-dione%252Bas%252Bpotential%252Bantidepressant%252Bagents%26aulast%3DZag%25C3%25B3rska%26aufirst%3DAgnieszka%26date%3D2016%26date%3D2016%26volume%3D31%26issue%3Dsup3%26spage%3D10%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Więckowska</span>, <span class="hlFld-ContribAuthor ">Marcin  Kołaczkowski</span>, <span class="hlFld-ContribAuthor ">Adam  Bucki</span>, <span class="hlFld-ContribAuthor ">Justyna  Godyń</span>, <span class="hlFld-ContribAuthor ">Monika  Marcinkowska</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Więckowski</span>, <span class="hlFld-ContribAuthor ">Paula  Zaręba</span>, <span class="hlFld-ContribAuthor ">Agata  Siwek</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Kazek</span>, <span class="hlFld-ContribAuthor ">Monika  Głuch-Lutwin</span>, <span class="hlFld-ContribAuthor ">Paweł  Mierzejewski</span>, <span class="hlFld-ContribAuthor ">Przemysław  Bienkowski</span>, <span class="hlFld-ContribAuthor ">Halina  Sienkiewicz-Jarosz</span>, <span class="hlFld-ContribAuthor ">Damijan  Knez</span>, <span class="hlFld-ContribAuthor ">Tomasz  Wichur</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>, <span class="hlFld-ContribAuthor ">Barbara  Malawska</span>. </span><span class="cited-content_cbyCitation_article-title">Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT 6 receptor antagonists. Design, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>124 </em>, 63-81. <a href="https://doi.org/10.1016/j.ejmech.2016.08.016" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.08.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.08.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.08.016%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bmulti-target-directed%252Bligands%252Bfor%252BAlzheimer%252527s%252Bdisease%25253A%252BCombining%252Bcholinesterase%252Binhibitors%252Band%252B5-HT%252B6%252Breceptor%252Bantagonists.%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DWi%25C4%2599ckowska%26aufirst%3DAnna%26date%3D2016%26volume%3D124%26spage%3D63%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monika  Marcinkowska</span>, <span class="hlFld-ContribAuthor ">Marcin  Kołaczkowski</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Kamiński</span>, <span class="hlFld-ContribAuthor ">Adam  Bucki</span>, <span class="hlFld-ContribAuthor ">Maciej  Pawłowski</span>, <span class="hlFld-ContribAuthor ">Agata  Siwek</span>, <span class="hlFld-ContribAuthor ">Tadeusz  Karcz</span>, <span class="hlFld-ContribAuthor ">Barbara  Mordyl</span>, <span class="hlFld-ContribAuthor ">Gabriela  Starowicz</span>, <span class="hlFld-ContribAuthor ">Paulina  Kubowicz</span>, <span class="hlFld-ContribAuthor ">Elżbieta  Pękala</span>, <span class="hlFld-ContribAuthor ">Anna  Wesołowska</span>, <span class="hlFld-ContribAuthor ">Jerzy  Samochowiec</span>, <span class="hlFld-ContribAuthor ">Paweł  Mierzejewski</span>, <span class="hlFld-ContribAuthor ">Przemyslaw  Bienkowski</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of fluorinated imidazo[1,2- a ]pyridine derivatives with potential antipsychotic activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>124 </em>, 456-467. <a href="https://doi.org/10.1016/j.ejmech.2016.08.059" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.08.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.08.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.08.059%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bfluorinated%252Bimidazo%25255B1%25252C2-%252Ba%252B%25255Dpyridine%252Bderivatives%252Bwith%252Bpotential%252Bantipsychotic%252Bactivity%26aulast%3DMarcinkowska%26aufirst%3DMonika%26date%3D2016%26volume%3D124%26spage%3D456%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Grażyna  Chłoń-Rzepa</span>, <span class="hlFld-ContribAuthor ">Adam  Bucki</span>, <span class="hlFld-ContribAuthor ">Marcin  Kołaczkowski</span>, <span class="hlFld-ContribAuthor ">Anna  Partyka</span>, <span class="hlFld-ContribAuthor ">Magdalena  Jastrzębska-Więsek</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Satała</span>, <span class="hlFld-ContribAuthor ">Andrzej J.  Bojarski</span>, <span class="hlFld-ContribAuthor ">Justyna  Kalinowska-Tłuścik</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Kazek</span>, <span class="hlFld-ContribAuthor ">Barbara  Mordyl</span>, <span class="hlFld-ContribAuthor ">Monika  Głuch-Lutwin</span>, <span class="hlFld-ContribAuthor ">Anna  Wesołowska</span>. </span><span class="cited-content_cbyCitation_article-title">Arylpiperazinylalkyl derivatives of 8-amino-1,3-dimethylpurine-2,6-dione as novel multitarget 5-HT/D receptor agents with potential antipsychotic activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2016,</strong> <em>31 </em>
                                    (6)
                                     , 1048-1062. <a href="https://doi.org/10.3109/14756366.2015.1088844" title="DOI URL">https://doi.org/10.3109/14756366.2015.1088844</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/14756366.2015.1088844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F14756366.2015.1088844%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DArylpiperazinylalkyl%252Bderivatives%252Bof%252B8-amino-1%25252C3-dimethylpurine-2%25252C6-dione%252Bas%252Bnovel%252Bmultitarget%252B5-HT%25252FD%252Breceptor%252Bagents%252Bwith%252Bpotential%252Bantipsychotic%252Bactivity%26aulast%3DCh%25C5%2582o%25C5%2584-Rzepa%26aufirst%3DGra%25C5%25BCyna%26date%3D2016%26date%3D2015%26volume%3D31%26issue%3D6%26spage%3D1048%26epage%3D1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paweł  Żmudzki</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Satała</span>, <span class="hlFld-ContribAuthor ">Grażyna  Chłoń-Rzepa</span>, <span class="hlFld-ContribAuthor ">Andrzej J.  Bojarski</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Kazek</span>, <span class="hlFld-ContribAuthor ">Agata  Siwek</span>, <span class="hlFld-ContribAuthor ">Anna  Gryboś</span>, <span class="hlFld-ContribAuthor ">Monika  Głuch-Lutwin</span>, <span class="hlFld-ContribAuthor ">Anna  Wesołowska</span>, <span class="hlFld-ContribAuthor ">Maciej  Pawłowski</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-5-HT/D
              2
              Receptor Affinity Relationship in a New Group of 1-Arylpiperazynylalkyl Derivatives of 8-Dialkylamino-3,7-dimethyl-1
              H
              -purine-2,6(3
              H
              ,7
              H
              )-dione. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2016,</strong> <em>349 </em>
                                    (10)
                                     , 774-784. <a href="https://doi.org/10.1002/ardp.201600162" title="DOI URL">https://doi.org/10.1002/ardp.201600162</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201600162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201600162%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DStructure-5-HT%25252FD%252B2%252BReceptor%252BAffinity%252BRelationship%252Bin%252Ba%252BNew%252BGroup%252Bof%252B1-Arylpiperazynylalkyl%252BDerivatives%252Bof%252B8-Dialkylamino-3%25252C7-dimethyl-1%252BH%252B-purine-2%25252C6%2525283%252BH%252B%25252C7%252BH%252B%252529-dione%26aulast%3D%25C5%25BBmudzki%26aufirst%3DPawe%25C5%2582%26date%3D2016%26date%3D2016%26volume%3D349%26issue%3D10%26spage%3D774%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Radoslaw  Magierski</span>, <span class="hlFld-ContribAuthor ">Tomasz  Sobow</span>. </span><span class="cited-content_cbyCitation_article-title">Serotonergic drugs for the treatment of neuropsychiatric symptoms in dementia. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Neurotherapeutics</span><span> <strong>2016,</strong> <em>16 </em>
                                    (4)
                                     , 375-387. <a href="https://doi.org/10.1586/14737175.2016.1155453" title="DOI URL">https://doi.org/10.1586/14737175.2016.1155453</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1586/14737175.2016.1155453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1586%2F14737175.2016.1155453%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Neurotherapeutics%26atitle%3DSerotonergic%252Bdrugs%252Bfor%252Bthe%252Btreatment%252Bof%252Bneuropsychiatric%252Bsymptoms%252Bin%252Bdementia%26aulast%3DMagierski%26aufirst%3DRadoslaw%26date%3D2016%26date%3D2016%26volume%3D16%26issue%3D4%26spage%3D375%26epage%3D387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marek  Bednarski</span>, <span class="hlFld-ContribAuthor ">Monika  Otto</span>, <span class="hlFld-ContribAuthor ">Magdalena  Dudek</span>, <span class="hlFld-ContribAuthor ">Marcin  Kołaczkowski</span>, <span class="hlFld-ContribAuthor ">Adam  Bucki</span>, <span class="hlFld-ContribAuthor ">Agata  Siwek</span>, <span class="hlFld-ContribAuthor ">Grażyna  Groszek</span>, <span class="hlFld-ContribAuthor ">Elżbieta  Maziarz</span>, <span class="hlFld-ContribAuthor ">Piotr  Wilk</span>, <span class="hlFld-ContribAuthor ">Jacek  Sapa</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Pharmacological Activity of a New Series of 1-(1
              H
              -Indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol Analogs. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2016,</strong> <em>349 </em>
                                    (3)
                                     , 211-223. <a href="https://doi.org/10.1002/ardp.201500234" title="DOI URL">https://doi.org/10.1002/ardp.201500234</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201500234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201500234%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%252Band%252BPharmacological%252BActivity%252Bof%252Ba%252BNew%252BSeries%252Bof%252B1-%2525281%252BH%252B-Indol-4-yloxy%252529-3-%2525282-%2525282-methoxyphenoxy%252529ethylamino%252529propan-2-ol%252BAnalogs%26aulast%3DBednarski%26aufirst%3DMarek%26date%3D2016%26date%3D2016%26volume%3D349%26issue%3D3%26spage%3D211%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arnold  van Loevezijn</span>, <span class="hlFld-ContribAuthor ">Jennifer  Venhorst</span>, <span class="hlFld-ContribAuthor ">Wouter I.  Iwema Bakker</span>, <span class="hlFld-ContribAuthor ">Jos H.M.  Lange</span>, <span class="hlFld-ContribAuthor ">Wouter  de Looff</span>, <span class="hlFld-ContribAuthor ">Remco  Henzen</span>, <span class="hlFld-ContribAuthor ">Jelle  de Vries</span>, <span class="hlFld-ContribAuthor ">Rob P.  van de Woestijne</span>, <span class="hlFld-ContribAuthor ">Arnold P.  den Hartog</span>, <span class="hlFld-ContribAuthor ">Stefan  Verhoog</span>, <span class="hlFld-ContribAuthor ">Martina A.W.  van der Neut</span>, <span class="hlFld-ContribAuthor ">Natasja M.W.J.  de Bruin</span>, <span class="hlFld-ContribAuthor ">Chris G.  Kruse</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of N ′-(arylsulfonyl)pyrazoline-1-carboxamidines by exploiting a novel interaction site in the 5-HT 6 antagonistic binding pocket. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (6)
                                     , 1605-1611. <a href="https://doi.org/10.1016/j.bmcl.2016.02.001" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.02.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.02.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOptimization%252Bof%252BN%252B%2525E2%252580%2525B2-%252528arylsulfonyl%252529pyrazoline-1-carboxamidines%252Bby%252Bexploiting%252Ba%252Bnovel%252Binteraction%252Bsite%252Bin%252Bthe%252B5-HT%252B6%252Bantagonistic%252Bbinding%252Bpocket%26aulast%3Dvan%2BLoevezijn%26aufirst%3DArnold%26date%3D2016%26volume%3D26%26issue%3D6%26spage%3D1605%26epage%3D1611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karolina  Pytka</span>, <span class="hlFld-ContribAuthor ">Anna  Partyka</span>, <span class="hlFld-ContribAuthor ">Magdalena  Jastrzębska-Więsek</span>, <span class="hlFld-ContribAuthor ">Agata  Siwek</span>, <span class="hlFld-ContribAuthor ">Monika  Głuch-Lutwin</span>, <span class="hlFld-ContribAuthor ">Barbara  Mordyl</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Kazek</span>, <span class="hlFld-ContribAuthor ">Anna  Rapacz</span>, <span class="hlFld-ContribAuthor ">Adrian  Olczyk</span>, <span class="hlFld-ContribAuthor ">Adam  Gałuszka</span>, <span class="hlFld-ContribAuthor ">Marian  Błachuta</span>, <span class="hlFld-ContribAuthor ">Anna  Waszkielewicz</span>, <span class="hlFld-ContribAuthor ">Henryk  Marona</span>, <span class="hlFld-ContribAuthor ">Jacek  Sapa</span>, <span class="hlFld-ContribAuthor ">Barbara  Filipek</span>, <span class="hlFld-ContribAuthor ">Anna  Wesołowska</span>, . </span><span class="cited-content_cbyCitation_article-title">Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT1A and 5-HT7 Antagonists in Animal Models. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2015,</strong> <em>10 </em>
                                    (11)
                                     , e0142499. <a href="https://doi.org/10.1371/journal.pone.0142499" title="DOI URL">https://doi.org/10.1371/journal.pone.0142499</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0142499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0142499%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DAntidepressant-%252Band%252BAnxiolytic-Like%252BEffects%252Bof%252BNew%252BDual%252B5-HT1A%252Band%252B5-HT7%252BAntagonists%252Bin%252BAnimal%252BModels%26aulast%3DPytka%26aufirst%3DKarolina%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D11%26spage%3De0142499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Czopek</span>, <span class="hlFld-ContribAuthor ">Marcin  Kołaczkowski</span>, <span class="hlFld-ContribAuthor ">Adam  Bucki</span>, <span class="hlFld-ContribAuthor ">Hanna  Byrtus</span>, <span class="hlFld-ContribAuthor ">Maciej  Pawłowski</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Kazek</span>, <span class="hlFld-ContribAuthor ">Andrzej J.  Bojarski</span>, <span class="hlFld-ContribAuthor ">Agata  Piaskowska</span>, <span class="hlFld-ContribAuthor ">Justyna  Kalinowska-Tłuścik</span>, <span class="hlFld-ContribAuthor ">Anna  Partyka</span>, <span class="hlFld-ContribAuthor ">Anna  Wesołowska</span>. </span><span class="cited-content_cbyCitation_article-title">Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (13)
                                     , 3436-3447. <a href="https://doi.org/10.1016/j.bmc.2015.04.026" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.04.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.04.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.04.026%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bspirohydantoin%252Bderivative%252Bas%252Ba%252Bpotent%252Bmultireceptor-active%252Bantipsychotic%252Band%252Bantidepressant%252Bagent%26aulast%3DCzopek%26aufirst%3DAnna%26date%3D2015%26volume%3D23%26issue%3D13%26spage%3D3436%26epage%3D3447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoshikazu  Uto</span>. </span><span class="cited-content_cbyCitation_article-title">1,2-Benzisoxazole compounds: a patent review (2009 – 2014). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2015,</strong> <em>25 </em>
                                    (6)
                                     , 643-662. <a href="https://doi.org/10.1517/13543776.2015.1027192" title="DOI URL">https://doi.org/10.1517/13543776.2015.1027192</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2015.1027192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2015.1027192%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3D1%25252C2-Benzisoxazole%252Bcompounds%25253A%252Ba%252Bpatent%252Breview%252B%2525282009%252B%2525E2%252580%252593%252B2014%252529%26aulast%3DUto%26aufirst%3DYoshikazu%26date%3D2015%26date%3D2015%26volume%3D25%26issue%3D6%26spage%3D643%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agnieszka  Zagórska</span>, <span class="hlFld-ContribAuthor ">Marcin  Kołaczkowski</span>, <span class="hlFld-ContribAuthor ">Adam  Bucki</span>, <span class="hlFld-ContribAuthor ">Agata  Siwek</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Kazek</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Satała</span>, <span class="hlFld-ContribAuthor ">Andrzej J.  Bojarski</span>, <span class="hlFld-ContribAuthor ">Anna  Partyka</span>, <span class="hlFld-ContribAuthor ">Anna  Wesołowska</span>, <span class="hlFld-ContribAuthor ">Maciej  Pawłowski</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–activity relationships and molecular studies of novel arylpiperazinylalkyl purine-2,4-diones and purine-2,4,8-triones with antidepressant and anxiolytic-like activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>97 </em>, 142-154. <a href="https://doi.org/10.1016/j.ejmech.2015.04.046" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.04.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.04.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.04.046%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593activity%252Brelationships%252Band%252Bmolecular%252Bstudies%252Bof%252Bnovel%252Barylpiperazinylalkyl%252Bpurine-2%25252C4-diones%252Band%252Bpurine-2%25252C4%25252C8-triones%252Bwith%252Bantidepressant%252Band%252Banxiolytic-like%252Bactivity%26aulast%3DZag%25C3%25B3rska%26aufirst%3DAgnieszka%26date%3D2015%26volume%3D97%26spage%3D142%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paweł  Żmudzki</span>, <span class="hlFld-ContribAuthor ">Grażyna  Chłoń-Rzepa</span>, <span class="hlFld-ContribAuthor ">Andrzej J.  Bojarski</span>, <span class="hlFld-ContribAuthor ">Małgorzata  Zygmunt</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Kazek</span>, <span class="hlFld-ContribAuthor ">Barbara  Mordyl</span>, <span class="hlFld-ContribAuthor ">Maciej  Pawłowski</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-5-HT Receptor Affinity Relationship in a New Group of 7-Arylpiperazynylalkyl and 7-Tetrahydroisoquinolinylalkyl Derivatives of 8-Amino-1,3-dimethyl-1
              H
              -purine-2,6(3
              H
              ,7
              H
              )-dione. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2015,</strong> <em>348 </em>
                                    (4)
                                     , 229-241. <a href="https://doi.org/10.1002/ardp.201400392" title="DOI URL">https://doi.org/10.1002/ardp.201400392</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201400392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201400392%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DStructure-5-HT%252BReceptor%252BAffinity%252BRelationship%252Bin%252Ba%252BNew%252BGroup%252Bof%252B7-Arylpiperazynylalkyl%252Band%252B7-Tetrahydroisoquinolinylalkyl%252BDerivatives%252Bof%252B8-Amino-1%25252C3-dimethyl-1%252BH%252B-purine-2%25252C6%2525283%252BH%252B%25252C7%252BH%252B%252529-dione%26aulast%3D%25C5%25BBmudzki%26aufirst%3DPawe%25C5%2582%26date%3D2015%26date%3D2015%26volume%3D348%26issue%3D4%26spage%3D229%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcin  Kołaczkowski</span>, <span class="hlFld-ContribAuthor ">Monika  Marcinkowska</span>, <span class="hlFld-ContribAuthor ">Adam  Bucki</span>, <span class="hlFld-ContribAuthor ">Joanna  Śniecikowska</span>, <span class="hlFld-ContribAuthor ">Maciej  Pawłowski</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Kazek</span>, <span class="hlFld-ContribAuthor ">Agata  Siwek</span>, <span class="hlFld-ContribAuthor ">Magdalena  Jastrzębska-Więsek</span>, <span class="hlFld-ContribAuthor ">Anna  Partyka</span>, <span class="hlFld-ContribAuthor ">Anna  Wasik</span>, <span class="hlFld-ContribAuthor ">Anna  Wesołowska</span>, <span class="hlFld-ContribAuthor ">Paweł  Mierzejewski</span>, <span class="hlFld-ContribAuthor ">Przemyslaw  Bienkowski</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>92 </em>, 221-235. <a href="https://doi.org/10.1016/j.ejmech.2014.12.045" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.12.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.12.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.12.045%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B5-HT6%252Breceptor%252Bantagonists%25252FD2%252Breceptor%252Bpartial%252Bagonists%252Btargeting%252Bbehavioral%252Band%252Bpsychological%252Bsymptoms%252Bof%252Bdementia%26aulast%3DKo%25C5%2582aczkowski%26aufirst%3DMarcin%26date%3D2015%26volume%3D92%26spage%3D221%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/medium/jm-2013-01895u_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/large/jm-2013-01895u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401895u&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/medium/jm-2013-01895u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/large/jm-2013-01895u_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of multifunctional ligands. Proposed binding modes presented for (1<i>R</i>)-3,<i>N</i>-dimethyl-<i>N</i>-[1-methyl-3-(4-methylpiperidin-1-yl)propyl]benzenesulfonamide (SB-258719)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> in 5-HT<sub>7</sub>R (A) and compound <b>2</b> in the 5-HT<sub>6</sub>R (C) and hERG channel (D). Amino acid residues engaged in ligand binding (within 4 Å from the ligand atoms) are shown as thick sticks together with their van der Waals surfaces (wire frame). Distances between key amino acid moieties and ligand structural elements are shown in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Tables S1 and S2. The numbers in brackets next to the residues in the hERG channel indicate the subunit number. Docking of <b>2</b> in M<sub>1</sub>R resulted in no valid poses (E). Dotted yellow lines represent H-bonds with polar residues. For the sake of clarity, ECL2 was hidden (A and C). TMH, transmembrane helix; ECL, extracellular loop.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/large/jm-2013-01895u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401895u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/medium/jm-2013-01895u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/large/jm-2013-01895u_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding mode of compound <b>2</b> in (A) 5-HT<sub>7</sub>R, (B) 5-HT<sub>2A</sub>R, (C) D<sub>2</sub>R, and (D) 5-HT<sub>6</sub>R. Residues in the binding site (within 4 Å from the ligand atoms) are presented as thick sticks together with their van der Waals surfaces (wire frame). Distances between key amino acid moieties and ligand structural elements are shown in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Table S2. Dotted yellow lines represent H-bonds with polar residues. Where possible, ECL2 was partially or entirely hidden for the sake of clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/large/jm-2013-01895u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401895u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/medium/jm-2013-01895u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/large/jm-2013-01895u_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. General structures of hybrid molecules, benzazolepiperazines/piperidines I–III and arylsulfonyl fragments Ar (<b>1</b>–<b>15</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/large/jm-2013-01895u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401895u&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/medium/jm-2013-01895u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/large/jm-2013-01895u_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of Hybrid Molecules<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/large/jm-2013-01895u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401895u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, KI, DMF, rt, 48 h or DIPEA, KI, DMF/CH<sub>3</sub>CN 1:1, 70 °C, 3 days; (b) 40% aq MeNH<sub>2</sub>, rt, 76 h; (c) Et<sub>3</sub>N, DCM, 3 h, 10 °C then rt.</p></p></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/medium/jm-2013-01895u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/large/jm-2013-01895u_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Binding mode of the compounds (A) <b>51</b> and (B) <b>72</b> in the 5-HT<sub>6</sub> receptor. Residues in the binding site (within 4 Å from the ligand atoms) are presented as thick sticks together with their van der Waals surfaces (wire frame). Distances between key amino acid moieties and ligand structural elements are shown in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Tables S3 and S4. Dotted yellow lines represent H-bonds with polar residues. ECL2 was partially hidden for the sake of clarity. TMH, transmembrane helix; ECL, extracellular loop.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401895u/production/images/large/jm-2013-01895u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401895u&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i46">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45046" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45046" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 67 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Liperoti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corsonello, A.</span><span> </span><span class="NLM_article-title">Antipsychotics for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)</span> <span class="citation_source-journal">Curr. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.2174%2F157015908784533860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=19305792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVaktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=117-124&author=R.+Liperotiauthor=C.+Pedoneauthor=A.+Corsonello&title=Antipsychotics+for+the+Treatment+of+Behavioral+and+Psychological+Symptoms+of+Dementia+%28BPSD%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Antipsychotics for the treatment of behavioral and psychological symptoms of dementia (BPSD)</span></div><div class="casAuthors">Liperoti, Rosa; Pedone, Claudio; Corsonello, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-124</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Behavioral and psychol. symptoms of dementia (BPSD), i.e. verbal and phys. aggression, agitation, psychotic symptoms (hallucinations and delusions), sleep disturbances, oppositional behavior, and wandering, are a common and potentially severe problem complicating dementia.  Their prevalence is very high and it is estd. that up to 90% of patients with Alzheimer's disease (AD) may present at least one BPSD.  Beside the obvious impact on the quality of life of people with dementia, BPSD are responsible for increased risk of patient institutionalization and increased costs.  Furthermore, they are assocd. with caregivers' stress and depression.  Drugs used include antipsychotics, antidepressants, anticonvulsivants, anxiolytics, cholinesterase inhibitors and N-methyl-D-aspartate receptor modulators.  Among these, the most commonly used are anti-psychotics.  These drugs have been used for many decades, but in the last years new compds. have been marketed with the promise of comparable efficacy but less frequent adverse effects (esp. extra-pyramidal side effects).  Their safety, however, has been challenged by data showing a potential increase in adverse cerebrovascular side effects and mortality.  This review will summarize the pathophysiol. and neuropharmacol. of BPSD, it will describe the characteristics of the anti-psychotics most commonly used focusing on their efficacy and safety in BPSD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAjjq7EOofHrVg90H21EOLACvtfcHk0ljA7lKir4_6og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVaktLc%253D&md5=701fde11f34cc112cff2ba303853e36d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F157015908784533860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157015908784533860%26sid%3Dliteratum%253Aachs%26aulast%3DLiperoti%26aufirst%3DR.%26aulast%3DPedone%26aufirst%3DC.%26aulast%3DCorsonello%26aufirst%3DA.%26atitle%3DAntipsychotics%2520for%2520the%2520Treatment%2520of%2520Behavioral%2520and%2520Psychological%2520Symptoms%2520of%2520Dementia%2520%2528BPSD%2529%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2008%26volume%3D6%26spage%3D117%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Jeste, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blazer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meeks, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tariot, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaffe, K.</span><span> </span><span class="NLM_article-title">ACNP White Paper: Update on Use of Antipsychotic Drugs in Elderly Persons with Dementia</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">957</span><span class="NLM_x">–</span> <span class="NLM_lpage">970</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=957-970&author=D.+V.+Jesteauthor=D.+Blazerauthor=D.+Caseyauthor=T.+Meeksauthor=C.+Salzmanauthor=L.+Schneiderauthor=P.+Tariotauthor=K.+Yaffe&title=ACNP+White+Paper%3A+Update+on+Use+of+Antipsychotic+Drugs+in+Elderly+Persons+with+Dementia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJeste%26aufirst%3DD.%2BV.%26aulast%3DBlazer%26aufirst%3DD.%26aulast%3DCasey%26aufirst%3DD.%26aulast%3DMeeks%26aufirst%3DT.%26aulast%3DSalzman%26aufirst%3DC.%26aulast%3DSchneider%26aufirst%3DL.%26aulast%3DTariot%26aufirst%3DP.%26aulast%3DYaffe%26aufirst%3DK.%26atitle%3DACNP%2520White%2520Paper%253A%2520Update%2520on%2520Use%2520of%2520Antipsychotic%2520Drugs%2520in%2520Elderly%2520Persons%2520with%2520Dementia%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26spage%3D957%26epage%3D970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Carson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonagh, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, K.</span><span> </span><span class="NLM_article-title">A Systematic Review of the Efficacy and Safety of Atypical Antipsychotics in Patients with Psychological and Behavioral Symptoms of Dementia</span> <span class="citation_source-journal">J. Am. Geriatr. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">354</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1111%2Fj.1532-5415.2005.00566.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=16460391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FnsFOqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=354-361&author=S.+Carsonauthor=M.+S.+McDonaghauthor=K.+Peterson&title=A+Systematic+Review+of+the+Efficacy+and+Safety+of+Atypical+Antipsychotics+in+Patients+with+Psychological+and+Behavioral+Symptoms+of+Dementia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A systematic review of the efficacy and safety of atypical antipsychotics in patients with psychological and behavioral symptoms of dementia</span></div><div class="casAuthors">Carson Susan; McDonagh Marian S; Peterson Kim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Geriatrics Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">354-61</span>
        ISSN:<span class="NLM_cas:issn">0002-8614</span>.
    </div><div class="casAbstract">Although the Food and Drug Administration (FDA) has not approved atypical antipsychotics for use in patients with dementia, they are commonly prescribed in this population.  Recent concerns about increased risk of cerebrovascular events and mortality have led to warnings.  A systematic review was conducted to assess the benefits and harms of atypical antipsychotics when used in patients with behavioral and psychological symptoms of dementia.  Electronic searches (through March 2005) of the Cochrane Library, Medline, Embase, and PsycINFO were supplemented with hand searches of reference lists, dossiers submitted by pharmaceutical companies, and a review of the FDA Website and industry-sponsored results database.  Using predetermined criteria, each study was assessed for inclusion, and data about study design, population, interventions, and outcomes were abstracted.  An overall quality rating (good, fair, or poor) was assigned based on internal validity.  The evidence for olanzapine and risperidone supports their effectiveness compared with placebo.  Short-term adverse events were similar to placebo.  Risperidone had no advantage over haloperidol on efficacy measures in the better-quality studies.  Risperidone had an advantage over haloperidol on some measures of extrapyramidal symptoms.  Evidence for the other atypical antipsychotics is too limited to assess efficacy and safety.  Trials were short term and conducted in highly selected populations.  The potential for increased risk of cerebrovascular adverse events and mortality is a serious concern.  To make judgments about when the benefits of atypical antipsychotics outweigh the potential harms, clinicians need more information.  Additional data from existing trials and more-complete reporting of trial results could provide this information.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQZBZckcskL0xFwe7cAcrfPfW6udTcc2eZMDliPib2wYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FnsFOqtQ%253D%253D&md5=d9c2bdfb8a6f44c9fbe2b42273f19c7d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1532-5415.2005.00566.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1532-5415.2005.00566.x%26sid%3Dliteratum%253Aachs%26aulast%3DCarson%26aufirst%3DS.%26aulast%3DMcDonagh%26aufirst%3DM.%2BS.%26aulast%3DPeterson%26aufirst%3DK.%26atitle%3DA%2520Systematic%2520Review%2520of%2520the%2520Efficacy%2520and%2520Safety%2520of%2520Atypical%2520Antipsychotics%2520in%2520Patients%2520with%2520Psychological%2520and%2520Behavioral%2520Symptoms%2520of%2520Dementia%26jtitle%3DJ.%2520Am.%2520Geriatr.%2520Soc.%26date%3D2006%26volume%3D54%26spage%3D354%26epage%3D361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">U.S. Food and Drug Administration</span><span class="NLM_x">. </span>Public Health Advisory: Deaths with Antipsychotics in Elderly Patients with Behavioral Disturbances; <span class="NLM_publisher-name">Center for Drug Evaluation and Research</span>: <span class="NLM_publisher-loc">Rockville, MD</span>, Apr 11,<span class="NLM_x"> </span><span class="NLM_year">2005</span>. <a href="http://www.fda.gov/Drugs/DrugSafety" class="extLink">www.fda.gov/Drugs/DrugSafety</a> (accessed Nov 28, 2013).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=U.S.+Food+and+Drug+Administration&title=Public+Health+Advisory%3A+Deaths+with+Antipsychotics+in+Elderly+Patients+with+Behavioral+Disturbances"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DPublic%2520Health%2520Advisory%253A%2520Deaths%2520with%2520Antipsychotics%2520in%2520Elderly%2520Patients%2520with%2520Behavioral%2520Disturbances%26pub%3DCenter%2520for%2520Drug%2520Evaluation%2520and%2520Research%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">U.S. Food and Drug Administration</span><span class="NLM_x">. </span>Information on Conventional Antipsychotics. <span class="NLM_publisher-name">Center for Drug Evaluation and Research</span>: <span class="NLM_publisher-loc">Rockville, MD</span>, Jun 16,<span class="NLM_x"> </span><span class="NLM_year">2008</span>. <a href="http://www.fda.gov/Drugs/DrugSafety" class="extLink">www.fda.gov/Drugs/DrugSafety</a> (accessed Nov 28, 2013).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=U.S.+Food+and+Drug+Administration&title=Information+on+Conventional+Antipsychotics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DInformation%2520on%2520Conventional%2520Antipsychotics%26pub%3DCenter%2520for%2520Drug%2520Evaluation%2520and%2520Research%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Schulze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Bussche, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaeske, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaduszkiewicz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, F.</span><span> </span><span class="NLM_article-title">Impact of Safety Warnings on Antipsychotic Prescriptions in Dementia: Nothing Has Changed but the Years and the Substances</span> <span class="citation_source-journal">Eur. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1034</span><span class="NLM_x">–</span> <span class="NLM_lpage">1042</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1016%2Fj.euroneuro.2013.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=23498307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFajsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1034-1042&author=J.+Schulzeauthor=H.+van+den+Busscheauthor=G.+Glaeskeauthor=H.+Kaduszkiewiczauthor=B.+Wieseauthor=F.+Hoffmann&title=Impact+of+Safety+Warnings+on+Antipsychotic+Prescriptions+in+Dementia%3A+Nothing+Has+Changed+but+the+Years+and+the+Substances"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of safety warnings on antipsychotic prescriptions in dementia: Nothing has changed but the years and the substances</span></div><div class="casAuthors">Schulze, Jana; van den Bussche, Hendrik; Glaeske, Gerd; Kaduszkiewicz, Hanna; Wiese, Birgitt; Hoffmann, Falk</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1034-1042</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dementia patients suffering from behavioral and psychol. symptoms (BPSD) are often treated with antipsychotics.  Trial results document an increased risk for serious adverse events and mortality in dementia patients taking these agents.  Furthermore, the efficacy of treating BPSD with antipsychotics seems to be only modest.  Using data of a German statutory health insurance company, we examd. prescription trends of antipsychotics in prevalent dementia patients in the context of official warnings.  The study period is 2004-2009.  We studied trends in demographics, age and sex, as well as need of care and the intake of typical and atypical antipsychotics.  Seeking for linear trends adjusted for age, sex and level of care between 2004 and 2009, we obtained p-values from a multivariate logistic regression.  Prescription vols. were calcd. by no. of packages as well as defined daily doses (DDDs) using multiple linear regressions for trends in prescriptions amt.  We included 3460-8042 patients per yr (mean age 80 years).  The prescription prevalence of antipsychotics decreased from 35.5% in 2004 to 32.5% in 2009 (multivariate anal. for linear trend: p=0.1645).  Overall prescriptions for typical antipsychotics decreased (from 27.2% in 2004 to 23.0% in 2009, p<0.0001) and prescriptions for atypical antipsychotics increased from 17.1% to 18.9% (p<0.0001).  The mean DDD per treated patient increased from 80.5 to 91.2 (2004-2009; p=0.0047).  Our findings imply that warnings of international drug authorities and manufacturers against adverse drug events in dementia patients receiving antipsychotics did not impact overall prescription behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFa2CSPI3OaLVg90H21EOLACvtfcHk0lhXhcNQ9HCVeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFajsr0%253D&md5=8513f2c5a854e15bcc458a835b8136d1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2013.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2013.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DSchulze%26aufirst%3DJ.%26aulast%3Dvan%2Bden%2BBussche%26aufirst%3DH.%26aulast%3DGlaeske%26aufirst%3DG.%26aulast%3DKaduszkiewicz%26aufirst%3DH.%26aulast%3DWiese%26aufirst%3DB.%26aulast%3DHoffmann%26aufirst%3DF.%26atitle%3DImpact%2520of%2520Safety%2520Warnings%2520on%2520Antipsychotic%2520Prescriptions%2520in%2520Dementia%253A%2520Nothing%2520Has%2520Changed%2520but%2520the%2520Years%2520and%2520the%2520Substances%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2013%26volume%3D23%26spage%3D1034%26epage%3D1042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Riemer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levet-Trafit, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R. H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bös, M.</span><span> </span><span class="NLM_article-title">Influence of the 5-HT6 Receptor on Acetylcholine Release in the Cortex: Pharmacological Characterization of 4-(2-Bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a Potent and Selective 5-HT6 Receptor Antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1273</span><span class="NLM_x">–</span> <span class="NLM_lpage">1276</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm021085c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1273-1276&author=C.+Riemerauthor=E.+Borroniauthor=B.+Levet-Trafitauthor=J.+R.+Martinauthor=S.+Poliauthor=R.+H.+P.+Porterauthor=M.+B%C3%B6s&title=Influence+of+the+5-HT6+Receptor+on+Acetylcholine+Release+in+the+Cortex%3A+Pharmacological+Characterization+of+4-%282-Bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl%29phenylamine%2C+a+Potent+and+Selective+5-HT6+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm021085c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm021085c%26sid%3Dliteratum%253Aachs%26aulast%3DRiemer%26aufirst%3DC.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DLevet-Trafit%26aufirst%3DB.%26aulast%3DMartin%26aufirst%3DJ.%2BR.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DPorter%26aufirst%3DR.%2BH.%2BP.%26aulast%3DB%25C3%25B6s%26aufirst%3DM.%26atitle%3DInfluence%2520of%2520the%25205-HT6%2520Receptor%2520on%2520Acetylcholine%2520Release%2520in%2520the%2520Cortex%253A%2520Pharmacological%2520Characterization%2520of%25204-%25282-Bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl%2529phenylamine%252C%2520a%2520Potent%2520and%2520Selective%25205-HT6%2520Receptor%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1273%26epage%3D1276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Liu, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">5-HT6 Antagonists as Potential Treatment for Cognitive Dysfunction</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2009&pages=145-168&author=K.+G.+Liuauthor=A.+J.+Robichaud&title=5-HT6+Antagonists+as+Potential+Treatment+for+Cognitive+Dysfunction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%2BG.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3D5-HT6%2520Antagonists%2520as%2520Potential%2520Treatment%2520for%2520Cognitive%2520Dysfunction%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2009%26volume%3D70%26spage%3D145%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Wesołowska, A.</span><span> </span><span class="NLM_article-title">Potential Role of the 5-HT6 Receptor in Depression and Anxiety: An Overview of Preclinical Data</span> <span class="citation_source-journal">Pharmacol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">564</span><span class="NLM_x">–</span> <span class="NLM_lpage">577</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1016%2FS1734-1140%2810%2970315-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=20884998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitFGju7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=564-577&author=A.+Weso%C5%82owska&title=Potential+Role+of+the+5-HT6+Receptor+in+Depression+and+Anxiety%3A+An+Overview+of+Preclinical+Data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data</span></div><div class="casAuthors">Wesolowska, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reports</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">564-577</span>CODEN:
                <span class="NLM_cas:coden">PRHEDU</span>;
        ISSN:<span class="NLM_cas:issn">1734-1140</span>.
    
            (<span class="NLM_cas:orgname">Polish Academy of Sciences, Institute of Pharmacology</span>)
        </div><div class="casAbstract">A review.  Mental disorders, such as depression and anxiety, pose both medical and social challenges.  The clin. efficacy of current antidepressant/anxiolytic therapies is unsatisfactory; both antidepressant and anxiolytic drugs induce a variety of unwanted effects and have delayed onsets of action.  Thus, a search for better and safer agents is continuously in progress.  Preclin. results published so far have brought new insights into the possible role of recently discovered serotonin 5-HT6 receptors in these disorders.  This review surveys the current state of knowledge regarding potential antidepressant and anxiolytic activities of selective 5-HT6 receptor ligands, namely, full agonists and antagonists, in animal models commonly used to predict such activity.  Evidence indicates that both 5-HT6 agonists and antagonists may evoke identical responses in animal models of depression and anxiety; however, the possible mechanisms of these effects seem to be diverse and are not clearly understood.  Esp. interesting are the augmented effects achieved by combining antidepressants or diazepam with a selective 5-HT6 receptor antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI0iD46m6HHrVg90H21EOLACvtfcHk0lgIG5C9sqtwHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitFGju7w%253D&md5=4284754e9b9fb26d3026605123567973</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS1734-1140%2810%2970315-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1734-1140%252810%252970315-7%26sid%3Dliteratum%253Aachs%26aulast%3DWeso%25C5%2582owska%26aufirst%3DA.%26atitle%3DPotential%2520Role%2520of%2520the%25205-HT6%2520Receptor%2520in%2520Depression%2520and%2520Anxiety%253A%2520An%2520Overview%2520of%2520Preclinical%2520Data%26jtitle%3DPharmacol.%2520Rep.%26date%3D2010%26volume%3D62%26spage%3D564%26epage%3D577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Wesołowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikiforuk, A.</span><span> </span><span class="NLM_article-title">Effects of the Brain-Penetrant and Selective 5-HT6 Receptor Antagonist SB-399885 in Animal Models of Anxiety and Depression</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1274</span><span class="NLM_x">–</span> <span class="NLM_lpage">1283</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2007&pages=1274-1283&author=A.+Weso%C5%82owskaauthor=A.+Nikiforuk&title=Effects+of+the+Brain-Penetrant+and+Selective+5-HT6+Receptor+Antagonist+SB-399885+in+Animal+Models+of+Anxiety+and+Depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeso%25C5%2582owska%26aufirst%3DA.%26aulast%3DNikiforuk%26aufirst%3DA.%26atitle%3DEffects%2520of%2520the%2520Brain-Penetrant%2520and%2520Selective%25205-HT6%2520Receptor%2520Antagonist%2520SB-399885%2520in%2520Animal%2520Models%2520of%2520Anxiety%2520and%2520Depression%26jtitle%3DNeuropharmacology%26date%3D2007%26volume%3D52%26spage%3D1274%26epage%3D1283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Woolley, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fone, K. C.</span><span> </span><span class="NLM_article-title">5-ht6 Receptors</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=59-79&author=M.+L.+Woolleyauthor=C.+A.+Marsdenauthor=K.+C.+Fone&title=5-ht6+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">5-ht6 receptors</span></div><div class="casAuthors">Woolley, Marie L.; Marsden, Charles A.; Fone, Kevin C. F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-79</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The 5-hydroxytryptamine6 (5-ht6) was 1 of the most recent addns. to the 5-HT receptor family, selective antagonists have recently been developed and potential functional roles are now becoming apparent.  The high affinity of a wide range of psychiatric drugs for the 5-ht6 receptor, together with its almost exclusive expression in the central nervous system, being abundant in limbic and cortical regions, has stimulated significant research interest.  The 5-ht6 receptor appears to regulate glutamatergic and cholinergic neuronal activity, and increasing evidence suggests that it may be involved in the regulation of cognition, feeding and, possibly, affective state and seizures.  The current article will review all aspects of the discovery, genetics, distribution, pharmacol., and function of the 5-ht6 receptor.  Taken together, this wealth of information warrants the use of the upper case nomenclature for the 5-ht6 receptor to be approved and its true status recognized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozK0SUNoG7ubVg90H21EOLACvtfcHk0lgIG5C9sqtwHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWks78%253D&md5=3883fe6d1a7764bf81a6b22e255fbf4d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoolley%26aufirst%3DM.%2BL.%26aulast%3DMarsden%26aufirst%3DC.%2BA.%26aulast%3DFone%26aufirst%3DK.%2BC.%26atitle%3D5-ht6%2520Receptors%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2004%26volume%3D3%26spage%3D59%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Maher-Edwards, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvartau-Hind, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P.</span><span> </span><span class="NLM_article-title">Double-Blind, Controlled Phase II Study of a 5-HT6 Receptor Antagonist, SB-742457, in Alzheimer’s Disease</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">374</span><span class="NLM_x">–</span> <span class="NLM_lpage">385</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.2174%2F156720510791383831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=20043816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslSms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=374-385&author=G.+Maher-Edwardsauthor=M.+Zvartau-Hindauthor=A.+J.+Hunterauthor=M.+Goldauthor=G.+Hoptonauthor=G.+Jacobsauthor=M.+Davyauthor=P.+Williams&title=Double-Blind%2C+Controlled+Phase+II+Study+of+a+5-HT6+Receptor+Antagonist%2C+SB-742457%2C+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Double-blind, controlled phase II study of a 5-HT6 receptor antagonist, SB-742457, in Alzheimer's disease</span></div><div class="casAuthors">Maher-Edwards, G.; Zvartau-Hind, M.; Hunter, A. J.; Gold, M.; Hopton, G.; Jacobs, G.; Davy, M.; Williams, P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">374-385</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: This randomized, double-blind, placebo-controlled study investigated the efficacy and tolerability of the 5-HT6 receptor antagonist, SB-742457, in subjects with mild-to-moderate probable Alzheimer's disease (AD).  Methods: Participating subjects had a Mini-Mental State Examn. (MMSE) score of 12 to 26 after a 4-wk, single-blind, placebo run-in phase, and were randomized (2:1:1:2) to receive placebo, SB-742457 5 mg, 15 mg, or 35 mg once daily for 24 wk.  Coprimary efficacy endpoints were the Clinician's Interview-Based Impression of Change with care-giver input (CIBIC+) score and change from baseline in Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) score at Week 24, in the intent-to-treat (ITT) population.  A model-based design provided 90% power to detect a linear trend in treatment response across increasing doses and ≥90% power to compare SB-742457 35 mg with placebo.  Results: 371 subjects were randomized.  In the ITT population (n = 357), linear trend anal. at Week 24 suggested a dose response for CIBIC+ with a mean slope of -0.05 points/5-mg dose increase (95% confidence interval [CI]: -0.09, -0.01; p = 0.016).  The dose response slope for change from baseline in ADAS-Cog was -0.22 points/5-mg dose increase (95% CI: -0.45, 0.01; p = 0.059).  The adjusted mean treatment difference from placebo at Week 24 for SB-742457 35 mg (-0.31) was significant on CIBIC+ (95% CI: -0.62, -0.00; p = 0.047) but non-significant on ADAS-Cog (-1.28 [95% CI: -2.96, 0.40]; p = 0.135).  Adverse events occurred in 24-37% in the SB-742457 groups vs 29% for placebo; 11-16% discontinued SB-742457 vs 15% for placebo.  Comments: SB-742457 was generally safe and well tolerated and may be efficacious in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonAtHIMhwg2rVg90H21EOLACvtfcHk0lgIG5C9sqtwHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslSms7s%253D&md5=9deecf58e64bdcc615c4e0d9b6a8874f</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F156720510791383831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720510791383831%26sid%3Dliteratum%253Aachs%26aulast%3DMaher-Edwards%26aufirst%3DG.%26aulast%3DZvartau-Hind%26aufirst%3DM.%26aulast%3DHunter%26aufirst%3DA.%2BJ.%26aulast%3DGold%26aufirst%3DM.%26aulast%3DHopton%26aufirst%3DG.%26aulast%3DJacobs%26aufirst%3DG.%26aulast%3DDavy%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DP.%26atitle%3DDouble-Blind%252C%2520Controlled%2520Phase%2520II%2520Study%2520of%2520a%25205-HT6%2520Receptor%2520Antagonist%252C%2520SB-742457%252C%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2010%26volume%3D7%26spage%3D374%26epage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">H. Lundbeck A/S</span><span class="NLM_x">. </span><span> </span><span class="NLM_article-title">Lundbeck’s Lu AE58054 Meets Primary Endpoint in Large Placebo-Controlled Clinical Proof of Concept Study in People with Alzheimer’s Disease</span>.  <span class="citation_source-journal">Corp. Release</span> <span class="NLM_volume">472</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span>. Published Online: May 29,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span>. <a href="http://investor.lundbeck.com/releasedetail.cfm?ReleaseID=677436" class="extLink">http://investor.lundbeck.com/releasedetail.cfm?ReleaseID=677436</a> (accessed Oct 23, 2012).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=472&publication_year=2012&pages=1-4&author=H.+Lundbeck+A%2FS&title=Lundbeck%E2%80%99s+Lu+AE58054+Meets+Primary+Endpoint+in+Large+Placebo-Controlled+Clinical+Proof+of+Concept+Study+in+People+with+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DLundbeck%25E2%2580%2599s%2520Lu%2520AE58054%2520Meets%2520Primary%2520Endpoint%2520in%2520Large%2520Placebo-Controlled%2520Clinical%2520Proof%2520of%2520Concept%2520Study%2520in%2520People%2520with%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DCorp.%2520Release%26volume%3D472%26spage%3D1%26epage%3D4%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Wesołowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikiforuk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachowicz, K.</span><span> </span><span class="NLM_article-title">Potential Anxiolytic and Antidepressant Effects of the Selective 5-HT7 Receptor Antagonist SB 269970 after Intrahippocampal Administration to Rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">553</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1016%2Fj.ejphar.2006.09.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=17097082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Ciu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=553&publication_year=2006&pages=185-190&author=A.+Weso%C5%82owskaauthor=A.+Nikiforukauthor=K.+Stachowicz&title=Potential+Anxiolytic+and+Antidepressant+Effects+of+the+Selective+5-HT7+Receptor+Antagonist+SB+269970+after+Intrahippocampal+Administration+to+Rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats</span></div><div class="casAuthors">Wesolowska, Anna; Nikiforuk, Agnieszka; Stachowicz, Katarzyna</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">553</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">185-190</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Using conflict drinking and forced swimming tests in rats, we examd. the anxiolytic- and the antidepressant-like activity, resp., of (2R)-1-[(3-hydroxyphenyl)sulfonyl]-2-[2-(4-methyl-1-piperidinyl)ethyl]-pyrrolidine (SB 269970), a selective 5-HT7 receptor antagonist, after its intrahippocampal administration.  SB 269970 at doses of 0.3, 1 and 3 μg showed an anticonflict effect which was weaker than that of diazepam (40 μg), whereas SB 269970 at doses of 3 and 10 μg had marked anti-immobility action comparable to that of imipramine (0.1 μg).  Importantly, the anxiolytic- and antidepressant-like activity of SB 269970 seemed to be specific, since that agent - when given by the same route in doses effective in either model - affected neither the shock threshold, nor the non-punished water consumption, nor the exploratory activity of rats.  The obtained results indicate that the hippocampus is one of the neuroanatomical structures involved in the potential anxiolytic and, in particular, antidepressant activity of SB 269970.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBHrggXO0ITrVg90H21EOLACvtfcHk0lh1Ojc4s0devA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Ciu7bP&md5=60726295111355c2aa4aa9f3b175c302</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.09.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.09.064%26sid%3Dliteratum%253Aachs%26aulast%3DWeso%25C5%2582owska%26aufirst%3DA.%26aulast%3DNikiforuk%26aufirst%3DA.%26aulast%3DStachowicz%26aufirst%3DK.%26atitle%3DPotential%2520Anxiolytic%2520and%2520Antidepressant%2520Effects%2520of%2520the%2520Selective%25205-HT7%2520Receptor%2520Antagonist%2520SB%2520269970%2520after%2520Intrahippocampal%2520Administration%2520to%2520Rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D553%26spage%3D185%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Galici, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atack, J. R.</span><span> </span><span class="NLM_article-title">Effects of SB-269970, a 5-HT7 Receptor Antagonist, in Mouse Models Predictive of Antipsychotic-Like Activity</span> <span class="citation_source-journal">Behav. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1097%2FFBP.0b013e3282f62d8c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=18332680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtVektLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=153-159&author=R.+Galiciauthor=J.+D.+Boggsauthor=K.+L.+Millerauthor=P.+Bonaventureauthor=J.+R.+Atack&title=Effects+of+SB-269970%2C+a+5-HT7+Receptor+Antagonist%2C+in+Mouse+Models+Predictive+of+Antipsychotic-Like+Activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity</span></div><div class="casAuthors">Galici, Ruggero; Boggs, Jamin D.; Miller, Kirsten L.; Bonaventure, Pascal; Atack, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-159</span>CODEN:
                <span class="NLM_cas:coden">BPHAEL</span>;
        ISSN:<span class="NLM_cas:issn">0955-8810</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">5-HT7 receptors have been linked to a no. of psychiatric disorders including anxiety and depression.  The localization of 5-HT7 receptors in the thalamus, a key sensory processing center, and the high affinity of many atypical antipsychotic compds. for these receptors have led to the speculation of the utility of 5-HT7 antagonists in schizophrenia.  The goal of these studies was to examine the effects of pharmacol. blockade and genetic ablation of 5-HT7 receptors in animal models predictive of antipsychotic-like activity.  We evaluated the effects of SB-269970, a selective 5-HT7 receptor antagonist, on amphetamine and ketamine-induced hyperactivity and prepulse inhibition (PPI) deficits.  In addn., sensorimotor gating function and locomotor activity were evaluated in 5-HT7 knockout mice.  Locomotor activity was measured for up to 180 min using an automated IR photobeam system, and PPI was evaluated in startle chambers.  SB-269970 (3, 10 and 30 mg/kg, i.p.) significantly blocked amphetamine [3 mg/kg, s.c. (s.c.)] and ketamine (30 mg/kg, s.c.)-induced hyperactivity and reversed amphetamine (10 mg/kg, s.c.)-induced but not ketamine (30 mg/kg, s.c.)-induced PPI deficits, without changing spontaneous locomotor activity and startle amplitude.  The largest dose of SB-269970 did not block the effects of amphetamine in 5-HT7 knockout mice.  Collectively, these results indicate that blockade of 5-HT7 receptors partially modulates glutamatergic and dopaminergic function and could be clin. useful for the treatment of pos. symptoms of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx7-6Jq_YB-7Vg90H21EOLACvtfcHk0lh1Ojc4s0devA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtVektLk%253D&md5=df107f3585744046400818d90dcbba2e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1097%2FFBP.0b013e3282f62d8c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFBP.0b013e3282f62d8c%26sid%3Dliteratum%253Aachs%26aulast%3DGalici%26aufirst%3DR.%26aulast%3DBoggs%26aufirst%3DJ.%2BD.%26aulast%3DMiller%26aufirst%3DK.%2BL.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DAtack%26aufirst%3DJ.%2BR.%26atitle%3DEffects%2520of%2520SB-269970%252C%2520a%25205-HT7%2520Receptor%2520Antagonist%252C%2520in%2520Mouse%2520Models%2520Predictive%2520of%2520Antipsychotic-Like%2520Activity%26jtitle%3DBehav.%2520Pharmacol.%26date%3D2008%26volume%3D19%26spage%3D153%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Waters, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stean, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virley, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kew, J. N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, I.</span><span> </span><span class="NLM_article-title">Effects of the Selective 5-HT(7) Receptor Antagonist SB-269970 in Animal Models of Psychosis and Cognition</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">228</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2012&pages=211-218&author=K.+A.+Watersauthor=T.+O.+Steanauthor=B.+Hammondauthor=D.+J.+Virleyauthor=N.+Uptonauthor=J.+N.+C.+Kewauthor=I.+Hussain&title=Effects+of+the+Selective+5-HT%287%29+Receptor+Antagonist+SB-269970+in+Animal+Models+of+Psychosis+and+Cognition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWaters%26aufirst%3DK.%2BA.%26aulast%3DStean%26aufirst%3DT.%2BO.%26aulast%3DHammond%26aufirst%3DB.%26aulast%3DVirley%26aufirst%3DD.%2BJ.%26aulast%3DUpton%26aufirst%3DN.%26aulast%3DKew%26aufirst%3DJ.%2BN.%2BC.%26aulast%3DHussain%26aufirst%3DI.%26atitle%3DEffects%2520of%2520the%2520Selective%25205-HT%25287%2529%2520Receptor%2520Antagonist%2520SB-269970%2520in%2520Animal%2520Models%2520of%2520Psychosis%2520and%2520Cognition%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2012%26volume%3D228%26spage%3D211%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Kim, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maneen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, S. M.</span><span> </span><span class="NLM_article-title">Building a Better Antipsychotic: Receptor Targets for the Treatment of Multiple Symptom Dimensions of Schizophrenia</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=78-85&author=D.+H.+Kimauthor=M.+J.+Maneenauthor=S.+M.+Stahl&title=Building+a+Better+Antipsychotic%3A+Receptor+Targets+for+the+Treatment+of+Multiple+Symptom+Dimensions+of+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DManeen%26aufirst%3DM.%2BJ.%26aulast%3DStahl%26aufirst%3DS.%2BM.%26atitle%3DBuilding%2520a%2520Better%2520Antipsychotic%253A%2520Receptor%2520Targets%2520for%2520the%2520Treatment%2520of%2520Multiple%2520Symptom%2520Dimensions%2520of%2520Schizophrenia%26jtitle%3DNeurotherapeutics%26date%3D2009%26volume%3D6%26spage%3D78%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designed Multiple Ligands. An Emerging Drug Discovery Paradigm</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6523</span><span class="NLM_x">–</span> <span class="NLM_lpage">6543</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058225d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6523-6543&author=R.+Morphyauthor=Z.+Rankovic&title=Designed+Multiple+Ligands.+An+Emerging+Drug+Discovery+Paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Designed Multiple Ligands.</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6523-6543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review discusses main areas in designed multiple ligands (DMLs) discovery that include 5HT transporter-based DMLs for depression, dopamine D2-receptor based DMLs for schizophrenia, histamine H1 receptor-based DMLs for allergies, DMLs targeting the angiotensin system for hypertension, nonsteroidal anti-inflammatory drugs, and PPAR-based DMLs for metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgouWcjsiKgbVg90H21EOLACvtfcHk0lhpRlnrm5JjRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL&md5=00e3bf5a521fc91996ce95bb379a0b5c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm058225d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058225d%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigned%2520Multiple%2520Ligands.%2520An%2520Emerging%2520Drug%2520Discovery%2520Paradigm%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6523%26epage%3D6543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Reynolds, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirk, S. L.</span><span> </span><span class="NLM_article-title">Metabolic Side Effects of Antipsychotic Drug Treatment: Pharmacological Mechanisms</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1016%2Fj.pharmthera.2009.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=19931306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFyiu77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2010&pages=169-179&author=G.+P.+Reynoldsauthor=S.+L.+Kirk&title=Metabolic+Side+Effects+of+Antipsychotic+Drug+Treatment%3A+Pharmacological+Mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic side effects of antipsychotic drug treatment - pharmacological mechanisms</span></div><div class="casAuthors">Reynolds, Gavin P.; Kirk, Shona L.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">169-179</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Obesity and metabolic syndrome, with increased risk of eventual cardiovascular disease and type II diabetes, are significant problems for patients receiving antipsychotic drugs and are likely contribute to their decreased life expectancy.  Several drug-related mechanisms may contribute to these problems, including effects both influencing food intake and on glucose and lipid metab.  The metabolic consequences of different antipsychotic drugs vary substantially; these variations reflect differences in receptor pharmacol. and provide clues as to the underlying pharmacol. mechanisms.  The two drugs with the greatest effects on body wt., olanzapine and clozapine, also have high affinity for the 5-HT2C and histamine H1 receptors, which implicate these receptors in antipsychotic-induced wt. gain, while peripheral M3 muscarinic receptor antagonism as well as central 5-HT2C effects may contribute to obesity-independent diabetes.  Other receptor mechanisms may have additive or synergistic effects; dopamine D2 receptor antagonism can enhance 5-HT2C-mediated effects on food intake, as well as influencing lipid and glucose metab. via disinhibition of prolactin secretion.  Pharmacogenetic assocns. of drug-induced wt. gain with 5-HT2C receptor and leptin gene polymorphisms, among others, have provided further clues.  Elevated leptin secretion in the absence of a decrease in food intake indicates drug-induced leptin insensitivity in the hypothalamus.  The minimal wt. gain seen with ziprasidone and aripiprazole may reflect their having further pharmacol. effects that protect against changes in food intake and related metabolic factors.  Understanding the pharmacol. of metabolic consequences of current antipsychotic drug treatment is clearly the key to developing improved pharmacotherapies that avoid these problematic and limiting adverse effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt7JyuRcCdILVg90H21EOLACvtfcHk0lhpRlnrm5JjRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFyiu77E&md5=548d49d2cca697e4405549be6ba0dd6f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2009.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2009.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DG.%2BP.%26aulast%3DKirk%26aufirst%3DS.%2BL.%26atitle%3DMetabolic%2520Side%2520Effects%2520of%2520Antipsychotic%2520Drug%2520Treatment%253A%2520Pharmacological%2520Mechanisms%26jtitle%3DPharmacol.%2520Ther.%26date%3D2010%26volume%3D125%26spage%3D169%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Bai, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liou, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, C.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, S.-J.</span><span> </span><span class="NLM_article-title">Association between HTR2C Polymorphisms and Metabolic Syndrome in Patients with Schizophrenia Treated with Atypical Antipsychotics</span> <span class="citation_source-journal">Schizophr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1016%2Fj.schres.2010.11.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=21185157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A280%3ADC%252BC3M7lt12htA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2011&pages=179-186&author=Y.+M.+Baiauthor=T.-T.+Chenauthor=Y.-J.+Liouauthor=C.-J.+Hongauthor=S.-J.+Tsai&title=Association+between+HTR2C+Polymorphisms+and+Metabolic+Syndrome+in+Patients+with+Schizophrenia+Treated+with+Atypical+Antipsychotics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Association between HTR2C polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics</span></div><div class="casAuthors">Bai Ya Mei; Chen Tzu-Ting; Liou Ying-Jay; Hong Chen-Jee; Tsai Shih-Jen</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">179-86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Previous research indicates that common single-nucleotide polymorphisms (SNPs) in the serotonin 5-HT2C receptor gene (HTR2C) are associated with metabolic syndrome (MetS) related to antipsychotic treatment.  This study analyzes a large sample of patients with schizophrenia treated with atypical antipsychotics to determine whether variation in the HTR2C is associated with MetS.  METHODS:  Six tag SNPs, capturing all common genetic variations in the HTR2C gene in the Han population, were genotyped in 456 Chinese schizophrenic inpatients treated with atypical antipsychotics (clozapine: 171, olanzapine: 91, and risperidone: 194).  RESULTS:  Single-marker based analysis shows that of the six HTR2C SNPs, the rs498177 SNP showed a significant association with MetS in female patients, and the C allele was associated with an increased risk of MetS (for genotype TT/TC/CC: MetS vs. non-MetS=50%/27%/23% vs. 69%/28%/3%, and for allele T/C: MetS vs. non-MetS=63%/37% vs. 83%/17%, p=0.0007).  Haplotype analysis shows that the A-C type of rs521018-rs498177 in the HTR2C gene significantly decreased the risk of MetS (corrected p=0.0108) in female patients.  CONCLUSIONS:  The results of this study support the role of HTR2C genetic variants in susceptibility to MetS in patients treated with atypical antipsychotics.  However, this association is gender-dependent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTnBdXwzFJU0FvAgqb2vdc5fW6udTcc2eboW7SI3yUyjrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7lt12htA%253D%253D&md5=cd478a49cd55f3e036443560be5bac18</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.schres.2010.11.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.schres.2010.11.030%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DY.%2BM.%26aulast%3DChen%26aufirst%3DT.-T.%26aulast%3DLiou%26aufirst%3DY.-J.%26aulast%3DHong%26aufirst%3DC.-J.%26aulast%3DTsai%26aufirst%3DS.-J.%26atitle%3DAssociation%2520between%2520HTR2C%2520Polymorphisms%2520and%2520Metabolic%2520Syndrome%2520in%2520Patients%2520with%2520Schizophrenia%2520Treated%2520with%2520Atypical%2520Antipsychotics%26jtitle%3DSchizophr.%2520Res.%26date%3D2011%26volume%3D125%26spage%3D179%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Rodefer, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnt, J.</span><span> </span><span class="NLM_article-title">Reversal of Subchronic PCP-Induced Deficits in Attentional Set Shifting in Rats by Sertindole and a 5-HT6 Receptor Antagonist: Comparison among Antipsychotics</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">2657</span><span class="NLM_x">–</span> <span class="NLM_lpage">2666</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=2657-2666&author=J.+S.+Rodeferauthor=T.+N.+Nguyenauthor=J.-J.+Karlssonauthor=J.+Arnt&title=Reversal+of+Subchronic+PCP-Induced+Deficits+in+Attentional+Set+Shifting+in+Rats+by+Sertindole+and+a+5-HT6+Receptor+Antagonist%3A+Comparison+among+Antipsychotics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodefer%26aufirst%3DJ.%2BS.%26aulast%3DNguyen%26aufirst%3DT.%2BN.%26aulast%3DKarlsson%26aufirst%3DJ.-J.%26aulast%3DArnt%26aufirst%3DJ.%26atitle%3DReversal%2520of%2520Subchronic%2520PCP-Induced%2520Deficits%2520in%2520Attentional%2520Set%2520Shifting%2520in%2520Rats%2520by%2520Sertindole%2520and%2520a%25205-HT6%2520Receptor%2520Antagonist%253A%2520Comparison%2520among%2520Antipsychotics%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26spage%3D2657%26epage%3D2666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Kołaczkowski, M.; Kowalski, P.; Jaśkowska, J.; Marcinkowska, M.; Mitka, K.; Bucki, A.; Wesołowska, A.; Pawłowski, M.</span><span> </span><span class="NLM_article-title">Arylsulfonamides for the Treatment of CNS Diseases</span>. PCT Int. Appl. WO 2012035123 (A1), Mar 22,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+Ko%C5%82aczkowski&author=P.+Kowalski&author=J.+Ja%C5%9Bkowska&author=M.+Marcinkowska&author=K.+Mitka&author=A.+Bucki&author=A.+Weso%C5%82owska&author=M.+Paw%C5%82owski&title=Arylsulfonamides+for+the+Treatment+of+CNS+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKo%25C5%2582aczkowski%26aufirst%3DM.%26atitle%3DArylsulfonamides%2520for%2520the%2520Treatment%2520of%2520CNS%2520Diseases%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Kołaczkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mierzejewski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienkowski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesołowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman-Tancredi, A.</span><span> </span><span class="NLM_article-title">Antipsychotic, Antidepressant, and Cognitive-Impairment Properties of Antipsychotics: Rat Profile and Implications for Behavioral and Psychological Symptoms of Dementia</span> <span class="citation_source-journal">Naunyn–Schmiedeberg’s Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">557</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1007%2Fs00210-014-0966-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=24599316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsF2isbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2014&pages=545-557&author=M.+Ko%C5%82aczkowskiauthor=P.+Mierzejewskiauthor=P.+Bienkowskiauthor=A.+Weso%C5%82owskaauthor=A.+Newman-Tancredi&title=Antipsychotic%2C+Antidepressant%2C+and+Cognitive-Impairment+Properties+of+Antipsychotics%3A+Rat+Profile+and+Implications+for+Behavioral+and+Psychological+Symptoms+of+Dementia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Antipsychotic, antidepressant, and cognitive-impairment properties of antipsychotics: rat profile and implications for behavioral and psychological symptoms of dementia</span></div><div class="casAuthors">Kolaczkowski, Marcin; Mierzejewski, Pawel; Bienkowski, Przemyslaw; Wesolowska, Anna; Newman-Tancredi, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">387</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">545-557</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Many dementia patients exhibit behavioral and psychol. symptoms (BPSD), including psychosis and depression.  Although antipsychotics are frequently prescribed off-label, they can have marked side effects.  In addn., comparative preclin. studies of their effects are surprisingly scarce, and strategies for discovery of novel pharmacotherapeutics are lacking.  We therefore compared eight antipsychotics in rat behavioral tests of psychosis, antidepressant-like activity, and cognitive impairment as a basis for preclin. evaluation of new drug candidates.  The methods used in this study include inhibition of MK-801-induced hyperactivity, forced swim test (FST), passive avoidance (PA), spontaneous locomotor activity, and catalepsy.  The drugs exhibited antipsychotic-like activity in the MK-801 test but with diverse profiles in the other models.  Risperidone impaired PA performance, but with some dose sepn. vs. its actions in the MK-801 test.  In contrast, clozapine, olanzapine, lurasidone, and asenapine showed little or no dose sepn. in these tests.  Aripiprazole did not impair PA performance but was poorly active in the MK-801 test.  Diverse effects were also obsd. in the FST: chlorpromazine was inactive and most other drugs reduced immobility over narrow dose ranges, whereas clozapine reduced immobility over a wider dose range, overlapping with antipsychotic activity.  Although the propensity of second-generation antipsychotics to produce catalepsy was lower, they all elicited pronounced sedation.  Consistent with clin. data, most currently available second-generation antipsychotics induced cognitive and motor side effects with little sepn. from therapeutic-like doses.  This study provides a uniform in vivo comparative basis on which to evaluate future early-stage drug candidates intended for potential pharmacotherapy of BPSD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjkNKMBogumrVg90H21EOLACvtfcHk0lgo5umqVj1dRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsF2isbc%253D&md5=1202744b1594b23d9fa454061ef45ee6</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2Fs00210-014-0966-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-014-0966-4%26sid%3Dliteratum%253Aachs%26aulast%3DKo%25C5%2582aczkowski%26aufirst%3DM.%26aulast%3DMierzejewski%26aufirst%3DP.%26aulast%3DBienkowski%26aufirst%3DP.%26aulast%3DWeso%25C5%2582owska%26aufirst%3DA.%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26atitle%3DAntipsychotic%252C%2520Antidepressant%252C%2520and%2520Cognitive-Impairment%2520Properties%2520of%2520Antipsychotics%253A%2520Rat%2520Profile%2520and%2520Implications%2520for%2520Behavioral%2520and%2520Psychological%2520Symptoms%2520of%2520Dementia%26jtitle%3DNaunyn%25E2%2580%2593Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D2014%26volume%3D387%26spage%3D545%26epage%3D557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Kołaczkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawłowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bojarski, A. J.</span><span> </span><span class="NLM_article-title">Receptor-Based Pharmacophores for Serotonin 5-HT7R Antagonists-Implications to Selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6732</span><span class="NLM_x">–</span> <span class="NLM_lpage">6741</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060300c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6732-6741&author=M.+Ko%C5%82aczkowskiauthor=M.+Nowakauthor=M.+Paw%C5%82owskiauthor=A.+J.+Bojarski&title=Receptor-Based+Pharmacophores+for+Serotonin+5-HT7R+Antagonists-Implications+to+Selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm060300c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060300c%26sid%3Dliteratum%253Aachs%26aulast%3DKo%25C5%2582aczkowski%26aufirst%3DM.%26aulast%3DNowak%26aufirst%3DM.%26aulast%3DPaw%25C5%2582owski%26aufirst%3DM.%26aulast%3DBojarski%26aufirst%3DA.%2BJ.%26atitle%3DReceptor-Based%2520Pharmacophores%2520for%2520Serotonin%25205-HT7R%2520Antagonists-Implications%2520to%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6732%26epage%3D6741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Lemke, T. L.; Williams, D. A.</span> <span class="citation_source-book">Foye’s Principles of Medicinal Chemistry</span>; <span class="NLM_publisher-name">Lippincott Williams & Wilkins</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=T.+L.+Lemke&author=D.+A.+Williams&title=Foye%E2%80%99s+Principles+of+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLemke%26aufirst%3DT.%2BL.%26btitle%3DFoye%25E2%2580%2599s%2520Principles%2520of%2520Medicinal%2520Chemistry%26pub%3DLippincott%2520Williams%2520%2526%2520Wilkins%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Haga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yurugi-Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiroishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span> </span><span class="NLM_article-title">Structure of the Human M2Muscarinic Acetylcholine Receptor Bound to an Antagonist</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">482</span><span class="NLM_x">, </span> <span class="NLM_fpage">547</span><span class="NLM_x">–</span> <span class="NLM_lpage">551</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1038%2Fnature10753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=22278061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ejsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=482&publication_year=2012&pages=547-551&author=K.+Hagaauthor=A.+C.+Kruseauthor=H.+Asadaauthor=T.+Yurugi-Kobayashiauthor=M.+Shiroishiauthor=C.+Zhangauthor=W.+I.+Weisauthor=T.+Okadaauthor=B.+K.+Kobilkaauthor=T.+Hagaauthor=T.+Kobayashi&title=Structure+of+the+Human+M2Muscarinic+Acetylcholine+Receptor+Bound+to+an+Antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist</span></div><div class="casAuthors">Haga, Kazuko; Kruse, Andrew C.; Asada, Hidetsugu; Yurugi-Kobayashi, Takami; Shiroishi, Mitsunori; Zhang, Cheng; Weis, William I.; Okada, Tetsuji; Kobilka, Brian K.; Haga, Tatsuya; Kobayashi, Takuya</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">482</span>
        (<span class="NLM_cas:issue">7386</span>),
    <span class="NLM_cas:pages">547-551</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The X-ray crystal structure of the M2 muscarinic acetylcholine receptor, which is essential for the physiol. control of cardiovascular function, is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosewFev-FNErVg90H21EOLACvtfcHk0lgo5umqVj1dRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ejsro%253D&md5=c33b8d9303d58db7dfdd4c18ec4f597b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnature10753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10753%26sid%3Dliteratum%253Aachs%26aulast%3DHaga%26aufirst%3DK.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DAsada%26aufirst%3DH.%26aulast%3DYurugi-Kobayashi%26aufirst%3DT.%26aulast%3DShiroishi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DOkada%26aufirst%3DT.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DHaga%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DT.%26atitle%3DStructure%2520of%2520the%2520Human%2520M2Muscarinic%2520Acetylcholine%2520Receptor%2520Bound%2520to%2520an%2520Antagonist%26jtitle%3DNature%26date%3D2012%26volume%3D482%26spage%3D547%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Kruse, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arlow, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbaum, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosemond, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chae, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dror, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wess, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span> </span><span class="NLM_article-title">Structure and Dynamics of the M3Muscarinic Acetylcholine Receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">482</span><span class="NLM_x">, </span> <span class="NLM_fpage">552</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=482&publication_year=2012&pages=552-556&author=A.+C.+Kruseauthor=J.+Huauthor=A.+C.+Panauthor=D.+H.+Arlowauthor=D.+M.+Rosenbaumauthor=E.+Rosemondauthor=H.+F.+Greenauthor=T.+Liuauthor=P.+S.+Chaeauthor=R.+O.+Drorauthor=D.+E.+Shawauthor=W.+I.+Weisauthor=J.+Wessauthor=B.+K.+Kobilka&title=Structure+and+Dynamics+of+the+M3Muscarinic+Acetylcholine+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DA.%2BC.%26aulast%3DArlow%26aufirst%3DD.%2BH.%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26aulast%3DRosemond%26aufirst%3DE.%26aulast%3DGreen%26aufirst%3DH.%2BF.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DChae%26aufirst%3DP.%2BS.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DWess%26aufirst%3DJ.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DStructure%2520and%2520Dynamics%2520of%2520the%2520M3Muscarinic%2520Acetylcholine%2520Receptor%26jtitle%3DNature%26date%3D2012%26volume%3D482%26spage%3D552%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Pearlstein, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preobrazhenskaya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shchekotikhin, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korolev, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lysenkova, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miroshnikova, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampe, D.</span><span> </span><span class="NLM_article-title">Characterization of HERG Potassium Channel Inhibition Using CoMSiA 3D QSAR and Homology Modeling Approaches</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1829</span><span class="NLM_x">–</span> <span class="NLM_lpage">1835</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1016%2FS0960-894X%2803%2900196-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=12729675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1Kjtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1829-1835&author=R.+A.+Pearlsteinauthor=R.+J.+Vazauthor=J.+Kangauthor=X.-L.+Chenauthor=M.+Preobrazhenskayaauthor=A.+E.+Shchekotikhinauthor=A.+M.+Korolevauthor=L.+N.+Lysenkovaauthor=O.+V.+Miroshnikovaauthor=J.+Hendrixauthor=D.+Rampe&title=Characterization+of+HERG+Potassium+Channel+Inhibition+Using+CoMSiA+3D+QSAR+and+Homology+Modeling+Approaches"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches</span></div><div class="casAuthors">Pearlstein, Robert A.; Vaz, Roy J.; Kang, Jiesheng; Chen, Xiao-Liang; Preobrazhenskaya, Maria; Shchekotikhin, Andrey E.; Korolev, Alexander M.; Lysenkova, Ludmila N.; Miroshnikova, Olga V.; Hendrix, James; Rampe, David</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1829-1835</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A data set consisting of twenty-two sertindole analogs and ten structurally diverse inhibitors, spanning a wide range in potency, was analyzed using CoMSiA.  A homol. model of HERG was constructed from the crystal structure of the open MthK potassium channel.  A complementary relationship between our CoMSiA and homol. models is apparent when the long inhibitor axis is oriented parallel to the longitudinal axis of the pore, with the tail region pointed toward the selectivity filter.  The key elements of the pharmacophore, the CoMSiA and the homol. model are: (1) The hydrophobic feature optimally consists of an arom. group that is capable of engaging in π-stacking with a Phe656 side chain.  Optionally, a second arom. or hydrophobic group present in some inhibitors may contact an addnl. Phe656 side chain. (2) The basic nitrogen appears to undergo a π-cation interaction with Tyr652. (3) The pore diam. (12 A+), and depth of the selectivity loop relative to the intracellular opening, act as constraints on the conformation-dependent inhibitor dimensions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnw_0UOBKeybVg90H21EOLACvtfcHk0lh5G4VjPN0EIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1Kjtrk%253D&md5=6c14583c31c65a3c71731a51e6b9e0f7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900196-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900196-3%26sid%3Dliteratum%253Aachs%26aulast%3DPearlstein%26aufirst%3DR.%2BA.%26aulast%3DVaz%26aufirst%3DR.%2BJ.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.-L.%26aulast%3DPreobrazhenskaya%26aufirst%3DM.%26aulast%3DShchekotikhin%26aufirst%3DA.%2BE.%26aulast%3DKorolev%26aufirst%3DA.%2BM.%26aulast%3DLysenkova%26aufirst%3DL.%2BN.%26aulast%3DMiroshnikova%26aufirst%3DO.%2BV.%26aulast%3DHendrix%26aufirst%3DJ.%26aulast%3DRampe%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520HERG%2520Potassium%2520Channel%2520Inhibition%2520Using%2520CoMSiA%25203D%2520QSAR%2520and%2520Homology%2520Modeling%2520Approaches%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1829%26epage%3D1835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Osterberg, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aqvist, J.</span><span> </span><span class="NLM_article-title">Exploring Blocker Binding to a Homology Model of the Open hERG K+ Channel Using Docking and Molecular Dynamics Methods</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">579</span><span class="NLM_x">, </span> <span class="NLM_fpage">2939</span><span class="NLM_x">–</span> <span class="NLM_lpage">2944</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=579&publication_year=2005&pages=2939-2944&author=F.+Osterbergauthor=J.+Aqvist&title=Exploring+Blocker+Binding+to+a+Homology+Model+of+the+Open+hERG+K%2B+Channel+Using+Docking+and+Molecular+Dynamics+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOsterberg%26aufirst%3DF.%26aulast%3DAqvist%26aufirst%3DJ.%26atitle%3DExploring%2520Blocker%2520Binding%2520to%2520a%2520Homology%2520Model%2520of%2520the%2520Open%2520hERG%2520K%252B%2520Channel%2520Using%2520Docking%2520and%2520Molecular%2520Dynamics%2520Methods%26jtitle%3DFEBS%2520Lett.%26date%3D2005%26volume%3D579%26spage%3D2939%26epage%3D2944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Forbes, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabbs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duckworth, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, N.</span><span> </span><span class="NLM_article-title">(R)-3,N-Dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-Yl) propyl]benzenesulfonamide: The First Selective 5-HT7 Receptor Antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">657</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970519e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=655-657&author=I.+T.+Forbesauthor=S.+Dabbsauthor=D.+M.+Duckworthauthor=A.+J.+Jenningsauthor=F.+D.+Kingauthor=P.+J.+Lovellauthor=A.+M.+Brownauthor=L.+Collinauthor=J.+J.+Haganauthor=D.+N.+Middlemissauthor=G.+J.+Rileyauthor=D.+R.+Thomasauthor=N.+Upton&title=%28R%29-3%2CN-Dimethyl-N-%5B1-methyl-3-%284-methyl-piperidin-1-Yl%29+propyl%5Dbenzenesulfonamide%3A+The+First+Selective+5-HT7+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm970519e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970519e%26sid%3Dliteratum%253Aachs%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DDabbs%26aufirst%3DS.%26aulast%3DDuckworth%26aufirst%3DD.%2BM.%26aulast%3DJennings%26aufirst%3DA.%2BJ.%26aulast%3DKing%26aufirst%3DF.%2BD.%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DCollin%26aufirst%3DL.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DRiley%26aufirst%3DG.%2BJ.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26aulast%3DUpton%26aufirst%3DN.%26atitle%3D%2528R%2529-3%252CN-Dimethyl-N-%255B1-methyl-3-%25284-methyl-piperidin-1-Yl%2529%2520propyl%255Dbenzenesulfonamide%253A%2520The%2520First%2520Selective%25205-HT7%2520Receptor%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D655%26epage%3D657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Kołaczkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mierzejewski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bieńkowski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesołowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman-Tancredi, A.</span><span> </span><span class="NLM_article-title">ADN-1184 a Monoaminergic Ligand with 5-HT6/7 Receptor Antagonist Activity: Pharmacological Profile and Potential Therapeutic Utility</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">984</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1111%2Fbph.12509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=24199650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1ehtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=973-984&author=M.+Ko%C5%82aczkowskiauthor=P.+Mierzejewskiauthor=P.+Bie%C5%84kowskiauthor=A.+Weso%C5%82owskaauthor=A.+Newman-Tancredi&title=ADN-1184+a+Monoaminergic+Ligand+with+5-HT6%2F7+Receptor+Antagonist+Activity%3A+Pharmacological+Profile+and+Potential+Therapeutic+Utility"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">ADN-1184 a monoaminergic ligand with 5-HT6/7 receptor antagonist activity: pharmacological profile and potential therapeutic utility</span></div><div class="casAuthors">Kolaczkowski, M.; Mierzejewski, P.; Bienkowski, P.; Wesolowska, A.; Newman-Tancredi, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">973-984</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose: Many dementia patients exhibit behavioral and psychol. symptoms (BPSD) that include psychosis, aggressivity, depression and anxiety.  Antipsychotic drugs are frequently prescribed but fail to significantly attenuate mood deficits, may interfere with cognitive function and are assocd. with motor and cardiac side effects, which are problematic in elderly patients.  A need therefore exists for drugs that are better suited for the treatment of BPSD.  Exptl. Approach: We used in vitro cellular and in vivo behavioral tests to characterize ADN-1184, a novel arylsulfonamide ligand with potential utility for treatment of BPSD.  Key Results: ADN-1184 exhibits substantial 5-HT6/5-HT7/5-HT2A/D2 receptor affinity and antagonist properties in vitro.  In tests of antipsychotic-like activity, it reversed MK-801-induced hyperactivity and stereotypies and inhibited conditioned avoidance response (MED = 3 mg·kg-1 i.p.).  Remarkably, ADN-1184 also reduced immobility time in the forced swim test at low doses (0.3 and 1 mg·kg-1 i.p.; higher doses were not significantly active).  Notably, up to 30 mg·kg-1 ADN-1184 did not impair memory performance in the passive avoidance test or elicit significant catalepsy and only modestly inhibited spontaneous locomotor activity (MED = 30 mg·kg-1 i.p.).  Conclusions and Implications: ADN-1184 combines antipsychotic-like with antidepressant-like properties without interfering with memory function or locomotion.  This profile is better than that of commonly used atypical antipsychotics tested under the same conditions and suggests that it is feasible to identify drugs that improve BPSD, without exacerbating cognitive deficit or movement impairment, which are of particular concern in patients with dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRj9iM1zSMXrVg90H21EOLACvtfcHk0lh5G4VjPN0EIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1ehtbw%253D&md5=d72b8585ba495cc647ba280bbcf0d896</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1111%2Fbph.12509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12509%26sid%3Dliteratum%253Aachs%26aulast%3DKo%25C5%2582aczkowski%26aufirst%3DM.%26aulast%3DMierzejewski%26aufirst%3DP.%26aulast%3DBie%25C5%2584kowski%26aufirst%3DP.%26aulast%3DWeso%25C5%2582owska%26aufirst%3DA.%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26atitle%3DADN-1184%2520a%2520Monoaminergic%2520Ligand%2520with%25205-HT6%252F7%2520Receptor%2520Antagonist%2520Activity%253A%2520Pharmacological%2520Profile%2520and%2520Potential%2520Therapeutic%2520Utility%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D973%26epage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Millan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivet, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audinot, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman-Tancredi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiofiss, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Queriaux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Despaux, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peglion, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dekeyne, A.</span><span> </span><span class="NLM_article-title">S18327 (1-[2-[4-(6-Fluoro-1, 2-benzisoxazol-3-Yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a Novel, Potential Antipsychotic Displaying Marked Antagonist Properties at Alpha(1)- and Alpha(2)-Adrenergic Receptors: II. Functional Profile and a Multiparametric Comparison with Haloperidol, Clozapine, and 11 Other Antipsychotic Agents</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=10604931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhslGntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2000&pages=54-66&author=M.+J.+Millanauthor=M.+Broccoauthor=J.+M.+Rivetauthor=V.+Audinotauthor=A.+Newman-Tancrediauthor=L.+Maiofissauthor=S.+Queriauxauthor=N.+Despauxauthor=J.+L.+Peglionauthor=A.+Dekeyne&title=S18327+%281-%5B2-%5B4-%286-Fluoro-1%2C+2-benzisoxazol-3-Yl%29piperid-1-yl%5Dethyl%5D3-phenyl+imidazolin-2-one%29%2C+a+Novel%2C+Potential+Antipsychotic+Displaying+Marked+Antagonist+Properties+at+Alpha%281%29-+and+Alpha%282%29-Adrenergic+Receptors%3A+II.+Functional+Profile+and+a+Multiparametric+Comparison+with+Haloperidol%2C+Clozapine%2C+and+11+Other+Antipsychotic+Agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at α1- and α2-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents</span></div><div class="casAuthors">Millan, Mark J.; Brocco, Mauricette; Rivet, Jean-Michel; Audinot, Valerie; Newman-Tancredi, Adrian; Maiofiss, Lisa; Queriaux, Sophie; Despaux, Nicole; Peglion, Jean-Louis; Dekeyne, Anne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-66</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">S18327 was dose-dependently active in several models of potential antipsychotic activity involving dopaminergic hyperactivity: inhibition of apomorphine-induced climbing in mice, of cocaine- and amphetamine-induced hyperlocomotion in rats, and of conditioned avoidance responses in rats.  Furthermore, reflecting its high affinity at serotonin2A sites, S18327 potently blocked phencyclidine-induced locomotion and 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane-induced head-twitches in rats.  In models of glutamatergic hypoactivity, S18327 blocked hyperlocomotion and spontaneous tail-flicks elicited by the N-methyl-D-aspartate antagonist dizocilpine.  The actions of S18327, together with its binding profile at multiple monoaminergic receptors (15 parameters in total), were compared with those of clozapine, haloperidol, and 11 other antipsychotics by multiparametric anal., and the resulting dendrogram positioned S18327 close to clozapine.  Consistent with a clopazine-like profile, S18327 generalized to a clozapine discriminative stimulus and evoked latent inhibition in rats, blocked aggression in isolated mice, and displayed anxiolytic properties in the ultrasonic vocalization and Vogel procedures in rats.  Relative to the above paradigms, only markedly (>20-fold) higher doses of S18327 were active in models predictive of potential extrapyramidal side effects: induction of catalepsy and prolactin secretion, and inhibition of methylphenidate-induced gnawing in rats.  S18327 showed only modest affinity for histaminic and muscarinic receptors.  Multiparametric anal. of these data distinguished S18327 from both haloperidol (high extrapyramidal potential) and clozapine (high histaminic and muscarinic affinity).  In conclusion, S18327 displays a broad-based pattern of potential antipsychotic activity at doses appreciably lower than those eliciting extrapyramidal side effects.  In this respect, S18327 closely resembles clozapine, but it is chem. distinct and displays weak affinity for histaminic and muscarinic receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgjrqW0hyvMLVg90H21EOLACvtfcHk0lhpBbpSQT-KGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhslGntw%253D%253D&md5=8ec991a5e87a8f49603e5354caebda98</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3DBrocco%26aufirst%3DM.%26aulast%3DRivet%26aufirst%3DJ.%2BM.%26aulast%3DAudinot%26aufirst%3DV.%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26aulast%3DMaiofiss%26aufirst%3DL.%26aulast%3DQueriaux%26aufirst%3DS.%26aulast%3DDespaux%26aufirst%3DN.%26aulast%3DPeglion%26aufirst%3DJ.%2BL.%26aulast%3DDekeyne%26aufirst%3DA.%26atitle%3DS18327%2520%25281-%255B2-%255B4-%25286-Fluoro-1%252C%25202-benzisoxazol-3-Yl%2529piperid-1-yl%255Dethyl%255D3-phenyl%2520imidazolin-2-one%2529%252C%2520a%2520Novel%252C%2520Potential%2520Antipsychotic%2520Displaying%2520Marked%2520Antagonist%2520Properties%2520at%2520Alpha%25281%2529-%2520and%2520Alpha%25282%2529-Adrenergic%2520Receptors%253A%2520II.%2520Functional%2520Profile%2520and%2520a%2520Multiparametric%2520Comparison%2520with%2520Haloperidol%252C%2520Clozapine%252C%2520and%252011%2520Other%2520Antipsychotic%2520Agents%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D292%26spage%3D54%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Kongsamut, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roehr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampe, D.</span><span> </span><span class="NLM_article-title">A Comparison of the Receptor Binding and HERG Channel Affinities for a Series of Antipsychotic Drugs</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1016%2FS0014-2999%2802%2902074-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=12176106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtlKjsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2002&pages=37-41&author=S.+Kongsamutauthor=J.+Kangauthor=X.-L.+Chenauthor=J.+Roehrauthor=D.+Rampe&title=A+Comparison+of+the+Receptor+Binding+and+HERG+Channel+Affinities+for+a+Series+of+Antipsychotic+Drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs</span></div><div class="casAuthors">Kongsamut, Sathapana; Kang, Jiesheng; Chen, Xiao-Liang; Roehr, Joachim; Rampe, David</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">450</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-41</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Many antipsychotic drugs produce QT interval prolongation on the ECG.  Blockade of the human cardiac K+ channel known as human ether-a-go-go-related gene (HERG) often underlies such clin. findings.  In fact, HERG channel inhibition is now commonly used as a screen to predict the ability of a drug to prolong QT interval.  However, the exact relation between HERG channel blockade, target receptor binding affinity and clin. QT prolongation is not known.  Using patch-clamp electrophysiol., the authors examd. a series of seven antipsychotic drugs for their ability to block HERG, and detd. their IC50 values.  The authors then compared these results to their binding affinities (Ki values) for the dopamine D2 receptor, the 5-HT2A receptor and, where available, to clin. QT prolongation data.  The authors found that sertindole, pimozide and thioridazine displayed little (<10-fold) or no selectivity for dopamine D2 or 5-HT2A receptors relative to their HERG channel affinities.  This lack of selectivity likely underlies the significant QT interval prolongation obsd. with administration of these drugs.  Of the other drugs tested (ziprasidone, quetiapine, risperidone and olanzapine), olanzapine displayed the greatest selectivity for dopamine D2 and 5-HT2A receptor binding (100-1000-fold) compared to its HERG channel IC50.  The authors also compared these HERG channel IC50 values to QT interval prolongation and plasma drug levels obtained in a recent clin. study.  The authors found that the ratio of total plasma drug concn. to HERG IC50 value was indicative of the degree of QT prolongation obsd.  Target receptor affinity and expected clin. plasma levels are important parameters to consider for the interpretation of HERG channel data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1PPyFCa8xyrVg90H21EOLACvtfcHk0lhpBbpSQT-KGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtlKjsbo%253D&md5=8b5879e5d59e01dcd490e71d57844fdf</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2902074-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252902074-5%26sid%3Dliteratum%253Aachs%26aulast%3DKongsamut%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.-L.%26aulast%3DRoehr%26aufirst%3DJ.%26aulast%3DRampe%26aufirst%3DD.%26atitle%3DA%2520Comparison%2520of%2520the%2520Receptor%2520Binding%2520and%2520HERG%2520Channel%2520Affinities%2520for%2520a%2520Series%2520of%2520Antipsychotic%2520Drugs%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D450%26spage%3D37%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Millan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cara, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dekeyne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panayi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Groote, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cistarelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billiras, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobert, A.</span><span> </span><span class="NLM_article-title">Selective Blockade of Dopamine D(3) versus D(2) Receptors Enhances Frontocortical Cholinergic Transmission and Social Memory in Rats: A Parallel Neurochemical and Behavioral Analysis</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">1047</span><span class="NLM_x">–</span> <span class="NLM_lpage">1061</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1111%2Fj.1471-4159.2006.04262.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=17266737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisFGnu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2007&pages=1047-1061&author=M.+J.+Millanauthor=B.+Di+Caraauthor=A.+Dekeyneauthor=F.+Panayiauthor=L.+De+Grooteauthor=D.+Sicardauthor=L.+Cistarelliauthor=R.+Billirasauthor=A.+Gobert&title=Selective+Blockade+of+Dopamine+D%283%29+versus+D%282%29+Receptors+Enhances+Frontocortical+Cholinergic+Transmission+and+Social+Memory+in+Rats%3A+A+Parallel+Neurochemical+and+Behavioral+Analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Selective blockade of dopamine D3 versus D2 receptors enhances frontal cortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioral analysis</span></div><div class="casAuthors">Millan, Mark J.; Di Cara, Benjamin; Dekeyne, Anne; Panayi, Fany; De Groote, Lotte; Sicard, Dorothee; Cistarelli, Laetitia; Billiras, Rodolphe; Gobert, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1047-1061</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Though dopaminergic mechanisms modulate cholinergic transmission and cognitive function, the significance of specific receptor subtypes remains uncertain.  Here, we examd. the roles of dopamine D3 vs. D2 receptors.  By analogy with tacrine (0.16-2.5 mg/kg, s.c.), the selective D3 receptor antagonists, S33084 (0.01-0.63) and SB277,011 (0.63-40.0), elicited dose-dependent, pronounced and sustained elevations in dialysis levels of acetylcholine (ACh) in the frontal cortex, but not the hippocampus, of freely-moving rats.  The actions of these antagonists were stereospecifically mimicked by (+)S14297 (1.25), whereas its inactive distomer, (-)S17777, was ineffective.  The preferential D2 receptor antagonist, L741,626 (10.0), failed to modify levels of ACh.  S33084 (0.01-0.63) and SB277,011 (0.16-2.5) also mimicked tacrine (0.04-0.63) by dose-dependently attenuating the deleterious influence of scopolamine (1.25) upon social memory (recognition by an adult rat of a juvenile conspecific).  Further, (+)S14297 (1.25) vs. (-)S17777 stereospecifically blocked the action of scopolamine.  Using an intersession interval of 120 min (spontaneous loss of recognition), S33084 (0.04-0.63), SB277,011 (0.16-10.0) and (+)S14297 (0.63-10.0) likewise mimicked tacrine (0.16-2.5) in enhancing social memory.  In contrast, L741,626 (0.16-10.0) displayed amnesic properties.  In conclusion, selective blockade of D3 receptors facilitates frontal cortical cholinergic transmission and improves social memory in rats.  These data support the pertinence of D3 receptors as a target for treatment of disorders in which cognitive function is compromised.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdxC_Nsga5b7Vg90H21EOLACvtfcHk0li5fT-Jb1e84g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisFGnu7g%253D&md5=e40dfd968d9f0a5ba2554511d84cd01e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04262.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04262.x%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3DDi%2BCara%26aufirst%3DB.%26aulast%3DDekeyne%26aufirst%3DA.%26aulast%3DPanayi%26aufirst%3DF.%26aulast%3DDe%2BGroote%26aufirst%3DL.%26aulast%3DSicard%26aufirst%3DD.%26aulast%3DCistarelli%26aufirst%3DL.%26aulast%3DBilliras%26aufirst%3DR.%26aulast%3DGobert%26aufirst%3DA.%26atitle%3DSelective%2520Blockade%2520of%2520Dopamine%2520D%25283%2529%2520versus%2520D%25282%2529%2520Receptors%2520Enhances%2520Frontocortical%2520Cholinergic%2520Transmission%2520and%2520Social%2520Memory%2520in%2520Rats%253A%2520A%2520Parallel%2520Neurochemical%2520and%2520Behavioral%2520Analysis%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D100%26spage%3D1047%26epage%3D1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Frånberg, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, T. H.</span><span> </span><span class="NLM_article-title">Involvement of 5-HT2A Receptor and α2-Adrenoceptor Blockade in the Asenapine-Induced Elevation of Prefrontal Cortical Monoamine Outflow</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">650</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2012&pages=650-660&author=O.+Fr%C3%A5nbergauthor=M.+M.+Marcusauthor=T.+H.+Svensson&title=Involvement+of+5-HT2A+Receptor+and+%CE%B12-Adrenoceptor+Blockade+in+the+Asenapine-Induced+Elevation+of+Prefrontal+Cortical+Monoamine+Outflow"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFr%25C3%25A5nberg%26aufirst%3DO.%26aulast%3DMarcus%26aufirst%3DM.%2BM.%26aulast%3DSvensson%26aufirst%3DT.%2BH.%26atitle%3DInvolvement%2520of%25205-HT2A%2520Receptor%2520and%2520%25CE%25B12-Adrenoceptor%2520Blockade%2520in%2520the%2520Asenapine-Induced%2520Elevation%2520of%2520Prefrontal%2520Cortical%2520Monoamine%2520Outflow%26jtitle%3DSynapse%26date%3D2012%26volume%3D66%26spage%3D650%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Wang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shofer, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoff, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFall, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raskind, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peskind, E. R.</span><span> </span><span class="NLM_article-title">Prazosin for the Treatment of Behavioral Symptoms in Patients with Alzheimer Disease with Agitation and Aggression</span> <span class="citation_source-journal">Am. J. Geriatr. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">744</span><span class="NLM_x">–</span> <span class="NLM_lpage">751</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1097%2FJGP.0b013e3181ab8c61" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=19700947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A280%3ADC%252BD1MrntlGmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=744-751&author=L.+Y.+Wangauthor=J.+B.+Shoferauthor=K.+Rohdeauthor=K.+L.+Hartauthor=D.+J.+Hoffauthor=Y.+H.+McFallauthor=M.+A.+Raskindauthor=E.+R.+Peskind&title=Prazosin+for+the+Treatment+of+Behavioral+Symptoms+in+Patients+with+Alzheimer+Disease+with+Agitation+and+Aggression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression</span></div><div class="casAuthors">Wang Lucy Y; Shofer Jane B; Rohde Kirsten; Hart Kim L; Hoff David J; McFall Yun H; Raskind Murray A; Peskind Elaine R</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">744-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  Agitation/aggression in Alzheimer disease (AD) is a major cause of patient distress, caregiver burden, and institutionalization.  Enhanced behavioral responsiveness to central nervous system norepinephrine (NE) release may contribute to the pathophysiology of agitation/aggression in AD.  Prazosin, a nonsedating generic medication used for hypertension and benign prostatic hypertrophy, antagonizes NE effects at brain postsynaptic alpha-1 adrenoreceptors.  This pilot study examined the efficacy and tolerability of prazosin for behavioral symptoms in patients with agitation/aggression in AD.  DESIGN:  Double-blind, placebo controlled, parallel group study.  SETTING:  A university AD center and a nursing home in Seattle, WA.  PARTICIPANTS:  Twenty-two nursing home and community-dwelling participants with agitation/aggression and probable or possible AD (mean age: 80.6 +/- 11.2).  INTERVENTION:  Randomization to placebo (N = 11) or prazosin (N = 11).  Medication was initiated at 1 mg/day and increased up to 6 mg/day using a flexible dosing algorithm.  MEASUREMENTS:  The Brief Psychiatric Rating Scale (BPRS) and Neuropsychiatric Inventory (NPI) at Weeks 1, 2, 4, 6, and 8.  The Clinical Global Impression of Change (CGIC) at Week 8.  RESULTS:  Participants taking prazosin (mean dose: 5.7 +/- 0.9 mg/day) had greater improvements than those taking placebo (mean dose: 5.6 +/- 1.2 mg/day) on the NPI (mean change: -19 +/- 21 versus -2 +/- 15, chi = 6.32, df = 1, p = 0.012) and BPRS (mean change: -9 +/- 9 versus -3 +/- 5, chi = 4.42, df = 1, p = 0.036) based on linear mixed effects models and the CGIC (mean: 2.6 +/- 1.0 versus 4.5 +/- 1.6, z = 2.57, p = 0.011 [Mann-Whitney test]).  Adverse effects and blood pressure changes were similar between prazosin and placebo groups.  CONCLUSION:  Prazosin was well tolerated and improved behavioral symptoms in patients with agitation/aggression in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQHerY8I1UKWUPI-fCgwosgfW6udTcc2eZpkDBk94-fhbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrntlGmsw%253D%253D&md5=e08f8232272a62e15ba0ad29fb7c176c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1097%2FJGP.0b013e3181ab8c61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FJGP.0b013e3181ab8c61%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%2BY.%26aulast%3DShofer%26aufirst%3DJ.%2BB.%26aulast%3DRohde%26aufirst%3DK.%26aulast%3DHart%26aufirst%3DK.%2BL.%26aulast%3DHoff%26aufirst%3DD.%2BJ.%26aulast%3DMcFall%26aufirst%3DY.%2BH.%26aulast%3DRaskind%26aufirst%3DM.%2BA.%26aulast%3DPeskind%26aufirst%3DE.%2BR.%26atitle%3DPrazosin%2520for%2520the%2520Treatment%2520of%2520Behavioral%2520Symptoms%2520in%2520Patients%2520with%2520Alzheimer%2520Disease%2520with%2520Agitation%2520and%2520Aggression%26jtitle%3DAm.%2520J.%2520Geriatr.%2520Psychiatry%26date%3D2009%26volume%3D17%26spage%3D744%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Szot, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenup, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverenz, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peskind, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raskind, M. A.</span><span> </span><span class="NLM_article-title">Compensatory Changes in the Noradrenergic Nervous System in the Locus Ceruleus and Hippocampus of Postmortem Subjects with Alzheimer’s Disease and Dementia with Lewy Bodies</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1523%2FJNEUROSCI.4265-05.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=16407544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD28XosFWkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=467-478&author=P.+Szotauthor=S.+S.+Whiteauthor=J.+L.+Greenupauthor=J.+B.+Leverenzauthor=E.+R.+Peskindauthor=M.+A.+Raskind&title=Compensatory+Changes+in+the+Noradrenergic+Nervous+System+in+the+Locus+Ceruleus+and+Hippocampus+of+Postmortem+Subjects+with+Alzheimer%E2%80%99s+Disease+and+Dementia+with+Lewy+Bodies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies</span></div><div class="casAuthors">Szot, Patricia; White, Sylvia S.; Greenup, J. Lynne; Leverenz, James B.; Peskind, Elaine R.; Raskind, Murray A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">467-478</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">In Alzheimer's disease (AD), there is a significant loss of locus ceruleus (LC) noradrenergic neurons.  However, functional and anatomical evidence indicates that the remaining noradrenergic neurons may be compensating for the loss.  Because the noradrenergic system plays an important role in learning and memory, it is important to det. whether compensation occurs in noradrenergic neurons in the LC and hippocampus of subjects with AD or a related dementing disorder, dementia with Lewy bodies (DLB).  We obsd. profound neuronal loss in the LC in AD and DLB subjects with three major changes in the noradrenergic system consistent with compensation: (1) an increase in tyrosine hydroxylase (TH) mRNA expression in the remaining neurons; (2) sprouting of dendrites into peri-LC dendritic zone, as detd. by α2-adrenoreceptors (ARs) and norepinephrine transporter binding sites; and (3) sprouting of axonal projections to the hippocampus as detd. by α2-ARs.  In AD and DLB subjects, the postsynaptic α1-ARs were normal to elevated.  Expression of α1A- and α2A-AR mRNA in the hippocampus of AD and DLB subjects were not altered, but expression of α1D- and α2C-AR mRNA was significantly reduced in the hippocampus of AD and DLB subjects.  Therefore, in AD and DLB subjects, there is compensation occurring in the remaining noradrenergic neurons, but there does appear to be a loss of specific AR in the hippocampus.  Because changes in these noradrenergic markers in AD vs. DLB subjects were similar (except neuronal loss and the increase in TH mRNA were somewhat greater in DLB subjects), the presence of Lewy bodies in addn. to plaques and tangles in DLB subjects does not appear to further affect the noradrenergic compensatory changes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxgbShoKhvPrVg90H21EOLACvtfcHk0li5fT-Jb1e84g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosFWkuw%253D%253D&md5=0aaa93806c5f581442e6a8be0e33ac17</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4265-05.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4265-05.2006%26sid%3Dliteratum%253Aachs%26aulast%3DSzot%26aufirst%3DP.%26aulast%3DWhite%26aufirst%3DS.%2BS.%26aulast%3DGreenup%26aufirst%3DJ.%2BL.%26aulast%3DLeverenz%26aufirst%3DJ.%2BB.%26aulast%3DPeskind%26aufirst%3DE.%2BR.%26aulast%3DRaskind%26aufirst%3DM.%2BA.%26atitle%3DCompensatory%2520Changes%2520in%2520the%2520Noradrenergic%2520Nervous%2520System%2520in%2520the%2520Locus%2520Ceruleus%2520and%2520Hippocampus%2520of%2520Postmortem%2520Subjects%2520with%2520Alzheimer%25E2%2580%2599s%2520Disease%2520and%2520Dementia%2520with%2520Lewy%2520Bodies%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D467%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Reiner, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamondi, A.</span><span> </span><span class="NLM_article-title">Mechanisms of Antihistamine-Induced Sedation in the Human Brain: H1 Receptor Activation Reduces a Background Leakage Potassium Current</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">588</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1994&pages=579-588&author=P.+B.+Reinerauthor=A.+Kamondi&title=Mechanisms+of+Antihistamine-Induced+Sedation+in+the+Human+Brain%3A+H1+Receptor+Activation+Reduces+a+Background+Leakage+Potassium+Current"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReiner%26aufirst%3DP.%2BB.%26aulast%3DKamondi%26aufirst%3DA.%26atitle%3DMechanisms%2520of%2520Antihistamine-Induced%2520Sedation%2520in%2520the%2520Human%2520Brain%253A%2520H1%2520Receptor%2520Activation%2520Reduces%2520a%2520Background%2520Leakage%2520Potassium%2520Current%26jtitle%3DNeuroscience%26date%3D1994%26volume%3D59%26spage%3D579%26epage%3D588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Kirk, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glazebrook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grayson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neill, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, G. P.</span><span> </span><span class="NLM_article-title">Olanzapine-Induced Weight Gain in the Rat: Role of 5-HT2C and Histamine H1 Receptors</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">207</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2009&pages=119-125&author=S.+L.+Kirkauthor=J.+Glazebrookauthor=B.+Graysonauthor=J.+C.+Neillauthor=G.+P.+Reynolds&title=Olanzapine-Induced+Weight+Gain+in+the+Rat%3A+Role+of+5-HT2C+and+Histamine+H1+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKirk%26aufirst%3DS.%2BL.%26aulast%3DGlazebrook%26aufirst%3DJ.%26aulast%3DGrayson%26aufirst%3DB.%26aulast%3DNeill%26aufirst%3DJ.%2BC.%26aulast%3DReynolds%26aufirst%3DG.%2BP.%26atitle%3DOlanzapine-Induced%2520Weight%2520Gain%2520in%2520the%2520Rat%253A%2520Role%2520of%25205-HT2C%2520and%2520Histamine%2520H1%2520Receptors%26jtitle%3DPsychopharmacology%26date%3D2009%26volume%3D207%26spage%3D119%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">De Deyn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeste, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breder, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwamoto, T.</span><span> </span><span class="NLM_article-title">Aripiprazole for the Treatment of Psychosis in Patients with Alzheimer’s Disease: A Randomized, Placebo-Controlled Study</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1097%2F01.jcp.0000178415.22309.8f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=16160622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVShsLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=463-467&author=P.+De+Deynauthor=D.+V.+Jesteauthor=R.+Swaninkauthor=D.+Kosticauthor=C.+Brederauthor=W.+H.+Carsonauthor=T.+Iwamoto&title=Aripiprazole+for+the+Treatment+of+Psychosis+in+Patients+with+Alzheimer%E2%80%99s+Disease%3A+A+Randomized%2C+Placebo-Controlled+Study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Aripiprazole for the treatment of psychosis in patients with Alzheimer's disease: a randomized, placebo-controlled study</span></div><div class="casAuthors">De Deyn, Peter; Jeste, Dilip V.; Swanink, Rene; Kostic, Dusan; Breder, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">463-467</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">This study compared the efficacy, safety, and tolerability of aripiprazole, a novel antipsychotic, with placebo in patients with psychosis assocd. with Alzheimer's Disease (AD).  This 10-wk, double-blind, multicenter study randomized 208 outpatients (mean age, 81.5 years) with AD-assocd. psychosis to aripiprazole (n = 106) or placebo (n = 102).  The initial aripiprazole dose of 2 mg/d was titrated upwards (5, 10, or 15 mg/d) according to efficacy and tolerability.  Evaluations included Neuropsychiatric Inventory (NPI) Psychosis subscale and Brief Psychiatric Rating Scale (BPRS), adverse event (AE) reports, extrapyramidal symptoms (EPS) rating scales, and body wt.  Overall, 172 patients (83%) completed the study.  Mean aripiprazole dose at end point was 10.0 mg/d.  The NPI Psychosis subscale score showed improvements in both groups (aripiprazole, -6.55; placebo, -5.52; P = 0.17 at end point).  Aripiprazole-treated patients showed significantly greater improvements from baseline in BPRS Psychosis and BPRS Core subscale scores at end point compared with placebo.  AEs were generally mild to moderate in severity and included (aripiprazole vs. placebo): urinary tract infection (8% vs. 12%), accidental injury (8% vs. 5%), somnolence (8% vs. 1%), and bronchitis (6% vs. 3%).  Somnolence was mild and not assocd. with falls or accidental injury.  There were no significant differences from placebo in EPS scores, or clin. significant ECG abnormalities, vital signs, or wt.  In conclusion, aripiprazole showed similar improvements to placebo in psychotic symptoms as assessed by NPI Psychosis subscale scores, but significantly greater effects on BPRS Core and Psychosis assessments in community-living AD patients with psychosis.  Aripiprazole was safe and well tolerated in this patient population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcxfeaX0-hlrVg90H21EOLACvtfcHk0lhrZMDK0UgbPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVShsLjP&md5=1f6f19fd6321c2060958ccf31ea1a71b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1097%2F01.jcp.0000178415.22309.8f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.jcp.0000178415.22309.8f%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BDeyn%26aufirst%3DP.%26aulast%3DJeste%26aufirst%3DD.%2BV.%26aulast%3DSwanink%26aufirst%3DR.%26aulast%3DKostic%26aufirst%3DD.%26aulast%3DBreder%26aufirst%3DC.%26aulast%3DCarson%26aufirst%3DW.%2BH.%26aulast%3DIwamoto%26aufirst%3DT.%26atitle%3DAripiprazole%2520for%2520the%2520Treatment%2520of%2520Psychosis%2520in%2520Patients%2520with%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520A%2520Randomized%252C%2520Placebo-Controlled%2520Study%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D2005%26volume%3D25%26spage%3D463%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Kołaczkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawłowski, M.</span><span> </span><span class="NLM_article-title">Ligand-Optimized Homology Models of D1 and D2 Dopamine Receptors: Application for Virtual Screening</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">638</span><span class="NLM_x">–</span> <span class="NLM_lpage">648</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci300413h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1yhsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=638-648&author=M.+Ko%C5%82aczkowskiauthor=A.+Buckiauthor=M.+Federauthor=M.+Paw%C5%82owski&title=Ligand-Optimized+Homology+Models+of+D1+and+D2+Dopamine+Receptors%3A+Application+for+Virtual+Screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-Optimized Homology Models of D1 and D2 Dopamine Receptors: Application for Virtual Screening</span></div><div class="casAuthors">Kolaczkowski, Marcin; Bucki, Adam; Feder, Marcin; Pawlowski, Maciej</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">638-648</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent breakthroughs in crystallog. studies of G protein-coupled receptors (GPCRs), together with continuous progress in mol. modeling methods, have opened new perspectives for structure-based drug discovery.  A crucial enhancement in this area was development of induced fit docking procedures that allow optimization of binding pocket conformation guided by the features of its active ligands.  In the course of our research program aimed at discovery of novel antipsychotic agents, our attention focused on dopaminergic D2 and D1 receptors (D2R and D1R).  Thus, we decided to investigate whether the availability of a novel structure of the closely related D3 receptor and application of induced fit docking procedures for binding pocket refinement would permit the building of models of D2R and D1R that facilitate a successful virtual screening (VS).  Here, we provide an in-depth description of the modeling procedure and the discussion of the results of a VS benchmark we performed to compare efficiency of the ligand-optimized receptors in comparison with the regular homol. models.  We obsd. that application of the ligand-optimized models significantly improved the VS performance both in terms of BEDROC (0.325 vs 0.182 for D1R and 0.383 vs 0.301 for D2R) as well as EF1% (20 vs 11 for D1R and 18 vs 10 for D2R).  In contrast, no improvement was obsd. for the performance of a D2R model built on the D3R template, when compared with that derived from the structure of the previously published and more evolutionary distant β2 adrenergic receptor.  The comparison of results for receptors built according to various protocols and templates revealed that the most significant factor for the receptor performance was a proper selection of tool ligand used in induced fit docking procedure.  Taken together, our results suggest that the described homol. modeling procedure could be a viable tool for structure-based GPCR ligand design, even for the targets for which only a relatively distant structural template is available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHGgw5lOnO9bVg90H21EOLACvtfcHk0lhrZMDK0UgbPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1yhsb0%253D&md5=58f111e8132b7229898f1a44feb6199b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fci300413h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci300413h%26sid%3Dliteratum%253Aachs%26aulast%3DKo%25C5%2582aczkowski%26aufirst%3DM.%26aulast%3DBucki%26aufirst%3DA.%26aulast%3DFeder%26aufirst%3DM.%26aulast%3DPaw%25C5%2582owski%26aufirst%3DM.%26atitle%3DLigand-Optimized%2520Homology%2520Models%2520of%2520D1%2520and%2520D2%2520Dopamine%2520Receptors%253A%2520Application%2520for%2520Virtual%2520Screening%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26spage%3D638%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Kowalski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaśkowska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bojarski, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duszyńska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kołaczkowski, M.</span><span> </span><span class="NLM_article-title">Evaluation of 1-Arylpiperazine Derivative of Hydroxybenzamides as 5-HT 1A and 5-HT7 Serotonin Receptor Ligands: An Experimental and Molecular Modeling Approach</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">192</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2011&pages=192-198&author=P.+Kowalskiauthor=J.+Ja%C5%9Bkowskaauthor=A.+J.+Bojarskiauthor=B.+Duszy%C5%84skaauthor=A.+Buckiauthor=M.+Ko%C5%82aczkowski&title=Evaluation+of+1-Arylpiperazine+Derivative+of+Hydroxybenzamides+as+5-HT+1A+and+5-HT7+Serotonin+Receptor+Ligands%3A+An+Experimental+and+Molecular+Modeling+Approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKowalski%26aufirst%3DP.%26aulast%3DJa%25C5%259Bkowska%26aufirst%3DJ.%26aulast%3DBojarski%26aufirst%3DA.%2BJ.%26aulast%3DDuszy%25C5%2584ska%26aufirst%3DB.%26aulast%3DBucki%26aufirst%3DA.%26aulast%3DKo%25C5%2582aczkowski%26aufirst%3DM.%26atitle%3DEvaluation%2520of%25201-Arylpiperazine%2520Derivative%2520of%2520Hydroxybenzamides%2520as%25205-HT%25201A%2520and%25205-HT7%2520Serotonin%2520Receptor%2520Ligands%253A%2520An%2520Experimental%2520and%2520Molecular%2520Modeling%2520Approach%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D2011%26volume%3D48%26spage%3D192%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Aranda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raviña, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masaguer, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Areias, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domínguez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selent, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loza, M. I.</span><span> </span><span class="NLM_article-title">Synthesis, Binding Affinity, and Molecular Docking Analysis of New Benzofuranone Derivatives as Potential Antipsychotics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6085</span><span class="NLM_x">–</span> <span class="NLM_lpage">6094</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800602w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6085-6094&author=R.+Arandaauthor=K.+Villalbaauthor=E.+Ravi%C3%B1aauthor=C.+F.+Masaguerauthor=J.+Breaauthor=F.+Areiasauthor=E.+Dom%C3%ADnguezauthor=J.+Selentauthor=L.+L%C3%B3pezauthor=F.+Sanzauthor=M.+Pastorauthor=M.+I.+Loza&title=Synthesis%2C+Binding+Affinity%2C+and+Molecular+Docking+Analysis+of+New+Benzofuranone+Derivatives+as+Potential+Antipsychotics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm800602w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800602w%26sid%3Dliteratum%253Aachs%26aulast%3DAranda%26aufirst%3DR.%26aulast%3DVillalba%26aufirst%3DK.%26aulast%3DRavi%25C3%25B1a%26aufirst%3DE.%26aulast%3DMasaguer%26aufirst%3DC.%2BF.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DAreias%26aufirst%3DF.%26aulast%3DDom%25C3%25ADnguez%26aufirst%3DE.%26aulast%3DSelent%26aufirst%3DJ.%26aulast%3DL%25C3%25B3pez%26aufirst%3DL.%26aulast%3DSanz%26aufirst%3DF.%26aulast%3DPastor%26aufirst%3DM.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26atitle%3DSynthesis%252C%2520Binding%2520Affinity%252C%2520and%2520Molecular%2520Docking%2520Analysis%2520of%2520New%2520Benzofuranone%2520Derivatives%2520as%2520Potential%2520Antipsychotics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6085%26epage%3D6094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Dukat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosier, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolanos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Binding of Serotonin and N1-Benzenesulfonyltryptamine-Related Analogs at Human 5-HT6 Serotonin Receptors: Receptor Modeling Studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">611</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070910s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=603-611&author=M.+Dukatauthor=P.+D.+Mosierauthor=R.+Kolanosauthor=B.+L.+Rothauthor=R.+A.+Glennon&title=Binding+of+Serotonin+and+N1-Benzenesulfonyltryptamine-Related+Analogs+at+Human+5-HT6+Serotonin+Receptors%3A+Receptor+Modeling+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm070910s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070910s%26sid%3Dliteratum%253Aachs%26aulast%3DDukat%26aufirst%3DM.%26aulast%3DMosier%26aufirst%3DP.%2BD.%26aulast%3DKolanos%26aufirst%3DR.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DBinding%2520of%2520Serotonin%2520and%2520N1-Benzenesulfonyltryptamine-Related%2520Analogs%2520at%2520Human%25205-HT6%2520Serotonin%2520Receptors%253A%2520Receptor%2520Modeling%2520Studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D603%26epage%3D611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">De la Fuente, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martín-Fontecha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sallander, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamú, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellissier, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claeysen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumuis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Rodríguez, M. L.</span><span> </span><span class="NLM_article-title">Benzimidazole Derivatives as New Serotonin 5-HT6 Receptor Antagonists. Molecular Mechanisms of Receptor Inactivation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1357</span><span class="NLM_x">–</span> <span class="NLM_lpage">1369</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901672k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1357-1369&author=T.+De+la+Fuenteauthor=M.+Mart%C3%ADn-Fontechaauthor=J.+Sallanderauthor=B.+Benham%C3%BAauthor=M.+Campilloauthor=R.+A.+Medinaauthor=L.+P.+Pellissierauthor=S.+Claeysenauthor=A.+Dumuisauthor=L.+Pardoauthor=M.+L.+L%C3%B3pez-Rodr%C3%ADguez&title=Benzimidazole+Derivatives+as+New+Serotonin+5-HT6+Receptor+Antagonists.+Molecular+Mechanisms+of+Receptor+Inactivation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm901672k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901672k%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2Bla%2BFuente%26aufirst%3DT.%26aulast%3DMart%25C3%25ADn-Fontecha%26aufirst%3DM.%26aulast%3DSallander%26aufirst%3DJ.%26aulast%3DBenham%25C3%25BA%26aufirst%3DB.%26aulast%3DCampillo%26aufirst%3DM.%26aulast%3DMedina%26aufirst%3DR.%2BA.%26aulast%3DPellissier%26aufirst%3DL.%2BP.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DDumuis%26aufirst%3DA.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26atitle%3DBenzimidazole%2520Derivatives%2520as%2520New%2520Serotonin%25205-HT6%2520Receptor%2520Antagonists.%2520Molecular%2520Mechanisms%2520of%2520Receptor%2520Inactivation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1357%26epage%3D1369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Van Loevezijn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venhorst, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwema Bakker, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Korte, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Looff, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoog, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Wees, J.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Hoeve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Woestijne, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Neut, M. A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borst, A. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dongen, M. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bruin, N. M. W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keizer, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, C. G.</span><span> </span><span class="NLM_article-title">N′-(Arylsulfonyl)pyrazoline-1-carboxamidines as Novel, Neutral 5-Hydroxytryptamine 6 Receptor (5-HT6R) Antagonists with Unique Structural Features</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7030</span><span class="NLM_x">–</span> <span class="NLM_lpage">7054</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200466r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7030-7054&author=A.+Van+Loevezijnauthor=J.+Venhorstauthor=W.+I.+Iwema+Bakkerauthor=C.+G.+de+Korteauthor=W.+de+Looffauthor=S.+Verhoogauthor=J.-W.+van+Weesauthor=M.+van+Hoeveauthor=R.+P.+van+de+Woestijneauthor=M.+A.+W.+van+der+Neutauthor=A.+J.+M.+Borstauthor=M.+J.+P.+van+Dongenauthor=N.+M.+W.+J.+de+Bruinauthor=H.+G.+Keizerauthor=C.+G.+Kruse&title=N%E2%80%B2-%28Arylsulfonyl%29pyrazoline-1-carboxamidines+as+Novel%2C+Neutral+5-Hydroxytryptamine+6+Receptor+%285-HT6R%29+Antagonists+with+Unique+Structural+Features"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm200466r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200466r%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BLoevezijn%26aufirst%3DA.%26aulast%3DVenhorst%26aufirst%3DJ.%26aulast%3DIwema%2BBakker%26aufirst%3DW.%2BI.%26aulast%3Dde%2BKorte%26aufirst%3DC.%2BG.%26aulast%3Dde%2BLooff%26aufirst%3DW.%26aulast%3DVerhoog%26aufirst%3DS.%26aulast%3Dvan%2BWees%26aufirst%3DJ.-W.%26aulast%3Dvan%2BHoeve%26aufirst%3DM.%26aulast%3Dvan%2Bde%2BWoestijne%26aufirst%3DR.%2BP.%26aulast%3Dvan%2Bder%2BNeut%26aufirst%3DM.%2BA.%2BW.%26aulast%3DBorst%26aufirst%3DA.%2BJ.%2BM.%26aulast%3Dvan%2BDongen%26aufirst%3DM.%2BJ.%2BP.%26aulast%3Dde%2BBruin%26aufirst%3DN.%2BM.%2BW.%2BJ.%26aulast%3DKeizer%26aufirst%3DH.%2BG.%26aulast%3DKruse%26aufirst%3DC.%2BG.%26atitle%3DN%25E2%2580%25B2-%2528Arylsulfonyl%2529pyrazoline-1-carboxamidines%2520as%2520Novel%252C%2520Neutral%25205-Hydroxytryptamine%25206%2520Receptor%2520%25285-HT6R%2529%2520Antagonists%2520with%2520Unique%2520Structural%2520Features%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7030%26epage%3D7054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Medina, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sallander, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamú, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porras, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Rodríguez, M. L.</span><span> </span><span class="NLM_article-title">Synthesis of New Serotonin 5-HT7 Receptor Ligands. Determinants of 5-HT7/5-HT1A Receptor Selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2384</span><span class="NLM_x">–</span> <span class="NLM_lpage">2392</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8014553" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2384-2392&author=R.+A.+Medinaauthor=J.+Sallanderauthor=B.+Benham%C3%BAauthor=E.+Porrasauthor=M.+Campilloauthor=L.+Pardoauthor=M.+L.+L%C3%B3pez-Rodr%C3%ADguez&title=Synthesis+of+New+Serotonin+5-HT7+Receptor+Ligands.+Determinants+of+5-HT7%2F5-HT1A+Receptor+Selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm8014553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8014553%26sid%3Dliteratum%253Aachs%26aulast%3DMedina%26aufirst%3DR.%2BA.%26aulast%3DSallander%26aufirst%3DJ.%26aulast%3DBenham%25C3%25BA%26aufirst%3DB.%26aulast%3DPorras%26aufirst%3DE.%26aulast%3DCampillo%26aufirst%3DM.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26atitle%3DSynthesis%2520of%2520New%2520Serotonin%25205-HT7%2520Receptor%2520Ligands.%2520Determinants%2520of%25205-HT7%252F5-HT1A%2520Receptor%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2384%26epage%3D2392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Farid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearlstein, R. A.</span><span> </span><span class="NLM_article-title">New Insights about HERG Blockade Obtained from Protein Modeling, Potential Energy Mapping, and Docking Studies</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3160</span><span class="NLM_x">–</span> <span class="NLM_lpage">3173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1016%2Fj.bmc.2005.12.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=16413785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1ehs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=3160-3173&author=R.+Faridauthor=T.+Dayauthor=R.+A.+Friesnerauthor=R.+A.+Pearlstein&title=New+Insights+about+HERG+Blockade+Obtained+from+Protein+Modeling%2C+Potential+Energy+Mapping%2C+and+Docking+Studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies</span></div><div class="casAuthors">Farid, Ramy; Day, Tyler; Friesner, Richard A.; Pearlstein, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3160-3173</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We created a homol. model of the homo-tetrameric pore domain of HERG using the crystal structure of the bacterial potassium channel, KvAP, as a template.  We docked a set of known blockers with well-characterized effects on channel function into the lumen of the pore between the selectivity filter and extracellular entrance using a novel docking and refinement procedure incorporating Glide and Prime.  Key arom. groups of the blockers are predicted to form multiple simultaneous ring stacking and hydrophobic interactions among the eight arom. residues lining the pore.  Furthermore, each blocker can achieve these interactions via multiple docking configurations.  To further interpret the docking results, we mapped hydrophobic and hydrophilic potentials within the lumen of each refined docked complex.  Hydrophilic iso-potential contours define a 'propeller-shaped' vol. at the selectivity filter entrance.  Hydrophobic contours define a hollow 'crown-shaped' vol. located above the 'propeller', whose hydrophobic 'rim' extends along the pore axis between Tyr652 and Phe656.  Blockers adopt conformations/binding orientations that closely mimic the shapes and properties of these contours.  Blocker basic groups are localized in the hydrophilic 'propeller', forming electrostatic interactions with Ser624 rather than a generally accepted π-cation interaction with Tyr652.  Terfenadine, cisapride, sertindole, ibutilide, and clofilium adopt similar docked poses, in which their N-substituents bridge radially across the hollow interior of the 'crown' (analogous to the hub and spokes of a wheel), and project arom./hydrophobic portions into the hydrophobic 'rim'.  MK-499 docks with its longitudinal axis parallel to the axis of the pore and crown', and its hydrophobic groups buried within the hydrophobic 'rim'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-1RsiljwGxrVg90H21EOLACvtfcHk0ljHKJNOSe94kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1ehs7o%253D&md5=8df638aa78d2d35337bb82d8a94357c4</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.12.032%26sid%3Dliteratum%253Aachs%26aulast%3DFarid%26aufirst%3DR.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DPearlstein%26aufirst%3DR.%2BA.%26atitle%3DNew%2520Insights%2520about%2520HERG%2520Blockade%2520Obtained%2520from%2520Protein%2520Modeling%252C%2520Potential%2520Energy%2520Mapping%252C%2520and%2520Docking%2520Studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D3160%26epage%3D3173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbaum, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, S. G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thian, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">High-Resolution Crystal Structure of an Engineered Human beta2-Adrenergic G Protein-Coupled Receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">1258</span><span class="NLM_x">–</span> <span class="NLM_lpage">1265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1126%2Fscience.1150577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=17962520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmur7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=1258-1265&author=V.+Cherezovauthor=D.+M.+Rosenbaumauthor=M.+A.+Hansonauthor=S.+G.+F.+Rasmussenauthor=F.+S.+Thianauthor=T.+S.+Kobilkaauthor=H.-J.+Choiauthor=P.+Kuhnauthor=W.+I.+Weisauthor=B.+K.+Kobilkaauthor=R.+C.+Stevens&title=High-Resolution+Crystal+Structure+of+an+Engineered+Human+beta2-Adrenergic+G+Protein-Coupled+Receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein-Coupled Receptor</span></div><div class="casAuthors">Cherezov, Vadim; Rosenbaum, Daniel M.; Hanson, Michael A.; Rasmussen, Soren G. F.; Thian, Foon Sun; Kobilka, Tong Sun; Choi, Hee-Jung; Kuhn, Peter; Weis, William I.; Kobilka, Brian K.; Stevens, Raymond C.; Takeda, S.; Kadowaki, S.; Haga, T.; Takaesu, H.; Mitaku, S.; Fredriksson, R.; Lagerstrom, M. C.; Lundin, L. G.; Schioth, H. B.; Pierce, K. L.; Premont, R. T.; Lefkowitz, R. J.; Lefkowitz, R. J.; Shenoy, S. K.; Rosenbaum, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">5854</span>),
    <span class="NLM_cas:pages">1258-1265</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Second extracellular loop, which in the β2-adrenergic receptor contains an unusual pair of disulfide bonds and an extra helix.  This loop and the absence Heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors constitute the largest family of eukaryotic signal transduction proteins that communicate across the membrane.  We report the crystal structure of a human β2-adrenergic receptor-T4 lysozyme fusion protein bound to the partial inverse agonist carazolol at 2.4 angstrom resoln.  The structure provides a high-resoln. view of a human G protein-coupled receptor bound to a diffusible ligand.  Ligand-binding site accessibility is enabled by the second extracellular loop, which is held out of the binding cavity by a pair of closely spaced disulfide bridges and a short helical segment within the loop.  Cholesterol, a necessary component for crystn., mediates an intriguing parallel assocn. of receptor mols. in the crystal lattice.  Although the location of carazolol in the β2-adrenergic receptor is very similar to that of retinal in rhodopsin, structural differences in the ligand-binding site and other regions highlight the challenges in using rhodopsin as a template model for this large receptor family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC-8wZ2k2GHLVg90H21EOLACvtfcHk0ljHKJNOSe94kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmur7I&md5=12c5bacb8464a4b243fe9341192b5b3b</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1126%2Fscience.1150577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1150577%26sid%3Dliteratum%253Aachs%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DRasmussen%26aufirst%3DS.%2BG.%2BF.%26aulast%3DThian%26aufirst%3DF.%2BS.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DChoi%26aufirst%3DH.-J.%26aulast%3DKuhn%26aufirst%3DP.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DHigh-Resolution%2520Crystal%2520Structure%2520of%2520an%2520Engineered%2520Human%2520beta2-Adrenergic%2520G%2520Protein-Coupled%2520Receptor%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D1258%26epage%3D1265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Kurowski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bujnicki, J. M.</span><span> </span><span class="NLM_article-title">GeneSilico Protein Structure Prediction Meta-Server</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">3305</span><span class="NLM_x">–</span> <span class="NLM_lpage">3307</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=3305-3307&author=M.+A.+Kurowskiauthor=J.+M.+Bujnicki&title=GeneSilico+Protein+Structure+Prediction+Meta-Server"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKurowski%26aufirst%3DM.%2BA.%26aulast%3DBujnicki%26aufirst%3DJ.%2BM.%26atitle%3DGeneSilico%2520Protein%2520Structure%2520Prediction%2520Meta-Server%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2003%26volume%3D31%26spage%3D3305%26epage%3D3307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Jain, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bairoch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redaschi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzek, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGarvey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasteiger, E.</span><span> </span><span class="NLM_article-title">Infrastructure for the Life Sciences: Design and Implementation of the UniProt Website</span> <span class="citation_source-journal">BMC Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=136&author=E.+Jainauthor=A.+Bairochauthor=S.+Duvaudauthor=I.+Phanauthor=N.+Redaschiauthor=B.+E.+Suzekauthor=M.+J.+Martinauthor=P.+McGarveyauthor=E.+Gasteiger&title=Infrastructure+for+the+Life+Sciences%3A+Design+and+Implementation+of+the+UniProt+Website"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DE.%26aulast%3DBairoch%26aufirst%3DA.%26aulast%3DDuvaud%26aufirst%3DS.%26aulast%3DPhan%26aufirst%3DI.%26aulast%3DRedaschi%26aufirst%3DN.%26aulast%3DSuzek%26aufirst%3DB.%2BE.%26aulast%3DMartin%26aufirst%3DM.%2BJ.%26aulast%3DMcGarvey%26aufirst%3DP.%26aulast%3DGasteiger%26aufirst%3DE.%26atitle%3DInfrastructure%2520for%2520the%2520Life%2520Sciences%253A%2520Design%2520and%2520Implementation%2520of%2520the%2520UniProt%2520Website%26jtitle%3DBMC%2520Bioinformatics%26date%3D2009%26volume%3D10%26spage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Arnold, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordoli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwede, T.</span><span> </span><span class="NLM_article-title">The SWISS-MODEL Workspace: A Web-Based Environment for Protein Structure Homology Modelling</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1093%2Fbioinformatics%2Fbti770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=16301204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD28XovVCltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=195-201&author=K.+Arnoldauthor=L.+Bordoliauthor=J.+Koppauthor=T.+Schwede&title=The+SWISS-MODEL+Workspace%3A+A+Web-Based+Environment+for+Protein+Structure+Homology+Modelling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling</span></div><div class="casAuthors">Arnold, Konstantin; Bordoli, Lorenza; Kopp, Juergen; Schwede, Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-201</span>CODEN:
                <span class="NLM_cas:coden">BOINFP</span>;
        ISSN:<span class="NLM_cas:issn">1367-4803</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Motivation: Homol. models of proteins are of great interest for planning and analyzing biol. expts. when no exptl. three-dimensional structures are available.  Building homol. models requires specialized programs and up-to-date sequence and structural databases.  Integrating all required tools, programs and databases into a single web-based workspace facilitates access to homol. modeling from a computer with web connection without the need of downloading and installing large program packages and databases.  Results: SWISS-MODEL workspace is a web-based integrated service dedicated to protein structure homol. modeling.  It assists and guides the user in building protein homol. models at different levels of complexity.  A personal working environment is provided for each user where several modeling projects can be carried out in parallel.  Protein sequence and structure databases necessary for modeling are accessible from the workspace and are updated in regular intervals.  Tools for template selection, model building and structure quality evaluation can be invoked from within the workspace.  Workflow and usage of the workspace are illustrated by modeling human Cyclin A1 and human Transmembrane Protease 3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDwXLAG5Kz27Vg90H21EOLACvtfcHk0lguUurLN9-tww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovVCltw%253D%253D&md5=66fa733d2ad6d2abf7d3d87ae837ebce</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbti770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbti770%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DK.%26aulast%3DBordoli%26aufirst%3DL.%26aulast%3DKopp%26aufirst%3DJ.%26aulast%3DSchwede%26aufirst%3DT.%26atitle%3DThe%2520SWISS-MODEL%2520Workspace%253A%2520A%2520Web-Based%2520Environment%2520for%2520Protein%2520Structure%2520Homology%2520Modelling%26jtitle%3DBioinformatics%26date%3D2006%26volume%3D22%26spage%3D195%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Guex, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peitsch, M. C.</span><span> </span><span class="NLM_article-title">SWISS-MODEL and the Swiss-PdbViewer: An Environment for Comparative Protein Modeling</span> <span class="citation_source-journal">Electrophoresis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2714</span><span class="NLM_x">–</span> <span class="NLM_lpage">2723</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1002%2Felps.1150181505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=9504803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADyaK1cXhvFaks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=2714-2723&author=N.+Guexauthor=M.+C.+Peitsch&title=SWISS-MODEL+and+the+Swiss-PdbViewer%3A+An+Environment+for+Comparative+Protein+Modeling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">SWISS-MODEL and the Swiss-PdbViewer. An environment for comparative protein modeling</span></div><div class="casAuthors">Guex, Nicolas; Peitsch, Manuel C.</div><div class="citationInfo"><span class="NLM_cas:title">Electrophoresis</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2714-2723</span>CODEN:
                <span class="NLM_cas:coden">ELCTDN</span>;
        ISSN:<span class="NLM_cas:issn">0173-0835</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">Comparative protein modeling is increasingly gaining interest since it is of great assistance during the rational design of mutagenesis expts.  The availability of this method, and the resulting models, has however been restricted by the availability of expensive computer hardware and software.  To overcome these limitations, the authors have developed an environment for comparative protein modeling that consists of SWISS-MODEL, a server for automated comparative protein modeling and of the SWISS-PdbViewer, a sequence to structure workbench.  The Swiss-PdbViewer not only acts as a client for SWISS-MODEL, but also provides a large selection of structure anal. and display tools.  In addn., the authors provide the SWISS-MODEL Repository, a database contg. more than 3500 automatically generated protein models.  By making such tools freely available to the scientific community, the authors hope to increase the use of protein structures and models in the process of expt. design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQsoTgcUeb6bVg90H21EOLACvtfcHk0lguUurLN9-tww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhvFaks70%253D&md5=f97197dfdb1cf196099b0576f150d14b</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1002%2Felps.1150181505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Felps.1150181505%26sid%3Dliteratum%253Aachs%26aulast%3DGuex%26aufirst%3DN.%26aulast%3DPeitsch%26aufirst%3DM.%2BC.%26atitle%3DSWISS-MODEL%2520and%2520the%2520Swiss-PdbViewer%253A%2520An%2520Environment%2520for%2520Comparative%2520Protein%2520Modeling%26jtitle%3DElectrophoresis%26date%3D1997%26volume%3D18%26spage%3D2714%26epage%3D2723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Schwede, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guex, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peitsch, M. C.</span><span> </span><span class="NLM_article-title">SWISS-MODEL: An Automated Protein Homology-Modeling Server</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">3381</span><span class="NLM_x">–</span> <span class="NLM_lpage">3385</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=3381-3385&author=T.+Schwedeauthor=J.+Koppauthor=N.+Guexauthor=M.+C.+Peitsch&title=SWISS-MODEL%3A+An+Automated+Protein+Homology-Modeling+Server"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchwede%26aufirst%3DT.%26aulast%3DKopp%26aufirst%3DJ.%26aulast%3DGuex%26aufirst%3DN.%26aulast%3DPeitsch%26aufirst%3DM.%2BC.%26atitle%3DSWISS-MODEL%253A%2520An%2520Automated%2520Protein%2520Homology-Modeling%2520Server%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2003%26volume%3D31%26spage%3D3381%26epage%3D3385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Sherman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farid, R.</span><span> </span><span class="NLM_article-title">Use of an Induced Fit Receptor Structure in Virtual Screening</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1111%2Fj.1747-0285.2005.00327.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=16492153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVSjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=83-84&author=W.+Shermanauthor=H.+S.+Beardauthor=R.+Farid&title=Use+of+an+Induced+Fit+Receptor+Structure+in+Virtual+Screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Use of an induced fit receptor structure in virtual screening</span></div><div class="casAuthors">Sherman, Woody; Beard, Hege S.; Farid, Ramy</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-84</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The automated induced fit docking protocol was used to generate the DFG-out conformation from a p38 MAP kinase activation loop starting from a DFG-in structure (1a9u) and the ligand from 1kv1 (BMU).  In a virtual screening study of 25K decoy ligands and 46 known actives, using an ensemble consisting of the induced fit docking structure (DFG-out) and the 1a9u crystal structure (DFG-in), 14 actives were identified in the top 1% of the database, including BMU and BIRB 796.  3 Actives were identified when 1a9u was used alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PRgtFzy8u7Vg90H21EOLACvtfcHk0lguUurLN9-tww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVSjtL0%253D&md5=efe9900aacaaea6af805c1cbdb350c73</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2005.00327.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2005.00327.x%26sid%3Dliteratum%253Aachs%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DFarid%26aufirst%3DR.%26atitle%3DUse%2520of%2520an%2520Induced%2520Fit%2520Receptor%2520Structure%2520in%2520Virtual%2520Screening%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2006%26volume%3D67%26spage%3D83%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Sherman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farid, R.</span><span> </span><span class="NLM_article-title">Novel Procedure for Modeling Ligand/receptor Induced Fit Effects</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050540c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCgsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=534-553&author=W.+Shermanauthor=T.+Dayauthor=M.+P.+Jacobsonauthor=R.+A.+Friesnerauthor=R.+Farid&title=Novel+Procedure+for+Modeling+Ligand%2Freceptor+Induced+Fit+Effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Procedure for Modeling Ligand/Receptor Induced Fit Effects</span></div><div class="casAuthors">Sherman, Woody; Day, Tyler; Jacobson, Matthew P.; Friesner, Richard A.; Farid, Ramy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">534-553</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present a novel protein-ligand docking method that accurately accounts for both ligand and receptor flexibility by iteratively combining rigid receptor docking (Glide) with protein structure prediction (Prime) techniques.  While traditional rigid-receptor docking methods are useful when the receptor structure does not change substantially upon ligand binding, success is limited when the protein must be "induced" into the correct binding conformation for a given ligand.  We provide an in-depth description of our novel methodol. and present results for 21 pharmaceutically relevant examples.  Traditional rigid-receptor docking for these 21 cases yields an av. RMSD of 5.5 Å.  The av. ligand RMSD for docking to a flexible receptor for the 21 pairs is 1.4 Å; the RMSD is ≤1.8 Å for 18 of the cases.  For the three cases with RMSDs greater than 1.8 Å, the core of the ligand is properly docked and all key protein/ligand interactions are captured.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm3E6ctnPGSrVg90H21EOLACvtfcHk0lguUurLN9-tww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCgsr7I&md5=388811ead5cee1fd460951263de486cb</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm050540c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050540c%26sid%3Dliteratum%253Aachs%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DFarid%26aufirst%3DR.%26atitle%3DNovel%2520Procedure%2520for%2520Modeling%2520Ligand%252Freceptor%2520Induced%2520Fit%2520Effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D534%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klicic, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenkin, P. S.</span><span> </span><span class="NLM_article-title">Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1739</span><span class="NLM_x">–</span> <span class="NLM_lpage">1749</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+A+New+Approach+for+Rapid%2C+Accurate+Docking+and+Scoring.+1.+Method+and+Assessment+of+Docking+Accuracy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0lgF783Z5-jd_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520A%2520New%2520Approach%2520for%2520Rapid%252C%2520Accurate%2520Docking%2520and%2520Scoring.%25201.%2520Method%2520and%2520Assessment%2520of%2520Docking%2520Accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenwood, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanschagrin, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span> </span><span class="NLM_article-title">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6177</span><span class="NLM_x">–</span> <span class="NLM_lpage">6196</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051256o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6177-6196&author=R.+A.+Friesnerauthor=R.+B.+Murphyauthor=M.+P.+Repaskyauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=T.+A.+Halgrenauthor=P.+C.+Sanschagrinauthor=D.+T.+Mainz&title=Extra+Precision+Glide%3A+Docking+and+Scoring+Incorporating+a+Model+of+Hydrophobic+Enclosure+for+Protein-Ligand+Complexes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span></div><div class="casAuthors">Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P.; Frye, Leah L.; Greenwood, Jeremy R.; Halgren, Thomas A.; Sanschagrin, Paul C.; Mainz, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6177-6196</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel scoring function to est. protein-ligand binding affinities has been developed and implemented as the Glide 4.0 XP scoring function and docking protocol.  In addn. to unique water desolvation energy terms, protein-ligand structural motifs leading to enhanced binding affinity are included:(1) hydrophobic enclosure where groups of lipophilic ligand atoms are enclosed on opposite faces by lipophilic protein atoms, (2) neutral-neutral single or correlated hydrogen bonds in a hydrophobically enclosed environment, and (3) five categories of charged-charged hydrogen bonds.  The XP scoring function and docking protocol have been developed to reproduce exptl. binding affinities for a set of 198 complexes (RMSDs of 2.26 and 1.73 kcal/mol over all and well-docked ligands, resp.) and to yield quality enrichments for a set of fifteen screens of pharmaceutical importance.  Enrichment results demonstrate the importance of the novel XP mol. recognition and water scoring in sepg. active and inactive ligands and avoiding false positives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZiwN12vaY7Vg90H21EOLACvtfcHk0lgF783Z5-jd_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D&md5=ea428c82ead0d8c27f8c1a7b694a1edf</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm051256o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051256o%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DSanschagrin%26aufirst%3DP.%2BC.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26atitle%3DExtra%2520Precision%2520Glide%253A%2520Docking%2520and%2520Scoring%2520Incorporating%2520a%2520Model%2520of%2520Hydrophobic%2520Enclosure%2520for%2520Protein-Ligand%2520Complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6177%26epage%3D6196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honig, B.</span><span> </span><span class="NLM_article-title">On the Role of the Crystal Environment in Determining Protein Side-Chain Conformations</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1016%2FS0022-2836%2802%2900470-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=12096912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD38XltVKmu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2002&pages=597-608&author=M.+P.+Jacobsonauthor=R.+A.+Friesnerauthor=Z.+Xiangauthor=B.+Honig&title=On+the+Role+of+the+Crystal+Environment+in+Determining+Protein+Side-Chain+Conformations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">On the Role of the Crystal Environment in Determining Protein Side-chain Conformations</span></div><div class="casAuthors">Jacobson, Matthew P.; Friesner, Richard A.; Xiang, Zhexin; Honig, Barry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">597-608</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The role of crystal packing in detg. the obsd. conformations of amino acid side-chains in protein crystals is investigated by (1) anal. of a database of proteins that have been crystd. in different unit cells (space group or unit cell dimensions) and (2) theor. predictions of side-chain conformations with the crystal environment explicitly represented.  Both of these approaches indicate that the crystal environment plays an important role in detg. the conformations of polar side-chains on the surfaces of proteins.  Inclusion of the crystal environment permits a more sensitive measurement of the achievable accuracy of side-chain prediction programs, when validating against structures obtained by x-ray crystallog.  Our side-chain prediction program uses an all-atom force field and a Generalized Born model of solvation and is thus capable of modeling simple packing effects (i.e. van der Waals interactions), electrostatic effects, and desolvation, which are all important mechanisms by which the crystal environment impacts obsd. side-chain conformations.  Our results are also relevant to the understanding of changes in side-chain conformation that may result from ligand docking and protein-protein assocn., insofar as the results reveal how side-chain conformations change in response to their local environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgHEOVpIEiErVg90H21EOLACvtfcHk0lgF783Z5-jd_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltVKmu70%253D&md5=006de6bd2d0f233ab32d6798dc1a3fbc</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2802%2900470-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252802%252900470-9%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DHonig%26aufirst%3DB.%26atitle%3DOn%2520the%2520Role%2520of%2520the%2520Crystal%2520Environment%2520in%2520Determining%2520Protein%2520Side-Chain%2520Conformations%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2002%26volume%3D320%26spage%3D597%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pincus, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapp, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, T. J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honig, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">A Hierarchical Approach to All-Atom Protein Loop Prediction</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1002%2Fprot.10613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=15048827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFKhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=351-367&author=M.+P.+Jacobsonauthor=D.+L.+Pincusauthor=C.+S.+Rappauthor=T.+J.+F.+Dayauthor=B.+Honigauthor=D.+E.+Shawauthor=R.+A.+Friesner&title=A+Hierarchical+Approach+to+All-Atom+Protein+Loop+Prediction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">A hierarchical approach to all-atom protein loop prediction</span></div><div class="casAuthors">Jacobson, Matthew P.; Pincus, David L.; Rapp, Chaya S.; Day, Tyler J. F.; Honig, Barry; Shaw, David E.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">351-367</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The application of all-atom force fields (and explicit or implicit solvent models) to protein homol.-modeling tasks such as side-chain and loop prediction remains challenging both because of the expense of the individual energy calcns. and because of the difficulty of sampling the rugged all-atom energy surface.  Here the authors address this challenge for the problem of loop prediction through the development of numerous new algorithms, with an emphasis on multiscale and hierarchical techniques.  As a first step in evaluating the performance of the authors' loop prediction algorithm, the authors have applied it to the problem of reconstructing loops in native structures; the authors also explicitly include crystal packing to provide a fair comparison with crystal structures.  In brief, large nos. of loops are generated by using a dihedral angle-based buildup procedure followed by iterative cycles of clustering, side-chain optimization, and complete energy minimization of selected loop structures.  The authors evaluate this method by the largest test set yet used for validation of a loop prediction method, with a total of 833 loops ranging from 4 to 12 residues in length.  Av./median backbone root-mean-square deviations (RMSDs) to the native structures (superimposing the body of the protein, not the loop itself) are 0.42/0.24 Å for 5 residue loops, 1.00/0.44 Å for 8 residue loops, and 2.47/1.83 Å for 11 residue loops.  Median RMSDs are substantially lower than the avs. because of a small no. of outliers; the causes of these failures are examd. in some detail, and many can be attributed to errors in assignment of protonation states of titratable residues, omission of ligands from the simulation, and, in a few cases, probable errors in the exptl. detd. structures.  When these obvious problems in the data sets are filtered out, av. RMSDs to the native structures improve to 0.43 Å for 5 residue loops, 0.84 Å for 8 residue loops, and 1.63 Å for 11 residue loops.  In the vast majority of cases, the method locates energy min. that are lower than or equal to that of the minimized native loop, thus indicating that sampling rarely limits prediction accuracy.  The overall results are, to the authors' knowledge, the best reported to date, and the authors attribute this success to the combination of an accurate all-atom energy function, efficient methods for loop buildup and side-chain optimization, and, esp. for the longer loops, the hierarchical refinement protocol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHqYMnqaWXvLVg90H21EOLACvtfcHk0ljTojBa7WR6gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFKhsrc%253D&md5=e0eff655eeefb30ea00ae041ea9099c8</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2Fprot.10613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.10613%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DPincus%26aufirst%3DD.%2BL.%26aulast%3DRapp%26aufirst%3DC.%2BS.%26aulast%3DDay%26aufirst%3DT.%2BJ.%2BF.%26aulast%3DHonig%26aufirst%3DB.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DA%2520Hierarchical%2520Approach%2520to%2520All-Atom%2520Protein%2520Loop%2520Prediction%26jtitle%3DProteins%26date%3D2004%26volume%3D55%26spage%3D351%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Gaulton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellis, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bento, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Light, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGlinchey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalovich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Lazikani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J. P.</span><span> </span><span class="NLM_article-title">ChEMBL: A Large-Scale Bioactivity Database for Drug Discovery</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">D1100</span><span class="NLM_x">–</span> <span class="NLM_lpage">1107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1093%2Fnar%2Fgkr777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=21948594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs12htbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=D1100-1107&author=A.+Gaultonauthor=L.+J.+Bellisauthor=A.+P.+Bentoauthor=J.+Chambersauthor=M.+Daviesauthor=A.+Herseyauthor=Y.+Lightauthor=S.+McGlincheyauthor=D.+Michalovichauthor=B.+Al-Lazikaniauthor=J.+P.+Overington&title=ChEMBL%3A+A+Large-Scale+Bioactivity+Database+for+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">ChEMBL: a large-scale bioactivity database for drug discovery</span></div><div class="casAuthors">Gaulton, Anna; Bellis, Louisa J.; Bento, A. Patricia; Chambers, Jon; Davies, Mark; Hersey, Anne; Light, Yvonne; McGlinchey, Shaun; Michalovich, David; Al-Lazikani, Bissan; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D1100-D1107</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">ChEMBL is an Open Data database contg. binding, functional and ADMET information for a large no. of drug-like bioactive compds.  These data are manually abstracted from the primary published literature on a regular basis, then further curated and standardized to maximize their quality and utility across a wide range of chem. biol. and drug-discovery research problems.  Currently, the database contains 5.4 million bioactivity measurements for more than 1 million compds. and 5200 protein targets.  Access is available through a web-based interface, data downloads and web services at: https://www.ebi.ac.uk/chembldb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9e9jRENTtubVg90H21EOLACvtfcHk0ljTojBa7WR6gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs12htbjN&md5=aedf7793e1ca54b6a4fa272ea3ef7d0e</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkr777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkr777%26sid%3Dliteratum%253Aachs%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DBellis%26aufirst%3DL.%2BJ.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DChambers%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DM.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DLight%26aufirst%3DY.%26aulast%3DMcGlinchey%26aufirst%3DS.%26aulast%3DMichalovich%26aufirst%3DD.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DChEMBL%253A%2520A%2520Large-Scale%2520Bioactivity%2520Database%2520for%2520Drug%2520Discovery%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2012%26volume%3D40%26spage%3DD1100%26epage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Allen, F. H.</span><span> </span><span class="NLM_article-title">The Cambridge Structural Database: A Quarter of a Million Crystal Structures and Rising</span> <span class="citation_source-journal">Acta Crystallogr., Sect. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1107%2FS0108768102003890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=12037359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADC%252BD38XktVOqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=380-388&author=F.+H.+Allen&title=The+Cambridge+Structural+Database%3A+A+Quarter+of+a+Million+Crystal+Structures+and+Rising"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">The Cambridge Structural Database: a quarter of a million crystal structures and rising</span></div><div class="casAuthors">Allen, Frank H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section B: Structural Science</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">B58</span>
        (<span class="NLM_cas:issue">3, No. 1</span>),
    <span class="NLM_cas:pages">380-388</span>CODEN:
                <span class="NLM_cas:coden">ASBSDK</span>;
        ISSN:<span class="NLM_cas:issn">0108-7681</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">The Cambridge Structural Database (CSD) now contains data for more than a quarter of a million small-mol. crystal structures.  The information content of the CSD, together with methods for data acquisition, processing and validation, are summarized, with particular emphasis on the chem. information added by CSD editors.  Nearly 80% of new structural data arrives electronically, mostly in CIF format, and the CCDC acts as the official crystal structure data depository for 51 major journals.  The CCDC now maintains both a CIF archive (more than 73000 CIFs dating from 1996), as well as the distributed binary CSD archive; the availability of data in both archives is discussed.  A statistical survey of the CSD is also presented and projections concerning future accession rates indicate that the CSD will contain at least 500000 crystal structures by the year 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Uk3GetkiibVg90H21EOLACvtfcHk0ljTojBa7WR6gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktVOqu74%253D&md5=406cd0df6ea9035a0ebf8dd9eccbd1f8</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1107%2FS0108768102003890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108768102003890%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DF.%2BH.%26atitle%3DThe%2520Cambridge%2520Structural%2520Database%253A%2520A%2520Quarter%2520of%2520a%2520Million%2520Crystal%2520Structures%2520and%2520Rising%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520B%26date%3D2002%26volume%3D58%26spage%3D380%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Strader, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigal, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candelore, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rands, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, R. A.</span><span> </span><span class="NLM_article-title">Conserved Aspartic Acid Residues 79 and 113 of the Beta-Adrenergic Receptor Have Different Roles in Receptor Function</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x">, </span> <span class="NLM_fpage">10267</span><span class="NLM_x">–</span> <span class="NLM_lpage">10271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1988&pages=10267-10271&author=C.+D.+Straderauthor=I.+S.+Sigalauthor=M.+R.+Candeloreauthor=E.+Randsauthor=W.+S.+Hillauthor=R.+A.+Dixon&title=Conserved+Aspartic+Acid+Residues+79+and+113+of+the+Beta-Adrenergic+Receptor+Have+Different+Roles+in+Receptor+Function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStrader%26aufirst%3DC.%2BD.%26aulast%3DSigal%26aufirst%3DI.%2BS.%26aulast%3DCandelore%26aufirst%3DM.%2BR.%26aulast%3DRands%26aufirst%3DE.%26aulast%3DHill%26aufirst%3DW.%2BS.%26aulast%3DDixon%26aufirst%3DR.%2BA.%26atitle%3DConserved%2520Aspartic%2520Acid%2520Residues%252079%2520and%2520113%2520of%2520the%2520Beta-Adrenergic%2520Receptor%2520Have%2520Different%2520Roles%2520in%2520Receptor%2520Function%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1988%26volume%3D263%26spage%3D10267%26epage%3D10271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Andiné, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widermark, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axelsson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olofsson, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mårtensson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandberg, M.</span><span> </span><span class="NLM_article-title">Characterization of MK-801-Induced Behavior as a Putative Rat Model of Psychosis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">1393</span><span class="NLM_x">–</span> <span class="NLM_lpage">1408</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=10454519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADyaK1MXlsVOqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=1999&pages=1393-1408&author=P.+Andin%C3%A9author=N.+Widermarkauthor=R.+Axelssonauthor=G.+Nybergauthor=U.+Olofssonauthor=E.+M%C3%A5rtenssonauthor=M.+Sandberg&title=Characterization+of+MK-801-Induced+Behavior+as+a+Putative+Rat+Model+of+Psychosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of MK-801-induced behavior as a putative rat model of psychosis</span></div><div class="casAuthors">Andine, Peter; Widermark, Nina; Axelsson, Rolf; Nyberg, Gosta; Olofsson, Ulla; Martensson, Erik; Sandberg, Mats</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1393-1408</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The objective of this study was to characterize the behavior induced by the N-methyl-D-aspartate receptor antagonist MK-801 (dizocilpine maleate) in rats as a model of psychosis.  The temporal profile, dose dependence, age, and sex differences of the behavior are described.  A gas chromatog. method for the anal. of MK-801 in plasma and brain was developed.  Female rats showed 4 to 10 times more MK-801-induced behavior and displayed around 25 times higher serum and brain concns. of MK-801 than male rats.  Twenty-one neuroactive compds., including a no. of excitatory amino acid-active substances, were tested for the effect on MK-801-induced behavior.  Neuroleptics blocked MK-801-induced behavior in a dose-dependent manner that correlated to their antipsychotic potency in humans.  Adenosine receptor agonists and an N-methyl-D-aspartate receptor-assocd. glycine site antagonist showed putative antipsychotic effects.  In conclusion, MK-801-induced behavior represents a rat excitatory amino acid hypofunction model of psychosis that appears to be of clin. relevance and may be of value in the search for new antipsychotic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAjgP7sdQKXrVg90H21EOLACvtfcHk0lgOZKZ0Kdw5Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlsVOqtLs%253D&md5=2a131b0078312ed59679b0327a30bc6c</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndin%25C3%25A9%26aufirst%3DP.%26aulast%3DWidermark%26aufirst%3DN.%26aulast%3DAxelsson%26aufirst%3DR.%26aulast%3DNyberg%26aufirst%3DG.%26aulast%3DOlofsson%26aufirst%3DU.%26aulast%3DM%25C3%25A5rtensson%26aufirst%3DE.%26aulast%3DSandberg%26aufirst%3DM.%26atitle%3DCharacterization%2520of%2520MK-801-Induced%2520Behavior%2520as%2520a%2520Putative%2520Rat%2520Model%2520of%2520Psychosis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D290%26spage%3D1393%26epage%3D1408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Schreiber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audinot, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veiga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millan, M. J.</span><span> </span><span class="NLM_article-title">(1-(2,5-Dimethoxy-4 iodophenyl)-2-aminopropane)-Induced Head- Twitches in the Rat Are Mediated by 5-Hydroxytryptamine (5-HT) 2A Receptors: Modulation by Novel 5-HT2A/2C Antagonists, D1 Antagonists and 5-HT1A Agonists</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=7714755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADyaK2MXltVGlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1995&pages=101-112&author=R.+Schreiberauthor=M.+Broccoauthor=V.+Audinotauthor=A.+Gobertauthor=S.+Veigaauthor=M.+J.+Millan&title=%281-%282%2C5-Dimethoxy-4+iodophenyl%29-2-aminopropane%29-Induced+Head-+Twitches+in+the+Rat+Are+Mediated+by+5-Hydroxytryptamine+%285-HT%29+2A+Receptors%3A+Modulation+by+Novel+5-HT2A%2F2C+Antagonists%2C+D1+Antagonists+and+5-HT1A+Agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">(1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT)2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists</span></div><div class="casAuthors">Schreiber, Rudy; Brocco, Mauricette; Audinot, Valerie; Gobert, Alain; Veiga, Sylvie; Millan, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-12</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">In this study, the involvement of serotonergic and dopaminergic receptors in the modulation of the head-twitch (HTW) response to the 5-hydroxytryptamine (5-HT)2A/5-HT2C agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, was characterized in rats using novel and selective ligands at 5-HT2A, 5-HT2C, D1, D2 and 5-HT1A receptors.  HTW were dose-dependently inhibited by the 5-HT2A/2C antagonists, ritanserin, metergoline, mesulergine, mianserin, ICI 169,369 and LY 58,537, by the preferential 5-HT2A antagonist, ketanserin and by the novel, selective 5-HT2A antagonist, SR 46349B.  A further selective 5-HT2A antagonist, MDL 100,907, very potently abolished HTW (ED50 = 0.005 mg/kg).  The order of relative potency correlated highly with their affinity at 5-HT1A (r = 0.83) but not 5-HT2C receptors (r = 0.06).  In addn., the novel, selective 5-HT2C antagonist, SB 200,646A, failed to abolish HTW and the 5-HT2C agonists/5-HT2A antagonists, 1-(3-chlorophenyl)piperazine and 1-(3-trifluoromethylphenyl)piperazine, blocked, rather than elicited, HTW.  The D1 antagonists, SCH 23390, NNC 112, NNC 756, SCH 39166 and A 69024, in this order of relative potency that correlated with their affinity at D1 receptors (r = 0.98), blocked HTW.  The D2 antagonists, raclopride, eticlopride and haloperidol also blocked HTW.  The 5-HT1A agonists, S 14671, S 14506, 8-hydroxy-2-(di-n-propylamino)tetralin, buspirone, ipsapirone and (+)-flesinoxan, abolished HTW.  The action of 8-hydroxy-2-(di-n-propylamino)tetralin was blocked by (-)-tertatolol (ID50 = 4.5 mg/kg), a novel 5-HT1A receptor antagonist.  Similarly, (-)-tertatolol attenuated the action of S 14506 and abolished that of S 14671, buspirone and ipsapirone.  A role of postsynaptic 5-HT1A receptors in the action of 5-HT1A agonists was suggested by the finding that p-chlorophenylalanine (3×300 mg/kg, i.p.), which depleted cerebral pools of 5-HT, did not modify the activity of ipsapirone.  The present data demonstrate that 5-HT2A receptors mediate HTW in rats and that both D1 and D2 receptors as well as (postsynaptic) 5-HT1A receptors play a role in their expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol-OqOe5qq7rVg90H21EOLACvtfcHk0lgOZKZ0Kdw5Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXltVGlt7s%253D&md5=83ea96a14372dd4ab2834f0197daa1c8</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiber%26aufirst%3DR.%26aulast%3DBrocco%26aufirst%3DM.%26aulast%3DAudinot%26aufirst%3DV.%26aulast%3DGobert%26aufirst%3DA.%26aulast%3DVeiga%26aufirst%3DS.%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26atitle%3D%25281-%25282%252C5-Dimethoxy-4%2520iodophenyl%2529-2-aminopropane%2529-Induced%2520Head-%2520Twitches%2520in%2520the%2520Rat%2520Are%2520Mediated%2520by%25205-Hydroxytryptamine%2520%25285-HT%2529%25202A%2520Receptors%253A%2520Modulation%2520by%2520Novel%25205-HT2A%252F2C%2520Antagonists%252C%2520D1%2520Antagonists%2520and%25205-HT1A%2520Agonists%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1995%26volume%3D273%26spage%3D101%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Porsolt, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blavet, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalfre, M.</span><span> </span><span class="NLM_article-title">Behavioral Despair in Rats: A New Model Sensitive to Antidepressant Treatments</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm401895u&amp;key=10.1016%2F0014-2999%2878%2990118-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm401895u&amp;key=204499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm401895u&amp;key=1%3ACAS%3A528%3ADyaE1cXhvVagsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1978&pages=379-391&author=R.+D.+Porsoltauthor=G.+Antonauthor=N.+Blavetauthor=M.+Jalfre&title=Behavioral+Despair+in+Rats%3A+A+New+Model+Sensitive+to+Antidepressant+Treatments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral despair in rats:  a new model sensitive to antidepressant treatments</span></div><div class="casAuthors">Porsolt, Roger D.; Anton, Guy; Blavet, Nadine; Jalfre, Maurice</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">379-91</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Rats when forced to swim in a cylinder from which they cannot escape will, after an initial period of vigorous activity, adopt a characteristic immobile posture which can be readily identified.  Immobility was decreased by various clin. effective antidepressant drugs at doses which otherwise decreased spontaneous motor activity in an open field.  Antidepressants could thus be distinguished from psychostimulants which decreased immobility at doses which increased general activity.  Anxiolytic compds. did not affect immobility, whereas major tranquilizers enhanced it.  Thus, immobility reflects a state of lowered mood in the rat which is selectively sensitive to antidepressant treatments.  Pos. findings with atypical antidepressant drugs such as iprindole and mianserin suggest that the method may be capable of discovering new antidepressants hitherto undetectable with classical pharmacol. tests.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0oUdFHAF1sLVg90H21EOLACvtfcHk0lgOZKZ0Kdw5Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhvVagsr0%253D&md5=293e1fe8766c76315e86bc375c810a58</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2878%2990118-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252878%252990118-8%26sid%3Dliteratum%253Aachs%26aulast%3DPorsolt%26aufirst%3DR.%2BD.%26aulast%3DAnton%26aufirst%3DG.%26aulast%3DBlavet%26aufirst%3DN.%26aulast%3DJalfre%26aufirst%3DM.%26atitle%3DBehavioral%2520Despair%2520in%2520Rats%253A%2520A%2520New%2520Model%2520Sensitive%2520to%2520Antidepressant%2520Treatments%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1978%26volume%3D47%26spage%3D379%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Ogren, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Köhler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjöstrand, S. E.</span><span> </span><span class="NLM_article-title">The Selective Dopamine D2 Receptor Antagonist Raclopride Discriminates between Dopamine-Mediated Motor Functions</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1986&pages=287-294&author=S.+O.+Ogrenauthor=H.+Hallauthor=C.+K%C3%B6hlerauthor=O.+Magnussonauthor=S.+E.+Sj%C3%B6strand&title=The+Selective+Dopamine+D2+Receptor+Antagonist+Raclopride+Discriminates+between+Dopamine-Mediated+Motor+Functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOgren%26aufirst%3DS.%2BO.%26aulast%3DHall%26aufirst%3DH.%26aulast%3DK%25C3%25B6hler%26aufirst%3DC.%26aulast%3DMagnusson%26aufirst%3DO.%26aulast%3DSj%25C3%25B6strand%26aufirst%3DS.%2BE.%26atitle%3DThe%2520Selective%2520Dopamine%2520D2%2520Receptor%2520Antagonist%2520Raclopride%2520Discriminates%2520between%2520Dopamine-Mediated%2520Motor%2520Functions%26jtitle%3DPsychopharmacology%26date%3D1986%26volume%3D90%26spage%3D287%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RH1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RH1','PDB','2RH1'); return false;">PDB: 2RH1</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i42"><a href="/doi/suppl/10.1021/jm401895u">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_55682"></div></div></div></div></div><hr /></hr><p class="last">Additional binding site and ligand binding mode descriptions, extended chemical information and compound characterization, and detailed purity data for all compounds. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401895u/suppl_file/jm401895u_si_001.pdf">jm401895u_si_001.pdf (1.14 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401895u&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm401895u%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-11" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401895u" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                9MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992e13ba213c5e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
